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Biotechnology is the scientific field of studying and applying the most efficient 
methods and techniques to get useful end-products for the human society by using 
viable micro-organisms, cells, and tissues of plants or animals, or even certain 
functional components of their organisms, that are grown in fully controlled 
conditions to maximize their specific metabolism inside fully automatic bioreactors. 
It is very important to make the specific difference between biotechnology as a 
distinct science of getting valuable products from molecules, cells or tissues of 
viable organisms, and any other applications of bioprocesses that are based on 
using the whole living plants or animals in different fields of human activities such 
as bioremediation, environmental protection, organic agriculture, or industrial 
exploitation of natural resources. The volume Advances in Applied Biotechnology is a 
scientific book containing recent advances of selected research works that are ongoing 
in certain biotechnological applications. Fourteen chapters divided in four sections 
related to the newest biotechnological achievements in environmental protection, 
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Preface 
According to the most accurate definition, biotechnology is the scientific field of 
studying and applying the most efficient methods and techniques to get useful end-
products for the human society by using viable micro-organisms, cells and tissues of 
plants or animals, or even certain functional components of their organisms that are 
grown in fully controlled conditions, to maximize their specific metabolism inside 
fully automatic bioreactors.  
Any other definition that does not emphasize the molecular, cellular, or tissue level of 
living organisms that are used in biotechnological applications through their selected 
cultures as well as the controlled micro-environment for their growing and 
development is not appropriate at all.  
It is very important to make the specific difference between biotechnology as a distinct 
science of getting valuable products from molecules, cells, or tissues of viable 
organisms, and any other applications of bioprocesses that are based on using the 
whole living plants or animals in different fields of human activities such as 
bioremediation, environmental protection, organic agriculture, or industrial 
exploitation of natural resources. 
This volume having the title ADVANCES IN APPLIED BIOTECHNOLOGY is a 
scientific book containing recent advances of selected research works that are ongoing 
in certain biotechnological applications. Fourteen chapters divided in four sections 
related to the newest biotechnological achievements in environmental protection, 
medicine and health care, biopharmaceutical producing, molecular genetics, and 
tissue engineering are presented in this book. 
The first part refers to environmental biotechnology and includes two chapters 
regarding total recycling of agricultural and food wastes through the biodegradation 
and bioconversion processes that are performed by selected microbial species in 
controlled cultivation systems. The next chapter is dedicated to the biotechnology of 
biopolymer producing by saving energy comparing with the conventional chemical 
processes. The last two chapters of this first part are dedicated to food quality safety 
and preservation through the biosynthesized anti-bacterial compounds, and by 
keeping the phenols as functional molecules in foods. 
XII Preface
In the second part, all chapters refer to the latest advances in microbial biotechnology 
to be used in recombinant protein production as well as heterologous protein 
biosynthesis. 
The chapters included in the third section are focused on recent achievements in 
molecular biotechnology and genetic engineering.   
In the final section, the chapters emphasize the main scientific results that were 
accomplished in tissue engineering as an important biotechnological tool in medicine 
and health care. 
Additionally, I would like to thank each one of the chapter authors for their 
tremendous work to present the most valuable achievements in their specific activity 
fields, and I really hope the readers will appreciate the high scientific content of any 
chapter included in this book. 
My special thanks are directed to Mr. Aleksandar Lazinica for his great kindness to 
invite me, after a rigorous selection process, to bring my scientific contribution to the 
publishing of this outstanding volume both as book editor and chapter author. 
Last but not least, I would like to thank the whole staff of InTech Open Access 
Publishing, especially Ms Alenka Urbancic and Mr Igor Babic, for their professional 
assistance and technical support during the whole book processing. 
Prof Marian Petre 
 University of Pitesti 
Romania 
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Biotechnology of Agricultural  
Wastes Recycling Through Controlled 
Cultivation of Mushrooms 
Marian Petre and Alexandru Teodorescu 
Department of Natural Sciences,  
Faculty of Sciences, University of Pitesti, 
Romania 
1. Introduction 
The agricultural wastes recycling with applications in agro-food industry is one of the 
biological challenging and technically demanding research in the biotechnology domain 
known to humankind so far. Annually, the accumulation of huge amounts of vineyard and 
winery wastes causes serious environmental damages nearby winemaking factories. Many 
of these ligno-cellulose wastes cause serious environmental pollution effects, if they are 
allowed to accumulate in the vineyards or much worse to be burned on the soil. At the same 
time, the cereal by-products coming from the cereal processing and bakery industry are 
produced in significant quantities all over the world (Moser, 1994; Verstraete & Top, 1992).  
To solve the environmental troubles raised by the accumulation of these organic wastes, the 
most efficient way is to recycle them through biological means (Smith, 1998). As a result of 
other recent studies, the cultivation of edible and medicinal mushrooms was applied using 
both the solid state cultivation and controlled submerged fermentation of different natural 
by-products of agro-food industry that provided a fast growth as well as high biomass 
productivity of the investigated strains (Petre& Teodorescu, 2009; Stamets, 2000). 
These plant wastes can be used as the main ingredients to prepare the organic composts for 
edible and medicinal mushrooms growing in order to get organic food and biological active 
compounds from the nutritive fungal biomass resulted after solid state cultivation or 
submerged fermentation of such natural materials (Petre & Petre, 2008; Petre et al., 2010).  
Taking into consideration this biological advantage there were tested some variants of 
biotechnology for agricultural wastes recycling through the controlled cultivation of edible 
and medicinal mushrooms Ganoderma lucidum (Curt.:Fr.) P. Karst (folk name: Reishi or Ling-
zhi), Lentinus edodes (Berkeley) Pegler (folk name: Shiitake) and Pleurotus ostreatus (Jacquin 
ex Fries) Kummer (folk name: Oyster Mushroom) on organic composts made of cereal grain 
by-products as well as winery and vineyard wastes (Petre & Teodorescu, 2010).  
2. The solid state cultivation of mushrooms on winery and vineyard wastes 
The main aim of this work was focused on screening the optimal biotechnology of edible 
and medicinal mushrooms growing through the solid-state cultivation by recycling different 
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kind of agricultural by-products and wastes coming from vineyard farms and winemaking 
industry (Petre et al., 2011).  
Taking into consideration that most of the edible and medicinal mushrooms species requires 
a specific micro-environment including complex nutrients, the influence of all physical and 
chemical factors upon fungal pellets production and mushroom fruit bodies formation has 
been studied by testing new biotechnological procedures (Oei, 2003).  
To establish the laboratory biotechnology of recycling the winery and vineyard wastes by 
using them as a growing source for edible mushrooms, two mushroom species of 
Basidiomycetes group, namely L. edodes (Berkeley) Pegler and P. ostreatus (Jacquin ex Fries) 
Kummer were used as pure mushroom cultures isolated from the natural environment and 
being preserved in the local collection of the University of Pitesti. The stock cultures were 
maintained on malt-extract agar (MEA) slants (20% malt extract, 2% yeast extract, 20% agar-
agar). Slants were incubated at 25°C for 120-168 h and stored at 4°C.  
The pure mushroom cultures were expanded by growing in 250-ml flasks containing 100 ml 
of liquid malt-extract medium at 23°C on rotary shaker incubators at 110 rev min -1 for 72-
120 h. After expanding, the pure mushroom cultures were inoculated into 100 ml of 3-5% 
(v/v) malt-yeast extract liquid medium, previously poured in 250 ml rotary shake flasks and 
then were maintained at 23-25°C (Petre & Teodorescu, 2010). 
The experiments of inoculum preparation were set up under the following conditions: 
constant temperature, 25°C; agitation speed, 90-120 rev min-1; initial pH, 5.5–6.5. All the seed 
mushroom cultures were incubated for 120–168 h.  
After that, the seed cultures of these mushroom species were inoculated in liquid culture 
media (20% malt extract, 10% wheat bran, 3% yeast extract, 1% peptone) at pH 6.5 
previously distributed into rotary shake flasks of 1,000 ml. During the incubation time, all 
the spawn cultures were maintained in special culture rooms, designed for optimal 
incubation at 25°C. Three variants of culture compost were prepared from marc of grapes 
and vineyard cuttings in the following ratios: 1:1, 1:2, 1:4 (w/w).  
The winery and vineyard wastes were mechanically pre-treated by using an electric 
grinding device to breakdown the lignin and cellulose structures in order to make them 
more susceptible to the enzyme actions. All the culture compost variants made of winery 
and vineyard wastes were transferred into 1,000 ml glass jars and disinfected by steam 
sterilization at 120°C for 60 min. When the jars filled with composts were chilled they were 
inoculated with the liquid spawn already prepared (Petre et al., 2010).  
Each culture compost variant for mushroom growing was inoculated using such liquid 
spawn having the age of 72–220 h and the volume size ranging between 3–9% (v/w). During 
the period of time of 18–20 d after this inoculation, the mushroom cultures had developed a 
significant mycelia biomass on the culture substrates (Carlile & Watkinson, 1996).  
According to the registered results of the performed experiments the optimal laboratory-
scale biotechnology for edible mushroom cultivation on composts made of marc of grapes 
and vineyard cuttings was established (Fig. 1).  
The effects induced by the composts composition, nitrogen and mineral sources as well as 
the inoculum amount upon the mycelia growing during the incubation period were 
investigated. There were made three variants of composts which were tested by comparing 
them with the control sample made of poplar sawdust (Petre & Teodorescu, 2010).  
 






Fig. 1. Scheme of laboratory-scale biotechnology for edible mushroom production by 
recycling winery and vineyard wastes 
The first variant of compost composition was prepared from vineyard cuttings, the second 
one from a mixture between marc of grapes and vineyard cuttings in equal proportions and 
the third one was made only from marc of grapes as full compost variant. The experiments 
were carried out for 288 h at 25°C with the initial pH 6.5 and the incubation period lasted for 
168-288 h (Petre et al., 2007). 
2.1 Results and discussion 
As it can be noticed in figure 2, the registered results show that from all tested compost 
variants the most suitable substrate for mycelia growing was that one prepared from marc 
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of grapes, because it showed the highest influence upon the mycelia growing and fresh 
























































Fig. 2. Comparative effects of composts composition upon mycelia growing of P. ostreatus 
(P.o.) and L. edodes (L.e.) 
This compost variant was followed by the mixture prepared from marc of grapes and 
vineyard cuttings in equal amounts (20-23 g %) and, finally, by the variant made of only 
vineyard cuttings (12-15 g %). From the tested nitrogen sources, barley bran was the most 
efficient upon the mycelia growing and fruit mushroom producing at 35-40 g % fresh 
fungal biomass weight, being closely followed by rice bran at 25–30 g %. Wheat bran is 
also a well known nitrogen source for fungal biomass synthesis but its efficiency in these 
experiments was relatively lower than the ones induced by the barley and rice bran added 
as natural organic nitrogen sources (Stamets, 2000). All registered data are the means of 
triple determinations. The effects of nitrogen sources were registered as they are 
presented in figure 3. Among the tested mineral sources, the natural calcium carbonate 
(CaCO3) from marine shells yielded the best mycelia growing as well as fungal biomass 
production at 28-32 g% and, for this reason, it was registered as the most appropriate 
mineral source, being followed by the natural gypsum (CaSO4 · 2 H2O) at 20-23 g %, as it 
is shown in figure 4.  
 




























































Fig. 3. Comparative effects of organic nitrogen sources upon mycelia growing of P. ostreatus 






















































Fig. 4. Comparative effects of mineral sources upon mycelia growing of P. ostreatus (P. o.) 
and L. edodes (L.e.) 
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Fig. 3. Comparative effects of organic nitrogen sources upon mycelia growing of P. ostreatus 






















































Fig. 4. Comparative effects of mineral sources upon mycelia growing of P. ostreatus (P. o.) 
and L. edodes (L.e.) 
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The mineral sources like hepta-hydrate magnesium sulfate (MgSO4 · 7 H2O) showed a quite 
moderate influence upon the fungal biomass growing as other researchers have already 
reported so far. All data are the means of triple determinations (Stamets, 2000; Chahal, 1994). 
The whole period of mushroom growing from the inoculation to the fruit body formation 
lasted between 25-30 d in case of P. ostreatus cultivating and 50-60 d for L. edodes, depending 
on each fungal species used in experiments (Chahal, 1994). However, during the whole 
period of fruit body formation, the culture parameters were set up and maintained at the 
following levels, depending on each mushroom species: air temperature, 15–17oC; the air 
flow volume, 5–6m3/h; air flow speed, 0.2–0.3 m/s; the relative moisture content, 80–85%, 
light intensity, 500–1,000 luces for 8–10 h/d. The final fruit body production of these 
mushroom species used in experiments was registered between 1.5 kg for L .edodes and 2.8 
kg for P. ostreatus, relative to 10 kg of composts made of vineyard and winery wastes, 
comparing with 0.7-1.2 kg on 10 kg of poplar sawdust used as control samples. 
3. The controlled submerged cultivation of mushrooms on winery wastes 
The submerged cultivation of mushroom mycelium is a promising biotechnological 
procedure which can be used for synthesis of pharmaceutical substances with anticancer, 
antiviral and immuno-stimulatory effects from the nutritive mushroom biomass (Wasser & 
Weis, 1994). As result of other recent studies, the continuous cultivation of edible and 
medicinal mushrooms was applied by using the submerged fermentation of different 
natural by-products of agro-food industry (Bae, et al., 2000; Jones, 1995; Moo-Joung, 1993). 
The biotechnology of controlled cultivation of medicinal mushrooms was established and 
tested in different variants of culture media that were made of different sorts of bran and 
broken seeds resulted from the industrial food processing of wheat, barley and rye seeds. 
This biotechnology can influence the faster growth as well as higher biomass productivity of 
G. lucidum and L. edodes mushroom species (Petre et al., 2010).  
The main stages of biotechnology to get high nutritive fungal biomass by controlled 
submerged fermentation were the followings:  
1. Preparation of culture media and pouring them into the cultivation vessel of the 
bioreactor.  
2. Steam sterilization of bioreactor vessel at 121°C and 1.1 atm. for 20 min. 
3. Inoculation of sterilized culture media with mycelium from pure cultures of selected 
strains inside the bioreactor vessel for submerged cultivation, using the sterile air hood 
with laminar flow. 
4. Running the submerged cultivation cycles under controlled conditions: temperature 23 
± 2°C, speed 70 rpm and continuous aeration at 1.1 atm. 
5. Collecting, cleaning and filtering the fungal pellets obtained by the submerged 
fermentation of substrates made of by-products resulted from cereal grains processing. 
Two mushroom species belonging to Basidiomycetes Class, namely G. lucidum (Curt.:Fr.) P. 
Karst  and L. edodes (Berkeley) Pegler were used as pure cultures in experiments. The stock 
cultures were maintained on malt-extract agar (MEA) slants. Slants were incubated at 25°C 
for 5-7 d and then stored at 4°C. The fungal cultures were grown in 250-ml flasks containing 
100 ml of MEYE (malt extract 20%, yeast extract 2%) medium at 23°C on rotary shaker 
incubators at 110 rev min-1 for 5-7 d. The fungal cultures were prepared by aseptically 
inoculating 100 ml in three variants of culture media by using 3-5% (v/v) of the seed culture 
and then cultivated at 23-25°C in 250 ml rotary shake flasks. The biotechnological 
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experiments were conducted under the following conditions: temperature, 25°C; agitation 
speed, 120-180 rev min-1; initial pH, 4.5–5.5. After 10–12 d of incubation the fungal cultures 
were ready to be inoculated aseptically into the glass vessel of 20 l laboratory-scale 
bioreactor, that was designed to be used for controlled submerged cultivation of edible and 
medicinal mushrooms on substrata made of wastes resulted from the industrial processing 
of cereal grains (Fig. 5).  
 
Fig. 5. General view of the Laboratory scale bioreactor (15 L) 
After a period of submerged fermentation lasting up to 120 h, small mushroom pellets 
developed inside the nutritive broth (Fig. 6, 7).  
 
Fig. 6. Mycelial biomass of G. lucidum collected after submerged fermentation 
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Fig. 7. Mycelial biomass in the shape of fungal pellets of L. edodes, collected after submerged 
fermentation 
The fermentation process was carried out by inoculating the growing medium volume 
(10,000 ml) with mycelia inside the culture vessel of the laboratory-scale bioreactor. The 
whole process of growing lasts for a single cycle between 5-7 days in case of L. edodes and 
between 3 to 5 days for G. lucidum. The strains of these fungal species were characterized by 
morphological and cultural stability, proven by their ability to maintain the phenotypic and 
taxonomic identities. The experiments were carried out in three repetitions. Observations on 
morphological and physiological characters of these two tested species of fungi were made 
after each culture cycle, highlighting the following aspects:  
- sphere-shaped structure of fungal pellets, sometimes elongated, irregular, with various 
sizes (from 2 to 5 mm in diameter), reddish-brown colour – G. lucidum culture (Fig. 8). 
 
Fig. 8. Stereomicroscopic view of G. lucidum pellets after controlled submerged fermentation     
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- elliptically-shaped structures of fungal pellets, with irregular diameters of 4 up to 7 mm 
showing mycelia congestion, which developed specific hyphae of L. edodes (Fig. 9). 
 
Fig. 9. Stereomicroscopic view of L. edodes pellets after controlled submerged fermentation     
Samples for analysis were collected at the end of the fermentation process, when pellets 
formed specific shapes and characteristic sizes. The fungal biomass was washed repeatedly 
with double distilled water in a sieve with 2 mm diameter eye, to remove the remained bran 
in each culture medium.  
3.1 Results and discussion 
Biochemical analyses of fungal biomass samples obtained by submerged cultivation of 
mushrooms were carried out separately for the solid fraction and liquid medium remained 
after the separation of fungal biomass by filtering. The percentage distribution of solid 
substrate and liquid fraction in the samples of fungal biomass are shown in table 1. 
 
Mushroom species 
Total volume of  
separated liquid per 
sample (ml) 
Total biomass weight 
per sample (g) 
Water content after 
separation (%) 
L. edodes 83 5.81 83.35 
L. edodes 105 7.83 82.50 
L. edodes 95 7.75 82.15 
L. edodes 80 5.70 79.55 
G. lucidum 75 7.95 83.70 
G. lucidum 115 6.70 82.95 
G. lucidum 97 5.45 80.75 
G. lucidum 110 6.30 77.70 
Table 1. Percentage distribution of solid substrate and liquid fraction in the preliminary 
samples of fungal biomass 
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In each experimental variant the amount of fresh biomass mycelia was determined. The 
percentage amount of dry biomass was determined by dehydration at 70°C, up to constant 
weight. Total protein content was determined by biuret method, whose principle is similar 
to the Lowry method, this method being recommended for the protein content ranging from 
0.5 to 20 mg/100 mg sample. In addition, this method required only one sample incubation 
period (20 min) and by using them was eliminated the interference with various chemical 
agents (ammonium salts, for example).  
The principle method is based on reaction that takes place between copper salts and 
compounds with two or more peptides in the composition in alkali, which results in a red-
purple complex, whose absorbance is read in a spectrophotometer in the visible domain  
(λ - 550 nm). The registered results are presented as the amounts of fresh and dry biomass as 
well as protein contents for each fungal species and variants of culture media (Tables 2, 3).  
 
Culture variants Fresh biomass (g) Dry biomass (%) Total protein (g % d.w.) 
I 20.30 5.23 0.55
II 23.95 6.10 0.53
III 22.27 4.79 0.73
IV 20.10 4.21 0.49
Control 4.7 0.5 0.2
Table 2. Fresh and dry biomass and protein content of L. edodes after submerged 
fermentation 
 
Culture variants Fresh biomass (g) Dry biomass (%) Total protein (g % d.w.) 
I 25.94 9.03 0.67 
II 22.45 10.70 0.55 
III 23.47 9.95 0.73 
IV 21.97 9.15 0.51 
Control 5.9 0.7 0.3 
Table 3. Fresh and dry biomass and protein content of G. lucidum after submerged 
fermentation 
According to the registered data, using wheat bran strains the growth of G. lucidum biomass 
was favoured, while the barley bran led to the increased growth of L. edodes mycelium and 
G. lucidum as well. In contrast, dry matter content was significantly higher when using 
barley bran for both species used. Protein accumulation was more intense in case of using 
barley bran compared with those of wheat and rye, at both species of mushrooms.  
The sugar content of dried mushroom pellets collected at the end of experiments was 
determined by using Dubois method (Wasser & Weis, 1994). The mushroom extracts were 
prepared by immersion of dried pellets inside a solution of NaOH pH 9, in the ratio 1:5.  
All dispersed solutions containing the dried pellets were maintained 24 h at a precise 
temperature of 250C, in full darkness, with continuous homogenization to avoid the 
oxidation reactions. After removal of solid residues by filtration, the samples were analyzed 
by the previous mention method. The nitrogen content of mushroom pellets was analyzed 
by Kjeldahl method (Table 4). 
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(g % d.w.) 
L. edodes I 5.15 6.30 0.55 
L. edodes II 4.93 5.35 0.53 
L. edodes III 4.50 5.70 0.73 
L. edodes IV 4.35 5.75 0.49 
 Control 0.55 0.30 0.2 
G. lucidum I 4.95 5.95 0.67 
G. lucidum II 5.05 6.15 0.55 
G. lucidum III 5.55 6.53 0.73 
G. lucidum IV 4.70 5.05 0.51 
 Control 0.45 0.35 0.3 
Table 4. The sugar, total nitrogen and total protein contents of dried mushroom pellets 
Comparing all registered data resulted from triple determinations, it can be noticed that the 
biochemical correlation between dry weight of mushroom pellets and their sugar and 
nitrogen contents is kept at a balanced ratio for each tested mushrooms (Stamets, 2000).  
Among all mushroom samples that were tested in biotechnological experiments G. lucidum 
G-3 showed the best values of their composition in sugars, total nitrogen and total protein 
contents. In this stage, 70-80% of the former fungal pellets were separated by collecting them 
from the culture vessel of the bioreactor and separating from the broth by slow vacuum 
filtration. On the base of these results, the optimal values of physical and chemical factors 
which influence the mushroom biomass synthesis were taken into consideration in order to 
established the following schematic flow of the biotechnology for mushroom biomass 
producing by submerged fermentation, as it is shown in figure 10. 
The main advantages of the submerged fermentation of winery wastes under the metabolic 
activity of selected mushrooms, by comparison with the solid state cultivation are the 
followings: 
a. the shortening of the biological cycle and cellular development in average from 8-10 
weeks to at mostly one week per cellular culture cycle;  
b. the ensuring of the optimal control of physical and chemical parameters which are 
essential for producing important amounts of mushroom pellets in a very short time;  
c. 20–30% reduction of energy and work expenses as well as the volume of the volume of 
raw materials materials which are manipulated during each culture cycle;  
d. 15-20% increasing of fungal biomass amount per medium volume unit for each 
mushrooms species;  
e. the whole removing of any pollutant sources during the biotechnological flux;  
f. the culture media for mushroom growing are integrally natural without using of 
artificial additives as it is used in classical cultivating procedures;  
g. the mushroom pellets produced by applying this biotechnology for ecological treatment 
of agricultural wastes was 100% made by natural means and will be used for food 
supplements production with therapeutic properties which will contribute to the 
increasing of health level of human consumers having nutritional metabolic deficiencies. 
h. the biochemical correlation between the dry weight of mushroom pellets and their sugar 
and nitrogen contents is kept at a balanced ratio for each tested mushroom species. 
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Fig. 10. Schematic flow of the biotechnology for mushroom biomass producing by 
submerged fermentation. 
4. The controlled cultivation of mushrooms in modular robotic system 
The agricultural works as well as industrial activities related to plant crops and their 
processing have generally been matched by a huge formation of wide range of 
lignocellulose wastes. All these vegetal wastes cause serious environmental troubles if they 
accumulate in the agro-ecosystems or much worse to be burned on the soil. For the human–
operational farms, all processes are made by human personnel exclusively, starting from 
filling of cultivation beds with compost, up to fruit-bodies harvesting (Reed et al., 2001).  
 
Biotechnology of Agricultural Wastes Recycling Through Controlled Cultivation of Mushrooms 
 
15 
In this respect, a strong tendency for increasing the number of researches in the field of 
mushroom’s automated cultivation, harvesting and processing technologies as well as for 
continuously development of new robotic equipments can be noticed (Reed et al., 2001).  
The solid state cultivation of edible and medicinal mushrooms Lentinula edodes and Pleurotus 
ostreatus could be performed by using a modular robotic system that provides the following 
fully automatic operations: sterilization of composts, inoculation in aseptic chamber by 
controlled injection device containing liquid mycelia as inoculum, incubation as well as 
mushroom fruit bodies formation in special growing chambers with controlled atmosphere 
and the picking up of edible and medicinal mushroom fruit bodies (Petre et al., 2009). 
The biotechnology concerning the controlled cultivation of edible mushrooms in continuous 
flow depends on the strictly maintaining of biotic as well as physical and chemical factors 
that could influence the bioprocess evolution. The proceeding of edible mushroom 
cultivation consists in a continuous biotechological flow, having a chain of succesive stages 
that are working in the non-sterile zone and mostly in the sterile zone of the modular robotic 
system. In this way, there is provided the technological security both from the structural and 
functional points of view in order to produce organic foods in highest security and food 
quality. The functional biotechnological model of the modular robotic system was designed 
for controlled cultivation and integrated processing of edible mushrooms to get ecological 
food in highest safety conditions (Petre et al., 2009).  
The modular robotic system designed for edible mushroom cultivation provides the 
automatic sterilization of composts, the  automatic inoculation inside the aseptic room by a 
special device of controlled injection of liquid mycelia, the incubation and fruit bodies 
formation in special chambers under controlled atmosphere as well as the automatic 
harvesting of mushroom fruit bodies (Petre et al., 2011).  
This system includes three major zones, respectively, the non-sterile zone, the sterile zone 
and the fruit-body processing zone (Fig. 11).  
Thus, during the first stage of the biotechnological flow, in the non-sterile zone of the 
cultivation system, a natural and nutritive compost is prepared from sawdust or shavings of 
deciduous woody species in the ratio of 30-40 parts per weight (p.p.w.), marc of grapes 
chemically untreated, in 20-30 p.p.w., brans of organic cereal seeds (wheat, barley, oat, rye, 
rice), in 10-20 p.p.w., yeasts, in 3-5 p.p.w., and powder of marine shells, in 1-3 p.p.w., for pH 
adjustment, which then, it is hidrated with demineralized water, in 20-30 p.p.w. In the next 
stage, such prepared compost is decanting in polyethylene thermoserilizable bags, which 
have round orifices of 0,3-0,5 mm in diameter, uniform distribuited between them, at 10-15 
cm distance, each one of them having a working volume of 10-20 kg (Petre et al., 2011).  
Beforehand, special devices for uniform distribution of mycelia as liquid inoculum are 
mounted inside of these bags. Then, these bags are fitted out with supporting devices on the 
transfer and transport systems and special devices for coupling to the automatic inoculation 
subdivision by controlled injection of liquid mycelia (Fig. 11). 
Each one of these zones is linked with next one by an interfacing zone. In this way, the non-
sterile zone is linked with the sterile zone through the first interfacing zone and this one is 
connected with the fruit body processing zone by the second interfacing area, as it is shown 
in figure 11. 
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Fig. 10. Schematic flow of the biotechnology for mushroom biomass producing by 
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In this respect, a strong tendency for increasing the number of researches in the field of 
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The biotechnology concerning the controlled cultivation of edible mushrooms in continuous 
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that are working in the non-sterile zone and mostly in the sterile zone of the modular robotic 
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quality. The functional biotechnological model of the modular robotic system was designed 
for controlled cultivation and integrated processing of edible mushrooms to get ecological 
food in highest safety conditions (Petre et al., 2009).  
The modular robotic system designed for edible mushroom cultivation provides the 
automatic sterilization of composts, the  automatic inoculation inside the aseptic room by a 
special device of controlled injection of liquid mycelia, the incubation and fruit bodies 
formation in special chambers under controlled atmosphere as well as the automatic 
harvesting of mushroom fruit bodies (Petre et al., 2011).  
This system includes three major zones, respectively, the non-sterile zone, the sterile zone 
and the fruit-body processing zone (Fig. 11).  
Thus, during the first stage of the biotechnological flow, in the non-sterile zone of the 
cultivation system, a natural and nutritive compost is prepared from sawdust or shavings of 
deciduous woody species in the ratio of 30-40 parts per weight (p.p.w.), marc of grapes 
chemically untreated, in 20-30 p.p.w., brans of organic cereal seeds (wheat, barley, oat, rye, 
rice), in 10-20 p.p.w., yeasts, in 3-5 p.p.w., and powder of marine shells, in 1-3 p.p.w., for pH 
adjustment, which then, it is hidrated with demineralized water, in 20-30 p.p.w. In the next 
stage, such prepared compost is decanting in polyethylene thermoserilizable bags, which 
have round orifices of 0,3-0,5 mm in diameter, uniform distribuited between them, at 10-15 
cm distance, each one of them having a working volume of 10-20 kg (Petre et al., 2011).  
Beforehand, special devices for uniform distribution of mycelia as liquid inoculum are 
mounted inside of these bags. Then, these bags are fitted out with supporting devices on the 
transfer and transport systems and special devices for coupling to the automatic inoculation 
subdivision by controlled injection of liquid mycelia (Fig. 11). 
Each one of these zones is linked with next one by an interfacing zone. In this way, the non-
sterile zone is linked with the sterile zone through the first interfacing zone and this one is 
connected with the fruit body processing zone by the second interfacing area, as it is shown 
in figure 11. 
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automatically transferred into the aseptic room to make the inoculation with liquid mycelia 
by using a robotic device of controlled injection. Further on, the pallets with the inoculated 
bags either are evacuated from the sterile zone or they are automatically transferred to the 
incubation and fruit body formation rooms. In these rooms of incubation and fruit body 
formation, both the optimal temperature of mycelia growing and the relative air humidity 
are provided as well as a constant steril air flow introduced under pressure by using an 
automatic device and an adecquate lighting level (Petre et al., 2011; Petre et al., 2009).  
In this way, the bags are maintained from 15 up to 30 days, during this time a mycelial net 
being formed from the hypha anastomosis having a compact structure and a white-yelowish 
color, that covers the whole surface of compost and from which the mushroom fruit bodies 
will emerge and develop soon as specific morphological structures of the origin species. 
These mushroom fruit bodies were grown and maturated in almost 3-10 days, depending on 
the cultivated mushroom species, at constant temperature of 18-210C, air relative humidity 
90-95% and controlled aeration at 3-5 air volume exchanges per hour and the suitable 
lighting at 2.000-3.000 luxes per hour, for 12 h daily. For the fruit bodies picking-up, the 
pallets are automatically discharged by the same robotic system and transferred to the 
automatic harvesting zone, where another robotic system automatically collects all the 
mushroom fruit bodies by a special designed device to be conditioned and packaged 
aseptically (Fig. 11). The modular robotic system designed for edible mushroom cultivation 
provides the automatic sterilization of composts, the automatic inoculation inside the 
aseptic room by a special device of controlled injection of liquid mycelia, the incubation and 
fruit bodies formation in special chambers under controlled atmosphere as well as the 
automatic picking-up of mushroom fruit bodies (Reed et al., 2001).  
Both interfacing zones were designed to keep the sterile zone at the highest level of food 
safety against the microbial contamination. Using this robotic biotechnological model of 
mushroom cultivation, the economical efficiency can be significantly increased comparing to 
the actual conventional technologies, by shorting the total time of mushroom cultivation 
cycles in average with 5-10 days, depending on the mushroom strains that were grown and 
providing high quality mushroom fruit bodies produced in complete safety cultivation 
system (Petre et al., 2009). 
4.1 Results and discussion 
To increase the specific processes of cellulose biodegradation of winery and vineyard wastes 
and finally induce their bioconversion into protein of fungal biomass, there were performed 
experiments to cultivate the mushroom species of P. ostreatus and L. edodes on the following 
variants of culture substrata (see Table 5). 
  
Variants of culture substrata Composition
S1 Winery wastes
S2 Mixture of winery  wastes and rye bran 2.5% 
S3 Mixture of winery  wastes and rise bran 2% 
S4 Mixture of vine cuttings and wheat bran 1% 
S5 Mixture of vine cuttings and barley bran 1.5% 
Control Pure cellulose
Table 5. The composition of five compost variants used in mushroom culture 
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the actual conventional technologies, by shorting the total time of mushroom cultivation 
cycles in average with 5-10 days, depending on the mushroom strains that were grown and 
providing high quality mushroom fruit bodies produced in complete safety cultivation 
system (Petre et al., 2009). 
4.1 Results and discussion 
To increase the specific processes of cellulose biodegradation of winery and vineyard wastes 
and finally induce their bioconversion into protein of fungal biomass, there were performed 
experiments to cultivate the mushroom species of P. ostreatus and L. edodes on the following 
variants of culture substrata (see Table 5). 
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The fungal cultures were grown by inoculating 100 ml of culture medium with 3-5% (v/v) 
of the seed culture and then cultivated at 23-25°C in 250 ml rotary shake flasks. The 
experiments were conducted under the following conditions: temperature, 25°C; agitation 
speed, 120-180 rev min -1; initial pH, 4.5–5.5. After 10–12 d of incubation the fungal cultures 
were inoculated aseptically into glass vessels containing sterilized liquid culture media in 
order to produce the spawn necessary for the inoculation of 10 kg plastic bags filled with 
compost made of winery and vineyard wastes (Petre et al., 2011; Petre et al., 2009).  
These compost variants were mixed with other natural ingredients in order to improve the 
enzymatic activity of mushroom mycelia and convert the cellulose content of winery and 
vineyard wastes into protein biomass. Until this stage, all the technological operations were 
handmade. In the next production phases, all the operations were designed to be carried out 
automatically by using a robotic modular system, which makes feasible the safety culture of 
edible mushrooms in continuous flow using as composts the winery and vineyard wastes.  
The modular robotic system designed for edible mushrooms cultivation provides the 
automatic sterilization of composts, the automatic inoculation inside the aseptic room by a 
special device of controlled injection of liquid mycelia, the incubation and fruit bodies 
formation in special chambers under controlled atmosphere and the automatic picking-up of 
mushroom fruit bodies. In this way, the whole bags filled with compost have to be sterilized 
at 90-1000C, by introducing them in a microwave sterilizer. In the next stage, all the 
sterilized bags must be inoculated with liquid mycelia, which have to be pumped through 
an aseptic injection device (Fig. 12). 
 
Fig. 12. General overview of the modular robotic system for controlled cultivating of 
mushrooms 
Then, all the inoculated bags have to be transferred inside the growing chambers for 
incubation. After a time period of 10-15 d from the sterilized plastic bags filled with 
compost, the first buttons of the mushroom fruit bodies emerged.  
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For a period of 20-30 d there were harvested between 1.5 – 3.5 kg of mushroom fruit bodies 
per 10 kg compost bag. The specific rates of cellulose biodegradation were determined using 
the direct method of biomass weighing the results being expressed as percentage of dry 
weight (d.w.) before and after their cultivation. The registered data are presented in Table 6. 
 
Variants of culture 
substrata 
Before cultivation (g% d.w.) After cultivation (g% d.w.) 
L. edodes P. ostreatus L. edodes P. ostreatus 
S1 2.6-2.7 2.7-2.9 0.5 0.9 
S2 2.3-2.5 2.5-2.8 0.4 0.7 
S3 2.3-2.5 2.3-2.5 0.5 0.4 
S4 2.5 -2.7 2.5 -2.7 0.7 0.8 
S5 2.7-2.9 2.5-2.7 0.5 0.7 
Control 3.0 3.0 1.4 1.5 
Table 6. The rate of cellulose degradation of culture substrata during the growing cycles of 
L. edodes and P. ostreatus 
The registered data revealed that by applying this biotechnology, the winery and vineyard 
wastes can be recycled as useful raw materials for mushroom compost preparation in order 
to get significant production of mushrooms.  
In this respect, the final fruit body production during the cultivation of these two mushroom 
species was registered as being between 20–28 kg relative to 100 kg of composts made of 
winery wastes. 
Significant bioconversion increasing of the winery and vineyard wastes by using the 
modular robotic system of continuous controlled cultivation of edible mushrooms can be 
achieved by: 
a. using pure strains of the mushroom species P. ostreatus and L. edodes whose biomass has 
got nutritive and functional properties proved by the research results of some achieved 
projects or others that are running now;   
b. excluding any potential contamination sources for the edible mushrooms by using total 
sterilization or filtration equipments in each production module, by controlling all raw 
and auxiliary materials, water and air; 
c. keeping the high precision and accuracy of the inoculation operations, incubation and 
fruit body formation of edible mushrooms which induce constant biomass composition 
of either fungal mycelia or mushroom fruit bodies; 
d. avoiding all errors in the sterile zone of production flow as well as the potential risk of 
edible mushroom contamination by the human operators. 
5. Conclusions 
According to the previous mentioned results, the following conclusions can be drawn:  
1. Most suitable organic compost for mycelia growing was prepared from marc of grapes, 
showing the highest influence upon the mycelia growing and fresh mushroom 
production of 32–35 g%.   
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2. From the tested nitrogen sources, barley bran was the most efficient upon the mycelia 
growing and fruit mushroom producing at 35-40 g%, being closely followed by rice 
bran at 25–30 g% both in case of P. ostreatus and L. edodes, all data being reported as 
fresh biomass. 
3. Among the tested mineral sources, the natural calcium carbonate (CaCO3) yielded the 
best mycelia growing as well as fungal biomass production at 28-32 g%; for this reason 
it was registered as the most appropriate mineral source being followed by natural 
gypsum (CaSO4 · 2 H2O) at 20-23 g%. 
4. The originality and novelty of this biotechnology of winery and vineyard wastes 
recycling was confirmed by the Patents no 121717/2008 and 121718/2008 issued by the 
Romanian Office of Patents and Trade Marks  
5. The mushroom pellets produced by applying the controlled cultivation of mushrooms 
as biotechnology for ecological treatment of winery wastes was 100% made by natural 
means and will be used for food supplements production with therapeutic properties 
which will contribute to the increasing of health level of human consumers with 
nutritional metabolic deficiencies. 
6. The biochemical correlation between the dry weight of mushroom pellets and their 
sugar and nitrogen contents was kept at a balanced ratio for each tested mushroom 
species. 
Among all mushroom samples that were tested in biotechnological experiments G. lucidum 
G-3 had shown the best values of its composition in sugars, total nitrogen and total protein 
content. 
7. The originality and novelty of these biotechnological procedures to recycle the cereal 
wastes in order to get high nutritive biomass of mushroom pellets were confirmed 
through the Patents no 121677/2008, 121678/2008 and 121679/2008 issued by the 
Romanian Office of Patents and Trade Marks 
8. By applying the biotechnology of controlled cultivation of edible mushrooms in 
modular robotic system, the final fruit body productions of both mushroom species P. 
ostreatus as well as L. edodes were registered as being between 20–28 kg relative to 100 
kg of composts made of winery wastes. 
9. The continuous controlled cultivation of edible mushrooms by using the modular 
robotic system can be achieved by: 
a. using pure strains of the mushroom species P. ostreatus and L. edodes whose 
biomass has got nutritive and functional properties proved by the research results 
of some achieved projects or others that are running now;   
b. excluding any potential contamination sources for the edible mushrooms by using 
total sterilization or filtration equipments in each production module, by 
controlling all raw and auxiliary materials, water and air; 
c. keeping the high precision and accuracy of the inoculation operations, incubation 
and fruit body formation of edible mushrooms which induce constant biomass 
composition of either fungal mycelia or mushroom fruit bodies; 
d. avoiding all errors in the sterile zone of production flow as well as the potential 
risk of edible mushroom contamination by the human operators. 
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10. The originality and novelty of this biotechnology of controlled cultivation of edible 
mushrooms in modular robotic system were confirmed by the Patent no 123132/20010, 
issued by the Romanian Office of Patents and Trade Marks. 
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10. The originality and novelty of this biotechnology of controlled cultivation of edible 
mushrooms in modular robotic system were confirmed by the Patent no 123132/20010, 
issued by the Romanian Office of Patents and Trade Marks. 
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1.1 Impacts of food waste 
Food waste is defined as wholesome edible material intended for human consumption arising 
at any point in the food supply chain that is instead discarded, lost, degraded or consumed by 
pests. The average consumer in Europe and North-America throws away ca. 100 kg of food 
per year according to a new report published by the UN’s Food and Agriculture Organization 
(Annual report of FAO, 2011 & Parfitt et al., 2010). The study centers on food loss and food 
waste during the whole supply chain from production to consumption and finds that around 
“one-third of the edible parts of food produced for human consumption gets lost or wasted 
globally” representing about 1.3 billion ton per year.  Around 20% of about 50 metric tons of 
waste that is generated annually in Japan is high moisture content refuse from kitchens and 
the food industries. The social, economic and environmental impacts of food waste are 
enormous. Such wastes readily decompose, generate odors, and sometimes cause illnesses. 
Municipal solid wastes including food waste are usually incinerated or land filled which 
ultimately generates many problems such as liberation of harmful compounds like dioxin and 
furans (Addink & Olie, 1995). Incineration facilities can be damaged by temperature 
fluctuations when food waste with high water content is burned in semi continuous process. 
In addition, it is difficult to recover energy from such waste incineration processes because the 
heating value of food waste is low (Harrison et al., 2000). This requires frequent and periodic 
collection and treatment of waste i.e. irrespective of their values. When excess food waste is 
disposed of in a landfill, it decomposes and is a significant source of methane gas, which is 
highly effective at trapping heat in the atmosphere than CO2 (Camobreco et al., 1999). 
Annually, food waste in the United States accounted for slightly more than 100 metric tons of 
methane originating from landfills. At the European level, the overall environmental impact is 
at least 170 metric tons of CO2 emitted annually.  
In this regard, the significance is considered as an important concept for aiming at the 
formation of the recycle-oriented society. Accordingly, untreated food waste contributes to 
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excess consumption of freshwater and fossil fuels which, along with methane and CO2 
emissions from decomposing food, impacts global climate change. The prompt 
implementation of total recycling system can play a beneficial role in the utilization of 
municipal waste.  
The design of this system can be conducted considering not only to the environmental impacts 
and energy increase in the recycling but also to the best economical efficiency as sustainable 
bio-based materials. So, management of municipal solid waste including kitchen waste via 
microbiological processes improves these wastes and reduces the need for both landfill space 
and fuel used in waste incineration. Direct composting and methane fermentation, which 
produce fertilizers and biogas, are alternative ways to reuse food waste but these processes 
have been applied only in rural areas. On the other hand, it has been found that municipal 
food waste is nutritious substratum for natural lactic acid bacteria (Sakai et al., 2000b). This 

















Large scale retail 
store (1) 28 437.5 12.3 15.6 10.4 1.5 1.3 
Large scale retail 
store (2)  124 290.0 36.0 13.1 31.3 2.2 1.8 
Convenience store 299 17.6 5.3 8.2 4.9 1.6 1.1 
Hotel (>100 room) 29 160.0 4.6 1.8 4.5 0.5 0.4 
Hospital (>100 
bed) 64 143.5 9.2 0 9.2 1.1 0.8 
Department 10 542.7 5.4 12.5 4.7 0.5 0.5 
Total 72.8 65.0 7.4 5.9 
Table 1. Food waste recycling generated in Kitakyushu-City, Japan. 
According to the report of Shirai & Sakai (2006), food waste collected from each town  
sectors of Kitakyushu-city of Japan, as shown in Table 1 above,  accumulated 7.4 tons of 
sugar per year (7.4 t/y) out of which consisted  80% glucose after the treatment with very 
low concentration of enzyme. Further, the overall glucose generated from the food waste  
from house kitchen is shown in Table 2 below. 
 
Day Site 
Food composition (%) Water
(%) 




waste) Cereal Fish & Meat Vegetables Fruits
2003/1/21 1 17.6 10.5 55.5 16.4 76.2 115 89 
2003/1/21 2 21.5 9.1 32.7 36.7 75.3 131 78 
2003/1/21 3 10.0 13.7 76.3 0 72.7 93 64 
2003/1/22 4 15.8 8.4 42.5 33.3 75.9 108 104 
2003/1/22 5 12.4 5.1 37.9 44.6 76.5 120 76 
2003/1/24 1 24.0 12.6 23.1 40.3 76.5 148 71 
2003/1/24 2 20.4 28.0 30.6 21.0 80.5 108 55 
2003/1/24 3 11.1 11.0 57.2 20.7 73.8 139 86 
2003/1/25 4 11.0 11.0 57.4 20.5 75.2 139 77 
2003/1/25 5 13.0 6.4 47.2 33.4 72.4 191 117 
Average  15.7 11.6 46.0 25.1 75.5 129 83 
Table 2. Composition of food refuse wasted from house kitchen at Kitakyushu area. 
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2. Bio-economy system 
Today’s industrial economy is largely dependent on petroleum oil which provides the basis 
of most of our energy and chemical feedstock. There is increasing concern over the impact of 
these traditional manufacturing processes on the environment. Therefore, considering to the 
resource materials’ exhaustion, we need to substantially reduce our dependence in the 
petroleum feedstock by establishing a bio-based economy. 
 
Fig. 1. Schematic Presentation of Sustainable Bio-Economy System (Revised from Kamm et 
al., 2005). 
The bio-economy is the sustainable production and conversion of biomass for a range of 
food, pharmaceuticals, fiber and industrial products, and energy. In it, the renewable 
biomass encompasses any biological material to be used as raw material (KBBE, 2010). It 
helps to: 
increase the scientific understanding of biomass resources and improve the tailoring of 
those resources; improve sustainable systems to develop, harvest and process biomass 
resources; improve efficiency and performance in conversion and distribution processes and 
technologies for the development of bio-based products; create the regulatory and market 
environment necessary for sustainable development and the use of bio-based products (Fig. 
1). Bio-based products are virtually similar to their petroleum-based counterparts but they 
are manufactured from renewable resources (Kamm et al., 2005).  
Generally biomass resources are strategic plant biomass rich in sugar (corn, rice, cassava, 
cane, beet etc) and oil (oil palm). To establish bio-economy, it is prerequisite to avoid 
confliction with food, cultivation field and deforestation.  There are also important biomass 
resources in residues from agriculture and forestry including both wet and dry waste 
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materials, for instance, sewage sludge and municipal solid waste. One of the pillars of bio-
economy system is the systematic conversion of biomass resources i.e. bio-refinery (Fig. 1). 
Similarly, the increased production of bio-fuels, especially biodiesel from the 
transesterification of fats and oils from oil plants (Palm, Soybean, Jatropha etc), is making 
glycerin a cheap organic material. Basically, conversion of these biomass resources to useful 
sustainable products includes two general pathways: thermo-chemical and bio-chemical 
conversion pathways. Briefly, biochemical conversion pathways use microorganisms to 
convert biomass resources into methane, hydrogen gas, and organic acid or simple alcohols 
usually in combination with some mechanical or chemical pre-treatment step. Substantial 
research effort has been expended to make this a raw material for various organic chemicals. 
Not the least of these is material that can be used in various thermoplastic and thermo-set 
polymers. Equally important, succinic acid, a biomass derived product posits its large 
potential for a variety of applications. This dicarboxylic acid can be converted to a huge 
amount of green chemical of industrial value, such as polyesters (derived from succinic acid 
and butandiol) which is used for soft plastics. 
3. Poly-L-lactic acid 
3.1 Lactic acid  
Lactic acid has both hydroxyl and carboxyl groups with one chiral carbon atom existing in 
two stereoisomers L- and  D-lactic acid, and it is widely used in the food, pharmaceutical, 
and general chemical industries (Sakai et al., 2001). The L form differs from the D form in its 
effect on polarized light. For L-lactic acid, the plane is rotated in a clockwise (dextro) 
direction; whereas, the D form rotates the plane in an anticlockwise (laevo) direction. 
Basically, the chemical synthesis only produces the racemic mixture of the L (+) and D (-) 
enantiomers, while microbial fermentation using biomass resources has the advantage of 
producing optically pure L(+)- or D(-)-lactic acid (Hafvendahl & Hagerdal, 2000). Among 
basic compounds from biomass, lactic acid is relatively unique C-3 compound obtained 
from C-6 glucose without any oxidation-reduction of the carbon atoms. Lactic acid can be 
polymerized to form the biodegradable and recyclable polyester poly-lactic acid which is 
considered a potential substitute for plastics manufactured from petroleum (Ohara & Sawa, 
1994). No doubt, we are subsequently focusing on the production of lactic acid with high 
optical purity from food waste (kitchen refuse).   
Optical purity is measured as; 
Optical purity (%) = ([L] − [D]) ×100/ ([L] + [D]) 
where [L] denotes to the concentration of L-lactic acid and [D] to that of D-lactic acid. 
We found that food waste collected from commercial sectors such as retail store, 
convenience store, college and university contained high amount of total sugars (129g/kg) 
as shown in Table 1 and 2 (Shirai & Sakai, 2006). They are mainly starch and can easily be 
converted to glucose enzymatically (82g/kg). Subsequently, for the production of lactic acid 
generating glucose from the food refuse was subjected to the fermentation using 
Lactobacillus rhamnosus which produces high amount of L-lactic acid (Sakai et al., 2004a, 
Fig.2). Considerably, the rate of lactic acid production was more than 85% which was 
satisfactory with the highest yield. 
 




Fig. 2. Lactic acid production profile from different commodities 
 
Fig. 3. Lactic acid yield using various kitchen refuse from commercial sectors 
3.2 Poly-lactic acid from food waste 
Poly lactic acid (PLA) is thermoplastic aliphatic polyester synthesized from L- or D-Lactic 
acid (Fig.4). Highly optical pure L- or D-lactic acid is necessary to obtain high crystalline 
poly-lactic acid which leads to the high strength, chemical and heat resistances of the 
polymers. PLA polymers range from amorphous glassy polymers with a glass transition of 
58°C to semi-crystalline/ highly crystalline products with crystalline melting points ranging 
from 130°C to 180°C. 
We propose a novel recycling system for municipal food waste that combines fermentation 
and chemical processes to produce high-quality poly-L-lactate (PLLA) biodegradable 
plastics (Fig. 5). The process consists of removal of endogenous D- or L-lactic acid from 
minced food waste by a Propionibacterium, L-lactic acid fermentation under semisolid 
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minced food waste by a Propionibacterium, L-lactic acid fermentation under semisolid 
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conditions, L-lactic acid purification via butyl esterification, and L-lactic acid polymerization 
via LL-lactide. The total design of the process enables a high yield of PLLA with high optical 
activity (i.e., a high proportion of optical isomers) and novel recycling of all materials 
produced at each step with energy savings and minimal emissions. Approximately, 50% of 
the total carbon was removed mostly as L-lactic acid and 100 kg of collected food waste 
yielded 7.0 kg PLLA. The physical properties of the PLLA yielded in this manner were 
comparable to those of PLLA generated from commercially available L-lactic acid (Table 4). 
Evaluation of the process is also discussed from the viewpoints of material and energy 
balances and environmental impacts (Fig. 5). 
Although the ester bond of poly-L-lactate (PLLA) is susceptible to some enzymes, including 
proteinases and lipases, and PLLA has been recognized as a biodegradable plastic (Sakai et 
al., 2001), its biodegradation in soil is rather slow and it depends on morphology and 
thickness (Miyazaki & Harano, 2001). Therefore, PLLA may better be developed as a 
chemically recyclable plastic with an appropriate collection system for the used materials 
but not as a single-use plastic (Nishida et al., 2004). 
  
Monomers and Dimers Melting Point(°C) Poly-lactic acid 
Melting point  
(°C) 
L-lactic acid 25.8 PLLA/PDLA Stereo-complex 245 
DL-lactic acid 16.8 PLLA 245 
LL-lactide 97.8 PLLA 175 
Meso-lactide 52.0 PDLA 175 
DL-lactide (Co-crystal) 124.0 PLDLA 50 
Table 3. Melting point for Lactic acid and its Polymers 
 
 
Fig. 4. Poly- L-lactic acid from starch 
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The proposed PLLA process has an energy advantage over even the general poly-lactide 
process because the feedstock is totally food waste. In the process with corn starch, nearly 
30% of gross fossil energy use goes into producing and processing corn to provide dextrose 
to feed the lactic acid fermentation. Since the feedstock to the proposed PLLA process is 
food waste that must otherwise be disposed of, the only upstream fossil energy allocated to 
the production of PLLA would be that required for collection of the separated waste (Sakai, 
2004b, 2007). 
 
Fig. 5. Process outline of PLLA production from food waste (A), Food waste (B), 
concentrated broth after lactic acid fermentation (C), Purified L-lactic acid (D), Fermentation 
residue (E), Pellets of PLLA. 
 
Optical purity 97.5% 
Average molecular weight 200kDa 
Melting point 175°C 
Glass transition temperature 58°C 
Table 4. Characteristics of PLLA produced from collected food waste. 
The material balance and energy requirements of the total process are summarized in Table 5. 
The overall experimental process yielded 68.8 g PLLA from 1 kg food waste (1.0 kg PLLA/14.6 
kg food waste). This means that 34% of total carbon in the food waste was recovered as PLLA. 
In comparison, the first commercial PLLA plant operated by Cargill Dow Polymers reportedly 
requires gross fossil process energy of 39.5 MJ/kg (Vink et al., 2003). Meanwhile, the process 
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energy required for production of bottle grade polyethylene terephthalate (PET) and high-
density polyethylene (HDPE) using petrochemicals is 27 MJ/kg and 23 MJ/kg respectively 
(Boustead, 2002). Furthermore, the process was designed to have low environmental impact. 
The fermentation residue is rich in nitrogen (C/N=6.5; concentrations of N, P and K were 75, 
2.6, and 0.7 mg/g dry matter respectively) reduced in weight to 14% of the untreated food 
waste, and the precipitated residue produced at the esterification step contains high 
concentrations of phosphorus and potassium (C/N = 7.7; concentrations of N, P and K were 
39, 28, and 23 mg/g dry matter respectively). These stable residues were confirmed to be 
useful fertilizers (Mori et al., 2008). Condensed water, ammonia, and butanol were reused 
during the process. Consequently, nearly all materials are converted to valuable resources or 
recycled in the process. As the production energy required is comparable to that required in 
the PLLA process using maize, we have been trying to improve the process especially to 
reduce energy required at the process of lactic acid fermentation as described below. 
Besides recycling process of municipal food waste using mesophile (L. rhamnosus), the 
prompt utilization of its biomass as a feed additive for the animals was also proceeded to 
fulfill the zero emission concept (Umeki, 2004, 2005). 
 
Items Content and Yield Carbon yield 
(%) (Kg/Kg wet waste) (Kg/Kg dry waste) 
Dry materiala 0.215 1.0 - 
Carbon contenta 0.101 0.470 100 
Total soluble sugara,b 0.143 0.665 - 
Lactic acid in culture filtratec 0.118 0.549 47 
Purified L-lactc acidc 0.099 0.459 37 
PLLAc 0.069 0.320 34 
Fermentation residued 0.14 0.101 27 
Esterification residuee 0.04 0.038 16 
a Average of 20 samples from 15 companies. 
b Average concentration in saccharified samples. 
c PLLA was experimentally produced from three representative culture filtrate samples. Average yield 
was calculated using efficiencies of each step (purified L-lactic acid from culture filtrate, 78.7%; PLLA 
from purified L-lactic acid, 91.9%). 
d Representative data: water contents of fermentation residue and esterification residue were 38% and 
6.4%, respectively. 
Table 5. Product yield and carbon balance 
4. Microorganisms for lactic acid production (MLAP) 
4.1 Lactic acid bacteria (LAB) 
The term lactic acid bacteria (LAB) means bacterial group that produces lactic acid as the 
major metabolite, and is used in different meaning from microorganism for lactic acid 
production (MLAP): they are gram-positive, acid tolerant, non-sporulating, non-respiring 
rod or cocci with low-GC content, able to produce L-type, D-type, or, L/D lactic acid as the 
major metabolic end product (more than 50%). Maximum growth temperature of it is up to 
43°C. The core genera of LAB are Lactobacillus, Leuconostoc, Pediococcus, Lactococcus, and 
Streptococcus as well as the more peripheral Aerococcus, Carnobacterium, Enterococcus, 
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Oenococcus, Teragenococcus, Vagococcus, and Weisella belonging to the order Lactobacillales. 
Lactobacillus rhamnosus has been reported for L-lactic production from kitchen refuse (Sakai 
et al., 2004b). Similarly, Oh et al., (2005) used strains of Enterococcus faecalis for the lactic acid 
production from sterilized wheat hydrolysates. On the other hand, microorganism which 
produces high amount L-lactic acid and is used for industrial lactic acid production 
(MLAP) distributed in more variety of genera in bacteria, yeast, and fungi. 
4.2 Non-LAB 
As non-LAB, Rhizopus oryzae, R. microsporus, Bacillus subtilis,  B. coagulans has been used for 
L-lactic acid production (Miura et al., 2003, Ohara et al., 1996 & Sakai et al., 2006c). 
Particularly, optically active L-lactic acid production from Rhizopus oryzae strains is 
significant (Miura et al., 2003). Industrial production of L-lactic acid using Rhizopus sps. has 
several advantages over using lactic acid bacteria (LAB).  
 
Fig. 6. Effect of incubation temperature on the growth of isolates.  A) Rhizopus oryzae (TISTR 
3514), B) Rhizopus microsporus (TISTR 3518) and C) Rhizopus oryzae (TISTR 3523). 
The fungus only produces L-lactic acid, while LAB frequently produces the D-isomers as 
well. Therefore, the optical purity of L-lactic acid produced from the fungus is relatively 
higher than that from LAB. L-lactic acid production has been reported in only the R. oryzae 
group. In addition, variety of studies on construction of lactic acid-producing Escherichia coli 
and Saccharomyces cerevisiae by genetic engineering have been reported (Sakai, 2008).These 
strains would be promising for the industrial production under strictly closed sterilized 
fermentation using certain purified substrate sugar. According to Kitpreechavanich et al., 
(2008), a thermotolerant Rhizopus strain which is capable of producing L-lactic acid from 
starch substrate was identified as R. microsporus (Fig. 6). 
4.3 Thermophilic/thermotolerant bacteria MLAP 
The term ‘thermophilic’ has been progressively more restricted to organisms which can 
grow or form products at temperatures between 45°C and 70°C with optimal 60°C (Madison 
et al., 2009). Dijkhuizen & Arfan (1990), reported that thermotolerant organisms grow at 
temperature between 35°C and 60°C with optimal 50°C -55°C. Thermophilic bacteria are 
common in soil, compost and volcanic habitats and have a limited species composition 
(Zeikus, 1979).  
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Meantime, we have found that several thermotolerant/thermophilic bacterial species in 
Bacillaceae are able to produce certain amount of optically active L-lactic acid (Table 7). 
Compared to Lactobacilli and Lactococci; Bacillus species generally show interesting microbial 
properties.  Most of them are basically aerobic and they form spores under certain 
environmental conditions.  They do not produce D-lactic acid. Some of them show growth 
limitation at temperatures around 70°C.  Some species produce polysaccharide-hydrolyzing 
enzymes such as amylase, chitinase, or xylanase. Many strains ferment glycerol, D-
galactose, D-fructose, D-xylose, sucrose, cellobiose as well as starch which are constituent 
sugars in food and agricultural waste. Therefore, not only the characteristics of this 
bacterium are quite suitable for the bioconversion of starch from food waste but also it 
would be applicable to other agricultural wastes.  
Thermotolerant strain Bacillus licheniformis has been explored for the L-lactic acid production 
from standard kitchen refuse under open condition i.e. 40g/l L-lactic acid with 97% optical 
activity and 2.5g/l.h productivity (Sakai & Yamanami 2006b). Moreover, thermophilic 
bacterium Bacillus coagulans is quite useful for producing optically active L-lactic acid from 
non-steriled kitchen refuse (Sakai & Ezaki, 2006c). The B. coagulans selectively grew at 55°C 
under open condition, while Lactobacillus plantarum, which is a major species in natural 
fermentation of kitchen refuse under mesophilic condition, suppressed its growth. 
Temperature and growth relations in different temperature classes of B. coagulans and L. 
plantarum are shown in Fig. 7. 
 
Fig. 7. Effect of temperature on growth of B. coagulans and L. plantarum 
5. Open fermentation for total recycle of food waste 
5.1 Merits of open fermentation 
Nonsterile open fermentation has various merits over conventional sterilized and closed 
fermentations. For example, it requires no facilities for sterilization and no steam for 
autoclaving. Thus, nonsterile open fermentation of kitchen refuse could be implemented at on-
site storage facilities for municipal food waste before the waste is transported to centralized 
processing plants. Because autoclaving is avoided, substrate sugars and other nutritional 
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constituents required for lactic acid fermentation remain intact. The Maillard reaction, for 
instance, not only decreases the amount of available sugars and amino acids but also produces 
unfavorable furfural compounds that inhibit bacterial growth. In addition, food waste is 
unsuitable for filter sterilization or separate autoclaving of substrate from other medium 
constituents. Nonsterile open fermentation avoids these complications; however, the optical 
purity of accumulated lactic acid from such fermentation at room temperature is low (Sakai & 
Ezaki, 2006c). This type of natural lactic acid fermentation also occurs during the collection and 
storage of municipal kitchen refuses (Sakai et al., 2004b). On the other hand, the thermophilic 
bacterium Bacillus coagulans is useful for producing optically active L-lactic acid from kitchen 
refuse under nonsterile condition (Heriban et al., 1993). 
5.2 Mesothermal recycle of food waste 
During the investigation of open fermentation at atmospheric temperature, we found that 
naturally-existed mesophile Lactobacillus plantarum preferentially proliferated and selectively 
accumulated lactic acid in non-sterile kitchen refuse (food waste) under pH swing control 
(intermittent pH adjustment) (Table 6). Despite the reproducible and selective proliferation 
of the species, this strain produced both L- and D-lactic acid with nearly equal racemic body 
ratio. As optically inactive lactic acid is not suitable for high-quality of PLA, we tried to 
improve the optical activity by inoculating L. rhamnosus or Lactococcus lactis which are L-
lactic acid producing LAB. But this kind of open fermentation also resulted proliferation of 
naturally existed L. plantarum and accumulation of lactic acid with low optical activity.  In 
comparison, Frederico et al., (1994) also reported that L. plantarum accumulated low amount 
of lactic acid during the fermentation of fruit juice under sterilized condition. As shown in 
Table 6 (Run 1-1 to 1-5), the amount of accumulated lactic acid varied according to the 
intervals of pH adjustment, and maximum accumulation was observed with pH adjustment 












1-1 7 0 1.05 19 83 
1-2 7 6 0.70 44 92 
1-3 7 12 0.58 45 94 
1-4 7 24 0.4 31 94 
1-5 7 _f) 0.25 13 87 
2-6 3 _g) 0.04 2.0 - 
2-7 5 6 0.42 32 96 
2-8 7 6 0.65 45 94 
2-9 10 6 0.58 45 92 
a) MKR samples of runs 1-1 to 1-5 and runs 2-6 to 2-9 were differently prepared. 
b) Interval of intermittent pH adjustment. 
c) Average production rate of lactic acid to reach maximum concentration. 
d) Maximum concentration of lactic acid accumulated. 
e) Ratio of accumulation of lactic acid to total organic acids 
f) MKR paste was adjusted at pH 7.0 initially and incubated without pH adjustment. 
g) No pH change was observed 
Table 6. Effect of intermittent pH adjustment on accumulation of lactic acid during the open 
fermentation of MKR paste by mesophile. 
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5.3 Molecular monitoring of bacteria during recycle of food waste 
From the very nature of a thing, non-sterilized fermentation process generally proceeds 
under a mixed culture condition. We have repeatedly isolated and identified the microbial 
structure during the course of open fermentation of kitchen refuse. Meantime, we 
cultivated, purified and characterized several microbial isolates, which counts laborious and 
time-consuming, and only predominant cultivable species can be identified. Therefore, we 
applied 16SrRNA-targeted fluorescence in-situ hybridization (FISH) to analyze the microbial 
population during open lactic acid fermentation (Sakai et al., 2004a, Fig. 8). For this, we 
designed probes for monitoring non-sterilized open fermentation of kitchen refuse such as a 
LAB group specific probe (LAC722) and a B. coagulans specific probe (Bcoa191). Similarly, 
specificity of Bcoa191 probe for B. coagulans in whole-cell hybridization of the new probe 
was confirmed B. coagulans, and differentiated the species from other bacteria as shown is 
Fig. 9 (Sakai & Ezaki, 2006c). 
 
 
Fig. 8. Typical FISH staining during open fermentation of kitchen refuse. Samples at time 
zero (A, B, C, D), or 48 hours (C, D, G, H), without (A, B, C, D) or with (E, F, G, H) 
inoculated seed culture stained with rhodamine-EUB338 (A, C, E, G) or FITC-LAC722(L) (B, 
D, F, H), (Sakai et al., 2004a). 
 




Fig. 9. Differential staining of B. coagulans using new probe Bcoa191 in 16S-Fluorescence In 
Situ Hybridization (FISH). B. coagulans cells were mixed with L. plantarum (A-C), L. 
rhamnosus (D-F), or E. coli (G-I). The mixed-cell samples were subjected to 16S-FISH, and the 
photomicrographs of phase contrast microscopic observation (A, D, G) and fluoro-
microscopic observation for rhodamine-EUB338 (B, E, H) or FITC-Bcoa191 (C, F, I) are 
shown (Sakai & Ezaki, 2006c). 
5.4 Thermotolerant MLAP in total recycle of food waste 
As shown in Table 6, the L-lactic production rate and optical purity of mesophilic lactic acid 
bacteria was low. We, furthermore, tried to use the thermotolerant Bacillus species for the 
total utilization of food waste for PLA production and its biomass utilization.  Production of 
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food waste. During the total utilization of food waste, the conditions for the fermentation of 
food waste were optimized as described previously (Sakai, 2006a, 2006e). Interestingly, 
novel thermotolerant strains B. soli U4-3 & U4-6 and B. subtilis N3-9 produced high amount 
of L-lactic acid within 6 hours of fermentation at 50°C with cent percent optical purity. L-
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was further used for the PLA production which is one of the instances in total recycle of 
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N1-3 Bacillus coagulans 20.6 69.0 99.8 
N1-4 B. coagulans 25.1 61.1 99.9 
N1-7 B. niacini 11.7 46.4 99.5 
N1-12 B. coagulans 28.6 60.2 100 
N2-1 B. coagulans 29.1 64.0 99.4 
N2-10 B. subtilis 31.5 68.9 99.0 
N3-6 B. subtilis 32.6 82.7 99.7 
N3-9 B. subtilis 35.1 74.0 100 
U4-3 B. soli 30.3 70.8 100 
U4-6 B. soli 29.3 85.5 100 
N5-7 B. subtilis 28.4 61.0 99.3 
N5-8 B. subtilis 23.3 55.3 99.0 
Table 7. L-lactic acid production by thermotolerant Bacillus strains isolated from high-
temperature and Aerobic fermenter. 
In general, for the  commercial production of poly-L-lactic acid plastic from biomass wastes, 
a feasible fermentation process to produce optically active L-lactic acid is required (Sakai, 
2004a, 2004b, 2006d). By using collected kitchen refuse, saccharified liquid containing 117g/l 
soluble sugar was obtained (Table 8). This figure is fairly representative of collected kitchen 
refuse (Table 2). Following the incubation with B. coagulans at 55°C, pH 6.5, 86g/l L-lactic 
acid with 97% optical purity was produced under non-sterile conditions. The yields of total 
lactic acid from total carbon and total sugar were 53% and 98% respectively. These figures 
are comparable to those achieved by L. rhamnosus incubation using sterilized collected 
kitchen refuse (Fig.10). 
 
Fig. 10. Open fermentation of MKR using B. coagulans under constant pH 6.5 at 55°C under 
open culture conditions. The changes in the concentrations of total lactic acid (closed 
squares), L-lactic acid (open squares), D-lactic acid (closed diamonds), total sugar (closed 
triangles), and glucose (open triangles) are represented along with pH change (close circles). 
 





with Lactobacillus rhamnosus 
Open fermentation with Bacillus 
coagulans 
Initial Final Initial Final 
Total sugar (g/l) 74 14 117 31 
Total lactic acid 
(g/l) 
3 61 2 86 
Optical purity (%) 1.4 95 2.9 97 
Carbon yield (%) - 38 - 53 
Sugar yield (%) - 97 - 98 
Table 8. Summary of open and closed fermentation of kitchen refuse using mesophile and 
thermophile. 
6. Conclusions and future prospective  
The majority of the worldwide industrial economics are now largely dependent on 
petroleum oil which provide basis for most all of our energy and chemical feedstock. 
Meanwhile, there is increasingly concern over the impact of these traditional manufacturing 
processes or the environment, i.e. the effect of CO2 emissions on global warming as well as 
exhaustion of fossil resources. In order to maintain the world population in terms of food, 
fuel, and organic chemicals, we need to substantially reduce our dependence on petroleum 
feedstock by establishing a bio-based economy. 
Principally, production and harvest of biomass plant is neither self-sustained nor 
environmentally friendly.  It is a harvesting-out process of nutritious compound from 
field. Food waste and wastewaters, further, are unavoidably produced to pollute 
environment. So that, the total system design for recycle of all elements, not only carbon 
as neutral but also including nitrogen, potassium and phosphorus, is important for 
sustainable biomass production. Cascade utilization of biobased-products and recycle of 
biomaterials in a waste stream and wastewater, is another key technology for carbon 
sequestration and for the sustainable production-utilization system like metabolic 
network in human body.  
We human beings are keeping our body function to be active by taking into the energy 
and chemicals as food. At the same time, we continuously use over half of total energy at 
our liver and pancreas, organs working in catabolism cleaning up our blood and 
recovering metabolites to maintain our body functions healthy. Treatment and utilization 
of waste materials may be compared with recycle of biomolecules via venous blood 
stream. In this context, our society has to further enrich the quality and quantity of 
‘venous industry’ to treat waste and recover resources from them sustaining our society to 
be healthy. 
Here, we present a total recycle system of food waste via chemical production with energy 
and facility savings and minimal emissions from waste materials.  It should be further 
investigated to trait by improving the leading case study in ‘Bio-economy system’. The 
challenge of the next decade will be to develop zero-emission bio-based environmentally 
friendly products from geographically distributed feedstock and worldwide generated food 
waste by simultaneous reduction of pollution indeed. 
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This review addresses recent achievements on the development of energy-saving and 
environmentally-friendly bioprocesses for the synthesis of polyhydroxyalkanoates (PHAs), 
a kind of non-petrochemical bioplastics. Different cutting-edge strategies developed in order 
to achieve bioprocesses with enhanced sustainability will be described. These are mainly 
based on the use of cheap substrates concomitantly lowering energy consumption levels, 
thus diminishing the environmental impact of PHAs production. We will also cover studies 
that shed light on the physiology of PHA-producing microorganisms by means of metabolic 
flux analysis, and also those that analyzed polymer modifications aimed at modifying 
physico-chemical properties. An overview of the applications of PHAs, including novel 
functionalized varieties, will conclude this review. 
1.1 Environmental preservation 
Microbial fermentations and many other industrial processes mostly rely on two fossil fuels 
(petroleum and gas) as sources of energy. This biased strategy has contributed to global 
climate change by emitting large amounts of carbon dioxide to the atmosphere and, as a 
collateral consequence, has favored the generation of an extended range of difficult-to-
dispose-of goods by petrochemical industries. Accumulation of microscopic plastic debris at 
sea is particularly alarming, as well as the exponentially increasing need of landfill for 
municipal solid waste disposal. This particular situation has renewed the interest in 
strategies based on energy-saving bioprocesses. These strategies propose the  replacement of 
petroleum by renewable resources and the manufacture of non-petrochemical goods, such 
as bioplastics, in order to reduce the pollution phenomena. 
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The name biopolymers is currently used for polymers that are either synthesized by living 
organisms or produced from substrates obtained from living organisms. Examples of the 
first kind of biopolymers are naturally occurring polymers such as cellulose, starch, and 
PHAs. Among the second kind, there are poly(lactic acid), that can be synthesized from 
biologically-obtained lactic acid, or even polyethylene, when it is produced from ethylene 
obtained from bio-ethanol. Bioplastics are biopolymers with plastic properties. Bioplastics 
synthesized by living organisms are generally biodegradable; and chemically synthesized 
polymers, especially those derived from petroleum, are generally non-biodegradable, while 
those that are "bio-based" (i.e., obtained using a biologically produced substrate such as bio-
ethanol), have several degrees of biodegradability. Polyethylene and polypropylene, 
whether bio-based or not, are considered non-biodegradable, even when there have been 
claims of slow degradation of these polymers in nature (Corti et al., 2010). There are 
exceptions to the relationship between biological origin and biodegradability, as not all 
biopolymers are biodegradable, and not all biodegradable polymers are biopolymers. There 
are some plastics obtained from non-biological processes that can also be biodegraded, such 
as poly(ε-caprolactone) and the petroleum derived polymer poly(butadiene adipate-co-
terephthalate) (Queiroz & Collares-Queiroz, 2009); and there are also polymers synthesized 
by microorganisms that are not biodegradable, such as polythioesthers, obtained by the 
polymerization of mercaptoalkanoic acids by PHA synthases (Steinbüchel, 2005). 
Currently, there are many different biodegradable bioplastics. Among these, we found 
blends containing natural polymers, such as starch and cellulose; and polymers synthesized 
chemically from different substrates, such as poly(lactic acid), poly(ε-caprolactone), and 
others (Rehm, 2010). Starch can be blended with other compounds to obtain polymers which 
could be used for several applications, but this material is quickly damaged in contact with 
water. Poly(lactic acid) is not normally degraded by microorganisms, but it is easily 
hydrolyzed and can be composted. PHAs are natural bioplastics produced by many bacteria 
from different substrates. In sharp contrast to the other bioplastics mentioned above, these 
polymers are totally biodegradable, as all microorganisms that naturally accumulate PHAs 
can degrade them. Moreover, PHAs can also be degraded by many other microorganisms, 
both bacteria and fungi, under either aerobic or anaerobic conditions. 
These polymers are synthesized naturally by a wide variety of bacterial species as a reserve 
for carbon and energy. Nowadays, PHAs continue to attract increasing industrial interest as 
renewable, biodegradable, biocompatible, and extremely versatile thermoplastics 
(Steinbüchel & Lütke-Eversloh, 2003; Suriyamongkol et al., 2007). PHAs are the only water-
proof thermoplastic materials available that are fully biodegraded both in aerobic and 
anaerobic environments. Two classes of PHAs are distinguished according to their 
monomer composition: short-chain length (SCL) PHAs and medium-chain length (MCL) 
PHAs. SCL-PHAs are polymers of 3-hydroxyacid monomers with a chain length of three to 
five carbon atoms, such as poly(3-hydroxybutyrate) (PHB, the most common PHA); whereas 
MCL-PHAs contain 3-hydroxyacid monomers with six to sixteen carbon atoms. All of them 
are optically active R-(—) compounds. This versatility is partly due to the wide substrate 
range of the PHA-synthesizing enzymes, and gives PHAs an extended spectrum of 
associated properties which is a clear advantage vis-à-vis to other bioplastics. Around 200 
different monomer constituents were found in the polymers analyzed so far (Steinbüchel & 
Lütke-Eversloh, 2003). 
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1.3 Environmental Issues  
Current high-yield bioprocesses for the synthesis of PHAs require fully aerobic conditions, 
which means that they are high energy-consuming processes. The environmental impact of 
replacing oil-derived plastics with biopolymers has been the subject of several studies, 
among them, those regarding bacterial PHB production in bioreactors (Gerngross, 1999). A 
complete life cycle assessment for PHB production from the cradle to the factory gate has 
been published by Harding et al. (2007). Those studies pointed out that, in spite of the fact 
that PHB is more environmentally friendly than oil-derived polymers, the great amount of 
energy required for its production must be taken into account when assessing its 
environmental impact. Similar results were obtained from research applied to the 
manufacturing of polymers obtained from transgenic plants (Zhong et al., 2009), or from 
agricultural substrates such as corn (Kim & Dale, 2005). 
From these researches  and other studies it was concluded that when the amount of energy 
used for sterilization, aeration, and agitation (both in the bioreactor and downstream 
processing), as well as the energy needed for the production of the agricultural feed-stocks to 
be used as carbon sources is considered, the environmental performance of PHAs equals that 
of petrochemical polymers. Different initiatives to overcome this problem are described below. 
2. Towards an enhanced sustainable production 
In the following sections, we will discuss several cutting-edge strategies intended to 
enhance the sustainability of PHA production processes (as summarized in Fig. 1). Even 
when they will discussed in a sequential fashion, beginning with the choice of suitable 
substrates up to the rational functionalization of polymer properties, it is important to 
mention that bioprocesses designed for PHA synthesis from agroindustrial by-products are 
subjected to continuous improvement. 
 
Fig. 1. Strategies used to enhance the sustainability of PHA production processes. Note that 
modifications to improve different steps in the process as a whole can be implemented in a 
cyclic, iterative fashion. 
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It is widely accepted that the prize of the carbon source is one of the main factors affecting 
the cost of PHAs, influencing the sustainability of production processes. However, the 
choice of a suitable carbon source is not a clearcut issue. The use of industrial and 
agricultural by-products could require extensive purification, equalling or even surpassing 
the energy demand of cost-intensive agricultural feed-stocks. 
Some early approaches to overcome this situation have integrated PHA and sugar 
production in a substrate- and energy-closed system (Nonato et al., 2001). Milk whey, a 
substrate which does not require extensive purification, was the most appropriate option for 
many other initiatives. Recently, glycerol has received attention as a potential carbon 
substrate due to its accumulation as a by-product of biodiesel synthesis. 
2.1.1 Milk whey 
About 80-90% of the processed milk volume is converted to whey during cheese and casein 
production by the dairy industry (Wong & Lee, 1998). Whey is rich in lactose, proteins, 
lipids, and lactic acid (Yang et al., 1994). After casein precipitation from raw milk, skimmed 
whey is produced, which is then concentrated and ultra-filtrated producing whey permeate 
(rich in lactose) and whey retentate (rich in proteins and containing a considerable amount 
of residual lactose). 
Some components of whey retentate are useful in the pharmaceutical industry. Whey 
permeate contains ca. 81% of the original lactose in milk and is appropriate for 
biotechnological processes (Nath et al., 2008). 
Young et al. (1994) evaluated for the first time the production of PHB from lactose by 
Burkholderia cepacia. Since then, many other isolated bacteria were evaluated for the 
production of PHB from lactose or milk whey (Nath et al., 2008). However, the cultures 
were always performed at low-cell-densities, thus hindering an appropriate evaluation of 
their economical relevance. The production of the copolymer poly(3-hydroxybutyrate-co-3-
hydroxyvalerate) [P(HB-co-HV)] from milk whey was also demonstrated in cultures either 
supplemented or not supplemented with valeric (pentanoic) acid (Koller et al., 2005, 2008). 
Production of PHAs with different monomer compositions using milk whey as the main 
carbon source will allow their use in different applications. 
Ralstonia eutropha1 has been extensively established as the platform for PHA production par 
excellence (Reinecke & Steinbüchel, 2009). However, it is unable to hydrolyse lactose, and 
galactose (its hydrolysis product) is not metabolized. Koller et al. (2007) proposed an 
alternative process consisting of two steps for PHB production from milk whey: lactose was 
first converted to lactic acid by lactobacilli, and the resulting lactic acid was then used as 
carbon source by R. eutropha for PHA production. Marangoni et al. (2002) hydrolyzed milk 
whey in order to make glucose available for R. eutropha, but it should be considered that 
galactose would remain unused in the culture medium since it is not metabolized by R. 
eutropha, as mentioned. After the expression of genes encoding β-galactosidase and 
                                                 
1R. eutropha is currently known as Cupriavidus necator. In this review we will adopt the name R. eutropha 
which is most frequently used in the literature, including the announcement of its complete genome 
sequence (Pohlmann et al., 2006). 
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galactokinase in R. eutropha it became able to use lactose, albeit at a very slow rate (Pries et 
al., 1990). Recently, the lacZ (encoding β-galactosidase) and lacI (encoding the lac operon 
repressor protein) genes from Escherichia coli were introduced in the genome of R. eutropha 
interrupting phaZ1 (encoding an intracellular PHB depolymerase). Cell concentration 
reached values higher than 8 g · L-1 and the PHB content was about 20-25% (wt/wt), 
demonstrating the capability of this recombinant R. eutropha strain to use lactose (Povolo et 
al., 2010). 
Lee and co-workers studied high-cell density cultures of recombinant E. coli for the 
production of PHB from milk whey (Ahn et al., 2000; Wong & Lee, 1998). The best results 
were reached when using a highly concentrated milk whey solution associated to an 
external membrane module to retain the cell mass inside the bioreactor. Under these 
working conditions, and after 36.5 h of cultivation, PHB volumetric productivities as high as 
4.6 g · L-1 · h-1 were reached (i.e., cell and PHB concentrations of 194 and 168 g · L-1, 
respectively). These processes were scaled up (30 and 300 L), but the productivities attained 
were low (Park et al., 2002). 
Kim (2000) also studied the production of PHB from milk whey by recombinant E. coli 
strains harboring the PHB biosynthetic genes from R. eutropha. After 35 h of cultivation, cell 
and PHB concentrations reached 55 and 32 g · L-1, respectively; corresponding to a PHB 
volumetric productivity of 0.9 g · L-1 · h-1. In a 24-h fed-batch process using milk whey and 
corn steep liquor as the main carbon and nitrogen sources, a recombinant E. coli strain 
(harboring the PHB biosynthetic genes from Azotobacter sp. strain FA8) reached cell and 
PHB concentrations of 70.1 and 51.1 g · L-1, respectively, corresponding to a PHB volumetric 
productivity of 2.13 g · L-1 · h-1 (Nikel et al., 2006a). 
PHB production processes from milk whey, based on fed-batch cultivation of recombinant 
E. coli strains and reaching high cell densities and PHB volumetric productivities, were 
established (Ahn et al., 2000; Nikel et al., 2006a; Wong & Lee, 1998), and are economically 
sound. However, further studies will be needed to scale up these processes keeping high 
productivities, cell concentration, and PHB content. Milk whey would satisfy the materials 
demands in processes for the production of other PHAs. However, taking into account the 
relevance of energy demands in these processes (Gerngross, 1999; Nonato et al., 2001), a 
renewable source must be considered to fulfill energy requirements and make the 
bioprocess truly sustainable. 
2.1.2 Sugarcane molasses 
Molasses is the residual syrup generated in sugar-refining mills after repeated sugar 
extraction by applying crystallization to sugarcane or sugar beet juice. At this point, sugar 
extraction is no longer economically viable, despite still having relatively high sucrose 
content. Low-grade molasses, inappropriate to be used in food or feed, has been suggested 
as substrate to produce PHAs (Solaiman et al., 2006). 
A number of processes have been developed using molasses to produce PHA by bacteria. 
Most of the data provided on polymer content seem not to be competitive or sustainable at 
the moment. Beet and soy molasses have also been tested as alternative substrates (Solaiman 
et al., 2006). PHA production from molasses has been reported using Gram negative 
bacteria, such as recombinant E. coli and Klebsiella strains (Zhang et al., 1994), R. eutropha 
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relevance of energy demands in these processes (Gerngross, 1999; Nonato et al., 2001), a 
renewable source must be considered to fulfill energy requirements and make the 
bioprocess truly sustainable. 
2.1.2 Sugarcane molasses 
Molasses is the residual syrup generated in sugar-refining mills after repeated sugar 
extraction by applying crystallization to sugarcane or sugar beet juice. At this point, sugar 
extraction is no longer economically viable, despite still having relatively high sucrose 
content. Low-grade molasses, inappropriate to be used in food or feed, has been suggested 
as substrate to produce PHAs (Solaiman et al., 2006). 
A number of processes have been developed using molasses to produce PHA by bacteria. 
Most of the data provided on polymer content seem not to be competitive or sustainable at 
the moment. Beet and soy molasses have also been tested as alternative substrates (Solaiman 
et al., 2006). PHA production from molasses has been reported using Gram negative 
bacteria, such as recombinant E. coli and Klebsiella strains (Zhang et al., 1994), R. eutropha 
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(Oliveira et al., 2004), Pseudomonas cepacia (Çelik et al., 2005), or Gram positive bacteria such 
as Bacillus strains (Kulpreecha et al., 2009). In some cases, molasses was only used as 
additive [0.3 to 2.5% (wt/wt)] to grow R. eutropha in liquid or solid-state cultures along with 
other main substrates, reaching a maximum PHA content ranging from 26 to 39% (wt/wt) 
(Beaulieu et al., 1995; Oliveira et al., 2004). P. cepacia G13 accumulated PHA up to 70% 
(wt/wt) in culture media supplemented with 3% (wt/vol) beet molasses (Çelik et al., 2005). 
Considering the use of sugarcane molasses as the main carbon source, Kulpreecha et al. 
(2009) tested Bacillus megaterium on sugarcane molasses and achieved a cell dry mass 
concentration of 72.7 g · L-1 in 24 h, with a PHB content of 42% (wt/wt); a good process that 
can still be improved since dissolved oxygen was a limiting factor. Brazil is currently one of 
the world leaders on sugarcane production (569 million tons in 2008-2009; Sawaya Jank, 
2011). Initial attempts to use sugarcane molasses or high-test-molasses to produce PHAs 
were partially limited by its high nitrogen content (unpublished data). 
Sugarcane molasses is no longer a waste material in Brazil but a by-product showing a good 
market value, and since 1970 it has been increasingly used on bio-ethanol production. The 
bagasse excess and sugarcane leaves are promising substrates to produce second-generation 
bio-ethanol. However, further developments are needed to solve the inability of yeasts to 
use the xylose fraction released from bagasse hydrolysis. Therefore, xylose and arabinose 
may be the new target by-products to be used in order to produce PHA in the integrated 
model of a sugar mill bio-refinery. 
2.1.3 Glycerol 
In the last years, a very important increase in the production of biodiesel has caused a sharp 
fall in the cost of glycerol, the main by-product of the biodiesel synthesis (da Silva et al., 
2009; Solaiman et al., 2006). As a result, glycerol has become a very attractive substrate for 
bacterial growth. Additionally, because carbon atoms in glycerol are more reduced than in 
glucose or lactose, cells using glycerol are in a more reduced physiological state, favoring 
polymer synthesis. The use of glycerol for microbial PHA synthesis has been analyzed in 
natural PHA producers, such as Methylobacterium rhodesianum and R. eutropha (Borman & 
Roth, 1999), several Pseudomonas strains (Solaiman et al., 2006), the recently described 
Zobellella denitrificans (Ibrahim & Steinbüchel, 2009), and Bacillus sp. (Reddy et al., 2009), 
among others. Glycerol has also been investigated as a substrate for PHB synthesis in 
recombinant E. coli carrying the PHB biosynthetic genes from Streptomyces aureofaciens 
(Mahishi et al., 2003), and Azotobacter sp. strain FA8 (Nikel et al., 2008b). 
PHAs obtained from glycerol were reported to have a significantly lower molecular weight 
(Mr) than polymers synthesized from other substrates, typically less than 1 MDa. In 
Methylobacterium extorquens and R. eutropha, PHB obtained from glycerol, ethanol, or 
methanol had a lower Mr than that obtained from other substrates (such as succinate, 
glucose, and fructose), and the Mr of the polymer was shown to decrease with increasing 
glycerol concentrations (Taidi et al., 1994). This effect was further analyzed and attributed to 
chain termination caused by glycerol (Madden et al., 1999). In studies performed using 
different Pseudomonas strains, the Mr of the polymers obtained, such as PHB produced by P. 
oleovorans and MCL-PHA synthesized by P. corrugata, was also observed to decrease with 
increasing glycerol concentrations [from 1% to 5% (wt/vol)] (Ashby et al., 2005). A recent 
study performed using R. eutropha describes PHB obtained from commercial glycerol and 
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from waste glycerol with a Mr of 957 and 786 kDa, respectively, less than half of that of PHB 
obtained from glucose (Cavalheiro et al., 2009). In contrast, in a recent report describing 
P(HB-co-HV) accumulation in a Bacillus strain, similar Mrs, lower than 700 kDa, were 
observed for the polymer obtained from the two carbon sources (Reddy et al., 2009). A low 
Mr is undesirable for industrial processing of the polymer, so the results available in the 
literature pointed to a drawback in the use of glycerol as a substrate for the microbial 
production of PHAs. However, based on recent results obtained with recombinant E. coli, it 
has been proposed that it is possible to obtain PHB from glycerol with Mrs similar to those 
of the polymer obtained from glucose or lactose by using adequate bacterial strains and 
culture conditions (de Almeida et al., 2010). 
2.2 Strains 
As stated before, industrial synthesis of PHAs must improve sustainability in order to reach 
an appropriate production cost and diminish environment damage. The manipulation of 
natural PHA producers and recombinant strains to achieve high PHA production has been 
the subject of many studies (reviewed in Aldor & Keasling, 2003; Jung et al., 2010; Keshavarz 
& Roy, 2010; Madison & Huisman, 1999; Steinbüchel, 2001), and will not be considered in 
this review. In spite of the fact that several bacterial species are currently being used in 
biotechnological processes, E. coli remains as the "workhorse" of industrial developments. 
This species has been the selected host for genetic techniques devised to introduce the PHA 
biosynthetic genes, improve their expression, provide suitable quality and concentration of 
substrates to the PHA synthase, as well as to modify the host strains to improve their 
performance in the bioreactor (Li et al., 2007). 
In this section, we will focus on recent studies using different E. coli mutant strains and 
metabolic flux analysis with the objective of increasing sustainability in PHAs synthesis 
processes. 
2.2.1 Modification of host strains 
When they are grown in bioreactors, all microorganisms, including PHB-producing 
recombinant E. coli strains, are subjected to extreme (and often oscillating) conditions, such 
as shear forces, extreme aeration (either low or high), pH, and growth temperatures chosen 
to obtain maximum product yield. These extreme conditions often lead to membrane 
debilitation, cell filamentation, or protein precipitation. A strategy used to avoid 
filamentation was to over-express the gene encoding FtsZ (involved in cell division) in E. 
coli harboring the pha genes from R. eutropha, thus improving the polymer productivity from 
2.08 g · L-1 · h-1 in the wild-type strain up to 3.4 g · L-1 · h-1 in the filamentation-suppressed 
derivative strain and consequently enhancing the process sustainability (Wang & Lee, 1997). 
Current processes for the synthesis of PHAs require fully aerobic conditions, which mean 
that they are high energy-consuming processes. Most of the energy requirement is needed to 
fulfill aeration and agitation inside the culture vessel of the bioreactor. Therefore, strategies 
aimed towards improving the respiratory capacity of the host strain under micro-aerobic 
growth conditions were developed to reduce aeration needs. Vitreoscilla haemoglobin is 
supposed to facilitate intracellular oxygen transfer and assimilation, and the gene encoding 
this protein was introduced in PHB-producing E. coli improving the growth and polymer 
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fall in the cost of glycerol, the main by-product of the biodiesel synthesis (da Silva et al., 
2009; Solaiman et al., 2006). As a result, glycerol has become a very attractive substrate for 
bacterial growth. Additionally, because carbon atoms in glycerol are more reduced than in 
glucose or lactose, cells using glycerol are in a more reduced physiological state, favoring 
polymer synthesis. The use of glycerol for microbial PHA synthesis has been analyzed in 
natural PHA producers, such as Methylobacterium rhodesianum and R. eutropha (Borman & 
Roth, 1999), several Pseudomonas strains (Solaiman et al., 2006), the recently described 
Zobellella denitrificans (Ibrahim & Steinbüchel, 2009), and Bacillus sp. (Reddy et al., 2009), 
among others. Glycerol has also been investigated as a substrate for PHB synthesis in 
recombinant E. coli carrying the PHB biosynthetic genes from Streptomyces aureofaciens 
(Mahishi et al., 2003), and Azotobacter sp. strain FA8 (Nikel et al., 2008b). 
PHAs obtained from glycerol were reported to have a significantly lower molecular weight 
(Mr) than polymers synthesized from other substrates, typically less than 1 MDa. In 
Methylobacterium extorquens and R. eutropha, PHB obtained from glycerol, ethanol, or 
methanol had a lower Mr than that obtained from other substrates (such as succinate, 
glucose, and fructose), and the Mr of the polymer was shown to decrease with increasing 
glycerol concentrations (Taidi et al., 1994). This effect was further analyzed and attributed to 
chain termination caused by glycerol (Madden et al., 1999). In studies performed using 
different Pseudomonas strains, the Mr of the polymers obtained, such as PHB produced by P. 
oleovorans and MCL-PHA synthesized by P. corrugata, was also observed to decrease with 
increasing glycerol concentrations [from 1% to 5% (wt/vol)] (Ashby et al., 2005). A recent 
study performed using R. eutropha describes PHB obtained from commercial glycerol and 
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from waste glycerol with a Mr of 957 and 786 kDa, respectively, less than half of that of PHB 
obtained from glucose (Cavalheiro et al., 2009). In contrast, in a recent report describing 
P(HB-co-HV) accumulation in a Bacillus strain, similar Mrs, lower than 700 kDa, were 
observed for the polymer obtained from the two carbon sources (Reddy et al., 2009). A low 
Mr is undesirable for industrial processing of the polymer, so the results available in the 
literature pointed to a drawback in the use of glycerol as a substrate for the microbial 
production of PHAs. However, based on recent results obtained with recombinant E. coli, it 
has been proposed that it is possible to obtain PHB from glycerol with Mrs similar to those 
of the polymer obtained from glucose or lactose by using adequate bacterial strains and 
culture conditions (de Almeida et al., 2010). 
2.2 Strains 
As stated before, industrial synthesis of PHAs must improve sustainability in order to reach 
an appropriate production cost and diminish environment damage. The manipulation of 
natural PHA producers and recombinant strains to achieve high PHA production has been 
the subject of many studies (reviewed in Aldor & Keasling, 2003; Jung et al., 2010; Keshavarz 
& Roy, 2010; Madison & Huisman, 1999; Steinbüchel, 2001), and will not be considered in 
this review. In spite of the fact that several bacterial species are currently being used in 
biotechnological processes, E. coli remains as the "workhorse" of industrial developments. 
This species has been the selected host for genetic techniques devised to introduce the PHA 
biosynthetic genes, improve their expression, provide suitable quality and concentration of 
substrates to the PHA synthase, as well as to modify the host strains to improve their 
performance in the bioreactor (Li et al., 2007). 
In this section, we will focus on recent studies using different E. coli mutant strains and 
metabolic flux analysis with the objective of increasing sustainability in PHAs synthesis 
processes. 
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When they are grown in bioreactors, all microorganisms, including PHB-producing 
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as shear forces, extreme aeration (either low or high), pH, and growth temperatures chosen 
to obtain maximum product yield. These extreme conditions often lead to membrane 
debilitation, cell filamentation, or protein precipitation. A strategy used to avoid 
filamentation was to over-express the gene encoding FtsZ (involved in cell division) in E. 
coli harboring the pha genes from R. eutropha, thus improving the polymer productivity from 
2.08 g · L-1 · h-1 in the wild-type strain up to 3.4 g · L-1 · h-1 in the filamentation-suppressed 
derivative strain and consequently enhancing the process sustainability (Wang & Lee, 1997). 
Current processes for the synthesis of PHAs require fully aerobic conditions, which mean 
that they are high energy-consuming processes. Most of the energy requirement is needed to 
fulfill aeration and agitation inside the culture vessel of the bioreactor. Therefore, strategies 
aimed towards improving the respiratory capacity of the host strain under micro-aerobic 
growth conditions were developed to reduce aeration needs. Vitreoscilla haemoglobin is 
supposed to facilitate intracellular oxygen transfer and assimilation, and the gene encoding 
this protein was introduced in PHB-producing E. coli improving the growth and polymer 
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yield, simultaneously avoiding the need of pure oxygen supplementation to achieve high-
cell-density cultures (Horng et al., 2010, 2011). 
Another approach was based on the control of the redox state. In E. coli, the two-component 
signal transduction system ArcAB modulates, the expression of many operons according to 
the redox state of the environment (Lynch & Lin, 1996). The main targets for repression by 
the phosphorylated regulator are the genes that encode the enzymes involved in aerobic 
respiration and oxidative bioreactions, such as those of the tricarboxylic acid cycle. E. coli arc 
mutants are unregulated for aerobic respiration, and the genes encoding components of the 
tricarboxylic acid cycle are fully expressed under micro-aerobic growth conditions. 
As a consequence, the pool of reducing equivalents is elevated and could be funneled into 
reduced bioproducts such as PHB. This approach enabled the increase of PHB content up to 
35% (wt/wt) in an arcA mutant strain grown in a semi-synthetic medium with gentle (75 
rpm) agitation, conditions in which no PHB was accumulated by the wild-type strain (Nikel 
et al., 2006b). Another global regulatory system manipulated to increase PHB synthesis is 
CreBC, a two-component signal transduction pair, where CreB is the regulator and CreC the 
sensor kinase. The cre regulon includes different genes, and some of them are involved in 
carbon metabolism (Avison et al., 2001). E. coli strain CT1061, an arcA and creC constitutive 
mutant, has enhanced carbon source consumption as well as a reducing intracellular 
environment (characterized by a high NADH/NAD+ ratio, ca. 1 mol · mol-1), making it 
adequate as a candidate host for reduced biochemical synthesis (Nikel et al., 2008a). 
Introduction of the PHB biosynthetic genes from Azotobacter sp. strain FA8 in E. coli CT1061 
resulted in increased PHB yield from glucose- or glycerol-supplemented semi-synthetic 
media, associated to the highly reduced redox state in this strain (Nikel et al., 2006b). 
Another approach, based on the same rationale, was the use of anaerobic promoters to 
achieve PHB production under micro- or anaerobic conditions. Among the promoters 
tested, the one for E. coli alcohol dehydrogenase was the most effective in promoting micro-
aerobic synthesis of PHB (Wei et al., 2009). 
2.2.2 Metabolic engineering of PHA biosynthesis 
Industrial microorganisms have been traditionally developed via multiple rounds of random 
mutagenesis followed by selection of desired phenotypes. However, these techniques do not 
take into account important features of the bioprocess itself, inter alia, increased 
sustainability. Approaches for microbial synthesis of valuable bioproducts have increasingly 
evolved towards more systematic strategies. Metabolic Engineering is a multidisciplinary 
field defined as the directed improvement of product(s) synthesis or cellular properties 
through the rationale modification of specific biochemical reaction(s), or the introduction of 
new one(s), as well as manipulating regulatory cellular processes (Stephanopoulos, 1999). In 
connection with this concept, Synthetic Biology is a newly coined term which defines a 
group of methodologies aimed at creating novel functional parts, modules, systems, and, 
ultimately, novel (micro)organisms through the integrated use of biological techniques and 
mathematical methods traditionally employed in Engineering designs (Lee et al., 2010). 
Metabolic Engineering and Systems Biology are different from other cellular engineering 
strategies since their systematic approaches focus on understanding the whole metabolic 
network in the cell. As a consequence, they can be used as powerful tools to increase 
bioprocess sustainability by taking into account different cellular and process features at the 
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same time. Metabolic Engineering is characterized by a cyclic process involving evaluation 
of metabolic performance of cells, establishment of appropriate target(s) for genetic 
engineering, and implementation of genetic modification(s) (Nielsen, 2001). The use of 
analytical tools and metabolic models to study the performance of cells and to identify the 
appropriate target for genetic modification allows distinguishing Metabolic Engineering 
from classical genetic engineering and characterize it as a system approach (Nielsen & 
Jewett, 2008). 
PHAs synthesis is an interesting target for Metabolic Engineering manipulation as both 
polymer assembly and accumulation take place in vivo, offering the chance to optimize 
different metabolic and cellular processes at the same time (Jung et al., 2010; Tyo et al., 
2010). The simplest Metabolic Engineering strategy for PHA synthesis manipulation would 
be to choose the appropriate carbon source(s) supplied to the bacterial host to control and 
direct carbon flux through relevant precursors and polymer biosynthesis enzymes. This 
strategy has traditionally been exploited to modulate polymer composition by varying the 
feed ratio of different substrate precursors (Lütke-Eversloh et al., 2001, Marangoni et al., 
2002). Additionally, knowledge of the metabolic network operation under PHA-producing 
conditions would enable the rational streamlining of catabolic pathways to harness the 
greatest possible amount of carbon source for polymer synthesis. Knowing the distribution 
of fluxes is an important way to improve PHA production process towards efficient (and 
sustainable) polymer accumulation. Intracellular fluxes are quantitative descriptors which 
can be used to choose appropriate targets for modification of the metabolic network activity, 
increasing the formation of a desired product (e.g., PHAs). 
In silico genome scale analysis of metabolic models were also implemented to identify 
potential targets for manipulation and strain improvement of efficient PHA producers. 
Using this approach, Lim et al. (2002) identified zwf and gnd (encoding glucose-6-phosphate 
dehydrogenase and 6-phosphogluconate dehydrogenase, respectively) as relevant targets 
for manipulation in recombinant E. coli to redirect catabolic fluxes towards the pentose 
phosphate pathway, resulting in a high NADPH/NADP+ ratio that favored PHA 
accumulation [up to 41% (wt/wt)]. Another study dealing with in silico metabolic analysis of 
PHB-accumulating E. coli strains showed that the Entner-Doudoroff pathway represents an 
important contribution to PHB synthesis (Hong et al., 2003), a fact also evidenced in 
proteomic analysis (Han et al., 2001). These studies clearly pointed towards the fact that 
choosing the adequate mutant background through systematic analysis of metabolic 
networks allowed the enhancement of PHB production processes. 
A breakthrough in Metabolic Engineering is related to the emergence of 13C-labeling 
methodologies to study the efficiency of complex metabolic networks. As the labeled 
substrate proceeds through the metabolic network, the pools of downstream metabolites 
become labeled and, at steady state, the fraction of labeled substrate in a given pool can be 
used to calculate the flux through that pathway. 13C-based metabolic flux analysis uses the 
labeling information in proteinogenic amino acids to infer the labeling patterns of the 
respective precursor metabolites from central carbon metabolism (Sauer, 2006). The labeling 
information can be determined either by gas chromatography-mass spectrometry or nuclear 
magnetic resonance spectroscopy. The resulting labeling information is used as additional 
constraints for metabolic network models that utilize the biochemical stoichiometry, the 
substrate uptake, product secretion, and biomass formation rates to compute the 
intracellular flux distribution. Two alternative labeling information interpretation methods 
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Advances in Applied Biotechnology 
 
50
are used: comprehensive isotopomer modeling (Wiechert, 2001), and net-flux calculation 
utilizing results from metabolic flux ratio analysis (Fischer et al., 2004). 
Metabolic networks are not the only targets for rational design of sustainable PHA 
production processes. In fact, regulatory circuits within the cell can be manipulated in order 
to obtain a desirable phenotype. Signal transduction pathways are involved in intercellular 
interactions and communication of extracellular conditions to the interior of the cell. The 
final outcome of such a signaling pathway is often the activation of specific transcription 
factor(s) that, in turn, control(s) gene expression. As stated before, in E. coli aerobic and 
anaerobic respiration, as well as fermentation pathways, are switched on and off by the 
ArcAB system, enabling bacterial cells to optimize energy generation according to the 
oxygen levels in the surrounding medium, and CreBC is responsive to the carbon source 
used and oxygen availability. Metabolic flux analysis based on 13C-labelling showed that 
both ArcAB and CreBC systems have a deep impact on central metabolic pathways of E. coli 
under micro-aerobic growth conditions (Nikel et al., 2009), offering valuable information for 
rationale modification of regulatory networks aimed at polymer (and other bioproducts) 
synthesis. These results highlighted the idea that manipulation of the genes encoding global 
regulators could provide a relevant tool for the modulation of central metabolism and 
reducing power availability for biotechnological purposes, rather than manipulating the 
genes directly involved in the metabolic pathway of interest. 
2.3 Bioprocesses and downstream processing 
During the bioprocess conducing to PHAs production, energy is needed for the generation 
of steam used for sterilization, aeration and agitation in the reactor, and downstream 
processing. Several strategies which aimed to enhance both the polymer yield and the 
process sustainability by means of diminishing energy consumption were developed. 
Bacterial growth in the reactor was the target of these attempts, which were specially 
centered on two key aspects: (i) the growth of recombinant E. coli (facultative aerobe) under 
conditions not fully aerobic, thus decreasing aeration and agitation needs, and (ii) the 
development of mixed cultures, which circumvents sterilization. 
Carlson et al. (2005) observed that recombinant E. coli DH5α carrying the pha genes from R. 
eutropha can support PHB accumulation in anaerobiosis when grown in rich media. The 
authors also developed a theoretical model of the biochemical network to interpret the 
experimental results and to study the metabolic capabilities of E. coli under anaerobic 
conditions. One of the few reports in the scientific literature on fed-batch cultivation in 
micro-aerobiosis describes a process for the synthesis of PHB developed under these 
conditions using glycerol as substrate and the concomitant synthesis of a valuable by-
product, bio-ethanol, during micro-aerobic PHB accumulation. Micro-aerobic fed-batch 
cultures allowed a 2.57-fold increase in volumetric productivity when compared with batch 
cultures, attaining a PHB content of 51% (wt/wt) (Nikel et al., 2008b). In this work, the 
authors introduced the pha genes from Azotobacter sp. strain FA8 into an arcA creC mutant of 
E. coli, unregulated for redox control and carbon catabolism. In a fed-batch aerobic 
cultivation of a recombinant E. coli it was also reported that a PHB content of 80% (wt/wt) 
was obtained with oxygen limitation and a small increase in agitation using milk whey as 
the main carbon source (Kim, 2000). 
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An alternative to fed-batch processes to produce PHA from waste materials is the use of 
open microbial mixed cultures (MMCs). MMCs are microbial populations, often with 
unknown composition, selected by the operational conditions imposed on the biological 
system (currently referred to as "feast and famine", or aerobic dynamic feeding) resulting on 
polymer accumulation not induced by nutrient limitation. This system reduces bioreactor 
and operation costs, including sterilization, and is suitable for the use of agroindustrial 
wastes with unknown or variable composition (Serafim et al., 2008). Studies using sugarcane 
molasses in MMCs showed that by controlling the concentration of the influent substrate in 
the bioreactor, 88% of the working microorganisms accumulated PHA up to 74.5% (wt/wt) 
(Albuquerque et al., 2010), corresponding to a PHA concentration of ca. 5.1 g · L-1. MMC 
have been extensively studied, including the implementation of different strategies to 
manipulate the polymer monomer composition (Albuquerque et al., 2011). MMCs allow the 
use of already existing wastewater treatment plants to produce PHA but require long 
operation periods, on the opposite of some existing processes. The choice of one or another 
operational mode (i.e., fed-batch or MMC) as a sustainable process depends on the scenario 
of each region. 
As stated before, PHB and related copolymers are produced in Brazil in a bioprocess facility 
integrated into a sugarcane mill. The energy necessary for the production process is 
provided by waste biomass. Carbon dioxide emissions to the environment are 
photosynthetically assimilated by the sugarcane crop and liquid wastes are recycled to the 
cane fields (Nonato et al., 2001). 
Considering downstream processing, the recovery of PHAs usually demand a considerable 
energy input for centrifugation and cell disruption (Harding et al., 2007).  Several strategies 
have been used to diminish the downstream processing costs and the toxic effects of organic 
solvents traditionally used for polymer solubilization (Berger et al., 1989). The methods 
based on non-PHA cell mass dissolution are considered a smart alternative (Kapritchkoff et 
al., 2006; Martínez et al., 2011). These methods, extensively reviewed by Jacquel et al. (2008), 
utilize alkali, enzymes, slightly acid solutions, and different pre-treatments. Among the 
recent achievements in this area, there is a new method based on dissolution of non-PHA 
cell mass by protons in aqueous solution and the crystallization of PHAs (Yu & Chen, 2006). 
By applying these conditions, high purity (97.9%) and high recovery yield (98.7%) were 
obtained. 
An eventual breakthrough in polymer recovery could be the generation of a suitable mutant 
of Alcanivorax borkumensis characterized by the extracellular deposition of MCL-PHA when 
grown on alkanes, allowing the recovery of the polymer from the culture medium (Sabirova 
et al., 2006). 
2.4 Tailor made polymers 
Microbiologists have the skills to engineer bacteria for the production of tailored polymeric 
reserve materials (Hunter, 2010). Since the discovery that some bacteria can incorporate 3-
hydroxyalkanoates bearing functional groups from related substrates (Lenz et al., 1992), 
research has led to structural diversification of PHAs by modulated processes during 
biosynthesis and chemical modifications (Hazer & Steinbüchel, 2007). Holmes et al. (1984) 
described the controlled synthesis of P(HB-co-HV) in R. eutropha, in which the 3-
hydroxyvalerate fraction in the polymer could be controlled by the concentration of 
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propionate in the growth medium. After the discovery of poly(3-hydroxyoctanoate-co-3-
hydroxyhexanoate) in octane-grown Pseudomonas oleovorans (de Smet et al., 1983), the range 
of different constituents of PHAs expanded rapidly, and ca. 200 different PHA monomers 
have been identified (Steinbüchel & Lütke-Eversloh, 2003). However, the most commonly 
applied route for tailoring PHAs is their in situ functionalization by biosynthetically 
producing side chains with terminal double bonds followed by chemistry (revised in Scholz, 
2010). PHAs with terminal double bonds were first described by Lageveen et al. (1988) and 
received a lot of follow-up research (Fritzsche et al., 1990; Hartmann et al., 2006; Park et al., 
1998). In Pseudomonads, PHAs that are formed from glycerol, gluconate, or related sugars 
have a different composition with respect to PHAs obtained from fatty acids. Whereas the 
latter PHAs have 3-hydroxyoctanoate as the main constituent, sugar-grown cells accumulate 
PHAs in which 3-hydroxydecanoate is the main constituent, along with small amounts of 
unsaturated monomers (Huijberts et al., 1992). 
The resulting tailor-made structural and material properties have positioned PHAs well to 
contribute to the manufacturing of second and third generation biomaterials for medical 
applications, which require a variety of tailor-made chemical architectures, physical 
properties, and surface characteristics (Chen, 2009; Escapa et al., 2011). Bacterial copolyesters 
with vinyl groups have attracted attention because the unsaturated terminal group is highly 
reactive when compared to other terminal groups. The evaluation of different plant oils as 
carbon source for PHA production by Pseudomonas spp. revealed the possibility of tailored 
synthesis of these polymers containing variable molar fractions of unsaturated monomers in a 
sustainable way (Silva-Queiroz et al., 2009). Some studies described the biosynthesis of alkyl 
esters substituted MCL-PHA (Scholz et al., 1994), as well as PHAs containing sulphur-groups 
in the side chains, comprising either thiophenoxy functional groups (Takagi et al., 1999), or 
thioesther groups (Ewering et al., 2002). Moreover, biopolymers with thioester linkages in the 
polymer backbone, containing 3-mercaptopropionate or 3-mercaptobutyrate in addition to 3-
hydroxybutyrate as the monomer constituents, were isolated from R. eutropha (Lütke-Eversloh 
et al., 2002). Molecular biology strategies designed to increase the production of MCL-PHA in 
Pseudomonas was firstly described in P. putida U (García et al., 1999). The existence in the 
genome of this strain of several sets of iso-enzymes encoding genes similar to those belonging 
to the fad regulon from E. coli from the β-oxidation of fatty acids have been described (Olivera 
et al., 2001a, 2001b). Engineered strains carrying mutations in the fadA-fadB genes had a strong 
intracellular accumulation of biopolyesters. Furthermore, the application of this strategy 
resulted in an over-accumulation of functionalized MCL-PHAs bearing aromatic side groups 
(Olivera et al., 2001b). 
Similarly, the existence of several sets of fad genes in the model microorganism P. putida 
KT2440 has been mentioned in the literature, which is in agreement with the huge metabolic 
versatility of this strain (Nelson et al., 2002). When the fadA and fadB genes were knocked-
out in its derived strain P. putida KT2442, PHAs with a higher fraction of long chain length 
monomers than the wild type, or even containing monomers with thioester-groups were 
produced (Escapa et al., 2011; Ouyang et al., 2007). Interestingly, terminal oxo- or thio-ester 
groups could undergo trans-esterifications reactions (Escapa et al., 2011). 
3. Applications 
The versatile copolymer P(HB-co-HV) was initially manufactured as shampoo bottles and 
other cosmetic containers (Hocking & Marchessault, 1994). Later on, pens, cups, and 
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packaging elements (e.g., films) made with PHAs also appeared in the market. PHAs are 
biocompatible and for this reason they have also attracted attention as raw material to be 
used in medical devices (Wu et al., 2009). Being composed by R-(—) monomers, PHAs are a 
source of chiral compounds with a high demand from the pharmaceutical industries (Chen 
& Wu, 2005). However, the manufacture of PHAs is carried out at small facilities and, as a 
consequence, it lacks the economic benefit of a large scale production (Chanprateep, 2010). 
A complete description of the goods produced as prototypes or already traded is presented 
by Philip et al. (2007). 
4. Future research 
- The technical potential substitution of plastic applications (thermoplastic and 
thermosets) and man-made fibers (e.g., staple fibers and filaments) by bio-based plastics 
have been estimated based on their typical physical properties. The potential of 
biobased plastics for replacement of petrochemical plastics is 90%, corresponding to 240 
million tons per year. PHA would respond for ca. 30 million tons (Akaraonye et al., 
2010). Realizing this potential represents a great challenge, especially in a sustainable 
way. 
- Bacterial growth in bioreactors needs an ad fundum understanding of microbial 
physiology and regulatory processes in order to select cultivation conditions aimed at 
an enhanced energy-saving process. All the attempts to grow PHA microbial producers 
under low oxygen supply provide an interesting starting point for these processes, but 
polymer yields are lower than those obtained under aerobic conditions. Additional 
process development and optimization are needed to achieve high PHA volumetric 
productivities and polymer content. 
- The use of industrial and agricultural by-products is certainly needed for sustainability. 
However, high amounts of energy are still needed for production, extraction, and 
purification of PHAs. Hence, the definition of renewable energy sources will be also 
quite important. 
- Metabolic-Engineering driven approaches should be a relevant tool to establish 
processes allowing to reach PHA yields close to the theoretical maximum from a given 
carbon source. Considering the relevance of carbon source on PHAs production cost, it 
will be important to explore the full metabolic potential of microbial cells. 
- The great diversity of monomers detected as PHAs constituents is certainly the feature 
determining their great potential for technical replacement of petrochemical 
thermoplastics. Therefore, directed evolution of enzymes involved in PHA biosynthesis 
and Metabolic Engineering approaches of bacterial hosts will be the driving force to 
establish bioprocesses for the controlled production of PHAs with monomer 
composition à la carte and hence suitable for a number of applications. The potential of 
technical replacement could even be increased as the outcome of intensive scientific and 
technological work to explore the diversity of PHAs composition. 
- Systems-level analysis of metabolic, signaling, and regulatory networks makes it 
possible to comprehensively understand global physiological processes taking place in 
PHA-accumulating E. coli strains. New targets and strategies for the improvement of 
PHA production will certainly be developed in the next future, including tailor-made 
PHAs with desired monomer compositions and Mrs. Ideally, and in order to design a 
completely sustainable PHA production process, strains developed using these system-
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based approaches should be further metabolically engineered to produce PHAs up to a 
sufficiently high polymer content with high productivity from the most inexpensive 
carbon source through fine-controlled fermentation schemes. 
Despite these great challenges, the current scenario is highly promising for the development 
of sustainable PHA production bioprocesses which could fulfill our needs for biopolymers 
applications. 
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based approaches should be further metabolically engineered to produce PHAs up to a 
sufficiently high polymer content with high productivity from the most inexpensive 
carbon source through fine-controlled fermentation schemes. 
Despite these great challenges, the current scenario is highly promising for the development 
of sustainable PHA production bioprocesses which could fulfill our needs for biopolymers 
applications. 
5. Acknowledgments 
This work was supported by the Ibero-American Programme for Science, Technology, and 
Development (CYTED). The authors are members of a CYTED network. 
6. References 
Ahn, W.S.; Park, S.J. & Lee, S.Y. (2000). Production of Poly(3-Hydroxybutyrate) by Fed-
Batch Culture of Recombinant Escherichia coli with a Highly Concentrated Whey 
Solution. Applied and Environmental Microbiology, Vol. 66, No. 8, (August 2000), pp. 
3624-3627, ISSN 0099-2240 
Akaraonye, E.; Keshavarz, T. & Roy, I. (2010). Production of Polyhydroxyalkanoates: The 
Future Green Materials of Choice. Journal of Chemical Technology and Biotechnology, 
Vol. 85, No. 6, (June 2010), pp. 732-743, ISSN 1097-4660 
Albuquerque, M.G.E.; Concas, S., Bengtsson, S. & Reis, M.A.M. (2010). Mixed Culture 
Polyhydroxyalkanoates Production from Sugar Molasses: The Use of a 2-Stage 
CSTR System for Culture Selection. Bioresource Technology, Vol. 101, No. 18, 
(September 2010), pp. 7112-7122, ISSN 0960-8524 
Albuquerque, M.G.E.; Martino, V., Pollet, E., Avérous, L. & Reis, M.A.M. (2011). Mixed 
Culture Polyhydroxyalkanoate (PHA) Production from Volatile Fatty Acid (VFA)-
Rich Streams: Effect of Substrate Composition and Feeding Regime on PHA 
Productivity, Composition and Properties. Journal of Biotechnology, Vol. 151, No. 1, 
(January 2011), pp. 66-76, ISSN 0168-1656 
Aldor, I.S. & Keasling, J.S. (2003). Process Design for Microbial Plastic Factories: Metabolic 
Engineering of Polyhydroxyalkanoates. Current Opinion in Biotechnology, Vol. 14, 
No. 5, (October 2003), pp. 475-483, ISSN 0958-1669 
Ashby, R.D.; Solaiman, D.K.Y. & Foglia, T. (2005). Synthesis of Short-/Medium-Chain-
Length Poly(Hydroxyalkanoate) Blends by Mixed Culture Fermentation of 
Glycerol. Biomacromolecules, Vol. 6, No. 4, (July 2005), pp. 2106-2112, ISSN 1525-7797 
Avison, M.B.; Horton, R.E., Walsh, T.R. & Bennett, P.M. (2001). Escherichia coli CreBC Is a 
Global Regulator of Gene Expression That Responds to Growth in Minimal Media. 
Journal of Biological Chemistry, Vol. 276, No. 29, (July 2001), pp. 26955-26961, ISSN 
0021-9258 
Beaulieu, M.; Beaulieu, Y., Mélinard, J., Pandian, S. & Goulet, J. (1995). Influence of 
Ammonium Salts and Cane Molasses on Growth of Alcaligenes eutrophus and 
Production of Polyhydroxybutyrate. Applied and Environmental Microbiology, Vol. 
61, No. 1, (January 1995), pp. 165-169, ISSN 0099-2240 
Berger, E.; Ramsay, B.A., Ramsay, J.A., Chavarie, C. & Braunegg, G. (1989). PHB Recovery 
by Hypochlorite Digestion of Non-PHB Biomass. Biotechnology Techniques, Vol. 3, 
No. 4, (April 1989), pp. 227-232, ISSN 0951-208X 
Making Green Polymers Even Greener: 
Towards Sustainable Production of Polyhydroxyalkanoates from Agroindustrial By-Products 
 
55 
Borman, E.J. & Roth, M. (1999). The Production of Polyhydroxybutyrate by Methylobacterium 
rhodesianum and Ralstonia eutropha in Media Containing Glycerol and Casein 
Hydrolysates. Biotechnology Letters, Vol. 21, No. 12, (December 1999), pp. 1059-1063, 
ISSN 0141-5492 
Carlson, R.; Wlaschin, A. & Srienc, F. (2005). Kinetic Studies and Biochemical Pathway 
Analysis of Anaerobic Poly-(R)-3-Hydroxybutyric Acid Synthesis in Escherichia coli. 
Applied and Environmental Microbiology, Vol. 71, No. 2, (February 2005), pp. 713-720, 
ISSN 0099-2240 
Cavalheiro, J.M.B.T.; de Almeida, M.C.M.D., Grandfils, C. & da Fonseca, M.M.R. (2009). 
Poly(3-Hydroxybutyrate) Production by Cupriavidus necator Using Waste Glycerol. 
Process Biochemistry, Vol. 44, No. 5, (May 2009), pp. 509-515, ISSN 1359-5113 
Çelik, G.Y.; Beyatli, Y. & Aslim, B. (2005). Determination of Poly-β-Hydroxybutyrate (PHB) 
in Sugarbeet Molasses by Pseudomonas cepacia G13 Strain. Zuckerindustrie, Vol. 130, 
No. 3, (March 2005), pp. 201-203, ISSN 0344-8657 
Chanprateep, S. (2010). Current Trends in Biodegradable Polyhydroxyalkanoates. Journal of 
Bioscience and Bioengineering, Vol. 110, No. 6, (December 2010), pp. 621-632, ISSN 
1389-1723 
Chen, G.G.Q. & Wu, Q. (2005). Microbial Production and Applications of Chiral 
Hydroxyalkanoates. Applied Microbiology and Biotechnology, Vol. 67, No. 5, (June 
2005), pp. 592-599, ISSN 0175-7598 
Chen, G.G.Q. (2009). A Microbial Polyhydroxyalkanoates (PHA) Based Bio- and Materials 
Industry. Chemical Society Reviews, Vol. 38, No. 8, (August 2009), pp. 2434-2446, 
ISSN 0306-0012 
Corti, A.; Muniyasamy, S., Vitali, M., Imam, S.H. & Chiellini, E. (2010). Oxidation and 
Biodegradation of Polyethylene Films Containing Pro-Oxidant Additives: 
Synergistic Effects of Sunlight Exposure, Thermal Aging and Fungal 
Biodegradation. Polymer Degradation and Stability, Vol. 95, No. 6, (June 2010), pp. 
1106-1114, ISSN 0141-3910 
da Silva, G.P.; Mack, M. & Contiero, J. (2009). Glycerol: A Promising and Abundant Carbon 
Source for Industrial Microbiology. Biotechnology Advances, Vol. 27, No. 1, (January-
February 2009), pp. 30-39, ISSN 0734-9750 
de Almeida, A.; Giordano, A.M., Nikel, P.I. & Pettinari, M.J. (2010). Effects of Aeration on 
the Synthesis of Poly(3-Hydroxybutyrate) from Glycerol and Glucose in 
Recombinant Escherichia coli. Applied and Environmental Microbiology, Vol. 76, No. 6, 
(March 2010), pp. 2036-2040, ISSN 0099-2240 
de Smet, M.J.; Eggink, G., Witholt, B., Kingma, J. & Wynberg, H. (1983). Characterization of 
Intracellular Inclusions Formed by Pseudomonas oleovorans During Growth on 
Octane. Journal of Bacteriology, Vol. 154, No. 2, (May 1983), pp. 870-878, ISSN 0021-
9193 
Escapa, I.F.; Morales, V., Martino, V.P., Pollet, E., Avérous, L., García, J.L. & Prieto, M.A. 
(2011). Disruption of β-Oxidation Pathway in Pseudomonas putida KT2442 to 
Produce New Functionalized PHAs with Thioester Groups. Applied Microbiology 
and Biotechnology, Vol. 89, No. 5, (March 2011), pp. 1583-1598, ISSN 0175-7598 
Ewering, C.; Lütke-Eversloh, T., Luftmann, H. & Steinbüchel, A. (2002). Identification of 
Novel Sulfur-Containing Bacterial Polyesters: Biosynthesis of Poly(3-Hydroxy-S-
Propyl-ω-Thioalkanoates) Containing Thioether Linkages in the Side Chains. 
Microbiology, Vol. 148, No. 5, (May 2002), pp. 1397-1406, ISSN 1350-0872 
 
Advances in Applied Biotechnology 
 
56
Fischer, E.; Zamboni, N. & Sauer, U. (2004). High-Throughput Metabolic Flux Analysis Based 
on Gas Chromatography-Mass Spectrometry Derived 13C Constraints. Analytical 
Biochemistry, Vol. 325, No. 2, (February 2004), pp. 308-316, ISSN 0003-2697 
Fritzsche, K.; Lenz, R.W. & Fuller, R.C. (1990). Production of Unsaturated Polyesters by 
Pseudomonas oleovorans. International Journal of Biological Macromolecules, Vol. 12, No. 
2, (April 1990), pp. 85-91, ISSN 0141-8130 
García, B.; Olivera, E.R., Miñambres, B., Fernández-Valverde, M., Cañedo, L.M., Prieto, 
M.A., García, J.L., Martínez, M. & Luengo, J.M. (1999). Novel Biodegradable 
Aromatic Plastics from a Bacterial Source. Genetic and Biochemical Studies on a 
Route of the Phenylacetyl-CoA Catabolon. Journal of Biological Chemistry, Vol. 274, 
No. 41, (October 1999), pp. 29228-29241, ISSN 0021-9258 
Gerngross, T.U. (1999). Can Biotechnology Move Us toward a Sustainable Society? Nature 
Biotechnology, Vol. 17, No. 6, (June 1999), pp. 541-544, ISSN 1087-0156 
Han, M.J.; Yoon, S.S. & Lee, S.Y. (2001). Proteome Analysis of Metabolically Engineered 
Escherichia coli Producing Poly(3-Hydroxybutyrate). Journal of Bacteriology, Vol. 183, 
No. 1, (January 2001), pp. 301-308, ISSN 0021-9193 
Harding, K.G.; Dennis, J.S., von Blottnitz, H. & Harrison, S.T.L. (2007). Environmental 
Analysis of Plastic Production Processes: Comparing Petroleum-Based 
Polypropylene and Polyethylene with Biologically Based Poly-β-Hydroxybutyric 
Acid Using Life Cycle Analysis. Journal of Biotechnology, Vol. 130, No. 1, (May 2007), 
pp. 57-66, ISSN 0168-1656 
Hartmann, R.; Hany, R., Pletscher, E., Ritter, A., Witholt, B. & Zinn, M. (2006). Tailor-Made 
Olefinic Medium-Chain-Length Poly[(R)-3-Hydroxyalkanoates] by Pseudomonas 
putida GPo1: Batch versus Chemostat Production. Biotechnology and Bioengineering, 
Vol. 93, No. 4, (March 2006), pp. 737-746, ISSN 1097-0290 
Hazer, B. & Steinbüchel, A. (2007). Increased Diversification of Polyhydroxyalkanoates by 
Modification Reactions for Industrial and Medical Applications. Applied 
Microbiology and Biotechnology, Vol. 74, No. 1, (February 2007), pp. 1-12, ISSN 0175-
7598 
Hocking, P.J. & Marchessault, R.H. (1994). Biopolyesters, In: Chemistry and Technology of 
Biodegradable Polymers, G.J.L. Griffin, (Ed.), pp. 48-96, Blackie Academic & 
Professional, ISBN 0-7514-0003-3, Glasgow, United Kingdom 
Holmes, P.A.; Collins, S.H. & Wright, L.F. (1984). 3-Hydroxybutyrate Polymers. U.S. Patent 
4,477,654, (October 1984)  
Hong, S.H.; Park, S.J., Moon, S.Y., Park, J.P. & Lee, S.Y. (2003). In Silico Prediction and 
Validation of the Importance of the Entner-Doudoroff Pathway in Poly(3-
Hydroxybutyrate) Production by Metabolically Engineered Escherichia coli. 
Biotechnology and Bioengineering, Vol. 83, No. 7, (September 2003), pp. 854-863, ISSN 
1097-0290 
Horng, Y.T.; Chang, K.C., Chien, C.C., Wei, Y.H., Sun, Y.M. & Soo, P.C. (2010). Enhanced 
Polyhydroxybutyrate (PHB) Production via the Coexpressed phaCAB and vgb Genes 
Controlled by Arabinose PBAD Promoter in Escherichia coli. Letters in Applied 
Microbiology, Vol. 50, No. 2, (February 2010), pp. 158-167, ISSN 1472-765X 
Horng, Y.T.; Chien, C.C., Wei, Y.H., Chen, S.Y., Lan, J.C., Sun, Y.M. & Soo, P.C. (2011). 
Functional cis-Expression of phaCAB Genes for Poly(3-Hydroxybutyrate) 
Production by Escherichia coli. Letters in Applied Microbiology, Vol. 52, No. 5, (May 
2011), pp. 475-483, ISSN 1472-765X 
Making Green Polymers Even Greener: 
Towards Sustainable Production of Polyhydroxyalkanoates from Agroindustrial By-Products 
 
57 
Huijberts, G.N.; Eggink, G., de Waard, P., Huisman, G.W. & Witholt, B. (1992). Pseudomonas 
putida KT2442 Cultivated on Glucose Accumulates Poly(3-Hydroxyalkanoates) 
Consisting of Saturated and Unsaturated Monomers. Applied and Environmental 
Microbiology, Vol. 58, No. 2, (February 1992), pp. 536-544, ISSN 0099-2240 
Hunter, P. (2010). Can Bacteria Save the Planet? EMBO Reports, Vol. 11, No. 4, (April 2010), 
pp. 266-269, ISSN 1469-221X 
Ibrahim, M.H.A. & Steinbüchel, A. (2009). Poly(3-Hydroxybutyrate) Production from 
Glycerol by Zobellella denitrificans MW1 via High-Cell-Density Fed-Batch 
Fermentation and Simplified Solvent Extraction. Applied and Environmental 
Microbiology, Vol. 75, No. 19, (October 2009), pp. 6222-6231, ISSN 0099-2240 
Jacquel, N.; Lo, C.W., Wei, Y.H., Wu, H.S. & Wang, S.S. (2008). Isolation and Purification of 
Bacterial Poly(3-Hydroxyalkanoates). Biochemical Engineering Journal, Vol. 39, No. 1, 
(April 2008), pp. 15-27, ISSN 1369-703X 
Jung, Y.K.; Lee, S.Y. & Tam, T.T. (2010). Towards Systems Metabolic Engineering of PHA 
Producers, In: Plastics from Bacteria: Natural Functions and Applications, G.G.Q. Chen, 
(Ed.), pp. 63-84, Springer-Verlag, ISBN 978-3-642-03286-8, Berlin, Germany 
Kapritchkoff, F.M.; Viotti, A.P., Alli, R.C.P., Zuccolo, M., Pradella, J.G.C., Maiorano, A.E., 
Miranda, E.A. & Bonomi, A. (2006). Enzymatic Recovery and Purification of 
Polyhydroxybutyrate Produced by Ralstonia eutropha. Journal of Biotechnology, Vol. 
122, No. 4, (April 2006), pp. 453-462, ISSN 0168-1656 
Keshavarz, T. & Roy, I. (2010). Polyhydroxyalkanoates: Bioplastics with a Green Agenda. 
Current Opinion in Microbiology, Vol. 13, No. 3, (June 2010), pp. 321-326, ISSN 1369-
5274 
Kim, B.S. (2000). Production of Poly(3-Hydroxybutyrate) from Inexpensive Substrates. 
Enzyme and Microbial Technology, Vol. 27, No. 10, (December 2000), pp. 774-777, 
ISSN 0141-0229 
Kim, S. & Dale, B.E. (2005). Lifecycle Assessment Study of Biopolymer 
(Polyhydroxyalkanoates) - Derived from No-Tilled Corn. The International Journal of 
Life Cycle Assessment, Vol. 10, No. 3, (May 2005), pp. 200-210, ISSN 0948-3349 
Koller, M.; Bona, R., Braunegg, G., Hermann, C., Horvat, P., Kroutil, M., Martinz, J., Neto, J., 
Pereira, L. & Varila, P. (2005). Production of Polyhydroxyalkanoates from 
Agricultural Waste and Surplus Materials. Biomacromolecules, Vol. 6, No. 2, (March 
2005), pp. 561-565, ISSN 1525-7797 
Koller, M.; Hesse, P., Bona, R., Kutschera, C., Atlić, A. & Braunegg, G. (2007). Potential of 
Various Archae- and Eubacterial Strains as Industrial Polyhydroxyalkanoate 
Producers from Whey. Macromolecular Bioscience, Vol. 7, No. 2, (February 2007), pp. 
218-226, ISSN 1616-5195 
Koller, M.; Bona, R., Chiellini, E., Grillo-Fernandes, E., Horvat, P., Kutschera, C., Hesse, P. & 
Braunegg, G. (2008). Polyhydroxyalkanoate Production from Whey by Pseudomonas 
hydrogenovora. Bioresource Technology, Vol. 99, No. 11, (July 2008), pp. 4854-4863, 
ISSN 0960-8524 
Kulpreecha, S.; Boonruangthavorn, A., Meksiriporn, B. & Thongchul, N. (2009). Inexpensive 
Fed-Batch Cultivation for High Poly(3-Hydroxybutyrate) Production by a New 
Isolate of Bacillus megaterium. Journal of Bioscience and Bioengineering, Vol. 107, No. 3, 
(March 2009), pp. 240-245, ISSN 1389-1723 
Lageveen, R.G.; Huisman, G.W., Preusting, H., Ketelaar, P., Eggink, G. & Witholt, B. (1988). 
Formation of Polyesters by Pseudomonas oleovorans: Effect of Substrates on 
Formation and Composition of Poly-(R)-3-Hydroxyalkanoates and Poly-(R)-3-
 
Advances in Applied Biotechnology 
 
56
Fischer, E.; Zamboni, N. & Sauer, U. (2004). High-Throughput Metabolic Flux Analysis Based 
on Gas Chromatography-Mass Spectrometry Derived 13C Constraints. Analytical 
Biochemistry, Vol. 325, No. 2, (February 2004), pp. 308-316, ISSN 0003-2697 
Fritzsche, K.; Lenz, R.W. & Fuller, R.C. (1990). Production of Unsaturated Polyesters by 
Pseudomonas oleovorans. International Journal of Biological Macromolecules, Vol. 12, No. 
2, (April 1990), pp. 85-91, ISSN 0141-8130 
García, B.; Olivera, E.R., Miñambres, B., Fernández-Valverde, M., Cañedo, L.M., Prieto, 
M.A., García, J.L., Martínez, M. & Luengo, J.M. (1999). Novel Biodegradable 
Aromatic Plastics from a Bacterial Source. Genetic and Biochemical Studies on a 
Route of the Phenylacetyl-CoA Catabolon. Journal of Biological Chemistry, Vol. 274, 
No. 41, (October 1999), pp. 29228-29241, ISSN 0021-9258 
Gerngross, T.U. (1999). Can Biotechnology Move Us toward a Sustainable Society? Nature 
Biotechnology, Vol. 17, No. 6, (June 1999), pp. 541-544, ISSN 1087-0156 
Han, M.J.; Yoon, S.S. & Lee, S.Y. (2001). Proteome Analysis of Metabolically Engineered 
Escherichia coli Producing Poly(3-Hydroxybutyrate). Journal of Bacteriology, Vol. 183, 
No. 1, (January 2001), pp. 301-308, ISSN 0021-9193 
Harding, K.G.; Dennis, J.S., von Blottnitz, H. & Harrison, S.T.L. (2007). Environmental 
Analysis of Plastic Production Processes: Comparing Petroleum-Based 
Polypropylene and Polyethylene with Biologically Based Poly-β-Hydroxybutyric 
Acid Using Life Cycle Analysis. Journal of Biotechnology, Vol. 130, No. 1, (May 2007), 
pp. 57-66, ISSN 0168-1656 
Hartmann, R.; Hany, R., Pletscher, E., Ritter, A., Witholt, B. & Zinn, M. (2006). Tailor-Made 
Olefinic Medium-Chain-Length Poly[(R)-3-Hydroxyalkanoates] by Pseudomonas 
putida GPo1: Batch versus Chemostat Production. Biotechnology and Bioengineering, 
Vol. 93, No. 4, (March 2006), pp. 737-746, ISSN 1097-0290 
Hazer, B. & Steinbüchel, A. (2007). Increased Diversification of Polyhydroxyalkanoates by 
Modification Reactions for Industrial and Medical Applications. Applied 
Microbiology and Biotechnology, Vol. 74, No. 1, (February 2007), pp. 1-12, ISSN 0175-
7598 
Hocking, P.J. & Marchessault, R.H. (1994). Biopolyesters, In: Chemistry and Technology of 
Biodegradable Polymers, G.J.L. Griffin, (Ed.), pp. 48-96, Blackie Academic & 
Professional, ISBN 0-7514-0003-3, Glasgow, United Kingdom 
Holmes, P.A.; Collins, S.H. & Wright, L.F. (1984). 3-Hydroxybutyrate Polymers. U.S. Patent 
4,477,654, (October 1984)  
Hong, S.H.; Park, S.J., Moon, S.Y., Park, J.P. & Lee, S.Y. (2003). In Silico Prediction and 
Validation of the Importance of the Entner-Doudoroff Pathway in Poly(3-
Hydroxybutyrate) Production by Metabolically Engineered Escherichia coli. 
Biotechnology and Bioengineering, Vol. 83, No. 7, (September 2003), pp. 854-863, ISSN 
1097-0290 
Horng, Y.T.; Chang, K.C., Chien, C.C., Wei, Y.H., Sun, Y.M. & Soo, P.C. (2010). Enhanced 
Polyhydroxybutyrate (PHB) Production via the Coexpressed phaCAB and vgb Genes 
Controlled by Arabinose PBAD Promoter in Escherichia coli. Letters in Applied 
Microbiology, Vol. 50, No. 2, (February 2010), pp. 158-167, ISSN 1472-765X 
Horng, Y.T.; Chien, C.C., Wei, Y.H., Chen, S.Y., Lan, J.C., Sun, Y.M. & Soo, P.C. (2011). 
Functional cis-Expression of phaCAB Genes for Poly(3-Hydroxybutyrate) 
Production by Escherichia coli. Letters in Applied Microbiology, Vol. 52, No. 5, (May 
2011), pp. 475-483, ISSN 1472-765X 
Making Green Polymers Even Greener: 
Towards Sustainable Production of Polyhydroxyalkanoates from Agroindustrial By-Products 
 
57 
Huijberts, G.N.; Eggink, G., de Waard, P., Huisman, G.W. & Witholt, B. (1992). Pseudomonas 
putida KT2442 Cultivated on Glucose Accumulates Poly(3-Hydroxyalkanoates) 
Consisting of Saturated and Unsaturated Monomers. Applied and Environmental 
Microbiology, Vol. 58, No. 2, (February 1992), pp. 536-544, ISSN 0099-2240 
Hunter, P. (2010). Can Bacteria Save the Planet? EMBO Reports, Vol. 11, No. 4, (April 2010), 
pp. 266-269, ISSN 1469-221X 
Ibrahim, M.H.A. & Steinbüchel, A. (2009). Poly(3-Hydroxybutyrate) Production from 
Glycerol by Zobellella denitrificans MW1 via High-Cell-Density Fed-Batch 
Fermentation and Simplified Solvent Extraction. Applied and Environmental 
Microbiology, Vol. 75, No. 19, (October 2009), pp. 6222-6231, ISSN 0099-2240 
Jacquel, N.; Lo, C.W., Wei, Y.H., Wu, H.S. & Wang, S.S. (2008). Isolation and Purification of 
Bacterial Poly(3-Hydroxyalkanoates). Biochemical Engineering Journal, Vol. 39, No. 1, 
(April 2008), pp. 15-27, ISSN 1369-703X 
Jung, Y.K.; Lee, S.Y. & Tam, T.T. (2010). Towards Systems Metabolic Engineering of PHA 
Producers, In: Plastics from Bacteria: Natural Functions and Applications, G.G.Q. Chen, 
(Ed.), pp. 63-84, Springer-Verlag, ISBN 978-3-642-03286-8, Berlin, Germany 
Kapritchkoff, F.M.; Viotti, A.P., Alli, R.C.P., Zuccolo, M., Pradella, J.G.C., Maiorano, A.E., 
Miranda, E.A. & Bonomi, A. (2006). Enzymatic Recovery and Purification of 
Polyhydroxybutyrate Produced by Ralstonia eutropha. Journal of Biotechnology, Vol. 
122, No. 4, (April 2006), pp. 453-462, ISSN 0168-1656 
Keshavarz, T. & Roy, I. (2010). Polyhydroxyalkanoates: Bioplastics with a Green Agenda. 
Current Opinion in Microbiology, Vol. 13, No. 3, (June 2010), pp. 321-326, ISSN 1369-
5274 
Kim, B.S. (2000). Production of Poly(3-Hydroxybutyrate) from Inexpensive Substrates. 
Enzyme and Microbial Technology, Vol. 27, No. 10, (December 2000), pp. 774-777, 
ISSN 0141-0229 
Kim, S. & Dale, B.E. (2005). Lifecycle Assessment Study of Biopolymer 
(Polyhydroxyalkanoates) - Derived from No-Tilled Corn. The International Journal of 
Life Cycle Assessment, Vol. 10, No. 3, (May 2005), pp. 200-210, ISSN 0948-3349 
Koller, M.; Bona, R., Braunegg, G., Hermann, C., Horvat, P., Kroutil, M., Martinz, J., Neto, J., 
Pereira, L. & Varila, P. (2005). Production of Polyhydroxyalkanoates from 
Agricultural Waste and Surplus Materials. Biomacromolecules, Vol. 6, No. 2, (March 
2005), pp. 561-565, ISSN 1525-7797 
Koller, M.; Hesse, P., Bona, R., Kutschera, C., Atlić, A. & Braunegg, G. (2007). Potential of 
Various Archae- and Eubacterial Strains as Industrial Polyhydroxyalkanoate 
Producers from Whey. Macromolecular Bioscience, Vol. 7, No. 2, (February 2007), pp. 
218-226, ISSN 1616-5195 
Koller, M.; Bona, R., Chiellini, E., Grillo-Fernandes, E., Horvat, P., Kutschera, C., Hesse, P. & 
Braunegg, G. (2008). Polyhydroxyalkanoate Production from Whey by Pseudomonas 
hydrogenovora. Bioresource Technology, Vol. 99, No. 11, (July 2008), pp. 4854-4863, 
ISSN 0960-8524 
Kulpreecha, S.; Boonruangthavorn, A., Meksiriporn, B. & Thongchul, N. (2009). Inexpensive 
Fed-Batch Cultivation for High Poly(3-Hydroxybutyrate) Production by a New 
Isolate of Bacillus megaterium. Journal of Bioscience and Bioengineering, Vol. 107, No. 3, 
(March 2009), pp. 240-245, ISSN 1389-1723 
Lageveen, R.G.; Huisman, G.W., Preusting, H., Ketelaar, P., Eggink, G. & Witholt, B. (1988). 
Formation of Polyesters by Pseudomonas oleovorans: Effect of Substrates on 
Formation and Composition of Poly-(R)-3-Hydroxyalkanoates and Poly-(R)-3-
 
Advances in Applied Biotechnology 
 
58
Hydroxyalkenoates. Applied and Environmental Microbiology, Vol. 54, No. 12, 
(December 1988), pp. 2924-2932, ISSN 0099-2240 
Lee, S.Y.; Kim, H.U., Yun, H., Sohn, S.B., Kim, J.S., Palsson, B.Ø., Herrgård, M.J. & Portnoy, 
V.A. (2010). Systems Biology, Genome-Scale Models, and Metabolic Engineering, 
In: The Metabolic Pathway Engineering Handbook - Tools and Applications, C.D. Smolke, 
(Ed.), pp. 15.1-15.11, CRC Press, ISBN 978-1-4200-7765-0, Boca Raton, Florida, 
United States of America 
Lenz, R.W.; Kim, Y.B. & Fuller, R.C. (1992). Production of Unusual Bacterial Polyesters by 
Pseudomonas oleovorans through Cometabolism. FEMS Microbiology Letters, Vol. 103, 
No. 2-4, (December 1992), pp. 207-214, ISSN 1574-6968 
Li, R.; Zhang, H. & Qi, Q. (2007). The Production of Polyhydroxyalkanoates in Recombinant 
Escherichia coli. Bioresource Technology, Vol. 98, No. 12, (September 2007), pp. 2313-
2320, ISSN 0960-8524 
Lim, S.J.; Jung, Y.M., Shin, H.D. & Lee, Y.H. (2002). Amplification of the NADPH-Related 
Genes zwf and gnd for the Oddball Biosynthesis of PHB in an E. coli Transformant 
Harboring a Cloned phbCAB Operon. Journal of Bioscience and Bioengineering, Vol. 
93, No. 6, (October 2002), pp. 543-549, ISSN 1389-1723 
Lütke-Eversloh, T.; Bergander, K., Luftmann, H. & Steinbüchel, A. (2001). Biosynthesis of 
Poly(3-Hydroxybutyrate-co-3-Mercaptobutyrate) as a Sulfur Analogue to Poly(3-
Hydroxybutyrate) (PHB). Biomacromolecules, Vol. 2, No. 3, (August 2001), pp. 1061-
1065, ISSN 1525-7797 
Lütke-Eversloh, T.; Fischer, A., Remminghorst, U., Kawada, J., Marchessault, R.H., 
Bögershausen, A., Kalwei, M., Eckert, H., Reichelt, R., Liu, S.J. & Steinbüchel, A. 
(2002). Biosynthesis of Novel Thermoplastic Polythioesters by Engineered 
Escherichia coli. Nature Materials, Vol. 1, No. 4, (December 2002), pp. 236-240, ISSN 
1476-1122 
Lynch, A.S. & Lin, E.C.C. (1996). Responses to Molecular Oxygen, In: Escherichia coli and 
Salmonella: Cellular and Molecular Biology, F.C. Neidhardt, R. Curtiss III, J.L. 
Ingraham, E.C.C. Lin, K.B. Low, B. Magasanik, W.S. Reznikoff, M. Riley, M. 
Schaechter, H.E. Umbarger, (Eds.), pp. 1526-1538, ASM Press, ISBN 1-5558-1084-5, 
Washington, D.C., United States of America 
Madden, L.A.; Anderson, A.J., Shah, D.T. & Asrar, J. (1999). Chain Termination in 
Polyhydroxyalkanoate Synthesis: Involvement of Exogenous Hydroxy-Compounds 
as Chain Transfer Agents. International Journal of Biological Macromolecules, Vol. 25, 
No. 1-3, (June 1999), pp. 43-53, ISSN 0141-8130 
Madison, L.L. & Huisman, G.W. (1999). Metabolic Engineering of Poly(3-
Hydroxyalkanoates): From DNA to Plastic. Microbiology and Molecular Biology 
Reviews, Vol. 63, No. 1, (March 1999), pp. 21-53, ISSN 1092-2172 
Mahishi, L.H.; Tripathi, G. & Rawal, S.K. (2003). Poly(3-Hydroxybutyrate) (PHB) Synthesis 
by Recombinant Escherichia coli Harbouring Streptomyces aureofaciens PHB 
Biosynthesis Genes: Effect of Various Carbon and Nitrogen Sources. Microbiological 
Research, Vol. 158, No. 1, (January 2003), pp. 19-27, ISSN 0944-5013 
Marangoni, C.; Furigo Jr., A. & de Aragão, G.M.F. (2002). Production of Poly(3-
Hydroxybutyrate-co-3-Hydroxyvalerate) by Ralstonia eutropha in Whey and 
Inverted Sugar with Propionic Acid Feeding. Process Biochemistry, Vol. 38, No. 2, 
(October 2002), pp. 137-141, ISSN 1359-5113 
Making Green Polymers Even Greener: 
Towards Sustainable Production of Polyhydroxyalkanoates from Agroindustrial By-Products 
 
59 
Martínez, V.; García, P., García, J.L. & Prieto, M.A. (2011). Controlled Autolysis Facilitates 
the Polyhydroxyalkanoate Recovery in Pseudomonas putida KT2440. Microbial 
Biotechnology, Vol. 4, No. 4, (July 2011), pp. 533-547, ISSN 1751-7915 
Nath, A.; Dixit, M., Bandiya, A., Chavda, S. & Desai, A.J. (2008). Enhanced PHB Production 
and Scale up Studies Using Cheese Whey in Fed Batch Culture of Methylobacterium 
sp. ZP24. Bioresource Technology, Vol. 99, No. 13, (September 2008), pp. 5749-5755, 
ISSN 0960-8524 
Nelson, K.E.; Weinel, C., Paulsen, I.T., Dodson, R.J., Hilbert, H., Martins dos Santos, V.A.P., 
Fouts, D.E., Gill, S.R., Pop, M., Holmes, M., Brinkac, L., Beanan, M., DeBoy, R.T., 
Daugherty, S., Kolonay, J., Madupu, R., Nelson, W., White, O., Peterson, J., Khouri, 
H., Hance, I., Chris Lee, P., Holtzapple, E., Scanlan, D., Tran, K., Moazzez, A., 
Utterback, T., Rizzo, M., Lee, K., Kosack, D., Moestl, D., Wedler, H., Lauber, J., 
Stjepandic, D., Hoheisel, J., Straetz, M., Heim, S., Kiewitz, C., Eisen, J.A., Timmis, 
K.N., Düsterhöft, A., Tümmler, B. & Fraser, C.M. (2002). Complete Genome 
Sequence and Comparative Analysis of the Metabolically Versatile Pseudomonas 
putida KT2440. Environmental Microbiology, Vol. 4, No. 12, (December 2002), pp. 799-
808, ISSN 1462-2920 
Nielsen, J. (2001). Metabolic Engineering. Applied Microbiology and Biotechnology, Vol. 55, No. 
3, (April 2001), pp. 263-283, ISSN 0175-7598 
Nielsen, J. & Jewett, M.C. (2008). Impact of Systems Biology on Metabolic Engineering of 
Saccharomyces cerevisiae. FEMS Yeast Research, Vol. 8, No. 1, (February 2008), pp. 
122-131, ISSN 1567-1364 
Nikel, P.I.; de Almeida, A., Melillo, E.C., Galvagno, M.A. & Pettinari, M.J. (2006a). New 
Recombinant Escherichia coli Strain Tailored for the Production of Poly(3-
Hydroxybutyrate) from Agroindustrial By-Products. Applied and Environmental 
Microbiology, Vol. 72, No. 6, (June 2006), pp. 3949-3954, ISSN 0099-2240 
Nikel, P.I.; Pettinari, M.J., Galvagno, M.A. & Méndez, B.S. (2006b). Poly(3-Hydroxybutyrate) 
Synthesis by Recombinant Escherichia coli arcA Mutants in Microaerobiosis. Applied 
and Environmental Microbiology, Vol. 72, No. 4, (April 2006), pp. 2614-2620, ISSN 
0099-2240 
Nikel, P.I.; de Almeida, A., Pettinari, M.J. & Méndez, B.S. (2008a). The Legacy of HfrH: 
Mutations in the Two-Component System CreBC Are Responsible for the Unusual 
Phenotype of an Escherichia coli arcA Mutant. Journal of Bacteriology, Vol. 190, No. 9, 
(May 2008), pp. 3404-3407, ISSN 0021-9193 
Nikel, P.I.; Pettinari, M.J., Galvagno, M.A. & Méndez, B.S. (2008b). Poly(3-Hydroxybutyrate) 
Synthesis from Glycerol by a Recombinant Escherichia coli arcA Mutant in Fed-Batch 
Microaerobic Cultures. Applied Microbiology and Biotechnology, Vol. 77, No. 6, 
(January 2008), pp. 1337-1343, ISSN 0175-7598 
Nikel, P.I.; Zhu, J., San, K.Y., Méndez, B.S. & Bennett, G.N. (2009). Metabolic Flux Analysis 
of Escherichia coli creB and arcA Mutants Reveals Shared Control of Carbon 
Catabolism under Microaerobic Growth Conditions. Journal of Bacteriology, Vol. 191, 
No. 17, (September 2009), pp. 5538-5548, ISSN 0021-9193 
Nonato, R.V.; Mantelatto, P.E. & Rossell, C.E.V. (2001). Integrated Production of 
Biodegradable Plastic, Sugar and Ethanol. Applied Microbiology and Biotechnology, 
Vol. 57, No. 1-2, (October 2001), pp. 1-5, ISSN 0175-7598 
Oliveira, F.C.; Freire, D.M. & Castilho, L.R. (2004). Production of Poly(3-Hydroxybutyrate) 
by Solid-State Fermentation with Ralstonia eutropha. Biotechnology Letters, Vol. 26, 
No. 24, (December 2004), pp. 1851-1855, ISSN 0141-5492 
 
Advances in Applied Biotechnology 
 
58
Hydroxyalkenoates. Applied and Environmental Microbiology, Vol. 54, No. 12, 
(December 1988), pp. 2924-2932, ISSN 0099-2240 
Lee, S.Y.; Kim, H.U., Yun, H., Sohn, S.B., Kim, J.S., Palsson, B.Ø., Herrgård, M.J. & Portnoy, 
V.A. (2010). Systems Biology, Genome-Scale Models, and Metabolic Engineering, 
In: The Metabolic Pathway Engineering Handbook - Tools and Applications, C.D. Smolke, 
(Ed.), pp. 15.1-15.11, CRC Press, ISBN 978-1-4200-7765-0, Boca Raton, Florida, 
United States of America 
Lenz, R.W.; Kim, Y.B. & Fuller, R.C. (1992). Production of Unusual Bacterial Polyesters by 
Pseudomonas oleovorans through Cometabolism. FEMS Microbiology Letters, Vol. 103, 
No. 2-4, (December 1992), pp. 207-214, ISSN 1574-6968 
Li, R.; Zhang, H. & Qi, Q. (2007). The Production of Polyhydroxyalkanoates in Recombinant 
Escherichia coli. Bioresource Technology, Vol. 98, No. 12, (September 2007), pp. 2313-
2320, ISSN 0960-8524 
Lim, S.J.; Jung, Y.M., Shin, H.D. & Lee, Y.H. (2002). Amplification of the NADPH-Related 
Genes zwf and gnd for the Oddball Biosynthesis of PHB in an E. coli Transformant 
Harboring a Cloned phbCAB Operon. Journal of Bioscience and Bioengineering, Vol. 
93, No. 6, (October 2002), pp. 543-549, ISSN 1389-1723 
Lütke-Eversloh, T.; Bergander, K., Luftmann, H. & Steinbüchel, A. (2001). Biosynthesis of 
Poly(3-Hydroxybutyrate-co-3-Mercaptobutyrate) as a Sulfur Analogue to Poly(3-
Hydroxybutyrate) (PHB). Biomacromolecules, Vol. 2, No. 3, (August 2001), pp. 1061-
1065, ISSN 1525-7797 
Lütke-Eversloh, T.; Fischer, A., Remminghorst, U., Kawada, J., Marchessault, R.H., 
Bögershausen, A., Kalwei, M., Eckert, H., Reichelt, R., Liu, S.J. & Steinbüchel, A. 
(2002). Biosynthesis of Novel Thermoplastic Polythioesters by Engineered 
Escherichia coli. Nature Materials, Vol. 1, No. 4, (December 2002), pp. 236-240, ISSN 
1476-1122 
Lynch, A.S. & Lin, E.C.C. (1996). Responses to Molecular Oxygen, In: Escherichia coli and 
Salmonella: Cellular and Molecular Biology, F.C. Neidhardt, R. Curtiss III, J.L. 
Ingraham, E.C.C. Lin, K.B. Low, B. Magasanik, W.S. Reznikoff, M. Riley, M. 
Schaechter, H.E. Umbarger, (Eds.), pp. 1526-1538, ASM Press, ISBN 1-5558-1084-5, 
Washington, D.C., United States of America 
Madden, L.A.; Anderson, A.J., Shah, D.T. & Asrar, J. (1999). Chain Termination in 
Polyhydroxyalkanoate Synthesis: Involvement of Exogenous Hydroxy-Compounds 
as Chain Transfer Agents. International Journal of Biological Macromolecules, Vol. 25, 
No. 1-3, (June 1999), pp. 43-53, ISSN 0141-8130 
Madison, L.L. & Huisman, G.W. (1999). Metabolic Engineering of Poly(3-
Hydroxyalkanoates): From DNA to Plastic. Microbiology and Molecular Biology 
Reviews, Vol. 63, No. 1, (March 1999), pp. 21-53, ISSN 1092-2172 
Mahishi, L.H.; Tripathi, G. & Rawal, S.K. (2003). Poly(3-Hydroxybutyrate) (PHB) Synthesis 
by Recombinant Escherichia coli Harbouring Streptomyces aureofaciens PHB 
Biosynthesis Genes: Effect of Various Carbon and Nitrogen Sources. Microbiological 
Research, Vol. 158, No. 1, (January 2003), pp. 19-27, ISSN 0944-5013 
Marangoni, C.; Furigo Jr., A. & de Aragão, G.M.F. (2002). Production of Poly(3-
Hydroxybutyrate-co-3-Hydroxyvalerate) by Ralstonia eutropha in Whey and 
Inverted Sugar with Propionic Acid Feeding. Process Biochemistry, Vol. 38, No. 2, 
(October 2002), pp. 137-141, ISSN 1359-5113 
Making Green Polymers Even Greener: 
Towards Sustainable Production of Polyhydroxyalkanoates from Agroindustrial By-Products 
 
59 
Martínez, V.; García, P., García, J.L. & Prieto, M.A. (2011). Controlled Autolysis Facilitates 
the Polyhydroxyalkanoate Recovery in Pseudomonas putida KT2440. Microbial 
Biotechnology, Vol. 4, No. 4, (July 2011), pp. 533-547, ISSN 1751-7915 
Nath, A.; Dixit, M., Bandiya, A., Chavda, S. & Desai, A.J. (2008). Enhanced PHB Production 
and Scale up Studies Using Cheese Whey in Fed Batch Culture of Methylobacterium 
sp. ZP24. Bioresource Technology, Vol. 99, No. 13, (September 2008), pp. 5749-5755, 
ISSN 0960-8524 
Nelson, K.E.; Weinel, C., Paulsen, I.T., Dodson, R.J., Hilbert, H., Martins dos Santos, V.A.P., 
Fouts, D.E., Gill, S.R., Pop, M., Holmes, M., Brinkac, L., Beanan, M., DeBoy, R.T., 
Daugherty, S., Kolonay, J., Madupu, R., Nelson, W., White, O., Peterson, J., Khouri, 
H., Hance, I., Chris Lee, P., Holtzapple, E., Scanlan, D., Tran, K., Moazzez, A., 
Utterback, T., Rizzo, M., Lee, K., Kosack, D., Moestl, D., Wedler, H., Lauber, J., 
Stjepandic, D., Hoheisel, J., Straetz, M., Heim, S., Kiewitz, C., Eisen, J.A., Timmis, 
K.N., Düsterhöft, A., Tümmler, B. & Fraser, C.M. (2002). Complete Genome 
Sequence and Comparative Analysis of the Metabolically Versatile Pseudomonas 
putida KT2440. Environmental Microbiology, Vol. 4, No. 12, (December 2002), pp. 799-
808, ISSN 1462-2920 
Nielsen, J. (2001). Metabolic Engineering. Applied Microbiology and Biotechnology, Vol. 55, No. 
3, (April 2001), pp. 263-283, ISSN 0175-7598 
Nielsen, J. & Jewett, M.C. (2008). Impact of Systems Biology on Metabolic Engineering of 
Saccharomyces cerevisiae. FEMS Yeast Research, Vol. 8, No. 1, (February 2008), pp. 
122-131, ISSN 1567-1364 
Nikel, P.I.; de Almeida, A., Melillo, E.C., Galvagno, M.A. & Pettinari, M.J. (2006a). New 
Recombinant Escherichia coli Strain Tailored for the Production of Poly(3-
Hydroxybutyrate) from Agroindustrial By-Products. Applied and Environmental 
Microbiology, Vol. 72, No. 6, (June 2006), pp. 3949-3954, ISSN 0099-2240 
Nikel, P.I.; Pettinari, M.J., Galvagno, M.A. & Méndez, B.S. (2006b). Poly(3-Hydroxybutyrate) 
Synthesis by Recombinant Escherichia coli arcA Mutants in Microaerobiosis. Applied 
and Environmental Microbiology, Vol. 72, No. 4, (April 2006), pp. 2614-2620, ISSN 
0099-2240 
Nikel, P.I.; de Almeida, A., Pettinari, M.J. & Méndez, B.S. (2008a). The Legacy of HfrH: 
Mutations in the Two-Component System CreBC Are Responsible for the Unusual 
Phenotype of an Escherichia coli arcA Mutant. Journal of Bacteriology, Vol. 190, No. 9, 
(May 2008), pp. 3404-3407, ISSN 0021-9193 
Nikel, P.I.; Pettinari, M.J., Galvagno, M.A. & Méndez, B.S. (2008b). Poly(3-Hydroxybutyrate) 
Synthesis from Glycerol by a Recombinant Escherichia coli arcA Mutant in Fed-Batch 
Microaerobic Cultures. Applied Microbiology and Biotechnology, Vol. 77, No. 6, 
(January 2008), pp. 1337-1343, ISSN 0175-7598 
Nikel, P.I.; Zhu, J., San, K.Y., Méndez, B.S. & Bennett, G.N. (2009). Metabolic Flux Analysis 
of Escherichia coli creB and arcA Mutants Reveals Shared Control of Carbon 
Catabolism under Microaerobic Growth Conditions. Journal of Bacteriology, Vol. 191, 
No. 17, (September 2009), pp. 5538-5548, ISSN 0021-9193 
Nonato, R.V.; Mantelatto, P.E. & Rossell, C.E.V. (2001). Integrated Production of 
Biodegradable Plastic, Sugar and Ethanol. Applied Microbiology and Biotechnology, 
Vol. 57, No. 1-2, (October 2001), pp. 1-5, ISSN 0175-7598 
Oliveira, F.C.; Freire, D.M. & Castilho, L.R. (2004). Production of Poly(3-Hydroxybutyrate) 
by Solid-State Fermentation with Ralstonia eutropha. Biotechnology Letters, Vol. 26, 
No. 24, (December 2004), pp. 1851-1855, ISSN 0141-5492 
 
Advances in Applied Biotechnology 
 
60
Olivera, E.R.; Carnicero, D., García, B., Miñambres, B., Moreno, M.A., Cañedo, L., DiRusso, 
C.C., Naharro, G. & Luengo, J.M. (2001a). Two Different Pathways Are Involved in 
the β-Oxidation of n-Alkanoic and n-Phenylalkanoic Acids in Pseudomonas putida U: 
Genetic Studies and Biotechnological Applications. Molecular Microbiology, Vol. 39, 
No. 4, (February 2001), pp. 863-874, ISSN 1365-2958 
Olivera, E.R.; Carnicero, D., Jodra, R., Miñambres, B., García, B., Abraham, G.A., Gallardo, 
A., Román, J.S., García, J.L., Naharro, G. & Luengo, J.M. (2001b). Genetically 
Engineered Pseudomonas: A Factory of New Bioplastics with Broad Applications. 
Environmental Microbiology, Vol. 3, No. 10, (October 2001), pp. 612-618, ISSN 1462-
2920 
Ouyang, S.P.; Luo, R.C., Chen, S.S., Liu, Q., Chung, A., Wu, Q. & Chen, G.G.Q. (2007). 
Production of Polyhydroxyalkanoates with High 3-Hydroxydodecanoate Monomer 
Content by fadB and fadA Knockout Mutant of Pseudomonas putida KT2442. 
Biomacromolecules, Vol. 8, No. 8, (August 2007), pp. 2504-2511, ISSN 1525-7797 
Park, S.J.; Park, J.P. & Lee, S.Y. (2002). Production of Poly(3-Hydroxybutyrate) from Whey 
by Fed-Batch Culture of Recombinant Escherichia coli in a Pilot-Scale Fermenter. 
Biotechnology Letters, Vol. 24, No. 3, (February 2002), pp. 185-189, ISSN 0141-5492 
Park, W.H.; Lenz, R.W. & Goodwin, S. (1998). Epoxidation of Bacterial Polyesters with 
Unsaturated Side Chains. I. Production and Epoxidation of Polyesters from 10-
Undecenoic Acid. Macromolecules, Vol. 31, No. 5, (March 1998), pp. 1480-1486, ISSN 
0024-9297 
Philip, S.; Keshavarz, T. & Roy, I. (2007). Polyhydroxyalkanoates: Biodegradable Polymers 
with a Range of Applications. Journal of Chemical Technology and Biotechnology, Vol. 
82, No. 3, (March 2007), pp. 233-247, ISSN 1097-4660 
Pohlmann, A.; Fricke, W.F., Reinecke, F., Kusian, B., Liesegang, H., Cramm, R., Eitinger, T., 
Ewering, C., Pötter, M., Schwartz, E., Strittmatter, A., Voß, I., Gottschalk, G., 
Steinbüchel, A., Friedrich, B. & Bowien, B. (2006). Genome Sequence of the 
Bioplastic-Producing "Knallgas" Bacterium Ralstonia eutropha H16. Nature 
Biotechnology, Vol. 24, No. 10, (October 2006), pp. 1257-1262, ISSN 1087-0156 
Povolo, S.; Toffano, P., Basaglia, M. & Casella, S. (2010). Polyhydroxyalkanoates Production 
by Engineered Cupriavidus necator from Waste Material Containing Lactose. 
Bioresource Technology, Vol. 101, No. 20, (October 2010), pp. 7902-7907, ISSN 0960-
8524 
Pries, A.; Steinbüchel, A. & Schlegel, H.G. (1990). Lactose- and Galactose-Utilizing Strains of 
Poly(Hydroxyalkanoic Acid)-Accumulating Alcaligenes eutrophus and Pseudomonas 
saccharophila Obtained by Recombinant DNA Technology. Applied Microbiology and 
Biotechnology, Vol. 33, No. 4, (July 1990), pp. 410-417, ISSN 0175-7598 
Queiroz, A.U.B. & Collares-Queiroz, F.P. (2009). Innovation and Industrial Trends in 
Bioplastics. Polymer Reviews, Vol. 49, No. 2, (April 2009), pp. 65-78, ISSN 1558-3724 
Reddy, S.V.; Thirumala, M. & Mahmood, S.K. (2009). A Novel Bacillus sp. Accumulating 
Poly(3-Hydroxybutyrate-co-3-Hydroxyvalerate) from a Single Carbon Substrate. 
Journal of Industrial Microbiology and Biotechnology, Vol. 36, No. 6, (June 2009), pp. 
837-843, ISSN 1367-5435 
Rehm, B.H.A. (2010). Bacterial Polymers: Biosynthesis, Modifications and Applications. 
Nature Reviews Microbiology, Vol. 8, No. 8, (August 2010), pp. 578-592, ISSN 1740-
1526 
Reinecke, F. & Steinbüchel, A. (2009). Ralstonia eutropha Strain H16 as Model Organism for 
PHA Metabolism and for Biotechnological Production of Technically Interesting 
Making Green Polymers Even Greener: 
Towards Sustainable Production of Polyhydroxyalkanoates from Agroindustrial By-Products 
 
61 
Biopolymers. Journal of Molecular Microbiology and Biotechnology, Vol. 16, No. 1-2, 
(October 2009), pp. 91-108, ISSN 1464-1801 
Sabirova, J.S.; Ferrer, M., Lünsdorf, H., Wray, V., Kalscheuer, R., Steinbüchel, A., Timmis, 
K.N. & Golyshin, P.N. (2006). Mutation in a "tesB-Like" Hydroxyacyl-Coenzyme A-
Specific Thioesterase Gene Causes Hyperproduction of Extracellular 
Polyhydroxyalkanoates by Alcanivorax borkumensis SK2. Journal of Bacteriology, Vol. 
188, No. 24, (December 2006), pp. 8452-8459, ISSN 0021-9193 
Sauer, U. (2006). Metabolic Networks in Motion: 13C-Based Flux Analysis. Molecular Systems 
Biology, Vol. 2, No. 1, (November 2006), pp. 62, ISSN 1744-4292 
Sawaya Jank, M. (2011). Company Production Rankings for Sugarcane, Sugar and Ethanol - 
South-Central Brazil. In: UNICA - Sugarcane Industry Association, 07.06.2011, 
Available from http://english.unica.com.br/dadosCotacao/estatistica/ 
Scholz, C.; Fuller, R.C. & Lenz, R.W. (1994). Growth and Polymer Incorporation of 
Pseudomonas oleovorans on Alkyl Esters of Heptanoic Acid. Macromolecules, Vol. 27, 
No. 10, (May 1994), pp. 2886-2889, ISSN 0024-9297 
Scholz, C. (2010). Perspectives to Produce Positively or Negatively Charged 
Polyhydroxyalkanoic Acids. Applied Microbiology and Biotechnology, Vol. 88, No. 4, 
(October 2010), pp. 829-837, ISSN 0175-7598 
Serafim, L.S.; Lemos, P.C., Albuquerque, M.G.E. & Reis, M.A.M. (2008). Strategies for PHA 
Production by Mixed Cultures and Renewable Waste Materials. Applied 
Microbiology and Biotechnology, Vol. 81, No. 4, (December 2008), pp. 615-628, ISSN 
0175-7598 
Silva-Queiroz, S.R.; Silva, L.F., Pradella, J.G.C., Pereira, E.M. & Gomez, J.G.C. (2009). 
PHAMCL Biosynthesis Systems in Pseudomonas aeruginosa and Pseudomonas putida 
Strains Show Differences on Monomer Specificities. Journal of Biotechnology, Vol. 
143, No. 2, (August 2009), pp. 111-118, ISSN 0168-1656 
Solaiman, D.K.Y.; Ashby, R.D., Foglia, T. & Marmer, W.N. (2006). Conversion of 
Agricultural Feedstock and Coproducts into Poly(Hydroxyalkanoates). Applied 
Microbiology and Biotechnology, Vol. 71, No. 6, (August 2006), pp. 783-789, ISSN 
0175-7598 
Steinbüchel, A. (2001). Perspectives for Biotechnological Production and Utilization of 
Biopolymers: Metabolic Engineering of Polyhydroxyalkanoate Biosynthesis as a 
Successful Example. Macromolecular Bioscience, Vol. 1, No. (January 2001), pp. 1-24, 
ISSN 1616-5195 
Steinbüchel, A. & Lütke-Eversloh, T. (2003). Metabolic Engineering and Pathway 
Construction for Biotechnological Production of Relevant Polyhydroxyalkanoates 
in Microorganisms. Biochemical Engineering Journal, Vol. 16, No. 2, (November 2003), 
pp. 81-96, ISSN 1369-703X 
Steinbüchel, A. (2005). Non-Biodegradable Biopolymers from Renewable Resources: 
Perspectives and Impacts. Current Opinion in Biotechnology, Vol. 16, No. 6, 
(December 2005), pp. 607-613, ISSN 0958-1669 
Stephanopoulos, G. (1999). Metabolic Fluxes and Metabolic Engineering. Metabolic 
Engineering, Vol. 1, No. 1, (January 1999), pp. 1-11, ISSN 1096-7176 
Suriyamongkol, P.; Weselake, R., Narine, S., Moloney, M. & Shah, S. (2007). Biotechnological 
Approaches for the Production of Polyhydroxyalkanoates in Microorganisms and 
Plants - a Review. Biotechnology Advances, Vol. 25, No. 2, (March-April 2007), pp. 
148-175, ISSN 0734-9750 
 
Advances in Applied Biotechnology 
 
60
Olivera, E.R.; Carnicero, D., García, B., Miñambres, B., Moreno, M.A., Cañedo, L., DiRusso, 
C.C., Naharro, G. & Luengo, J.M. (2001a). Two Different Pathways Are Involved in 
the β-Oxidation of n-Alkanoic and n-Phenylalkanoic Acids in Pseudomonas putida U: 
Genetic Studies and Biotechnological Applications. Molecular Microbiology, Vol. 39, 
No. 4, (February 2001), pp. 863-874, ISSN 1365-2958 
Olivera, E.R.; Carnicero, D., Jodra, R., Miñambres, B., García, B., Abraham, G.A., Gallardo, 
A., Román, J.S., García, J.L., Naharro, G. & Luengo, J.M. (2001b). Genetically 
Engineered Pseudomonas: A Factory of New Bioplastics with Broad Applications. 
Environmental Microbiology, Vol. 3, No. 10, (October 2001), pp. 612-618, ISSN 1462-
2920 
Ouyang, S.P.; Luo, R.C., Chen, S.S., Liu, Q., Chung, A., Wu, Q. & Chen, G.G.Q. (2007). 
Production of Polyhydroxyalkanoates with High 3-Hydroxydodecanoate Monomer 
Content by fadB and fadA Knockout Mutant of Pseudomonas putida KT2442. 
Biomacromolecules, Vol. 8, No. 8, (August 2007), pp. 2504-2511, ISSN 1525-7797 
Park, S.J.; Park, J.P. & Lee, S.Y. (2002). Production of Poly(3-Hydroxybutyrate) from Whey 
by Fed-Batch Culture of Recombinant Escherichia coli in a Pilot-Scale Fermenter. 
Biotechnology Letters, Vol. 24, No. 3, (February 2002), pp. 185-189, ISSN 0141-5492 
Park, W.H.; Lenz, R.W. & Goodwin, S. (1998). Epoxidation of Bacterial Polyesters with 
Unsaturated Side Chains. I. Production and Epoxidation of Polyesters from 10-
Undecenoic Acid. Macromolecules, Vol. 31, No. 5, (March 1998), pp. 1480-1486, ISSN 
0024-9297 
Philip, S.; Keshavarz, T. & Roy, I. (2007). Polyhydroxyalkanoates: Biodegradable Polymers 
with a Range of Applications. Journal of Chemical Technology and Biotechnology, Vol. 
82, No. 3, (March 2007), pp. 233-247, ISSN 1097-4660 
Pohlmann, A.; Fricke, W.F., Reinecke, F., Kusian, B., Liesegang, H., Cramm, R., Eitinger, T., 
Ewering, C., Pötter, M., Schwartz, E., Strittmatter, A., Voß, I., Gottschalk, G., 
Steinbüchel, A., Friedrich, B. & Bowien, B. (2006). Genome Sequence of the 
Bioplastic-Producing "Knallgas" Bacterium Ralstonia eutropha H16. Nature 
Biotechnology, Vol. 24, No. 10, (October 2006), pp. 1257-1262, ISSN 1087-0156 
Povolo, S.; Toffano, P., Basaglia, M. & Casella, S. (2010). Polyhydroxyalkanoates Production 
by Engineered Cupriavidus necator from Waste Material Containing Lactose. 
Bioresource Technology, Vol. 101, No. 20, (October 2010), pp. 7902-7907, ISSN 0960-
8524 
Pries, A.; Steinbüchel, A. & Schlegel, H.G. (1990). Lactose- and Galactose-Utilizing Strains of 
Poly(Hydroxyalkanoic Acid)-Accumulating Alcaligenes eutrophus and Pseudomonas 
saccharophila Obtained by Recombinant DNA Technology. Applied Microbiology and 
Biotechnology, Vol. 33, No. 4, (July 1990), pp. 410-417, ISSN 0175-7598 
Queiroz, A.U.B. & Collares-Queiroz, F.P. (2009). Innovation and Industrial Trends in 
Bioplastics. Polymer Reviews, Vol. 49, No. 2, (April 2009), pp. 65-78, ISSN 1558-3724 
Reddy, S.V.; Thirumala, M. & Mahmood, S.K. (2009). A Novel Bacillus sp. Accumulating 
Poly(3-Hydroxybutyrate-co-3-Hydroxyvalerate) from a Single Carbon Substrate. 
Journal of Industrial Microbiology and Biotechnology, Vol. 36, No. 6, (June 2009), pp. 
837-843, ISSN 1367-5435 
Rehm, B.H.A. (2010). Bacterial Polymers: Biosynthesis, Modifications and Applications. 
Nature Reviews Microbiology, Vol. 8, No. 8, (August 2010), pp. 578-592, ISSN 1740-
1526 
Reinecke, F. & Steinbüchel, A. (2009). Ralstonia eutropha Strain H16 as Model Organism for 
PHA Metabolism and for Biotechnological Production of Technically Interesting 
Making Green Polymers Even Greener: 
Towards Sustainable Production of Polyhydroxyalkanoates from Agroindustrial By-Products 
 
61 
Biopolymers. Journal of Molecular Microbiology and Biotechnology, Vol. 16, No. 1-2, 
(October 2009), pp. 91-108, ISSN 1464-1801 
Sabirova, J.S.; Ferrer, M., Lünsdorf, H., Wray, V., Kalscheuer, R., Steinbüchel, A., Timmis, 
K.N. & Golyshin, P.N. (2006). Mutation in a "tesB-Like" Hydroxyacyl-Coenzyme A-
Specific Thioesterase Gene Causes Hyperproduction of Extracellular 
Polyhydroxyalkanoates by Alcanivorax borkumensis SK2. Journal of Bacteriology, Vol. 
188, No. 24, (December 2006), pp. 8452-8459, ISSN 0021-9193 
Sauer, U. (2006). Metabolic Networks in Motion: 13C-Based Flux Analysis. Molecular Systems 
Biology, Vol. 2, No. 1, (November 2006), pp. 62, ISSN 1744-4292 
Sawaya Jank, M. (2011). Company Production Rankings for Sugarcane, Sugar and Ethanol - 
South-Central Brazil. In: UNICA - Sugarcane Industry Association, 07.06.2011, 
Available from http://english.unica.com.br/dadosCotacao/estatistica/ 
Scholz, C.; Fuller, R.C. & Lenz, R.W. (1994). Growth and Polymer Incorporation of 
Pseudomonas oleovorans on Alkyl Esters of Heptanoic Acid. Macromolecules, Vol. 27, 
No. 10, (May 1994), pp. 2886-2889, ISSN 0024-9297 
Scholz, C. (2010). Perspectives to Produce Positively or Negatively Charged 
Polyhydroxyalkanoic Acids. Applied Microbiology and Biotechnology, Vol. 88, No. 4, 
(October 2010), pp. 829-837, ISSN 0175-7598 
Serafim, L.S.; Lemos, P.C., Albuquerque, M.G.E. & Reis, M.A.M. (2008). Strategies for PHA 
Production by Mixed Cultures and Renewable Waste Materials. Applied 
Microbiology and Biotechnology, Vol. 81, No. 4, (December 2008), pp. 615-628, ISSN 
0175-7598 
Silva-Queiroz, S.R.; Silva, L.F., Pradella, J.G.C., Pereira, E.M. & Gomez, J.G.C. (2009). 
PHAMCL Biosynthesis Systems in Pseudomonas aeruginosa and Pseudomonas putida 
Strains Show Differences on Monomer Specificities. Journal of Biotechnology, Vol. 
143, No. 2, (August 2009), pp. 111-118, ISSN 0168-1656 
Solaiman, D.K.Y.; Ashby, R.D., Foglia, T. & Marmer, W.N. (2006). Conversion of 
Agricultural Feedstock and Coproducts into Poly(Hydroxyalkanoates). Applied 
Microbiology and Biotechnology, Vol. 71, No. 6, (August 2006), pp. 783-789, ISSN 
0175-7598 
Steinbüchel, A. (2001). Perspectives for Biotechnological Production and Utilization of 
Biopolymers: Metabolic Engineering of Polyhydroxyalkanoate Biosynthesis as a 
Successful Example. Macromolecular Bioscience, Vol. 1, No. (January 2001), pp. 1-24, 
ISSN 1616-5195 
Steinbüchel, A. & Lütke-Eversloh, T. (2003). Metabolic Engineering and Pathway 
Construction for Biotechnological Production of Relevant Polyhydroxyalkanoates 
in Microorganisms. Biochemical Engineering Journal, Vol. 16, No. 2, (November 2003), 
pp. 81-96, ISSN 1369-703X 
Steinbüchel, A. (2005). Non-Biodegradable Biopolymers from Renewable Resources: 
Perspectives and Impacts. Current Opinion in Biotechnology, Vol. 16, No. 6, 
(December 2005), pp. 607-613, ISSN 0958-1669 
Stephanopoulos, G. (1999). Metabolic Fluxes and Metabolic Engineering. Metabolic 
Engineering, Vol. 1, No. 1, (January 1999), pp. 1-11, ISSN 1096-7176 
Suriyamongkol, P.; Weselake, R., Narine, S., Moloney, M. & Shah, S. (2007). Biotechnological 
Approaches for the Production of Polyhydroxyalkanoates in Microorganisms and 
Plants - a Review. Biotechnology Advances, Vol. 25, No. 2, (March-April 2007), pp. 
148-175, ISSN 0734-9750 
 
Advances in Applied Biotechnology 
 
62
Taidi, B.; Anderson, A.J., Dawes, E.A. & Byrom, D. (1994). Effect of Carbon Source and 
Concentration on the Molecular Mass of Poly(3-Hydroxybutyrate) Produced by 
Methylobacterium extorquens and Alcaligenes eutrophus. Applied Microbiology and 
Biotechnology, Vol. 40, No. 6, (February 1994), pp. 786-790, ISSN 0175-7598 
Takagi, Y.; Hashii, M., Maehara, A. & Yamane, T. (1999). Biosynthesis of 
Polyhydroxyalkanoate with a Thiophenoxy Side Group Obtained from 
Pseudomonas putida. Macromolecules, Vol. 32, No. 25, (December 1999), pp. 8315-
8318, ISSN 0024-9297 
Tyo, K.E.; Fischer, C.R., Simeon, F. & Stephanopoulos, G. (2010). Analysis of 
Polyhydroxybutyrate Flux Limitations by Systematic Genetic and Metabolic 
Perturbations. Metabolic Engineering, Vol. 12, No. 3, (May 2010), pp. 187-195, ISSN 
1096-7176 
Wang, F. & Lee, S.Y. (1997). Production of Poly(3-Hydroxybutyrate) by Fed-Batch Culture of 
Filamentation-Supressed Recombinant Escherichia coli. Applied and Environmental 
Microbiology, Vol. 63, No. 12, (December 1997), pp. 4765-4769, ISSN 0099-2240 
Wei, X.X.; Shi, Z.Y., Yuan, M.Q. & Chen, G.G.Q. (2009). Effect of Anaerobic Promoters on the 
Microaerobic Production of Polyhydroxybutyrate (PHB) in Recombinant Escherichia 
coli. Applied Microbiology and Biotechnology, Vol. 82, No. 4, (March 2009), pp. 703-712, 
ISSN 0175-7598 
Wiechert, W. (2001). 13C Metabolic Flux Analysis. Metabolic Engineering, Vol. 3, No. 3, (July 
2001), pp. 195-206, ISSN 1096-7176 
Wong, H.H. & Lee, S.Y. (1998). Poly-(3-Hydroxybutyrate) Production from Whey by High-
Density Cultivation of Recombinant Escherichia coli. Applied Microbiology and 
Biotechnology, Vol. 50, No. 1, (July 1998), pp. 30-33, ISSN 0175-7598 
Wu, Q.; Wang, Y. & Chen, G.G.Q. (2009). Medical Application of Microbial Biopolyesters 
Polyhydroxyalkanoates. Artificial Cells, Blood Substitutes and Biotechnology, Vol. 37, 
No. 1, (January 2009), pp. 1-12, ISSN 1073-1199 
Yang, S.T.; Zhu, H., Li, Y. & Hong, G. (1994). Continuous Propionate Production from Whey 
Permeate Using a Novel Fibrous Bed Bioreactor. Biotechnology and Bioengineering, 
Vol. 43, No. 11, (May 1994), pp. 1124-1130, ISSN 1097-0290 
Young, F.K., Kastner, J.R. & May, S.W. (1994). Microbial Production of Poly-β-
Hydroxybutyric Acid from D-Xylose and Lactose by Pseudomonas cepacia. Applied 
and Environmental Microbiology, Vol. 60, No. 11, (November 1994), pp. 4195-4198, 
ISSN 0099-2240 
Yu, J. & Chen, L.X.L. (2006). Cost-Effective Recovery and Purification of 
Polyhydroxyalkanoates by Selective Dissolution of Cell Mass. Biotechnology 
Progress, Vol. 22, No. 2, (March 2006), pp. 547-553, ISSN 1520-6063 
Zhang, H.; Obias, V., Gonyer, K. & Dennis, D. (1994). Production of Polyhydroxyalkanoates 
in Sucrose-Utilizing Recombinant Escherichia coli and Klebsiella Strains. Applied and 
Environmental Microbiology, Vol. 60, No. 4, (April 1994), pp. 1198-1205, ISSN 0099-
2240 
Zhong, Z.W.; Song, B. & Huang, C.X. (2009). Environmental Impacts of Three 
Polyhydroxyalkanoate (PHA) Manufacturing Processes. Materials and 
Manufacturing Processes, Vol. 24, No. 5, (March 2009), pp. 519-523, ISSN 1042-6914 
4 
Fermentation Processes Using Lactic Acid 
Bacteria Producing Bacteriocins for 
Preservation and Improving Functional 
Properties of Food Products 
Grazina Juodeikiene1, Elena Bartkiene2, Pranas Viskelis3,  
Dalia Urbonaviciene3, Dalia Eidukonyte1 and Ceslovas Bobinas3 
1Kaunas University of Technology, 
2Veterinary Academy, Lithuanian University of Health Sciences, 
3Institute of Horticulture, Lithuanian Research Centre for Agriculture and Forestry, 
Lithuania 
1. Introduction 
During the recent years health-conscious consumers are looking for natural foods without 
chemical preservatives that will fit in their healthy lifestyle. The increasing consumption of 
precooked food, prone to temperature abuse, and the import of raw foods from developing 
countries are among the main causes of this situation. Biopreservation refers to extended 
shelf life and enhanced safety of foods using microorganisms and/or their metabolites (Ross 
et al., 2002). LAB is generally employed because they significantly contribute to the flavor, 
texture and, in many cases, to the nutritional value of the food products (McKay and 
Baldwin, 1990). LAB are used as natural or selected starters in food fermentations and exert 
the antimicrobial effect as a result of different metabolic processes (lactose metabolism, 
proteolytic enzymes, citrate uptake, bacteriophage resistance, bacteriocin production, 
polysaccharide biosynthesis, metal-ion resistance and antibiotic resistance) (Zotta, T., 2009; 
Corsetti, 2004). Lactic acid bacteria (LAB) play a key role in food fermentations where they 
not only contribute to the development of the desired sensory properties in the final product 
but also to their microbiological safety. LAB has a GRAS status (generally recognized as 
safe) and it has been estimated that 25% of the European diet and 60% of the diet in many 
developing countries consists of fermented foods (Stiles, 1996). Fermentation is one of the 
most ancient and most important food processing technologies. Fermentation is a relatively 
efficient, low energy preservation process, which increases the shelf life and decreases the 
need for refrigeration or other forms of food preservation technology. Currently, fermented 
foods are increasing in popularity (60% of the diet in industrialized countries) and, to assure 
the homogeneity, quality, and safety of products, they are produced by the intentional 
application in raw foods in different microbial systems (starter/protective cultures) 
(Holzapfel et al., 1995).  
Examples of vegetable lactic acid fermentations are: sauerkraut, cucumber pickles, and 
olives in the Western world; Egyptian pickled vegetables in the Middle East; Indian pickled 
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1. Introduction 
During the recent years health-conscious consumers are looking for natural foods without 
chemical preservatives that will fit in their healthy lifestyle. The increasing consumption of 
precooked food, prone to temperature abuse, and the import of raw foods from developing 
countries are among the main causes of this situation. Biopreservation refers to extended 
shelf life and enhanced safety of foods using microorganisms and/or their metabolites (Ross 
et al., 2002). LAB is generally employed because they significantly contribute to the flavor, 
texture and, in many cases, to the nutritional value of the food products (McKay and 
Baldwin, 1990). LAB are used as natural or selected starters in food fermentations and exert 
the antimicrobial effect as a result of different metabolic processes (lactose metabolism, 
proteolytic enzymes, citrate uptake, bacteriophage resistance, bacteriocin production, 
polysaccharide biosynthesis, metal-ion resistance and antibiotic resistance) (Zotta, T., 2009; 
Corsetti, 2004). Lactic acid bacteria (LAB) play a key role in food fermentations where they 
not only contribute to the development of the desired sensory properties in the final product 
but also to their microbiological safety. LAB has a GRAS status (generally recognized as 
safe) and it has been estimated that 25% of the European diet and 60% of the diet in many 
developing countries consists of fermented foods (Stiles, 1996). Fermentation is one of the 
most ancient and most important food processing technologies. Fermentation is a relatively 
efficient, low energy preservation process, which increases the shelf life and decreases the 
need for refrigeration or other forms of food preservation technology. Currently, fermented 
foods are increasing in popularity (60% of the diet in industrialized countries) and, to assure 
the homogeneity, quality, and safety of products, they are produced by the intentional 
application in raw foods in different microbial systems (starter/protective cultures) 
(Holzapfel et al., 1995).  
Examples of vegetable lactic acid fermentations are: sauerkraut, cucumber pickles, and 
olives in the Western world; Egyptian pickled vegetables in the Middle East; Indian pickled 
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vegetables and Korean kim-chi, Thai pak-sian-don, Chinese hum-choy, Malaysian pickled 
vegetables and Malaysian tempoyak. Lactic acid fermented cereals and tubers (cassava) 
include: Mexican pozol, Ghanaian kenkey, Nigerian gari; boiled rice/raw shrimp/raw fish 
mixtures: Philippine balao-balao, burong dalag; lactic fermented/leavened breads: 
sourdough breads in the Western world; Indian idli, dhokla, khaman, Sri-lankan hoppers; 
Ethiopian enjera, Sudanese kisra and Philippine puto; Lactic acid fermented cheeses in the 
Western world and Chinese sufu/tofu-ru. Lactic acid fermented yogurt/wheat mixtures: 
Egyptian kishk, Greek trahanas, Turkish tarhanas.  
Moreover, because of the improved organoleptic qualities of traditional fermented food, 
extensive research on its microbial biodiversity has been carried out with the goal of 
reproducing these qualities, which are attributed to native microbiota, in a controlled 
environment. 
Recent years the interest increased in bacteriocin-like inhibitory substances (BLIS) 
producing LAB because of their potential use as natural antimicrobial agents to enhance the 
safety of food products. Bacteriocins from LAB are described as “natural” inhibitors, in 
regard to LAB having a GRAS status. Bacteriocin-like inhibitory substances (BLIS) from LAB 
are antimicrobial compounds that possess bacteriocin requisites but that have not yet been 
characterized for their amino acid sequence (Jack et al., 1995). Bacteriocins from the 
generally recognized as safe LAB, have received significant attention as a novel approach to 
the control of pathogens in foods (Klaenhammer, 1993; Settani et al., 2005). Nisin is the first 
antimicrobial polypeptide found in LAB (Rogers, 1928); at the time of discovery, the 
producer strains were identified as Streptococcus lactis [later classified as Lactococcus lactis] 
(Schleifer et al., 1985). Today nisin is a permitted preservative in at least 48 countries, in 
which it is used in a variety of products, including cheese, canned food and cured meat 
(Delves-Broughton, 1990). Another commercially produced bacteriocin is pediocin PA-1 
produced by Pediococcus acidilactici and marketed as ATTA TM 2431 (Kerry Bioscience, 
Carrigaline, Co, Cork, Ireland). The source of natural or controlled microbiota and/or 
antimicrobial compounds could be traditional fermented foods. The health benefits 
attributed to peptides in these traditional products have, so far, not been established, 
however. Several factors can affect the bacteriocin activity including interaction with other 
bacteriocins, constituents from the cells as well as the growth medium, purity and 
concentration of exogenous added enzymes (Moreno et al., 2000). Enzymes present during 
food making originate from different sources: there are those that already exist in the plant 
raw material, those associated with the metabolic activity of yeasts or LAB, and those 
intentionally added to the formulations. For example, amylases are added for the 
intensification of the saccharification stage (Stauffer, 1994), while microbial lipases induce 
changes in lipid and short-chain fatty acid compositions (Martnez-Anaya, 1996). Up to date, 
numerous recent review articles focused on the isolation of novel LAB bacteriocin-like 
inhibitory substances produced by LAB, evaluation their inhibitory activities, classification, 
biochemical and genetic characterization, studying the sensitivity of the BLIS antimicrobial 
activity to different factors, e.g. enzymes in fermentation media and the mode of action of 
LAB bacteriocins, as well as on some of their food application (mainly animal origin) have 
been published. Unfortunately literature lacks of concentrated articles dealing with the use 
of bacteriocins or bacteriocin-producing strains for the biopreservation and improving 
functional properties of vegetable and fruit products. 
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2. Characterization of bacteriocins produced by lactic acid bacteria 
The antimicrobial ribosomal synthesized peptides produced by bacteria, including members 
of the LAB, are called bacteriocins. Such peptides are produced by many, if not all, bacterial 
species and kill closely related microorganisms (Jack et al., 1995). Due to their nature, they 
are inactivated by proteases in the gastrointestinal tract. Most of the LAB bacteriocins 
identified so far are thermo stable cationic molecules that have up to 60 amino acid residues 
and hydrophobic patches. Electrostatic interactions with negatively charged phosphate 
groups on target cell membranes are thought to contribute to the initial binding, forming 
pores and killing the cells after causing lethal damage and autolysin activation to digest the 
cellular wall (Gálvez et al., 1990). Example of damage caused by bacteriocin on L. 
monocytogenes CECT 4032 cells is presented in Figure 1. 
The LAB bacteriocins have many attractive characteristics that make them suitable 
candidates for use as food preservatives, such as: 
• Protein nature, inactivation by proteolytic enzymes of gastrointestinal tract 
• Non-toxic to laboratory animals tested and generally non-immunogenic 
• Inactive against eukaryotic cells 
• Generally thermo resistant (can maintain antimicrobial activity after pasteurization and 
sterilization) 
• Broad bactericidal activity affecting most of the Gram-positive bacteria and some, 
damaged, Gram-negative bacteria including various pathogens such as L. 
monocytogenes, Bacillus cereus, S. aureus, and Salmonella 
• Genetic determinants generally located in plasmid, which facilitates genetic 
manipulation to increase the variety of natural peptide analogues with desirable 
characteristics 
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vegetables and Korean kim-chi, Thai pak-sian-don, Chinese hum-choy, Malaysian pickled 
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biochemical and genetic characterization, studying the sensitivity of the BLIS antimicrobial 
activity to different factors, e.g. enzymes in fermentation media and the mode of action of 
LAB bacteriocins, as well as on some of their food application (mainly animal origin) have 
been published. Unfortunately literature lacks of concentrated articles dealing with the use 
of bacteriocins or bacteriocin-producing strains for the biopreservation and improving 
functional properties of vegetable and fruit products. 
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bacteriocin is produced by the GRAS microorganism Lactococcus lactis and is used as a food 
additive in at least 48 countries, particularly in processed cheese, dairy products and canned 
foods. Nisin is effective against food-borne pathogens such as L. monocytogenes and many 
other Gram-positive spoilage microorganisms (Thomas et al., 2000; Thomas and Delves-
Broughton, 2001). Nisin is listed as E-234, and may also be cited as nisin preservative or 
natural preservative. In addition to the work on nisin, several authors have outlined issues 
involved in the approval of new bacteriocins for food use (Harlander, 1993). 
2.1 The biosynthetic pathway of bacteriocins 
The biosynthetic pathways of bacteriocins with the focus on class II bacteriocins (mainly 
produced by LAB from fermented plant products) will be discussed in this section. All 
bacteriocins are synthesized as a biologically inactive prepeptide carrying an N-terminal 
leader peptide attached to the C-terminal propeptide (Hoover and Chen, 2005). 
The mode of action of lactic acid bacteria bacteriocins belonging to class I, II and III are 
presented in Figure 2.  
 
Fig. 2. Mode of action of bacteriocins by lactic acid bacteria.  
Some bacteriocins (or lantibiotics) of class I (e.g. nisin) have a dual mode of action: (1) they 
prevent correct cell wall synthesis that leads to cell death by binding to lipid II – the main 
transporter of peptidoglycan subunits from the cytoplasm to the cell wall and (2) they 
employ lipid II as a docking molecule to initiate a process of membrane insertion and pore 
formation leading to a rapid cell death (Gillor et al., 2008; Cotter et al., 2005; Wiedemann et 
al., 2001). The majority of class II bacteriocins kill by inducing membrane permeabilization 
and the subsequent leakage of molecules from target bacteria (Gillor et al., 2008). 
Bacteriolysins (bacteriolytic proteins belonging to class III) function directly on the cell wall 
of Gram-positive targets leading to death and lysis of the target cell (Cotter et al., 2005).  
Class II bacteriocins are synthesized as a prepeptide containing a conserved N-terminal 
leader and a characteristic double-glycine proteolytic processing site, and in contrast to 
lantibiotics, they do not undergo extensive posttranslational modification (Hoover and 
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Chen, 2005). The examples of the class II bacteriocins are Sakacin P, G, A and Pediocin  
PA-1/AcH.  
A general scheme of the biosynthetic pathway of class II bacteriocins is shown in Figure 3.  
 
Fig. 3. The biosynthesis of class II bacteriocins. 1. Formation of prebacteriocin and 
prepeptide of induction factor (IF). 2. The processing of the prebacteriocin and pre-IF, and 
translocation by the ABC-transporter, resulting in the release of mature bacteriocin and IF. 3. 
Histidine protein kinase (HPK) senses the presence of IF and autophosphorylates. 4. The 
transfer of the phosphoryl group (P) to the response regulator (RR). 5. The activation of the 
regulated genes transcription by the RR. 6. Producer immunity. 
The production of most class IIa bacteriocins is regulated by a three-component system 
which includes a histidine protein kinase, a response regulator, and an induction factor. 
Some class IIa bacteriocins are autoregulated by a two-component signal transduction 
system, which is a well-known phenomenon in lantibiotics (Sahl et al., 1998). A threshold 
concentration of the bacteriocin, which functions as a signal molecule accumulating during 
growth, triggers the transcription of the genes coding for bacteriocin production, suggesting 
a self-inducing cell density (quorum-sensing)-regulated system (Sahl et al., 1998). 
Class IIc bacteriocins are an exceptional case due to their production with a typical N-
terminal signal sequence of the sec-type, processing and excretion through the general 
secretory pathway (Leer et al., 1995; Worobo et al., 1995). Once the prepeptide is formed, it is 
processed to remove the leader peptide concomitant with export from the cell through a 
dedicated ABC-transporter and its accessory protein (Nes et al., 1996). 
2.2 Activity spectra and biochemical properties of LAB and their produced 
bacteriocins 
As mentioned before, LAB bacteriocins tend to be active against a wide range of mostly 
closely related Gram-positive bacteria (Jack et al., 1995). Gänzle (1998) corroborated this 
while reviewing the inhibitory spectrum of bavaricin A, BLIS C57, and plantaricin ST31, 
produced by sourdough LAB, indicating no inhibition of Gram-negative bacteria, whereas a 
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variety of Gram-positive bacteria were sensitive. The insensitivity of Gram-negative bacteria 
to bacteriocins from LAB strains might be explained by their outer membrane providing 
them with a permeability barrier (Messens et al., 2002). Furthermore, the producer strains 
are found to be immune towards their own bacteriocin (Gänzle, 1998). Studies on the 
resistance of List.monocytogenes strains towards bavaricin A confirmed that only 3 of the 245 
strains examined were resistant to bavaricin A (Larsen and Nørrung, 2003), meanwhile 
Rasch and Knøchel (1998) reported about the correlation between bavaricin A sensitivity 
and pediocin PA-1 sensitivity of the strains.  
The seldom inhibition of commonly encountered enteropathogenic bacteria (Enterobacter, 
Klebsiella, or Salmonella was announced as the weakness of the bacteriocins produced by 
Gram-positive bacteria. Gram-positive bacteriocins are restricted to kill other Gram-
positives and the killing range varies significantly (Gillor et al., 2008). Martínez-Cuesta et al. 
(2006) reported about the relatively narrow range of lactococcins A, B and M able to inhibit 
only Lactococcus, meanwhile some type A lantibiotics (e.g. nisin A, mutacin B-Ny266) had a 
wide range while killing Actinomyces, Bacillus, Clostridium, Corynebacterium, Enterococcus, 
Gardnerella, Lactococcus, Listeria, Micrococcus, Mycobacterium, Propionibacterium, Streptococcus, 
and Staphylococcus as shown by Mota-Meira et al. (2005). These particular bacteriocins were 
found to be active against some medically important Gram-negative strains of 
Campylobacter, Haemophilus, Helicobacter, and Neisseria (Morency et al., 2001).  
Furthermore, IIa class bacteriocins have relatively narrow killing spectrum as compared to I 
class bacteriocins and inhibit only closely related Gram-positive bacteria (Heng et al. 2007). 
However, pediocin was reported to have a fairly broad activity spectrum while inhibiting 
Streptococcus aureus and vegetative cells of Clostridium spp., Listeria and Bacillus spp. (Nes 
and Holo, 2000; Eijsink et al., 2002). Besides, maximum antimicrobial activity against 
Escherichia coli, Staphylococcus aureus and Bacillus cereus, though it was more effective against 
E. coli than others, showed bacteriocin produced by strain CA 44 of Lactobacillus genus 
isolated from carrot fermentation medium. This bacteriocin was stable at up to 100°C but its 
activity declined compared to that at 68°C and was completely lost at 121°C. The maximum 
antimicrobial activity was retained within the pH range of 4–5, but it was adversely affected 
by the addition of papain. Bacteriocin was also effective against B. cereus in different fruit 
products (pulp, juice and wine) indicating its potential application as a biopreservative in 
fruit products (Joshi et al., 2006).  
Quite a few studies on a bacterocin activity possessed by L. sakei strains have been 
performed. Schillinger and Lücke (1989) reported about 221 surveyed lactobacilli strains, 
among those 19 L. sakei strains, 3 L. plantarum strains and 1 L. curvatus strain were found to 
inhibit other lactobacilli. Bacteriocins were not identical according to the evaluation of 
supernatants antimicrobial spectra. Sakacin A produced by L. sakei Lb706 was reported to be 
active against List. monocytogenes strains 8732 and 17a, moreover 4 other strains of L. sakei 
and 1 strain of L. plantarum also shown antilisterial activity. Mørtvedt and Nes (1990) 
identified bacteriocin Lactosin S produced by L. sakei and described it as moderately heat 
stable, sensitive to protease and having antimicrobial activity against Lactobacillus, 
Pediococcus and Leuconostoc genera members. Furthermore, the instability of bacteriocin 
production and immunity was revealed by the plasmid biology investigation in L. sakei L45. 
Antagonistic effect of L. sakei CTC494 and sakacin K to different extents against List.innocua 
CTC1014 was demonstrated by Hugas and co-workers (1998). While Axelsson with co-
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workers (1988) developed a system for heterologous expression using a bacteriocin-negative 
L. sakei Lb790 strain, where into Lb790 introduced two plasmids allowed the production of 
various bacteriocins (sakacin P, pediocin PA-1, and piscicolin 61) at levels equal to or 
exceeding levels in correspondence with the wild type cultures. Cuozzo et al. (2000) 
investigated II b class bacteriocin lactocin 705 from L. casei CRL 705 and reported about the 
required of both two peptides presence for the inhibitory activity.  
The cloning, expression, and nucleotide sequence of the genes involved in the synthesis of 
pediocin PA-l was reported by Marugg et al. (1992). The genes were cloned and expressed in 
E. coli and 5.6-kbp fragment from the plasmid was found to be necessary for the bacteriocin 
production. Hoover and co-workers (1989) noted about the surveyed 37 pediococci cultures 
for the antagonistic effect against eight List. monocytogenes strains and indicated that a 
bacteriocin effect of these LABs against List. monocytogenes may not be limited to a few 
industrial starter cultures. 15 strains containing the Lactobacillus, Pediococcus, Lactococcus, and 
Leuconostoc genera were examined for the inhibition against eight strains of List. 
monocytogenes (Harris et al., 1989) and only cell-free supernatants from Lactobacillus species 
UAL11, P. acidilactici PAC 1.0, and Leuconostoc species UAL14 were reported to inhibit all 
eight strains of List. monocytogenes. The addition of proteolytic enzymes caused the 
prevention of the inhibition. Ennahar et al. (1996) found out that Lactobacillus plantarum 
WHE 92 produce a bacteriocin identical to pediocin AcH from P. acidilactici H, though 
pediocin AcH was produced more effectively in L. plantarum WHE 92 in the pH range of 5.0 
to 6.0 as compared to P. acidilactici H. Moreover, L. plantarum WHE 92 seems to have more 
effective means of antagonism against List. monocytogenes, since dairy products are normally 
higher than pH 5.0 (Hoover and Chen, 2005). Miller and co-workers (1998) applied PCR 
random mutagenesis for the construction of pediocin AcH amino acid substitution mutants. 
One mutant peptide was found to have a 2.8-fold higher activity against L. plantarum 
NCDO955, while other mutations were inactive and shown a reduced antagonism. Johnsen 
et al. (2000) increased the stability of pediocin PA-1 with the replaced methionine residue 
with alanine, isoleucine, or leucine in order to protect from oxidation, since this peptide was 
found to lose its activity while stored as refrigeration or ambient temperatures.  
Lacticin 3147 is a two peptide bacteriocin with a broad-spectrum activity and genetically 
resides on a self-transmissable plasmid that can be moved to other lactococci strains (Ross et 
al., 2000). McAuliffe and co-workers (1999) reported about a 3-log10 reduction in CFU/g of 
List. monocytogenes with the used Lc. lactis subs. lactis culture producing lacticin 3147. 
Bacteriocin S50 is another antimicrobial compound produced by lactococci, though it has a 
relatively narrow activity spectrum (Hoover and Chen, 2005). Lacticin FS92, containing 32 
amino acids, is a heat-stable bacteriocin and appears to be active against List. monocytogenes 
as noticed by Mao et al. (2001). List. monocytogenes resistant mutants were found to remain 
sensitive to lacticin FS92, but not to pediocin PA-1, curvaticin FS47 and lacticin FS56. The 
susceptibility of List. monocytogenes, List. innocua, and List. seeligeri strains was found to 
strain-dependent at each pH examined in response to lactocin 705, enterocin CRL35, and 
nisin (Castellano et al., 2001). 
3. Optimization of media and growth conditions for increased bacteriocin 
production  
The incorporation of bacteriocins as a biopreservative ingredient into model food systems 
has been studied extensively and has been shown to be effective in the control of 
pathogenic and spoilage microorganisms (Neysen and De Vuyst, 2005). LAB can also be 
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considered as protective cultures because they improve the microbiological quality as well 
as the safety of the food (Messens and De Vuyst, 2002) and can be a way to prevent 
product spoilage (Verluyten et al., 2004a). Lactic acid bacteria (LAB) are a group of 
microorganisms nutritionally exigent. They need a wide range of nutrients to grow and 
synthesize metabolic products, some nutritional requirements usually being strain 
specific. De Man-Rogosa-Sharpe (MRS) and yeast autolysate-peptone-tryptone-tween 80-
glucose (LAPTg) are standard culture media commonly used to support the growth of 
lactobacilli in the starting point of their cultivation. These media contain carbon and 
energy sources (carbohydrates, e.g. glucose), complex nitrogen sources (yeast extract, 
meat extract, tryptone and peptone) and supplements derived from oleic acid (Tween 80). 
MRS also includes inorganic and organic salts that have shown a stimulating effect or are 
essential for the growth of most of the species of this genus. Different components of 
culture media strongly affect the growth and bacteriocin production of several 
microorganisms that are mainly considered for food applications and must be included in 
fermentation processes, which are used on a production scale. Extruded wheat material is 
one of the candidates to be included as fermentation media for cultivation of bacteriocins 
producing LAB (Lactobacillus sakei MI806, Pediococcus pentosaceus MI810 and Pediococcus 
acidilactici MI807), previously isolated from spontaneous Lithuanian sourdoughs, in 
fermented products preparation formula for wheat bread production to have a higher 
positive effect compared with the control medium on LAB growth and their antimicrobial 
activities (Juodeikiene et al., 2011). 
Frequently, the conditions that lead to high bacteriocin production are similar to those 
prevailing during food fermentation processes (Leroy et al., 2002; Delgado et al., 2005; 
Neysen and De Vuyst, 2005). Bacteriocin production is usually proportional to growth and 
shows primary metabolite kinetics (Moretro et al., 2000) but often the correlation is weak 
(Delgado et al., 2005) and this is particularly evident for bacteriocins produced during the 
stationary phase (Jim´enez-D´az et al., 1993). Food preservation using in situ bacteriocin 
production requires a better understanding of the relationship between growth and 
bacteriocin production. Different bacteriocin exhibits different inhibition profile on food 
spoilage and pathogenic microorganisms. Therefore, they could be natural replacements for 
synthetic food preservatives. In order to increase the productivity of the bacteriocins, a 
better understanding on the factors affecting their production is essential. 
Bacteriocin titres change with environmental factors (Leal-S´anchez et al., 2002; Delgado et 
al., 2005), such as pH, temperature, and NaCl and ethanol concentrations. These 
environmental factors may influence growth negatively and thereby the secretion of the 
induction factor (Leal-S´anchez et al., 2002). Further, it has been suggested that some 
environmental factors reduce the binding of the induction factor to its receptor (Delgado et 
al., 2005). Bacteriocin production is strongly dependent on pH, nutrient sources and 
incubation temperature. Activity levels do not always correlate with cell mass or growth 
rate of the producer (Kim et al., 1997; Bogovic-Matijasic & Rogelj, 1998). Increased levels of 
bacteriocin production are often obtained at conditions lower than required for optimal 
growth (Bogovic-Matijasic & Rogelj, 1998; Todorov et al., 2000; Todorov & Dicks, 2004). 
Understanding the influence of food-related environmental factors on the induction of 
bacteriocins is essential for the effective commercial application of bacteriocin-producing 
LAB in the preservation of foods. 
Leal et al. (1998) optimized the production of bacteriocins by Lactobacillus plantarum LPCO10 
to allow the use of bacteriocins as natural food additives in canned vegetables and other 
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food systems. Results obtained indicated that the best conditions for bacteriocin production 
were shown with temperatures ranging from 22oC to 27oC, salt concentration from 2.3 to 
2.5%, and L. plantarum LPCO10 inoculum size ranging from 107.3 to 107.4 CFU/ml, fixing the 
initial glucose concentration at 2%, with no aeration of the culture. Under these optimal 
conditions, about 3.2 × 104 times more bacteriocin per liter of culture medium was obtained 
than that used to initially purify plantaricin S from L. plantarum LPCO10 to homogeneity. 
Delgado A. et al. (2007) by modeling studied the effects of some environmental factors on 
bacteriocin production by Lactobacillus plantarum 17.2b. Bacteriocin production by L. 
plantarum 17.2b was very sensitive to environmental conditions and uncoupled from 
growth. Maximum production required suboptimal growth temperatures, pH values above 
growth’s optimum and no NaCl. 
Many studies have focused on optimization of media and growth conditions of LAB for 
increased bacteriocin production. They have generally focused on the effects of pH, 
temperature, composition of the culture medium, and general microbial growth conditions 
(in vitro as well as in natural fermentations) on maximal bacteriocin production (FAO-WHO, 
2002; ANVISA, 2010; Cruz et al., 2009; Silveira et al., 2009; Minei et al., 2008; Galvez et al., 
2008). By supplementing the medium with growth limiting factors, such as carbohydrates, 
nitrogen, vitamins and potassium phosphate, or by adjusting the medium pH, levels of 
bacteriocin production is often increased.  
Several mechanisms have been proposed for the bacteriocins activity: alteration of 
enzymatic activity, inactivation of anionic carriers through the formation of selective and 
non-selective pores and inhibition of spore germination (Parada et al. 2007; Martinez and De 
Martinis, 2006). Powell et al. (2006), Todorov and Dicks (2005a), (2005b), (2006a), (2006b), 
Todorov et al. (2000), (2007a), (2007b), (2004) and Todorov (2008) reported higher bacteriocin 
production levels for L. plantarum ST194BZ, L. plantarum ST13BR, L. plantarum ST414BZ, L. 
plantarum ST664BZ, L. plantarum ST23LD, L. plantarum ST341LD, L. plantarum 423, L. 
plantarum AMAK, L. plantarum ST26MS, L. plantarum ST28MS, L. plantarum ST8KF, L. 
plantarum ST31 in optimized growth media. 
In general, the bactericidal/bacteriostatic action of bacteriocins encompasses the increased 
permeability of the cytoplasmic membrane of the target cells for a broad range of 
monovalent cations (e.g. Na+, K+, Li+, Cs+, Rb+ and choline) leading to the destruction of 
proton motive force by dissipation of the transmembrane pH gradient and eventually to the 
cell death (Simova et al., 2009; Oppegård et al., 2007). The bactericidal or bacteriostatic 
activity possessed by bacteriocins is influenced by the following factors: bacteriocin dose 
and purification degree, physiological status of the indicator cells (e.g. growth phase) and 
experimental conditions (e.g. temperature, pH, presence of agents disrupting cell wall 
integrity and other antimicrobial compounds) (Deraz et al., 2007; Cintas et al., 2001). An 
increased antibacterial activity of non-lanthionine-containing bacteriocins at low pH can be 
explained by the following factors: (1) more molecules are available to interact with the 
sensitive cells due to a lesser probability of the aggregation of hydrophilic peptides; (2) more 
molecules are available for the bactericidal action, since fewer molecules remain bound to 
the wall; (3) an enhanced capacity of hydrophilic bacteriocins to pass through hydrophilic 
regions of the cell wall of the sensitive bacteria; (4) an inhibited interaction at higher pH 
values between the non-lanthionine-containing bacteriocins and putative membrane 
receptors (Parada et al., 2007).  
 
Advances in Applied Biotechnology 
 
70
considered as protective cultures because they improve the microbiological quality as well 
as the safety of the food (Messens and De Vuyst, 2002) and can be a way to prevent 
product spoilage (Verluyten et al., 2004a). Lactic acid bacteria (LAB) are a group of 
microorganisms nutritionally exigent. They need a wide range of nutrients to grow and 
synthesize metabolic products, some nutritional requirements usually being strain 
specific. De Man-Rogosa-Sharpe (MRS) and yeast autolysate-peptone-tryptone-tween 80-
glucose (LAPTg) are standard culture media commonly used to support the growth of 
lactobacilli in the starting point of their cultivation. These media contain carbon and 
energy sources (carbohydrates, e.g. glucose), complex nitrogen sources (yeast extract, 
meat extract, tryptone and peptone) and supplements derived from oleic acid (Tween 80). 
MRS also includes inorganic and organic salts that have shown a stimulating effect or are 
essential for the growth of most of the species of this genus. Different components of 
culture media strongly affect the growth and bacteriocin production of several 
microorganisms that are mainly considered for food applications and must be included in 
fermentation processes, which are used on a production scale. Extruded wheat material is 
one of the candidates to be included as fermentation media for cultivation of bacteriocins 
producing LAB (Lactobacillus sakei MI806, Pediococcus pentosaceus MI810 and Pediococcus 
acidilactici MI807), previously isolated from spontaneous Lithuanian sourdoughs, in 
fermented products preparation formula for wheat bread production to have a higher 
positive effect compared with the control medium on LAB growth and their antimicrobial 
activities (Juodeikiene et al., 2011). 
Frequently, the conditions that lead to high bacteriocin production are similar to those 
prevailing during food fermentation processes (Leroy et al., 2002; Delgado et al., 2005; 
Neysen and De Vuyst, 2005). Bacteriocin production is usually proportional to growth and 
shows primary metabolite kinetics (Moretro et al., 2000) but often the correlation is weak 
(Delgado et al., 2005) and this is particularly evident for bacteriocins produced during the 
stationary phase (Jim´enez-D´az et al., 1993). Food preservation using in situ bacteriocin 
production requires a better understanding of the relationship between growth and 
bacteriocin production. Different bacteriocin exhibits different inhibition profile on food 
spoilage and pathogenic microorganisms. Therefore, they could be natural replacements for 
synthetic food preservatives. In order to increase the productivity of the bacteriocins, a 
better understanding on the factors affecting their production is essential. 
Bacteriocin titres change with environmental factors (Leal-S´anchez et al., 2002; Delgado et 
al., 2005), such as pH, temperature, and NaCl and ethanol concentrations. These 
environmental factors may influence growth negatively and thereby the secretion of the 
induction factor (Leal-S´anchez et al., 2002). Further, it has been suggested that some 
environmental factors reduce the binding of the induction factor to its receptor (Delgado et 
al., 2005). Bacteriocin production is strongly dependent on pH, nutrient sources and 
incubation temperature. Activity levels do not always correlate with cell mass or growth 
rate of the producer (Kim et al., 1997; Bogovic-Matijasic & Rogelj, 1998). Increased levels of 
bacteriocin production are often obtained at conditions lower than required for optimal 
growth (Bogovic-Matijasic & Rogelj, 1998; Todorov et al., 2000; Todorov & Dicks, 2004). 
Understanding the influence of food-related environmental factors on the induction of 
bacteriocins is essential for the effective commercial application of bacteriocin-producing 
LAB in the preservation of foods. 
Leal et al. (1998) optimized the production of bacteriocins by Lactobacillus plantarum LPCO10 
to allow the use of bacteriocins as natural food additives in canned vegetables and other 
Fermentation Processes Using Lactic Acid Bacteria Producing  
Bacteriocins for Preservation and Improving Functional Properties of Food Products 
 
71 
food systems. Results obtained indicated that the best conditions for bacteriocin production 
were shown with temperatures ranging from 22oC to 27oC, salt concentration from 2.3 to 
2.5%, and L. plantarum LPCO10 inoculum size ranging from 107.3 to 107.4 CFU/ml, fixing the 
initial glucose concentration at 2%, with no aeration of the culture. Under these optimal 
conditions, about 3.2 × 104 times more bacteriocin per liter of culture medium was obtained 
than that used to initially purify plantaricin S from L. plantarum LPCO10 to homogeneity. 
Delgado A. et al. (2007) by modeling studied the effects of some environmental factors on 
bacteriocin production by Lactobacillus plantarum 17.2b. Bacteriocin production by L. 
plantarum 17.2b was very sensitive to environmental conditions and uncoupled from 
growth. Maximum production required suboptimal growth temperatures, pH values above 
growth’s optimum and no NaCl. 
Many studies have focused on optimization of media and growth conditions of LAB for 
increased bacteriocin production. They have generally focused on the effects of pH, 
temperature, composition of the culture medium, and general microbial growth conditions 
(in vitro as well as in natural fermentations) on maximal bacteriocin production (FAO-WHO, 
2002; ANVISA, 2010; Cruz et al., 2009; Silveira et al., 2009; Minei et al., 2008; Galvez et al., 
2008). By supplementing the medium with growth limiting factors, such as carbohydrates, 
nitrogen, vitamins and potassium phosphate, or by adjusting the medium pH, levels of 
bacteriocin production is often increased.  
Several mechanisms have been proposed for the bacteriocins activity: alteration of 
enzymatic activity, inactivation of anionic carriers through the formation of selective and 
non-selective pores and inhibition of spore germination (Parada et al. 2007; Martinez and De 
Martinis, 2006). Powell et al. (2006), Todorov and Dicks (2005a), (2005b), (2006a), (2006b), 
Todorov et al. (2000), (2007a), (2007b), (2004) and Todorov (2008) reported higher bacteriocin 
production levels for L. plantarum ST194BZ, L. plantarum ST13BR, L. plantarum ST414BZ, L. 
plantarum ST664BZ, L. plantarum ST23LD, L. plantarum ST341LD, L. plantarum 423, L. 
plantarum AMAK, L. plantarum ST26MS, L. plantarum ST28MS, L. plantarum ST8KF, L. 
plantarum ST31 in optimized growth media. 
In general, the bactericidal/bacteriostatic action of bacteriocins encompasses the increased 
permeability of the cytoplasmic membrane of the target cells for a broad range of 
monovalent cations (e.g. Na+, K+, Li+, Cs+, Rb+ and choline) leading to the destruction of 
proton motive force by dissipation of the transmembrane pH gradient and eventually to the 
cell death (Simova et al., 2009; Oppegård et al., 2007). The bactericidal or bacteriostatic 
activity possessed by bacteriocins is influenced by the following factors: bacteriocin dose 
and purification degree, physiological status of the indicator cells (e.g. growth phase) and 
experimental conditions (e.g. temperature, pH, presence of agents disrupting cell wall 
integrity and other antimicrobial compounds) (Deraz et al., 2007; Cintas et al., 2001). An 
increased antibacterial activity of non-lanthionine-containing bacteriocins at low pH can be 
explained by the following factors: (1) more molecules are available to interact with the 
sensitive cells due to a lesser probability of the aggregation of hydrophilic peptides; (2) more 
molecules are available for the bactericidal action, since fewer molecules remain bound to 
the wall; (3) an enhanced capacity of hydrophilic bacteriocins to pass through hydrophilic 
regions of the cell wall of the sensitive bacteria; (4) an inhibited interaction at higher pH 
values between the non-lanthionine-containing bacteriocins and putative membrane 
receptors (Parada et al., 2007).  
 
Advances in Applied Biotechnology 
 
72
These studies highlight the possibility of increase antimicrobial activity of fermented 
products with the aim to improve food safety and quality characteristics. Besides the 
optimization of bacteriocin production and enhancement of its activity are economically 
important to reduce the production cost. 
4. Application of bacteriocins producing LAB for improving some safety 
characteristics of plant products 
4.1 Possibilities to prolong microbiological spoilage of bread using novel BLIS 
producing LAB 
Knowledge of fermenting microorganisms plays a defining role in the process of 
fermentation standardization and it is essential to have an exhaustive view of microbial 
interactions. The development of starter cultures for food fermentations follows a 
multidisciplinary approach and requires a thorough ecological study of these ecosystems. 
LAB are fundamental for the fermented product properties such as lactic fermentation, 
proteolysis, synthesis of volatile compounds, anti-mould and antiropiness effect. Since LAB 
are found to be the dominant microorganisms in sourdoughs, the rheology, flavour and 
nutritional properties of sourdough-based baked products greatly rely on their activity 
(Corsetti at al., 2003; Hammes and Gänzle, 1998; Gobbetti et al., 2005). Sourdough is used as 
an essential ingredient for acidification, leavening and production of flavour compounds 
and biopreservation of bread (Sadeghi, 2008; De Vuyst, 2007; Katina et al., 2005; Hansen, 
2004; Clarke et al., 2004). In bakery practice, sourdough is usually sustained by repeated 
inoculation, whereby a reproducible and controlled composition and activity of the 
sourdough microflora is paramount to achieve a constant stability of sourdough as well as a 
constant quality of the end-product. Besides, many researchers have reported about the high 
resistance of sourdough breads to the microbiological spoilage by moulds and rope-forming 
bacilli (Valerio et al., 2009; Hassan and Bullerman, 2008; Sadeghi, 2008; Ryan et al., 2008; 
Mentes et al., 2007). Mould causes mouldiness and bacteria belonging to the genus Bacillus 
(Şimşek et al., 2006) are capable of causing massive economic losses due to the considerable 
resistance allowing them to survive food processing (Errington, 2003; Driks, 2002). The 
bacterial spoilage of bread, known as ropiness, occurs as an unpleasant fruity odour (Mentes 
et al., 2007), and is still of major economic concern in the baking industry.  
4.1.1 Rope production in bread  
Ropiness is mainly caused by Bacillus subtilis and Bacillus licheniformis (Collins et al., 1991) 
which reportedly originate from the raw materials, the bakery atmosphere and equipment 
surfaces (Bailey and von Holy, 1993). These strains are also known to be food-borne 
pathogens when present at levels of 105 CFU/g in bread crumb (Kramer and Gilbert, 1989). 
Bacillus is a genus of rod-shaped, endospore-forming aerobic or facultatively anaerobic, 
Gram-positive bacteria (in some species cultures may turn Gram-negative with age) and a 
member of the division Firmicutes. Many species of the genus exhibit a wide range of 
physiologic abilities that allow them to live in every natural environment. Under stressful 
environmental conditions, the cells produce oval endospores that can stay dormant for 
extended periods (Ravel and Fraser, 2005; Kunst et al., 1997). Bacteria belonging to the genus 
Bacillus are capable of causing economic losses to the baking industry due to the food 
spoilage condition known as rope (Valerio et al., 2008; Thompson et al., 1993). The 
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predominant species involved in bread spoilage are Bacillus subtilis and B. licheniformis, 
though B. pumilus, B. megaterium and B. cereus are implicated as well (Şimşek et al., 2006; 
Rosenkvist and Hansen, 1995; Collins et al., 1991). These strains are also known to be food-
borne pathogens when present at levels of 105 CFU/g in bread crumb (Kramer and Gilbert, 
1989). Ropiness is noticed as an unpleasant odour, followed by a soft and sticky bread 
crumb caused by the enzymatic degradation and the production of extracellular slimy 
polysaccharides (Sadeghi, 2008; Valerio et al., 2008; Pepe et al., 2003). 
Figure 4 illustrates an example of ―ropy bread. B. subtilis spores have been isolated from 
ropy bread, meanwhile contamination of Bacillus have been reported to originate from raw 
materials, bakery environments and also from additives, including yeast, bread improvers, 
and gluten (Thompson et al., 1993; Rosenkvist and Hansen, 1995; Collins et al., 1991; 
Sorokulova et al., 2003; Bailey and von Holy, 1993).  
 
Fig. 4. Rope production in bread. 
B.subtilis spores being heat resistant can survive the baking process, since the maximum 
temperature in the loaf centre remains 97oC to 101oC for a few minutes (Östman, 2002; 
Rosenkvist and Hansen, 1995). During subsequent exposure to the warm (25oC to 30°C) and 
humid (water activity, ≥0.95) environmental conditions Bacillus spores germinate causing 
bread spoilage (Volavsek et al., 1992). The spore germination and growth of Bacillus 
vegetative cells during storage strongly depend on the water activity, pH and temperature 
(Condón et al., 1996; Quintavalla and Paroli, 1993). 
4.1.2 Spore formation in Bacillus subtilis 
Bacterial spores are very specialized, differentiated cell types and can survive the adverse 
conditions (e.g. starvation, high temperatures, ionizing radiation, mechanical abrasion, 
chemical solvents, detergents, hydrolytic enzymes, desiccation, pH extremes and 
antibiotics). Spores can cause massive problems in the food industry due to the considerable 
resistance allowing them to survive food processing and conservation methods (Errington, 
2003; Driks, 2002).  
The mature heat-resistant spore formation takes approx. 8 hours from the initial time of 
starvation. Numerous alterations in gene expression and a variety of physiological and 
morphological changes characterize the process of sporulation (Grossman and Losick, 1988). 
B. subtilis has been used as a model for the sporulation (the process of spore formation) 
studies (Errington, 2003; Eichenberger et al., 2004; Piggot and Hilbert, 2004; Phillips and 
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Strauch, 2002). Spore formation is a unique and complex process and can be divided into 
stages 0, II, III, IV, V, and VI (Grossman and Losick, 1988) involving asymmetric cell 
division, engulfment of the smaller cell and sacrifice of the original bacterial cell for the 
production of a single spore (Figure 5). 
 
Fig. 5. The sporulation cycle of Bacillus subtilis. 
Stage 0 is characterized as the cell commitment to sporulation that leads to the building of a 
septum (stage II). As a cell begins the process of forming an endospore, it divides 
asymmetrically, resulting in the creation of two compartments (the larger mother cell and 
the smaller prespore). Afterwards, the degradation of thepeptidoglycan in the septum 
occurs and mother cell engulfs the prespore, leading to the formation of a cell within a cell 
(stage III). The synthesis of the endospore-specific compounds, formation of the cortex and 
deposition of the coat (stages IV and V) proceeds due to the activities of the mother cell and 
prespore. Stages IV and V are followed by the final dehydration and maturation of the 
prespore (stages VI and VII). Finally, the mother cell is destroyed in a programmed cell 
death, and the endospore is released into the environment. The endospore remains dormant 
until it senses the return of more favourable conditions (Errington, 2003; Grossman and 
Losick, 1988; Phillips and Strauch, 2002).  
4.1.3 Strategy for the control of Bacillus spp. by BLIS producing LAB in bread 
production 
The initial Bacillus spore counts could be reduced by the recommended control procedures 
such as raw material quality, good sanitation of bakery equipment, stringent temperature 
control during baking, production cooling and storage environments (Bailey and von Holy, 
1993; Viljoen and von Holy, 1993). The use of chemical preservatives (propionic and acetic 
acids) was reported to be one of the ways for the inhibition of Bacillus germination and 
growth in bread, although the current trend is to reduce the levels of these substances 
(Pattison et al., 2004; Marín et al., 2002). The increase in acidity by using traditional 
sourdough fermentation is an effective way to limit the germination and growth of rope 
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forming bacteria (Sadeghi, 2008). Röcken (1996) reported about the enhanced thermal 
inactivation of B. subtilis spores by using an increased sourdough contents. Katina and co-
workers 2005 examined the ability of LAB to inhibit the growth of rope forming strains in 
wheat bread and announced about the growth inhibition of B. subtilis and B. licheniformis by 
Lactobacillus plantarum VTT E-78076 and Pediococcus pentosaceus VTT E-90390. The added 
heat-treated cultures of L. plantarum E5 and Leuc. mesenteroides A27 were reported to prevent 
the growth of approximately 104 rope-producing B. subtilis G1 spores per cm2 on bread slices 
for more than 15 days (Pepe et al., 2003). The inhibition of the rope spoilage of wheat bread 
was observed with the added 20–30 g of sourdough/100 g of wheat dough (Katina, K. et al., 
2002). Kingamkono and co-workers (1994), Svanberg and co-workers (1992) shown that food 
fermentation by LAB to pH 4.0 or lower inhibited the growth of Bacillus as well as other 
pathogenic microorganisms. Suomalainen and Mäyrä-Makinen (1999) reported about the 
inhibitory effect of Lactobacillus rhamnosus LC705 against Bacillus spp. in bakery products. 
Bogovič-Matijašić and co-workers (1998) found out the antimicrobial activity of Lactobacillus 
acidophilus LF221 producing two bacteriocins against different pathogens including B. 
cereus. Røssland and co-workers (2003) demonstrated that a rapid decrease in pH during 
log phase of fermentation was related with the B. cereus growth inhibition. Meanwhile B. 
cereus sporulated and existed as endospores with the pH reduced at a slower rate in early 
log phase.  
Several studies have been dedicated for the analysis of the antimicrobial activity of LAB and 
their produced bacteriocins, and have reported that the antifungal activity of LAB is lost 
after treatment with proteolytic enzymes. Batish et al. (1989) suggested that the antifungal 
substance produced by a LAB isolate was of proteinaceous nature since activity disappeared 
with proteinase treatment. Roy et al. (1996) isolated a Lactococcus lactis subsp. lactis with 
antagonistic activity against several filamentous fungi, that were lost after enzymatic 
treatment with chymotrypsin, trypsin and pronase Gourama (1997a) found that the 
inhibitory effect of a Lactobacillus casei strain against two Penicillium species was slightly 
reduced by treatment with trypsin and pepsin. Gourama and Bullerman (1995, 1997b) 
showed that a commercially available silage inoculant with a combination of Lactobacillus 
species (L. plantarum, L. delbrueckii subsp. bulgaricus and L. acidophilus) had antifungal and 
antiaflatoxin activity against A. flavus. The inhibitory activity was sensitive to treatments 
with trypsin and alpha-chymotrypsin, and it was concluded that the activity was due to a 
small peptide. 
The changes in LAB antimicrobial effect upon the interactions with the enzymes is very 
important in the baking industry where commercial enzyme preparations often are used for 
fermentation processes intensification and recently became one of the research topics.  
In one of the studies (Digaitiene et al., 2005), 270 bacterial strains were isolated from 
spontaneous sourdoughs and of these, five LAB (Lactobacillus sakei MI806, Pediococcus 
pentosaceus MI808, MI809 and MI810, Pediococcus acidilactici MI807) isolates were found to 
produce BLIS (sakacin 806, pediocin 808, 809, 810 and pediocin Ac807 respectively). Isolates 
of new bacteriocins producing LAB strains depend for subclass II. The results of inhibitory 
spectra studies and pH sensitivity analysis indicated that the BLIS under investigation were 
different from each other. These novel BLIS (sakacin 806, pediocin 808, pediocin 809, 
pediocin 810 and pediocin Ac807) have been tested for their antimicrobial activity against B. 
subtilis, one of the most important micro-organisms responsible for ropiness in bread; 
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Strauch, 2002). Spore formation is a unique and complex process and can be divided into 
stages 0, II, III, IV, V, and VI (Grossman and Losick, 1988) involving asymmetric cell 
division, engulfment of the smaller cell and sacrifice of the original bacterial cell for the 
production of a single spore (Figure 5). 
 
Fig. 5. The sporulation cycle of Bacillus subtilis. 
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furthermore their sensitivity to various baking enzymes has been examined (Narbutaite et 
al., 2008). Antimicrobial activity was tested using an overlay assay method; the results 
showed that the BLIS studied here were effective against B. subtilis. To our knowledge, this 
is the first report of BLIS-producing LAB isolated from sourdoughs which are active against 
B. subtilis.  
Bacteriocins have gained importance as natural biopreservatives for the control of spoilage 
and pathogenic organisms in foods. Latest studies highlights the possibility of using LAB 
exhibiting antimicrobial activity against B. subtilis in sourdough bread making, a desirable 
characteristic when selecting for more competitive starters. The strains described here can 
have an impact when used as starter cultures for traditional sourdough fermentation by 
delaying spore germination and inhibiting the outgrowth of B. subtilis. This opens up the 
possibility of using such LAB on an industry scale. Future work will also focus on obtaining 
the amino acid sequences of the BLIS presented here. 
4.2 Potential of lactic acid bacteria to degrade biogenic amines in different 
fermentation media 
A variety of fermented foods especially protein-rich foods e.g. fermented vegetables, legume 
products, beers and wines contain biogenic amines (BAs) (Kalač et al., 2002). During the 
fermentation process protein breakdown products, peptides and amino acids, used by 
spoilage and also by the fermentation microorganisms represent precursors for BAs 
formation (Hernandez-Jover et al., 1997; Bodmer et al., 1999). BAs are formed through the 
decarboxylation of specific free amino acids by exogenous decarboxylases released from the 
microbial population associated with the raw material.  
Some biogenic amines such as histamine (HIS), tyramine (TYR), putrescine (PUT) and 
cadaverine (CAD) are important for their physiological and toxicological effects on the 
human body. They may exert either psychoactive or vasoactive effects on sensitive humans. 
Histamine is physiologically the most important BA. Histamine has been found to cause the 
most frequent food-borne intoxications associated with BAs; it acts as a mediator and is 
involved in pathophysiological processes such as allergies and inflammations (Gonzaga et 
al, 2009). Tyramine can evoke nausea, vomiting, migraine, hypertention and headaches 
(Shalaby, 1996). Putrescine and cadaverine can increase the negative effect of other amines 
by interfering with detoxification enzymes that metabolize them (Stratton et al., 1991). The 
consumption of foods with high concentrations of BAs can induce adverse reactions such as 
nausea, headaches, rashes and changes in blood pressure (Ladero et al., 2010).  
The main BAs associated with such fermented plant product as wine are HIS, TYR and PUT 
(Ancin-Azpilicueta et al., 2008). Their presence in wine is considered as marker molecules of 
quality loss, and some EU countries even have recommendations for the amount of 
histamine acceptable in wine which impacts on the import and export of wines to these 
countires. Most fermented foods, such as cheese, fermented sausages and beer, which are 
consumed more frequently than wines, have biogenic amine content (Fernandez et al., 2007). 
However, the precence of alcohol in wine may enhance the activity of amines because it 
inhibits monoamine oxidase enzymes. These enzymes depending for the detoxification 
system in the intestinal tract of mammals convert amines into non-toxic products, which are 
further excreted out of the organism.  
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Regarding fruits and vegetables relatively low levels of biogenic amines were found in fruit 
juice and canned fruit/vegetable samples. The same tendency has been noticed in other 
publications, but sometimes the results are controversial. Moret et al., (2005) showed that 
vegetables generally contained low levels in biogenic amines (0.1–9.6 mg kg-1) while Kalač et 
al., (2002) found relatively high levels of the amines in vegetables (0.8–52.5 mg kg-1). The 
polyamines PUT and spermidin (SPM) are practically ubiquitous in all vegetables at a few 
mg/100 g of fresh weight and TYR is less widespread in vegetables (Kalač et al., 2002; Moret 
et al., 2005). They are implicated in a number of physiological processes, such as cell 
division regulation, plant growth, flowering, fruit development, response to stress and 
senescence (Bouchereau et al., 2000). Moreover, although PUT, SPD and other biogenic 
amines are generated in low quantities in most canned vegetables/fruits, they are not the 
primary metabolic products produced by the fermenting organisms (Stratton et al., 1991). 
With the exception of tempe (Saaid et al., 2009) and taucu, relatively low levels of biogenic 
amines are found in the soy bean products tested. Studies by Mower and Bhagavan (1989) 
showed higher level of TYR (450 mg kg-1) in salted black beans. The quantitative analysis of 
fermented products prepared for wheat bread production revealed that tyramine (32.6–215.8 
mg kg-1), histamine (20.8–96.7 mg kg-1), and putrescine (33.7–195.2 mg kg-1) showed as being 
the major occurring BAs (Bartkiene et al., 2011). Since several varieties of molds, yeasts and 
lactic acid bacteria are involved in the fermentation processes of such products and the raw 
material (soy bean) contains considerable amounts of protein, the formation of various amines 
might be expected during the fermentation (Shalaby, 1996). Studies have shown that biogenic 
amines in fermented soy bean products are most likely formed by the lactic microflora that is 
active during fermentation (Kirschbaum et al., 2000). TYR and HIS have been found at various 
levels in such products (Stratton et al., 1991). The variability of biogenic amines levels in the 
commercial fermented soy bean products samples had been attributed to the variations in 
manufacturing processes; variability in the ratio of soy bean in the raw material, microbial 
composition, conditions and duration of fermentation (Shalaby, 1996). 
Knowledge concerning the origin and factors involved in BAs production in fermented 
products e.g. wine is well documented, and recently several reviews on this topic have been 
published (Costantini et al., 2009; Moreno-Aribas and Polo, 2010). They are generated either 
as the result of endogenous decarboxylase-positive microorganisms in raw materials or by 
the growth of contaminating decarboxylase-positive microorganisms in fermented products. 
With regards to wine microorganisms, a large amount of literature is available on the 
production of BAs. Several research group support the view that biogenic amines are 
formed in winemaking mainly by lactic acid bacteria (LAB) due to the decarboxilation of the 
free amino acids (Constantini et al., 2006; Lucas et al., 2008). The levels of BAs usually 
increase during fermentation due to decarboxylase activity of the LAB used as starter 
culture. Low acid conditions, such as those occurring during fermentation, favour the 
decarboxylation of amino acids (De las Rivas et al., 2005). The levels of free amino acids 
usually increase in fermented products during fermentation due to the action of endogenous 
and exogenous proteases through proteolysis processes (Hughes et al., 2002). It is thought 
that proteolysis might provide the nutrient for spoilage microorganisms, leading to a 
promoted growth of those microorganisms (Riebroy et al., 2004).  
In this context, recently published paper (Garcia et al., 2011) reports novel data about the 
presence of histamine-, tyrosine- and putrescine-degrading enzymatic activities of wine-
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associated LAB. Of particular interest are the results concerning the degradation of 
putrescine, since no such degrading ability of any food LAB has previously been reported. 
The isolates tested (42 strains Oenococcus oeni, 7 strains Pediococcus parvulus, 4 strains P. 
pentosaceus, 6 strains Lactobacillus plantarum, 9 strains L. hilgardi, 3 strains L. zeae, 7 strains L. 
casei, 5 strains L. paracasei and 2 strains Leuconostoc mesenteroides) belong to the principal 
species of wine LAB and other related ecosystems and were selected because they came 
from wine cellars that often suffer from the problem of BAs in their wines (Moreno-Aribas 
and Polo, 2010). In this study the most potent amine-degrading species detected were L. 
plantarum, P. parvulus and, in particular, P. pentosaceus and L. casei, in spite of the fact that 
strains of these last species have never be reported to degrade histamine, tyramine and/or 
putriscine. None of the strains were able to produce these BAs as they did no show the 
decarboboxylase activity necessary for the production of these compounds in wine. 
However, this potential for histamine, tyramine and/or putrescine degradation among wine 
LAB does not appear to be very frequent, since out of the 85 strains examined, only nine 
displayed noteworthy amine-degrading activity in culture media. Further studies using 
other LAB species and/or strains may enable more potent amine-degrading enzyme 
producers to be identified. However, it was observed that positive strains displayed amine-
degrading activity against several biogenic amines simultaneoustly, in accordance with 
previous works that also reported the presence of either one or two amine oxidases in other 
food fermenting microorganisms, such as Micrococcus varians and Staphylococcuscarnosus 
(Leuschner et al., 1998).  
The fact that active bacteria which were able to significantly reduce the concentration of BAs 
in the conditions used in the study came from different fermentation media such as young 
wine, wood- aged wines, sherry wines (Table 1), suggest that there are ecological niches for 
the isolation of potential amine-degrading bacteria.  
 
Strains Degradation, % a,b 
Histamine Tyramine Putrescine 
L. casei IFI-CA-52 54 55 65 
L. hilgardi IFI-CA-41 n.e. n.e. 20 
L. plantarum IFI-CA-26 33 n.e. 24 
L. plantarum IFI-CA-54 23 17 24 
O. oeri IFI-CA-32 12 n.e. 16 
P. parvulus IFI-CA-30 20 15 53 
P. pentosaceous IFI-CA-30 10 12 49 
P. pentosaceous IFI-CA-83 19 22 39 
P. pentosaceous IFI-CA-86 n.e. 54 69 
a Activity is expressed as a percentage of control without strain and according to HPLC quantitative 
biogenic amine results. 
b Mean value (n=3); n.e. : no effect was observed. 
Table 1. Percentage of degradation of the biogenic amines (histamine, tyramine and 
putrescine) by wine-associated LAB in culture media 
Recently, homofermentative Pediococcus acidilactici were isolated from spontaneous rye 
sourdoughs and characterised as producing pediocin Ac807 with antimicrobial activity 
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against Bacillus subtilis (Digaitiene et al., 2005; Narbutaite et al., 2008). Since fermentation by 
using P. acidilactici could improve or modify flavour, taste, and texture of used plant 
additives for wheat bread production, the safety characteristics of fermented products rich 
in proteins are not always predictable. Therefore the BAs investigation in untreated whole 
lupine flours and fermented products of different lupines species (Lupinus angustifolius and 
Lupinus luteus) after spontaneous fermentation and fermentation by P. acidilactici has been 
carried out (Bartkiene et al., 2011). This study showed that the BAs levels were found to be 
lower after fermentation (by 17%) of L. luteus flour by P. acidilactici. Also the total amount of 
BAs was significantly reduced (25%) during spontaneous fermentation of L. luteus flour 
compared to non-treated samples. Opposite to the L. luteus, fermentation of L. angustifolius 
flour led to an increase of 20.5% and 44% of total amount of BAs in spontaneous and P. 
acidilactici sourdoughs, respectively. The different BAs in fermented products, which have 
been prepared using different kinds of lupine can be explained by the quality of the raw 
material and or by formation during the fermentation process involving microorganisms 
and these results are in agreement with previous research (Silla Santos, 1996).  
The presented results agree to the findings that the use of decarboxylase negative 
microorganisms, e.g. LAB as starter cultures could be an important factor to be considered 
in order to reduce the levels of BAs in fermented foods.  
4.3 Possible approaches of LAB and enzymes to biodegradation of mycotoxins 
Mycotoxins are secondary metabolites produced by a wide variety of filamentous fungi, 
including species from the genera Aspergillus, Fusarium and Penicillium. They cause 
nutritional losses and represent a significant hazard to the food and feed chain. Humans 
have long been exposed to mycotoxins by several different routes: directly, via foods of 
plant origin, including cereals from which bread and bakery products are derived; by air 
(both indoors and outdoors); or indirectly, through foods of animal origin. Many countries, 
therefore, have established measures to safeguard the health of consumers by establishing 
regulations for food and feed. The most economically important mycotoxins occurring in 
food and feed are aflatoxins, ochratoxin A, patulin, and the Fusarium toxins (zearalenon, 
trichothecenes, fumonisins etc.) (Chassy, 2010). 
Principally, there are three possibilities to avoid harmful effect of contamination of food and 
feed caused by mycotoxins: (1) prevention of contamination, (2) decontamination of 
mycotoxin-containing food and feed, and (3) inhibition of absorption of mycotoxin content 
of consumed food into the digestive tract (Halász et al., 2009). 
The theoretically soundest approach of prevention is doubtless to breed cereals and other 
food and feed plants for resistance to mould infection and consequently exclude mycotoxin 
production. Particularly in breeding wheat and corn, significant improvement of resistance 
has been achieved. The identification of microbial species (and genes coding enzymes 
degrading mycotoxins) allows transfer of these genes into plants and production of such 
enzymes by transgenic plants. In this way, the safety problems connected with the use of 
live microorganisms may be avoided. 
Another practical approach to prevention of mycotoxin contamination is the inhibition of 
the growth of molds and their production of mycotoxins. First, optimal harvesting, storage 
and processing methods, and conditions may be successful in prevention of mold growth. 
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associated LAB. Of particular interest are the results concerning the degradation of 
putrescine, since no such degrading ability of any food LAB has previously been reported. 
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species of wine LAB and other related ecosystems and were selected because they came 
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LAB does not appear to be very frequent, since out of the 85 strains examined, only nine 
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Strains Degradation, % a,b 
Histamine Tyramine Putrescine 
L. casei IFI-CA-52 54 55 65 
L. hilgardi IFI-CA-41 n.e. n.e. 20 
L. plantarum IFI-CA-26 33 n.e. 24 
L. plantarum IFI-CA-54 23 17 24 
O. oeri IFI-CA-32 12 n.e. 16 
P. parvulus IFI-CA-30 20 15 53 
P. pentosaceous IFI-CA-30 10 12 49 
P. pentosaceous IFI-CA-83 19 22 39 
P. pentosaceous IFI-CA-86 n.e. 54 69 
a Activity is expressed as a percentage of control without strain and according to HPLC quantitative 
biogenic amine results. 
b Mean value (n=3); n.e. : no effect was observed. 
Table 1. Percentage of degradation of the biogenic amines (histamine, tyramine and 
putrescine) by wine-associated LAB in culture media 
Recently, homofermentative Pediococcus acidilactici were isolated from spontaneous rye 
sourdoughs and characterised as producing pediocin Ac807 with antimicrobial activity 
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against Bacillus subtilis (Digaitiene et al., 2005; Narbutaite et al., 2008). Since fermentation by 
using P. acidilactici could improve or modify flavour, taste, and texture of used plant 
additives for wheat bread production, the safety characteristics of fermented products rich 
in proteins are not always predictable. Therefore the BAs investigation in untreated whole 
lupine flours and fermented products of different lupines species (Lupinus angustifolius and 
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carried out (Bartkiene et al., 2011). This study showed that the BAs levels were found to be 
lower after fermentation (by 17%) of L. luteus flour by P. acidilactici. Also the total amount of 
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compared to non-treated samples. Opposite to the L. luteus, fermentation of L. angustifolius 
flour led to an increase of 20.5% and 44% of total amount of BAs in spontaneous and P. 
acidilactici sourdoughs, respectively. The different BAs in fermented products, which have 
been prepared using different kinds of lupine can be explained by the quality of the raw 
material and or by formation during the fermentation process involving microorganisms 
and these results are in agreement with previous research (Silla Santos, 1996).  
The presented results agree to the findings that the use of decarboxylase negative 
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in order to reduce the levels of BAs in fermented foods.  
4.3 Possible approaches of LAB and enzymes to biodegradation of mycotoxins 
Mycotoxins are secondary metabolites produced by a wide variety of filamentous fungi, 
including species from the genera Aspergillus, Fusarium and Penicillium. They cause 
nutritional losses and represent a significant hazard to the food and feed chain. Humans 
have long been exposed to mycotoxins by several different routes: directly, via foods of 
plant origin, including cereals from which bread and bakery products are derived; by air 
(both indoors and outdoors); or indirectly, through foods of animal origin. Many countries, 
therefore, have established measures to safeguard the health of consumers by establishing 
regulations for food and feed. The most economically important mycotoxins occurring in 
food and feed are aflatoxins, ochratoxin A, patulin, and the Fusarium toxins (zearalenon, 
trichothecenes, fumonisins etc.) (Chassy, 2010). 
Principally, there are three possibilities to avoid harmful effect of contamination of food and 
feed caused by mycotoxins: (1) prevention of contamination, (2) decontamination of 
mycotoxin-containing food and feed, and (3) inhibition of absorption of mycotoxin content 
of consumed food into the digestive tract (Halász et al., 2009). 
The theoretically soundest approach of prevention is doubtless to breed cereals and other 
food and feed plants for resistance to mould infection and consequently exclude mycotoxin 
production. Particularly in breeding wheat and corn, significant improvement of resistance 
has been achieved. The identification of microbial species (and genes coding enzymes 
degrading mycotoxins) allows transfer of these genes into plants and production of such 
enzymes by transgenic plants. In this way, the safety problems connected with the use of 
live microorganisms may be avoided. 
Another practical approach to prevention of mycotoxin contamination is the inhibition of 
the growth of molds and their production of mycotoxins. First, optimal harvesting, storage 
and processing methods, and conditions may be successful in prevention of mold growth. 
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Although the primary goal is the prevention of mycotoxin contamination, mycotoxin 
formation appears to be unavoidable under certain adverse conditions.  
Treatment of grains by some chemicals to prevent mycotoxin formation is also possible. 
Most of these compounds work by inhibiting fungal growth. For example, approximately 
one hundred compounds have been found to inhibit aflatoxin production. Two extensively 
studied inhibitors of aflatoxin synthesis are dichlorvos (an organophosphate insecticide) and 
caffeine. As reported by (Halász et al., 2009) some surfactants have been found to suppress 
the growth of Aspergillus flavus and aflatoxin synthesis. 
When contamination cannot be prevented, physical and chemical decontamination methods 
have been employed with varying success in the past, principally for feed. Whichever 
decontamination strategy is used, it must meet some basic criteria:  
• the mycotoxin must be inactivated or destroyed by transformation to non-toxic 
compounds; 
• fungal spores and mycelia should be destroyed, so that new toxins are not formed; 
• the food or feed material should retain its nutritive value and remain palatable; 
• the physical properties of raw material should not change significantly; and 
• it must be economically feasible / the cost of decontamination should be less than the 
value of contaminated commodity. 
Partial removal of mycotoxin may be achieved by dry cleaning of the grain and in the 
milling process, as well. Milling led to a fractionation, with increased level of mycotoxin in 
bran and decreased level in flour. The majority of mycotoxins are heat-stable so heat 
treatment, usually applied in food technology, does not have significant effect on mycotoxin 
level. 
Efforts were made in several countries to find an economically acceptable way of 
destruction of mycotoxins into non-toxic products using different chemicals such as alkali 
and oxidative agents. Although such treatment reduces nearly completely the mycotoxin 
concentration, these chemicals also cause losses of some nutrients and such treatment is too 
drastic for grain destined for food uses. 
Although the different methods used at present have been to some extent successful, most 
methods have major disadvantages, starting with limited efficacy to losses of important 
nutrients and generally with high costs.  
More recently, biological decontamination and biodegradation of mycotoxins with 
microorganisms or enzymes, have been used (He et al., 2010; Juodeikiene et al., 2011). In this 
case no harmful chemicals where used, so no significant losses in nutritive value and 
palatability of decontaminated food and feed occurred. Today, ruminants appear to be a 
promising potential source of microbes or enzymes for use in the biotransformation of 
mycotoxins. 
One of the most frequently used strategies for biodegradation of mycotoxins includes 
isolation of microorganisms able to degrade the given mycotoxin and treatment of food or 
feed in an appropriate fermentation process. From the food safety point-of-view, 
fermentation with microorganisms commonly used in food production (fermentation with 
lactic acid bacteria, alcoholic fermentation, traditional fermentation of vegetable protein 
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used in South Asia, etc.) should be preferred. Knowledge of enzymes that take part in 
degradation of mycotoxins opens some new approaches: (1) the production of genetically 
modified species of microorganisms commonly used in food production and their use for 
production of enzymes mentioned above; or (2) the transfer of genes coding for these 
enzymes to transgenic plants and use the plants for production of mycotoxin degrading 
enzymes. 
In staple food such as bread and bakery products in the flour sector, yeast and lactobacilli 
now play an important role. It thus stands to reason that the same microbes and enzymes 
are the first to have been considered for use as detoxifying or decontaminating agents. This 
type of biodegradation could therefore prove a useful strategy for partially overcoming the 
problem of some mycotoxins. Indeed, this already takes place in bread and in sourdough 
processes (Bartkiene et al., 2008); and OTA in food can also undergo biodegradation 
(Abrunhosa et al., 2010) and certain antagonistic yeast strains can substantially degrade 
OTA. This might offer new possibilities for reducing this mycotoxin in bread and bakery 
products and their raw materials (Patharajan et al., 2011). The use of enzymes or engineered 
micro-organisms (provided that these are allowed by legislation) as processing aids in the 
bread and bakery sector would also prove beneficial. Genetic engineering technologies will 
improve the efficiency with which enzymes can be produced from these organisms, and will 
allow the production of engineered organisms which have the target genes. They will 
additionally increase the availability and bioavailability, and will improve the quality of the 
end product. 
4.3.1 Inhibition of mycotoxins biosynthesis by lactic acid bacteria 
Several papers dealing with the inhibition of mycotoxin biosynthesis by LAB have focused 
on aflatoxins (Thyagaraja & Hosono, 1994). During cell lysis, it is possible that LAB releases 
molecules that potentially inhibit mould growth and therefore lead to a lower accumulation 
of their mycotoxins (Gourama & Bullerman, 1995). These “anti-mycotoxinogenic” 
metabolites could also be produced during LAB growth. Gourama (1991), using a dialysis 
assay, demonstrated the occurrence of a metabolite that inhibits aflatoxin accumulation in 
Lactobacillus cell-free extracts. It was suggested that this inhibition of aflatoxin biosynthesis 
was not the result of a hydrogen peroxide production or a pH decrease (Karunaratne et al., 
1990). These findings were consistent with those of Gourama (1991), who suggested that 
inhibition of aflatoxin biosynthesis by Lactobacillus cell free supernatants was probably due 
to specific bacterial metabolites. Coallier-Ascah and Idziak (1985) reported a significant 
reduction of aflatoxin biosynthesis by Lactobacillus cell free supernatants and suggested that 
this inhibition was related to a heat stable, low-molecular-weight inhibitory compound. 
Although Lactobacillus spp. were found to delay aflatoxin biosynthesis, other lactic strains 
such as Lc. lactis were found to stimulate aflatoxin accumulation (Luchese and Harrigan, 
1990). 
4.3.2 Decontamination of mycotoxins using microorganisms by binding or 
degradation 
Biological detoxification of mycotoxins works mainly via two major processes, sorption and 
enzymatic degradation, both of which can be achieved by biological systems. Live micro-
organisms can absorb either by attaching the mycotoxin to their cell wall components or by 
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active internalization and accumulation. Dead microorganisms too can absorb mycotoxins, 
and this phenomenon can be exploited in the creation of biofilters for fluid decontamination 
or probiotics (which have proven binding capacity) to bind and remove the mycotoxin from 
the intestine.  
Another approach to the biological decontamination of mycotoxins involves their 
degradation by selected micro-organisms. Recently critical review on biological 
detoxification by (Dalié et al., 2009) summarized different and interesting aspects of the 
biological detoxification of mycotoxins.  
Micro-organism detoxification can be performed in many different ways (Magan and Olsen, 
2004): 
• The entire organism can be used as a starter culture, as in the fermentation of beer, wine 
and cider, or in lactic acid fermentation of vegetables, milk and meat. 
• The purified enzyme can be used in soluble or immobilized (biofilter) forms. 
• The gene encoding the enzymatic activity can be transferred and overexpressed in a 
heterologous system; interesting candidates for this application include yeasts, 
probiotics and plants. 
Biological methods have been applied for the biodegradation and decontamination of 
different mycotoxins. 
Aflatoxins. As the first mycotoxins to be discovered, were also the first target in screening 
for microbial degradation. Several examples of the detoxification of the most common and 
important mycotoxins are reviewed. Almost 40 years ago, several species of micro-
organisms – including yeasts, moulds, bacteria, actinomycetes and algae – were screened for 
detoxification activity; based on this studies only one isolate was found, Flavobacterium 
auranotiacum, which significantly removed aflatoxin from a liquid medium (Ciegler et al., 
1966).  
Later aflatoxins decontamination during fermentation was reported in several cases. About 
50% reduction in aflatoxins B1 and G1 has been reported during an early stage of miso 
fermentation. It was attributed to the degradation of the toxin by micro-organisms. 
Significant losses of aflatoxin B1 and ochratoxin A were observed during beer brewing (Chu 
et al., 1975). Detoxification of aflatoxin B1 occurred during the fermentation of milk by LAB 
and in dough fermentation during breadmaking. Digestive tract micro-organisms are able to 
reduce mycotoxin levels not only by binding and removal but also by detoxification.  
Most data dealing with the effects of LAB on the accumulation of mycotoxins are related to 
aflatoxin-producing moulds. Wiseman and Marth (1981) revealed the existence of an 
amensalism relationship between Lc. lactis and A. parasiticus. When these authors added the 
spores of A. parasiticus to a 13-day-old culture of Lc. lactis, they observed the entire 
repression of aflatoxin production. When the fungal spore suspension and the lactic strain 
were inoculated simultaneously, an increase in aflatoxin production was observed. In 
contrast, Coallier-Ascah and Idziak (1985) showed an inhibition of aflatoxin accumulation 
when both microorganisms were simultaneously cultivated in Lab-Lemco tryptone broth 
(LTB). Addition of glucose to the cultivation medium during the conidiation phase of the 
mould did not restore the the production of aflatoxin. 
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Several LAB have been found to be able to bind aflatoxin B1 in vitro (Kankaanpää et al., 2000; 
Gratz et al., 2004), with an efficiency depending on the bacterial strain (Shah & Wu, 1999). 
El-Nezami with co-workers (1998a) have evaluated the ability of five Lactobacillus to bind 
aflatoxins in vitro and have shown that probiotic strains such as Lb. rhamnosus GG and Lb. 
rhamnosus LC-705 were very effective for removing aflatoxin B1, with more than 80% of the 
toxin trapped in a 20μg/ml solution (Haskard et al.,1998). 
According to Coallier-Ascah and Idziak (1985), the inhibition of aflatoxin accumulation was 
not related to a pH decrease but rather to the occurrence of a low-molecular-weight 
metabolite produced by the LAB at the beginning of its exponential phase of growth. 
Inhibition of aflatoxin production by other LAB belonging to the genus Lactobacillus was also 
reported (Karunaratne et al., 1990). It was assumed that this inhibition resulted from the 
production of a metabolite different from hydrogen peroxide or organic acid (Gourama, 
1991). Haskard wich co-wokers (2001) demonstrated that Lb. rhamnosus GG (ATCC 53103) 
and Lb. rhamnosus LC-705 (DSM 7061) were able to eliminate aflatoxin B1 from the culture 
medium by a physical process.  
Several studies have suggested that the antimutagenic and anti-carcinogenic properties of 
probiotic bacteria can be attributed to their ability to non-covalently bind hazardous 
chemical compounds such as aflatoxins in the colon (El-Nezami et al., 1998b; Gratz et al., 
2004). Both viable and non-viable forms of the probiotic bacterium Lactobacillus rhamnosus 
GG effectively removed aflatoxin B1 from an aqueous solution (El-Nezami et al., 1998b). 
Since metabolic activation is not necessary, binding can be attributed to weak, non-covalent, 
physical interactions, such as association to hydrophobic pockets on the bacterial surface 
(Haskard et al., 2000). Coallier-Ascah and Idziak (1985) reported a significant reduction of 
aflatoxin biosynthesis by Lactobacillus cell free supernatants and suggested that this 
inhibition was related to a heat stable, low-molecular-weight inhibitory compound. 
Ochratoxin-A (OTA) The major OTA producers in food and feed products are considered to 
be A. alliaceus, A. carbonarius, A. ochraceus, A. steynii, A. westerdijkiae, P. nordicum and P. 
verrucosum (Frisvad et al., 2006). These are mainly associated with agricultural crops pre-
harvest, or in post harvest storage situations. Biological methods use microorganisms, which 
can decompose, transform or adsorb OTA to detoxify contaminated products or to avoid the 
toxic effects when mycotoxins are ingested. These are the technologies of choice for 
decontamination proposes because they present several advantages from being mediated by 
enzymatic reactions. For example, they are very specific, efficient, environmentally friendly, 
and they preserve nutritive quality.  
Two pathways may be involved in OTA microbiological degradation (Abrunhosa et al., 
2010). First, OTA can be biodegraded through the hydrolysis of the amide bond that links 
the L-β-phenylalanine molecule to the OTα moiety. Since OTα and L-β-phenylalanine are 
virtually non-toxic, this mechanism can be considered to be a detoxification pathway. 
Second, a more hypothetical process involves OTA being degraded via the hydrolysis of the 
lactone ring. In this case, the final degradation product is an opened lactone form of OTA, 
which is of similar toxicity to OTA when administered to rats. However, it is less toxic to 
mice and Bacillus brevis. Although this is hypothetical, it is likely to occur since 
microbiological lactonohydrolases, which undertake a similar transformation, are common. 
Several protozoal, bacterial, yeast and filamentous fungal species are able to biodegrade 
OTA. After success in clarifying the mechanism and degradation products of ochratoxin, 
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three directions in recent research may be observed (1) possibilities of bacterial degradation, 
study of molds able to degrade this mycotoxin and identification and isolation of enzymes 
taking part in the degradation process. 
Lactobacillus strains were demonstrated to eliminate 0.05 mg OTA/L added to culture 
medium - in particular, L. bulgaricus, L. helveticus, L. acidophillus, eliminated up to 94%, 72% 
and 46%, respectively, of OTA (Böhm et al., 2000); L. plantarum, L. brevis and L. 
sanfrancisco were reported to eliminate 54%, 50% and 37%, respectively, of 0.3 mg OTA/L 
after 24 h of incubation (Piotrowska and Zakowska, 2000). It is now generally accepted that 
OTA adsorption to the cells walls is the predominant mechanism involved in this OTA 
detoxification phenomenon by lactic acid bacteria (LAB). For example, adsorption effects 
were claimed by Turbic et al. (2002), who found that heat and acid treated cells from two 
Lactobacillus rhamnosus strains were more effective at removing OTA from phosphate buffer 
solutions than viable cells. The strains removed 36% to 76% in the buffer solution (pH 7.4) 
after 2 h at 37°C. Similarly, Piotrowska and Zakowska (2005) verified that L. acidophilus and 
L. rhamnosus caused OTA reductions of 70% and 87% of 1 mg OTA/L after five days at 37°C, 
and that significant levels of the OTA were present in the centrifuged bacteria cells. Other 
LAB (L. brevis, L. plantarum and L. sanfranciscencis) also produced smaller decreases on OTA 
(approximately 50%). Finally, Del Prete et al. (2007) tested 15 strains of oenological LAB in 
order to determine the in vitro capacity to remove OTA, and reported Oenococcus oeni as the 
most effective, with OTA reductions of 28%. The involvement of cell-binding mechanisms 
was confirmed as (i) up to 57% of the OTA absorbed by the cells was recovered through 
methanol extraction from the bacteria pellets; (ii) crude cell-free extracts were not able to 
degrade OTA; and (iii) degradation products were not detected. Nevertheless, some authors 
consider that metabolism may also be involved. For example, Fuchs et al. (2008) confirmed 
that viable cells of L. acidophilus removed OTA more efficiently then unviable. A L. 
acidophilus strain was able to decrease ≥95% the OTA in buffer solutions (pH 5.0) containing 
0.5 and 1 mg OTA/L when incubated at 37°C for 4 h. In addition, a detoxification effect was 
also demonstrated since pre-incubation of OTA with this strain reduced OTA toxicity to 
human derived liver cells (HepG2) (Fuchs et al., 2008). Other L. acidophilus strains 
demonstrated only a moderate reduction in OTA contents suggesting that the effect was 
strain specific. In summary, some LAB adsorbs OTA by a strain specific cell-wall binding 
mechanism, although some undetected catabolism can also be involved. The detection of 
this OTA catabolism may only be possible with radiolabeled OTA.  
The potential of LAB as mycotoxin decontaminating agents has been studied in different 
fermentation processes and reviewed (Shetty and Jespersen, 2006). The ochratoxin-A 
content, its fate during wine-making and possibilities of its degradation have been 
intensively studied. Overviews concerning presence and fate of this mycotoxin in grapes, 
wine and beer were published by Mateo et al. (2007) and Varga and Kozakiewicz (2006). 
Although the decrease of OTA content in liquid phase during vinification process is 
observed by the majority of researchers, reports are controversial regarding the mechanism 
of OTA removal. Is it a result of malolactic fermentation due to the action of lactic acid 
bacteria (Kozakiewicz  et al., 2003), or is it adsorption to yeast cell walls (Binder et al., 2000). 
Reports about the capacity of proteolytic enzymes to hydrolyze OTA can also be found. 
Furthermore, although the results of these studies look very promising for reducing OTA 
contamination, studies on model systems do not guarantee the degradation of OTA in situ, 
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using food or feed. Further studies are needed to characterize the products of degradation 
and to investigate the activity of these bacteria in food and feedstuffs. 
Patulin contamination of apple and other fruit-based foods and beverages is an important 
food safety issue due to the high consumption of these commodities. Patulin contamination 
is considered of greatest concern in apples and apple products; however, this mycotoxin has 
also been found in other fruits, such as pears, peaches, strawberries, blueberries, cherries, 
apricots and grapes as well as in cheese (Halász et al., 2009). The initial studies concerning 
degradation of patulin by actively fermenting yeasts were reported in the 1979 by Stinson et 
al. (1979). However, authors were not able to chemically characterize the products of 
degradation. More recently, Moss and Long (2002) reported that under fermentative 
conditions, the commercial yeast Saccharomyces cerevisiae transformed patulin into ascladiol.  
In a recent study (Richelli et al., 2007) the ability of Gluconobacter oxydans to degrade patulin 
was investigated and the degradation products of this mycotoxin determined. More than 
96% of patulin was degraded after twelve-hour treatment, due to change of chemical 
structure (opening of the pyran ring). The degradation product was confirmed to be 
ascladiol. The genus Gluconobacter, whose taxonomy is at present under worldwide study, is 
made up of five different species (Tanasupawat et al., 2004; Sievers et al., 1995) which have 
no health risk, and that are commonly used in food manufacturing. Apple juice inoculated 
with this bacterium and incubated for 3 days still tasted like juice and was drinkable. 
However, keeping in mind the toxicity of ascladiol and eventual unsatisfactory organoleptic 
properties of alcoholic apple (fruit) juice (apple wine), the use of this bacterium at the 
industrial level needs additional investigation. 
In screenings for patulin detoxifying bacteria, has been isolated a bacterium from fermented 
sausage; it was identified as Lactobacillus plantarum, and it significantly reduced patulin 
levels via an intracellular enzyme (Halász et al., 2009).  
Fusarium toxins Considerable amounts of the Fusarium mycotoxins zearalenone (ZEN) and 
its derivative α-zearalenol, were bound in vitro to the probiotic bacteria L. rhamnosus GG and 
L. rhamnosus LC705. Both heat-treated and acid-treated bacteria were capable of removing 
the toxins, indicating that binding, not metabolism is the mechanism by which the toxins are 
removed from the media (El-Nezami et al., 2002). Zearalenone was also degraded by a 
mixed bacterial culture. A few other microbial activities that transform zearalenone have 
been published but are protected by patents. Several micro-organisms have been found that 
can degrade DON and T-2. On the basis of morphological and phylogenetic studies, the 
degrader strain was classified as a bacterium belonging to the Agrobacterium Rhizobium 
group. Interactions between lactic strains and ZEN and its derivative, β-zearalenol were also 
investigated.  
DON levels did not change during beer malting and the amount of trichothecene did not 
change during wine alcoholic fermentation. In contrast, trichothecene and iso-trichothecin 
were decomposed during alcoholic fermentation of grape juice. It was suggested that the 
yeast epihydroxylase might be involved.  
A significant proportion (38–48%) of both toxins was trapped in the bacterial pellet and no 
degradation product of zearalenone or α-zearalenol was detected (El-Nezami et al., 2002), 
leading to the conclusion that binding and not metabolism was the mechanism by which the 
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toxins were removed from the media. Similar results were obtained with other mycotoxins 
including ochratoxin A (Del Prete et al., 2007; Fuchs et al., 2008) and fumonisin B1 and B2 
(Niderkorn et al., 2006).  
Therefore, two specific processes such as binding and inhibition of biosynthesis may be 
involved in the interaction between LAB and the accumulation of some mycotoxins. 
Concerning the mechanisms of action involved in the removal of fumonisins by LAB, 
Niderkorn (2007) suggested that peptidoglycans were the most plausible fumonisin binding 
sites. The quenching ability of LAB was increased when bacteria were killed using different 
physical and chemical treatments, while lysozyme and mutanolysin enzymes that target 
peptidoglycans partially inhibited it. It was also reported that tricarballylic acid chains 
found in fumonisin molecules played an important role in the binding process since 
hydrolysed fumonisin had less affinity for LAB, and free amine group inactivation had no 
effect on the binding process (Niderkorn, 2007). The same article attempted to explain the 
low affinity of fumonisin B1 using a molecular modelling approach. In fact, an additional 
hydroxyl group in fumonisin B1 could form a hydrogen bond with one of the tricarballylic 
acid chains, resulting in a spatial configuration where the tricarballylic acid chain is less 
available to interact with bacterial peptodoglycans.  
Removal of fumonisins by LAB was ascribed to adhesion to cell wall components rather 
than covalent binding or metabolism, since the dead cells fully retained their binding ability. 
Peptidoglycans probably play a key rule in this binding process. Therefore, elucidating the 
differences between bacterial cell wall components of LAB strains might make it possible to 
select LAB species with the potential to act as biopreservative agents capable of reducing 
exposure from fumonisins that occur in food and feed. 
5. Conclusions 
The use of bacteriocins and/or bacteriocin-producing strains of LAB are of great interest as 
they are generally recognized as safe organisms and their antimicrobial products as 
biopreservatives. Several studies confirmed that microorganisms and enzymes could be a 
practical way to reduce the concentrations of some contaminants and to avoid the toxic 
effects via bioremediation. This opens up wide possibilities of using such biotechnological 
means on an food industry scale. Further experiments like utilization of the strains in 
fermentation processes or using the enzyme preprations can exhibit great outcomes. Great 
source of BLIS producing LAB strains could be traditional fermentation processes which 
should be more widely distributed as novel microorganisms crossing the borders. Further 
development of these strains for the biopreservation of food products requires an 
understanding of the mechanisms of action of the antimicrobial activity and of the 
decontamination of certain contaminants e.g. biogenic amines and mycotoxins. It seems that, 
according to results of the experiments to date, microorganisms are the main living 
organisms applicable for the biodegradation of these contaminants. Progress in this field of 
molecular biology techniques, antimicrobial LAB strains with multi-functional properties, 
including the degradation of mycotoxins, can be engineered to significantly improve the 
quality, safety and acceptability of plant foods. Further studies and knowledge of enzymes 
taking part in mycotoxin degradation allows production of these enzymes and their use for 
detoxification instead of microorganisms or additionally with LAB strains. Despite the 
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intensive research in this field and of the numerous publications that confirm the ability of 
various microorganisms to degrade mycotoxins, lack of results achieved until now in the 
development of practical commercial technologies by using BLIS producing strains 
hampered progress. The majority of experiments were carried out in model systems and in 
laboratory conditions. The control of degradation products and the effects of detoxification 
on nutritive and sensory properties is in every case a decisive part of research and potential 
application. The use of antifungal LAB instead of chemical preservatives would enable the 
food industry to meet the request of consumers for natural products. Finally a practical 
technology should be developed and controlled from an economical point of view. Several 
studies confirmed that different environmental factors have strongly affected on the growth 
and bacteriocin production of several LAB strains that are mainly considered for food 
applications. However, it is desirable to continue the studies on this subject to select the 
most efficient factors and their combinations, which could be used on a production scale. 
Future work on LAB bacteriocin production, purification, obtaining the amino acid 
sequences of the BLIS to increase their activity is required.  
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1. Introduction 
Plants produce a great variety of organic compounds as a response to environmental 
stresses like microbial attack, insect/animal predation and ultraviolet radiations. The role of 
these metabolites is to increase plants resistance to these stresses. They can be classified into 
three major groups according to their biosynthetic route and structural features: terpenoids, 
alkaloids, and phenolic compounds. Phenolic compounds, which are mainly synthesized 
from phenylalanine produced by the shikimic acid pathway, are the most widely distributed 
in the plant kingdom. Plant tissues may contain up to several grams per kilogram of 
polyphenols. External stimuli such as microbial infections, ultraviolet radiation, low 
temperature, water and nutrition stresses induce their synthesis. The chemical structure of 
plant phenolics varies from simple to highly polymerized compounds as lignin and tannins. 
Phenolics have been categorized in different classes according to their basic carbon skeleton: 
the most relevant phenolic groups for nutritional health value are phenolic acids (C6-C1), 
phenylpropanoids (C6-C3) from which derivates the lignin polymer (C6-C3)n, coumarins 
(cyclized C6-C3) and flavonoids (C6-C3-C6). These compounds have a role in the visual 
appearance (peel and flesh pigmentation, browning), taste (astringency and bitterness), and 
health-promoting properties (free radical scavengers). This chapter focuses mainly on the 
biological activities of flavonoïds and on the effect of processes on the evolution of 
flavonoids and phenolic compounds during food transformations. 
2. Flavonoids: Classification and biological activities 
Flavonoids  except chalcones, aurones and isoflavones share the same basic skeleton, a 
flavanone nucleus containing two hexacarbonic aromatic rings formed by fifteen atoms of 
carbon (A and B) interconnected with an heterocyle C composed of three carbon atoms and 
one oxygen atom (Figure 1).  
This nucleus can undergo many modifications such as hydroxylation, alkylation or 
glycosylation. Depending on these modifications, the flavonoids are classified into 9 groups 
(chalcones, aurones, flavanones, dihydroflavanols, flavones, isoflavones, anthocyans, 
flavonols, flavanols).  Compounds belonging to the same group differ between them by the 
degree and the position of hydroxylation, the presence of substitute on the nucleus and the 
state of their polymerization (Table 1). 
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Fig. 1. The flavanone nucleus. 
Besides conferring coloration to plants, flavonoids can act as enzyme and microbial 
inhibitors, chelating agents, protection against UV, against free radicals. Moreover, 
flavonoids believed to have health properties such as analgesic, anti-inflammatory, anti-
allergic and protectors against cardiovascular diseases. These properties are attributed 
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Table 1. Different classes of flavonoids and their structures. 
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Table 1. Different classes of flavonoids and their structures. (Continuation) 
2.1 Anti-oxidant and anti-free radical activities of flavonoids 
The most described property of flavonoids is their capacity to protect the organism 
against free radicals and oxygenated reactive species (ORS) produced during the 
metabolism of oxygen (Grace, 1994). The cellular damage by the free radicals causes a 
change of the net charge of cells, thus modifying their osmotic pressure and inducing 
their swelling and their death. The free radicals act also on the mediators of the 
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inflammatory diseases, and accelerate the tissue damage. Moreover, cells lesions lead to 
an increase in the production of the ORS which induces the consumption and the 
depletion of the endogenous chelating agents. To protect against oxygenated reactive 
species, the organism and living cells  have developed several mechanisms (Halliwell, 
1995) including enzymes like the superoxyde dismutase, the catalase and the glutathion 
peroxidase, and also non-enzymatic homologues such as the glutathion, the ascorbic acid 
and l'α-tocopherol.  
The protective effect of flavonoids is due to several mechanisms such as free radicals 
trapping, enzymes inhibition and metallic ions chelation. These properties depend on the 
structure of the flavonoids and the degree of substitution and saturation (Table 1). 
2.1.1 Free radicals trapping 
The flavonoids can prevent the damage caused by the free radicals according to various 
ways; one of them is the direct trapping of the radicals. In this case, the flavonoids are 
oxidized by the radicals (R•) leading to less reactive and more stable species according to 
the following mechanisms (Halliwell, 1995): 
( ) ( )Flavonoid OH   R•  Flavonoid O•   RH+ → +  
The formed flavonoxy radical (flavonoid (O•)) is stabilized by resonance. The non-paired 
electron can be delocalized on the whole of the aromatic cycle. But, it can continue to evolve 
according to several processes (dimerisation, dismutation, recombination with other 
radicals, oxidation in quinon) either while reacting with radicals or other antioxidants, or 
with biomolecules. The flavonoxy (FL-O•) radical can react with another radical to form 
stable quinine as follows: 
 
The flavonoxy radical can interact with oxygen to give a quinone and a superoxide anion. 
This reaction is responsible for an undesirable prooxidant effect of flavonoids. So the 
capacity of flavonoids to act as antioxidant depends not only on the redox potential of the 
couple Flavonoid (O•)/ Flavonoid (OH), but also on the reactivity of generated flavonoxy 
radical (Van Acker et al., 1995). 
2.1.2 Effect on the mediator of nitric oxide synthesis 
Several flavonoids reduce the cellular lesions related to ischaemia, by interfering with the 
activity of nitric oxide synthase. The nitric oxide is produced by various types of cells such 
as the endothelium cells and the macrophages. The nitric oxide is produced through the 
constitutive activity of nitric oxide synthase. It plays a role for the maintenance of the 
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dilation of the blood-vessels, the relaxation of the smooth muscles, the signal of transduction 
and the inflammation (Parihar et al., 2008; Valko et al., 2007). However, at high 
concentrations it induces an irreversible oxidative damage on cellular walls; because the 
activated macrophages increase their simultaneous productions of nitric oxide and the 
superoxide anions. The nitric oxide reacts with the free radicals producing peroxynitrite 
anion (ONOO-), a more reactive species: 
+ .- . - +
2H + O + NO ONOO + H ONOOH→ ↔  
When the flavonoids are used as antioxidants, the free radicals are trapped thus reducing 
the conversion of nitric oxide into peroxynitrite (Shutenko et al., 1999). Flavonoids can also 
react with nitric oxide directly (Van Acker et al., 1995). Therefore, it was speculated that the 
trapping of nitric oxide by the flavonoids is in the origin of their protective effect of the 
cardiovascular system. 
2.1.3 Inhibition of the enzymes activities 
It is well known that flavonoids are able to inhibit the activities of several enzymes 
implicated in radical’s generation. Among these enzymes, the xanthine oxidase, 
lipoxygenase, cyclo-oxygenase, peroxidase and tyrosin kinase are the most studied. 
The xanthine dehydrogenase and the xanthine oxydase are implied in the metabolism of the 
xanthine into uric acid. The xanthine deshydrogenase is the configuration available under 
the normal physiological conditions, but it changes into xanthine oxydase during cells 
reperfusion (reoxygenation) and reacts with molecular oxygen to release the superoxyde 
radical (O2-). The flavonoids act as a strong inhibitor of the xanthine oxydase and as a 
trapper of the superoxide radical (Sanhueza et al., 1992).  
The flavonoids have also the capacity in one hand, to inhibit the metabolism of the acid 
arachidonic (Ferrandiz & Alcaraz, 1991) by inhibiting the lipooxygenase and thus 
preventing the production of the chimiotactic compounds from this acid. This 
characteristic gives to the flavonoids the anti-inflammatory and anti-thrombogenic 
properties. In the other hand, flavonoids have also the capacity to reduce the release of 
peroxidases and proteolytic enzymes and thus the production of the ROS (Middleton & 
Kandaswami, 1992).   
The activity of the tyrosin kinase is affected by the presence of the flavonoids (Nijveldt et al., 
2001). This enzyme is implied in several cellular functions such as the enzymatic catalysis, 
the transport through the membrane, the transduction of the signals for hormones or 
growth factors and the transfer of energy in the synthesis of ATP. So, the inhibition of this 
enzyme by the flavonoids interferes with the way of transduction of the signals controlling 
the cellular proliferation. 
2.1.4 Chelation of the metal ions 
The ions of iron (Fe2+) and copper (Cu+), are essential for certain physiological functions of 
living cells (Van Acker et al., 1995). They can be, either as components of hemoproteins, or 
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anion (ONOO-), a more reactive species: 
+ .- . - +
2H + O + NO ONOO + H ONOOH→ ↔  
When the flavonoids are used as antioxidants, the free radicals are trapped thus reducing 
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react with nitric oxide directly (Van Acker et al., 1995). Therefore, it was speculated that the 
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reperfusion (reoxygenation) and reacts with molecular oxygen to release the superoxyde 
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trapper of the superoxide radical (Sanhueza et al., 1992).  
The flavonoids have also the capacity in one hand, to inhibit the metabolism of the acid 
arachidonic (Ferrandiz & Alcaraz, 1991) by inhibiting the lipooxygenase and thus 
preventing the production of the chimiotactic compounds from this acid. This 
characteristic gives to the flavonoids the anti-inflammatory and anti-thrombogenic 
properties. In the other hand, flavonoids have also the capacity to reduce the release of 
peroxidases and proteolytic enzymes and thus the production of the ROS (Middleton & 
Kandaswami, 1992).   
The activity of the tyrosin kinase is affected by the presence of the flavonoids (Nijveldt et al., 
2001). This enzyme is implied in several cellular functions such as the enzymatic catalysis, 
the transport through the membrane, the transduction of the signals for hormones or 
growth factors and the transfer of energy in the synthesis of ATP. So, the inhibition of this 
enzyme by the flavonoids interferes with the way of transduction of the signals controlling 
the cellular proliferation. 
2.1.4 Chelation of the metal ions 
The ions of iron (Fe2+) and copper (Cu+), are essential for certain physiological functions of 
living cells (Van Acker et al., 1995). They can be, either as components of hemoproteins, or 
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of cofactors of various enzymes implicated in antioxidant defense system of cells.  Besides 
their beneficial role, they are also responsible for the production of the hydroxyl radical by 
the reduction of hydrogen peroxide (.OH) according to the following reaction: 
2+ + 3+ +
2 2H O  + Fe (Cu ) OH + OH + Fe (Cu )→ -⋅  
The flavonoids form a stable complex with transition metals  (Fe3+, Al3+, Cu2+, Zn2+); the 
stoichiometry of the complex and the site of chelation depend on the nature of the flavonoid 
mainly the presence of the catechol part (Le Nest et al., 2004) and the pH (Cornard & Merlin, 
2002a,b ). Moreover, this phenomenon of chelation is accompanied sometimes by the 
oxidation of the flavonoid (Cu2+, Fe3+). The chelation is occurred  generally on the hydroxyl 
groups in position 3' and 4' of the B cycle,  on the position 3 of hydroxyl group of A cycle 
and  on the positions  3 and 4 of  carbonyl group  of C cycle (Figure 2). 
 
Fig. 2. Chelation of flavonoids. 
When the flavonoids have several chelating metal sites, they can be polymerized. The 
copolymerization of the flavonoids and iron is responsible for anemia disease observed in 
large consumers of tea (Damas et al. 1985). The capacity of the flavonoids to complex metals 
is probably at the origin of the inhibition of many enzymes whose active site contains 
metals. 
2.2 Pharmacologic effects of flavonoids 
A general presentation of the hypothetical links between the mechanism of action and 
clinical effects of the consumption of flavonoids is summarized in Table 2 and Figure 3. The 
various clinical effects of the flavonoids are described in details in the following paragraphs. 
Biological activities of flavonoids (anti-cancer, anti-inflammatory, antioxidant) depend on 
the presence of several functional groups on the backbone of these compounds (Limem et 
al., 2008). The most important are the hydroxyl groups and their positions (3 and 4' on C and 
B cycles respectively or 3' and 4' on the cycle B), the double bond between carbon 2 and 3 
and 4 oxo function of the cycle C. The absence or the substitution of these groups leads to a 
significant reduction of biological activities of the flavonoids. The relation between 
flavonoids structure and biological activities is well summarized (Figure 4). 
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Consumption Effect References 
Quercetin –rich fruits and 
vegetables (during 15 years)
Decrease of apoplexy incidence Imai  
et  al., 1997 
Green tea (during 10-11 
years) 
Decrease of cancers risk ( lung, liver, colon)
Retard cancers progression 
Decrease of breast cancer risk
Nakachi et 
al., 1996/1998 
Dadzein, genistein and 
coumestrol -rich food
Decrease of prostate cancer risk Strom  
et al., 1999 
375mg of curcumin (3 times 
a day for 12 weeks) 
Effective treatment of anterior uveitis
Increase of blood levels of glutathione 
peroxidase
Lal  
et al., 1999 
55mg/day of isoflavonoids 
for 8 weeks 
No effect on lipid peroxidation Hodgson  
et al., 1999 
Extract of red vine leaf (360 
or 720 mg/day for 12 
weeks) 
Small effect on chronic venous insufficiency Kieswetter  
et al., 2000 
Green tea extract + linoleic 
acid (3g/day for 4weeks) 
Decrease of blood levels of malondialdehyde
No effect on other markers of oxidative stress 
or production of nitric oxide
Freese  
et  al.,  
1999 
Red vine phenolic 
compounds (3time 
660mg/day for 2 weeks)
Increase in serum antioxidant capacity Carbonneau  
et al., 1997 
Blackcurrant and apple 
juices (750 up 1500ml/day 
for one week) 
Decrease of blood levels of malondialdehyde
Increase in glutathione peroxidase (no other 
changes in antioxidant status)
Young  
et al.,  
1999 
Green or red tea (2g/day 
for 2 days) 
Transient increase in blood antioxidant 
parameters (radical scavenging)
Serafini  
et al., 1996 
113ml of alcohol-free red or 
white wine for 3 weeks
Transient increase in blood antioxidant 
parameters (radical scavenging)
Muzes  
et al., 1990 
1L/day of soy milk for 4 
weeks 
No effect on blood cholesterol
Decrease in oxidative damage of DNA bases
Mitchell & 
Collins, 1999 
Flavonones, vitamin C Decrease of prostate cancer risk Rossi  
et  al., 2007 




Reduction in plasma triglyceride 
concentration, cholesterol (LDL), 
apolipoproteins B, E and TNF α 
Zern  
et al., 2005 
Quercetin Reduced risk of mortality due to ischemic 
heart disease 
Reduced risk of lung cancer
Knekt  
et  al., 2002 
Quercetin, naringenin, 
hesperitin 
Reduced risk of breast cancer
Quercetin, myricetin Reduced risk of asthma
Kaempferol, naringin, 
hesperitin 
Reduced risk of type 2 diabetes
Myricetin Reduced risk of cerebrovascular diseases
Table 2. Effects of flavonoids consumption on biological activities. 
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Table 2. Effects of flavonoids consumption on biological activities. 
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Fig. 3. Assumption of the links between the mechanisms of action of flavonoids and their 
effects on diseases (Nijveldt et al., 2001). * indicates the reduction of the enzyme activity or 


































































































































































Fig. 4. Flavonoid structural elements necessary for biological activity: (+), the presence of 
structural elements promotes the cited activity; (-), the presence of structural elements 
reduces the cited activity. 
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Fig. 4. Flavonoid structural elements necessary for biological activity: (+), the presence of 
structural elements promotes the cited activity; (-), the presence of structural elements 
reduces the cited activity. 
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2.3 Extraction of flavonoids 
Extraction is the most important step in the development of analytical methods for plant 
extracts analysis. A summary of experimental conditions of the extraction methods is reported 
in Table 3. Basis unit operations of extraction is often the plant drying and its milling to obtain 
an homogenous powder and improve the extraction kinetic of the molecules. Methods as 
sonication, heating under reflux, extraction with Soxhlet apparatus are the most used (Ong, 
2004). However, these methods are often long and need large volumes of organic solvents, 
with low extraction rates. Molecules we want to extract can be polar, non-polar or heat 
sensitive; thus the extraction method must take all these parameters into account.  
To reduce the use of organic solvents and to improve the extraction rate, other methods such 
as extraction assisted by microwave, supercritical extraction, accelerated extraction by 
solvents, the pressurized liquid extraction, the pressurized extraction by hot water and the 
pressurized extraction by hot water associated to surfactants were introduced to the phenol 




Solvents Temperature  
(°C) 
Pressure Time 
Sonication Methanol, Ethanol, 
Mix alcohol/water 
Can be heated  1 h 
Soxhlet extraction Methanol, Ethanol, 
Mix alcohol/water 
Depending on the 
solvent used 











Carbon dioxid, Mix 
carbon 
dioxid/Methanol 









Methanol 80-200 10-20 bar 20-40 
min 
Pressurized 
extraction by hot 
water 
Water, water with 10-
30% ethanol 
80-300 10-50 bar 40-50 
min 
Pressurized 
extraction by hot 
water with 
surfactant 
Water with surfactant 
(triton X100 ou SDS) 
80-200 10-20 bar 40-50 
min 
Table 3. Experimental conditions for the phenol extraction.  
2.4 Flavonoid occurrence in foods 
Since several decades, many studies dealt with the analysis of foods to determine its 
composition in flavonoids. Many reviews were published, where the main flavonoids in foods 
are gathered. Tomás-Barberan et al. (2000) focused on fruits and vegetables. In 2009, INRA 
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(French National Institute Of Agricultural Research) developed a database on flavonoids in 
foods (http://www.phenol-explorer.eu). Table 4 was built according to data collected on the 
database of INRA; it presents some examples of foods containing flavonoids cited. Flavonoids 
chosen are the main found in foods, their quantity is specified into brackets. 
 






Red wine (0.05), Grapefruit (1.56), Mexican oregano (372), Almond 
(0.02) 
Grape fruit juice from concentrate (1.55), Lemon juice from 
concentrate (24.99), Orange juice from concentrate (51.68), 





Olive oil extra virgin (0.36), Thyme fresh (39.50), Olive black 
(3.43), Artichoke heads (42.10) 







Red wine (0.23), Red raspberry pure juice (0.04), Tea black bottled 
(0.13), Capers (104.29), Cumin (38.60). 
Red wine (0.83), Buckwheat whole grain flour (0.11), Chocolate 
dark (25), Black elderberry (42), Orange pure juice (1.06), Mexican 






Beer regular (0.11), Wine red (6.81), Barley whole grain flour 
(1.23), Cocoa powder (107.75), Grape black (5.46), Strawberry 
(6.36), Plum (4.60), Pistachio (3.50), Broad bean pod (16.23) 
Red wine (3.78), Chocolate dark (70.36), Blackberry (11.48), 
European cranberry (4.20), Apricot (4.19), Custard apple (5.63), 






Red wine (1.40), Highbush blueberry (6.09), Black grape (2.76), 
Black common bean (0.80) 
Red wine (9.97), White wine (0.04), Black grape (39.23), Red 
raspberry (0.62) 
 
Table 4. Examples of composition in flavonoids of certain foods.  
According to Table 4, foods containing great quantity of flavonoids are fruit and vegetables; 
the processing of these raw foods modify the flavonoid content according to the process 
conditions. For example, in olive oil extra virgin, there is 1.17 mg of apigenin for 100g, but if 
this oil is refined the apigenin content decrease to 0.03 mg/100 g. Thus processes induce 
some consequences on flavonoid composition in foods.   
3. Effect of food processing  
Processes used in food engineering are numerous. We focus on the effect of unit operations 
on the degradation of the phenolic compounds as flavonoids and their antioxidant activity. 
 
Advances in Applied Biotechnology 110 
2.3 Extraction of flavonoids 
Extraction is the most important step in the development of analytical methods for plant 
extracts analysis. A summary of experimental conditions of the extraction methods is reported 
in Table 3. Basis unit operations of extraction is often the plant drying and its milling to obtain 
an homogenous powder and improve the extraction kinetic of the molecules. Methods as 
sonication, heating under reflux, extraction with Soxhlet apparatus are the most used (Ong, 
2004). However, these methods are often long and need large volumes of organic solvents, 
with low extraction rates. Molecules we want to extract can be polar, non-polar or heat 
sensitive; thus the extraction method must take all these parameters into account.  
To reduce the use of organic solvents and to improve the extraction rate, other methods such 
as extraction assisted by microwave, supercritical extraction, accelerated extraction by 
solvents, the pressurized liquid extraction, the pressurized extraction by hot water and the 
pressurized extraction by hot water associated to surfactants were introduced to the phenol 




Solvents Temperature  
(°C) 
Pressure Time 
Sonication Methanol, Ethanol, 
Mix alcohol/water 
Can be heated  1 h 
Soxhlet extraction Methanol, Ethanol, 
Mix alcohol/water 
Depending on the 
solvent used 











Carbon dioxid, Mix 
carbon 
dioxid/Methanol 









Methanol 80-200 10-20 bar 20-40 
min 
Pressurized 
extraction by hot 
water 
Water, water with 10-
30% ethanol 
80-300 10-50 bar 40-50 
min 
Pressurized 
extraction by hot 
water with 
surfactant 
Water with surfactant 
(triton X100 ou SDS) 
80-200 10-20 bar 40-50 
min 
Table 3. Experimental conditions for the phenol extraction.  
2.4 Flavonoid occurrence in foods 
Since several decades, many studies dealt with the analysis of foods to determine its 
composition in flavonoids. Many reviews were published, where the main flavonoids in foods 
are gathered. Tomás-Barberan et al. (2000) focused on fruits and vegetables. In 2009, INRA 
 
Biological Activities and Effects of Food Processing on Flavonoids as Phenolic Antioxidants 111 
(French National Institute Of Agricultural Research) developed a database on flavonoids in 
foods (http://www.phenol-explorer.eu). Table 4 was built according to data collected on the 
database of INRA; it presents some examples of foods containing flavonoids cited. Flavonoids 
chosen are the main found in foods, their quantity is specified into brackets. 
 






Red wine (0.05), Grapefruit (1.56), Mexican oregano (372), Almond 
(0.02) 
Grape fruit juice from concentrate (1.55), Lemon juice from 
concentrate (24.99), Orange juice from concentrate (51.68), 





Olive oil extra virgin (0.36), Thyme fresh (39.50), Olive black 
(3.43), Artichoke heads (42.10) 







Red wine (0.23), Red raspberry pure juice (0.04), Tea black bottled 
(0.13), Capers (104.29), Cumin (38.60). 
Red wine (0.83), Buckwheat whole grain flour (0.11), Chocolate 
dark (25), Black elderberry (42), Orange pure juice (1.06), Mexican 






Beer regular (0.11), Wine red (6.81), Barley whole grain flour 
(1.23), Cocoa powder (107.75), Grape black (5.46), Strawberry 
(6.36), Plum (4.60), Pistachio (3.50), Broad bean pod (16.23) 
Red wine (3.78), Chocolate dark (70.36), Blackberry (11.48), 
European cranberry (4.20), Apricot (4.19), Custard apple (5.63), 






Red wine (1.40), Highbush blueberry (6.09), Black grape (2.76), 
Black common bean (0.80) 
Red wine (9.97), White wine (0.04), Black grape (39.23), Red 
raspberry (0.62) 
 
Table 4. Examples of composition in flavonoids of certain foods.  
According to Table 4, foods containing great quantity of flavonoids are fruit and vegetables; 
the processing of these raw foods modify the flavonoid content according to the process 
conditions. For example, in olive oil extra virgin, there is 1.17 mg of apigenin for 100g, but if 
this oil is refined the apigenin content decrease to 0.03 mg/100 g. Thus processes induce 
some consequences on flavonoid composition in foods.   
3. Effect of food processing  
Processes used in food engineering are numerous. We focus on the effect of unit operations 
on the degradation of the phenolic compounds as flavonoids and their antioxidant activity. 
 
Advances in Applied Biotechnology 112 
Among unit operations, we distinguish different categories: (i) the thermal processes such as 
pasteurization, baking, cooling, freezing, (ii) the non-thermal processes such as high 
pressure, pulsed electric fields, filtration, (iii) the mechanical processes such as peeling, 
cutting or mixing and (iv) the domestic processes that is to say processes by means of 
preparation of the convenience foods at consumers home. 
3.1 Thermal processes 
Thermal processes have a large influence in flavonoid availability in foods which depends 
on their magnitude and duration. Different heating methods (drying, microwaving, heating 
by an autoclave, roasting, water immersion, pasteurization, pressured-steam heating, 
blanching) were used and their effects were analyzed (Table 5). On this table, are gathered 
examples of significant studies to show the effect of thermal processes on the degradation of 
phenolic compounds.  
As shown in Table 5, most of thermal processes lead to a degradation of phenolic compounds 
except in some cases as the apple juice processing where an increase of temperature from 40°C 
to 70°C allows increasing flavonoid content (50%) (Gerard & Roberts, 2004). A roasting of 
130°C, 33 min increases the phenol content of cashew nuts (Chandrasekara & Shahidi, 2011); 
same results were noticed for peanuts (Yu et al., 2005). In these cases, an increase of 
temperature improves the extraction of phenolic compounds from foods; others results 
showed losses of phenolic compounds in different quantities. A loss of about 22% in total 
flavonoids has been observed in boiled products at a temperature of 50°C during 90s (Viña & 
Chaves, 2008).  For the roasting process  at 120°C, 20 min provokes a  decrease of  12%  of total 
flavonoid content (Zhang et al., 2010) and 15.9% for 160°C, 30min (Zielinski et al., 2009). 
Sharma & Gujral (2011) noticed for a roasting at 280°C during 20s, a loss of 8% in phenolic 
content.  Steam heating at 0.2 MPa during 40 min induces a decrease of 25% in flavonoid 
content (Huangb  et al., 2006; Zhang, et al., 2010). Similar findings were reported with 
microwaving at 700W during 10 min (Zhang, et al., 2010), 900 W during 120 s (Sharma & 
Gujral, 2011) and autoclaving at 100°C, 15 min (Choi et al., 2006). However, one blanching per 
immersion in water at 100°C during 4 min does not deteriorate flavonoids (Viña et al., 2007). 
Drying processes lead also to flavonoids degradation. The proportion lost depends on the 
drying method. Freeze-drying is the less aggressive method whereas hot air drying leads to 
major losses. As intermediate solutions microwave and vacuum drying can be used (Dong et 
al., 2011; Viña & Chaves, 2008; Zainol et al., 2009; Zhang et al., 2009). Pasteurization induces 
losses in phenolic compounds, significant losses are noticed for tomatoes’ sauce pasteurized at 
115°C during 5 min (Valverdú-Queralt et al., 2011), likewise a loose of 40% for a temperature 
of 85 °C during 5 min is measured by Hartman et al. (2008) for strawberries.  
A few studies identified phenolic compounds in foods and followed their degradation 
during heat treatment. They noticed that individual phenolic compounds are also subject to 
heat degradation. The identification and quantification of these compounds were performed 
with high performance liquid chromatography. Rutin in buckwheat groats is reported to be 
more stable to heat then vitexin, isovitexin , homoorientin and orientin during roasting  at 
160°C for 30 min (Zielinski, et al., 2009). However, an increase of the dehulling time (10 to 
130 min) leads to greater losses of rutin in the same product grains (Dietrych-Szostak & 
Oleszek, 1999). Boiling including soaking (100°C/121°C) with/or without draining stages 
induces 1-90% losses of quercetin and kaempferol in Brazilien beans (Ranilla et al., 2009). 
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Thermal pasteurization treatments (90°C, 60s) for strawberry juices have no effect on 
quercetin and kaempferol contents (Odriozola-Serrano et al., 2008), whereas it reduces 
naringin, rutin, quercetin and naringenin content for grapefruit juices (Igual et al, 2011). For 
Fuleki & Ricardo-Da-Silva (2003), pasteurization of grape juice increased the concentration 
of catechins in cold-pressed juices, but it decreased concentrations in hot-pressed juices. The 
concentration of most procyanidins was also increased by pasteurization. 
However, the above results may not be comparable, because on the one hand, the food 
matrix is different from one assay to another and on the other hand, the food matrix can act 
as a barrier to heat effect or induce the degradation. It is not easy then to dissociate the 
thermal processing effect from the food matrix effects. Thus, some authors studied the 
effects of thermal processes on model solutions of phenolic compounds; these studies are 
led especially on flavonoids. The data indicated that flavonoids in aqueous solutions show 
different sensitivity to heat treatment depending on their structures. However, whatever 
their structure a significant degradation is observed for temperature above 100°C.  For rutin, 
a higher stability compared to its aglycon form (quercitin) is observed (Buchner et al., 2006; 
Friedman, 1997; Makris & Rossiter, 2000; Takahama, 1986). These findings are attributed to 
the prevention of carbanion formation because of the glycosylation of the 3-hydroxyl group 
in the C-ring (Buchner, et al., 2006; Friedman, 1997; Takahama, 1986). Authors reported also 
that Luteolin was more stable to heat than rutin and luteolin-7-glucoside when heated at 
180°C for 180min (Murakami et al., 2004). The degradation of flavonoids is not only a 
function of temperature and magnitude of heating; it may depend also on other parameters 
such as pH, phytochemicals, structure and even the presence or absence of oxygen.  Indeed, 
original flavonol concentration has no effect on the degradation of rutin and quercetin. It is 
suggested that the reaction pathways are not influenced by the different flavonol solutions 
molarities (Buchner, et al., 2006). Moreover, under weak basic (Buchner, et al., 2006; 
Friedman, 1997; Takahama, 1986) and neutral (Friedman, 1997; Takahama, 1986) reaction 
conditions, more degradation of rutin and quercetin is observed (Buchner, et al., 2006). The 
absence of oxygen highly reduces quercetin degradation and prevents rutin breaking up 
during heating. The presence of oxygen is shown to accelerate quercetin and rutin 
degradation due to the presence of the reactive oxygen species (Buchner, et al., 2006; Makris 
& Rossiter, 2000). Chlorogenic acid is observed to protect rutin against degradation when a 
mixture of the two substances is heated at 180°C (Murakami, et al., 2004). 
Sometimes, authors dealt with the antioxidant activity of foods or solutions studied. It is 
difficult to summarize the evolution of the antioxidant activity according to conditions heat 
processes. Too numerous factors are implied in its evolution. Decreases in phenol content do 
not lead systematically to a decrease of the antioxidant activity. Indeed, the degradation 
products of phenolic compounds  can also have an antioxidant activity sometimes higher 
than the initial phenolic compounds (Buchner, et al., 2006; Murakami, et al., 2004); for high 
temperatures, these products can be Maillard products. Thus, an increase of antioxidant 
activity is noticed in many studies using thermal processes (Chandrasekara & Shahidi, 2011; 
Hartman et al., 2008; Sharma & Gujral., 2011). However interactions are important 
phenomena which act on the antioxidant activity of molecules. Depending on this 
environment, synergies between antioxidant compounds and the food matrix can occur 
(Wang et al., 2011). In some cases, the antioxidant capacity of flavonoids in a food matrix is 
enhanced (Freeman et al., 2010) ; while in other cases, the antioxidant capacity is reduced 
(Hidalgo et al., 2010). Thus, in other studies, antioxidant activity remains constant (Leitao et 
al., 2011) or can be decreased (Davidov-Pardo et al., 2011). 
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Among unit operations, we distinguish different categories: (i) the thermal processes such as 
pasteurization, baking, cooling, freezing, (ii) the non-thermal processes such as high 
pressure, pulsed electric fields, filtration, (iii) the mechanical processes such as peeling, 
cutting or mixing and (iv) the domestic processes that is to say processes by means of 
preparation of the convenience foods at consumers home. 
3.1 Thermal processes 
Thermal processes have a large influence in flavonoid availability in foods which depends 
on their magnitude and duration. Different heating methods (drying, microwaving, heating 
by an autoclave, roasting, water immersion, pasteurization, pressured-steam heating, 
blanching) were used and their effects were analyzed (Table 5). On this table, are gathered 
examples of significant studies to show the effect of thermal processes on the degradation of 
phenolic compounds.  
As shown in Table 5, most of thermal processes lead to a degradation of phenolic compounds 
except in some cases as the apple juice processing where an increase of temperature from 40°C 
to 70°C allows increasing flavonoid content (50%) (Gerard & Roberts, 2004). A roasting of 
130°C, 33 min increases the phenol content of cashew nuts (Chandrasekara & Shahidi, 2011); 
same results were noticed for peanuts (Yu et al., 2005). In these cases, an increase of 
temperature improves the extraction of phenolic compounds from foods; others results 
showed losses of phenolic compounds in different quantities. A loss of about 22% in total 
flavonoids has been observed in boiled products at a temperature of 50°C during 90s (Viña & 
Chaves, 2008).  For the roasting process  at 120°C, 20 min provokes a  decrease of  12%  of total 
flavonoid content (Zhang et al., 2010) and 15.9% for 160°C, 30min (Zielinski et al., 2009). 
Sharma & Gujral (2011) noticed for a roasting at 280°C during 20s, a loss of 8% in phenolic 
content.  Steam heating at 0.2 MPa during 40 min induces a decrease of 25% in flavonoid 
content (Huangb  et al., 2006; Zhang, et al., 2010). Similar findings were reported with 
microwaving at 700W during 10 min (Zhang, et al., 2010), 900 W during 120 s (Sharma & 
Gujral, 2011) and autoclaving at 100°C, 15 min (Choi et al., 2006). However, one blanching per 
immersion in water at 100°C during 4 min does not deteriorate flavonoids (Viña et al., 2007). 
Drying processes lead also to flavonoids degradation. The proportion lost depends on the 
drying method. Freeze-drying is the less aggressive method whereas hot air drying leads to 
major losses. As intermediate solutions microwave and vacuum drying can be used (Dong et 
al., 2011; Viña & Chaves, 2008; Zainol et al., 2009; Zhang et al., 2009). Pasteurization induces 
losses in phenolic compounds, significant losses are noticed for tomatoes’ sauce pasteurized at 
115°C during 5 min (Valverdú-Queralt et al., 2011), likewise a loose of 40% for a temperature 
of 85 °C during 5 min is measured by Hartman et al. (2008) for strawberries.  
A few studies identified phenolic compounds in foods and followed their degradation 
during heat treatment. They noticed that individual phenolic compounds are also subject to 
heat degradation. The identification and quantification of these compounds were performed 
with high performance liquid chromatography. Rutin in buckwheat groats is reported to be 
more stable to heat then vitexin, isovitexin , homoorientin and orientin during roasting  at 
160°C for 30 min (Zielinski, et al., 2009). However, an increase of the dehulling time (10 to 
130 min) leads to greater losses of rutin in the same product grains (Dietrych-Szostak & 
Oleszek, 1999). Boiling including soaking (100°C/121°C) with/or without draining stages 
induces 1-90% losses of quercetin and kaempferol in Brazilien beans (Ranilla et al., 2009). 
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Thermal pasteurization treatments (90°C, 60s) for strawberry juices have no effect on 
quercetin and kaempferol contents (Odriozola-Serrano et al., 2008), whereas it reduces 
naringin, rutin, quercetin and naringenin content for grapefruit juices (Igual et al, 2011). For 
Fuleki & Ricardo-Da-Silva (2003), pasteurization of grape juice increased the concentration 
of catechins in cold-pressed juices, but it decreased concentrations in hot-pressed juices. The 
concentration of most procyanidins was also increased by pasteurization. 
However, the above results may not be comparable, because on the one hand, the food 
matrix is different from one assay to another and on the other hand, the food matrix can act 
as a barrier to heat effect or induce the degradation. It is not easy then to dissociate the 
thermal processing effect from the food matrix effects. Thus, some authors studied the 
effects of thermal processes on model solutions of phenolic compounds; these studies are 
led especially on flavonoids. The data indicated that flavonoids in aqueous solutions show 
different sensitivity to heat treatment depending on their structures. However, whatever 
their structure a significant degradation is observed for temperature above 100°C.  For rutin, 
a higher stability compared to its aglycon form (quercitin) is observed (Buchner et al., 2006; 
Friedman, 1997; Makris & Rossiter, 2000; Takahama, 1986). These findings are attributed to 
the prevention of carbanion formation because of the glycosylation of the 3-hydroxyl group 
in the C-ring (Buchner, et al., 2006; Friedman, 1997; Takahama, 1986). Authors reported also 
that Luteolin was more stable to heat than rutin and luteolin-7-glucoside when heated at 
180°C for 180min (Murakami et al., 2004). The degradation of flavonoids is not only a 
function of temperature and magnitude of heating; it may depend also on other parameters 
such as pH, phytochemicals, structure and even the presence or absence of oxygen.  Indeed, 
original flavonol concentration has no effect on the degradation of rutin and quercetin. It is 
suggested that the reaction pathways are not influenced by the different flavonol solutions 
molarities (Buchner, et al., 2006). Moreover, under weak basic (Buchner, et al., 2006; 
Friedman, 1997; Takahama, 1986) and neutral (Friedman, 1997; Takahama, 1986) reaction 
conditions, more degradation of rutin and quercetin is observed (Buchner, et al., 2006). The 
absence of oxygen highly reduces quercetin degradation and prevents rutin breaking up 
during heating. The presence of oxygen is shown to accelerate quercetin and rutin 
degradation due to the presence of the reactive oxygen species (Buchner, et al., 2006; Makris 
& Rossiter, 2000). Chlorogenic acid is observed to protect rutin against degradation when a 
mixture of the two substances is heated at 180°C (Murakami, et al., 2004). 
Sometimes, authors dealt with the antioxidant activity of foods or solutions studied. It is 
difficult to summarize the evolution of the antioxidant activity according to conditions heat 
processes. Too numerous factors are implied in its evolution. Decreases in phenol content do 
not lead systematically to a decrease of the antioxidant activity. Indeed, the degradation 
products of phenolic compounds  can also have an antioxidant activity sometimes higher 
than the initial phenolic compounds (Buchner, et al., 2006; Murakami, et al., 2004); for high 
temperatures, these products can be Maillard products. Thus, an increase of antioxidant 
activity is noticed in many studies using thermal processes (Chandrasekara & Shahidi, 2011; 
Hartman et al., 2008; Sharma & Gujral., 2011). However interactions are important 
phenomena which act on the antioxidant activity of molecules. Depending on this 
environment, synergies between antioxidant compounds and the food matrix can occur 
(Wang et al., 2011). In some cases, the antioxidant capacity of flavonoids in a food matrix is 
enhanced (Freeman et al., 2010) ; while in other cases, the antioxidant capacity is reduced 
(Hidalgo et al., 2010). Thus, in other studies, antioxidant activity remains constant (Leitao et 
al., 2011) or can be decreased (Davidov-Pardo et al., 2011). 
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Microwave drying (Power : 
140, 240, 480, 560 
and 700 W;  time 
durations: 1, 2, 3, and 4 
min) 
Stability of total flavonoid 
content 
Dong et al., 2011 
Barley 
 Roasting (280°C, 20s) 
Microwave cooking (900 
W, 120s) 
A 8% loss in phenol content 
A 49.6 % loss in phenol 
content 
Sharma & Gujral, 
2011,  
Buckwheat 
Roasting 20min and 40min 
at 80°C and 120°C 
Pressurized steam-heating 
(0.1 MPa, 20 min ; 0.2 MPa, 
40 min) 
Microwaving (700W, 10 
min) 
20-30% increases depending 
on the conditions 
18-30% increases depending 
on the conditions 
 
20 % increase in flavonoid 
content 
Zhang et al., 2010 
Tomatoes Pasteurization (115°, 5 min) Losses in phenol content 
Valverdú-Queralt 
et al., 2010 
C. asiatica leaf, root 
and petiole 
Air-oven drying 
Vacuum oven drying 
Freeze drying 
 A 97% loss in flavonoid 
content 
A 87.6% loss in flavonoid 
content 
A 73% loss in flavonoid 
content 
Zainol et al., 2009 
Buckwheat seeds 
Buckwheat groats 
Heating at 160°C for 30 
min 
A 15.9% loss in flavonoid 
content 
A 12.2% loss in flavonoid 
content 
Zielinski et al., 
2009 
Strawberry 
Pasteurization (85°C, 5 
min) 
A 40% loss in phenol 
content 
Hartman et al, 
2008 
Celery 
Dry air (48°C,1h) 
Water immersion (50°C, 
90s) 
A 60% loss in flavonoid 
content 
A 22% loss in flavonoid 
content 
Viña et Chaves, 
2008 
Brussels sprouts Blanching (50°C) 
Stability of total flavonoid 
content 
Viña et al., 2007 
Mushroom (Shiitake) 
Autoclave : (100, 121°C, 10 
or 30 min) 
Increase of free flavonoids 
(64%) 
Decrease of bound 
flavonoids: 50% (100°C, 
30min), 75% (121°C, 10 
min), 90% (121°C, 30 min) 
Stability under (100°C, 10 
min) 
Choi et al., 2006 
Sweet potato Steaming (40 min) 
14 % increase in flavonoid 
content 
Huangb et al., 
2006 
Peanut Roasting (175°C, 5min) 
40% increase in total phenol 
content 
Yu et al., 2005 
Apple juice Heating at 40_C, 50_C, 
60_C and 70_C in a 
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Table 5. Effects of heat processes on phenolic content. (Continuation) 
3.2 Non thermal processes 
Certain authors showed the capacity of innovative processes (microwave, infra-red, high-
pressure processing) to less degrade the phenolic antioxidants in food as regard to thermal 
processes. Odriozola-Serrano et al. (2008) studied the effect of high-intensity pulsed electric 



































Grapefruit juices Pasteurization (95°C, 80s) 
Decrease of naringin, rutin, 
quercetin and naringenin 
content 





Atmospheric (100°C) and 
pressure boiling (121°C) 
with and without soaking 
and draining 
Increases of 1-90% of quercetin 
and 
kaempferol derivatives with 
soaking and drainning 





Roasting at  160°C for 30 
min. 
Losses of 80% of vitexin, 
isovitexin and rutin. 
Disappearance of 
homoorientin and orientin. 








Pasteurization (90°C, 60s ; 
90°C, 30s) 
Stability of kaempferol, 
quercetin and myricetin. 
10% increase of anthocyanins 
content (90°C, 60s) 
Odriozola-





Flash pasteurization (85°C) 
Increase of Catechins in cold-
pressed juice 
Decrease of Catechins in hot-
pressed juice 






Heating for (10,70, 130 
min) to 150°C then 
steaming (0.35 MPa, 20 
min) 
Increase of rutin and isovitexin 















Heating at 100°C for 300 
min under pH 5 and 8 with 
air or nitrogen perfusion 
Quercetin is more sensitive to 
heat under weak basic pH 
The presence of oxygen 
accelerates the degradation of 
quercetin and rutin 





Heating at 97°C for 240min 
under pH 8 
Quercetin is more sensitive to 
heat than rutin 
The presence of oxygen 
accelerates the degradation of 





Heating at 100°C for 300 or 
360min 
Heating at 180°C for 120 or 
180min 
Flavonoids are generally stable 
at 100°C 
Luteolin is more stable to heat 







Heating at 97°C for 240min 
under pH 8 
Quercetin is more sensitive to 
heat than rutin 
The presence of oxygen 
accelerates the degradation of 
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Microwave drying (Power : 
140, 240, 480, 560 
and 700 W;  time 
durations: 1, 2, 3, and 4 
min) 
Stability of total flavonoid 
content 
Dong et al., 2011 
Barley 
 Roasting (280°C, 20s) 
Microwave cooking (900 
W, 120s) 
A 8% loss in phenol content 
A 49.6 % loss in phenol 
content 
Sharma & Gujral, 
2011,  
Buckwheat 
Roasting 20min and 40min 
at 80°C and 120°C 
Pressurized steam-heating 
(0.1 MPa, 20 min ; 0.2 MPa, 
40 min) 
Microwaving (700W, 10 
min) 
20-30% increases depending 
on the conditions 
18-30% increases depending 
on the conditions 
 
20 % increase in flavonoid 
content 
Zhang et al., 2010 
Tomatoes Pasteurization (115°, 5 min) Losses in phenol content 
Valverdú-Queralt 
et al., 2010 
C. asiatica leaf, root 
and petiole 
Air-oven drying 
Vacuum oven drying 
Freeze drying 
 A 97% loss in flavonoid 
content 
A 87.6% loss in flavonoid 
content 
A 73% loss in flavonoid 
content 
Zainol et al., 2009 
Buckwheat seeds 
Buckwheat groats 
Heating at 160°C for 30 
min 
A 15.9% loss in flavonoid 
content 
A 12.2% loss in flavonoid 
content 
Zielinski et al., 
2009 
Strawberry 
Pasteurization (85°C, 5 
min) 
A 40% loss in phenol 
content 
Hartman et al, 
2008 
Celery 
Dry air (48°C,1h) 
Water immersion (50°C, 
90s) 
A 60% loss in flavonoid 
content 
A 22% loss in flavonoid 
content 
Viña et Chaves, 
2008 
Brussels sprouts Blanching (50°C) 
Stability of total flavonoid 
content 
Viña et al., 2007 
Mushroom (Shiitake) 
Autoclave : (100, 121°C, 10 
or 30 min) 
Increase of free flavonoids 
(64%) 
Decrease of bound 
flavonoids: 50% (100°C, 
30min), 75% (121°C, 10 
min), 90% (121°C, 30 min) 
Stability under (100°C, 10 
min) 
Choi et al., 2006 
Sweet potato Steaming (40 min) 
14 % increase in flavonoid 
content 
Huangb et al., 
2006 
Peanut Roasting (175°C, 5min) 
40% increase in total phenol 
content 
Yu et al., 2005 
Apple juice Heating at 40_C, 50_C, 
60_C and 70_C in a 
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Table 5. Effects of heat processes on phenolic content. (Continuation) 
3.2 Non thermal processes 
Certain authors showed the capacity of innovative processes (microwave, infra-red, high-
pressure processing) to less degrade the phenolic antioxidants in food as regard to thermal 
processes. Odriozola-Serrano et al. (2008) studied the effect of high-intensity pulsed electric 



































Grapefruit juices Pasteurization (95°C, 80s) 
Decrease of naringin, rutin, 
quercetin and naringenin 
content 





Atmospheric (100°C) and 
pressure boiling (121°C) 
with and without soaking 
and draining 
Increases of 1-90% of quercetin 
and 
kaempferol derivatives with 
soaking and drainning 





Roasting at  160°C for 30 
min. 
Losses of 80% of vitexin, 
isovitexin and rutin. 
Disappearance of 
homoorientin and orientin. 








Pasteurization (90°C, 60s ; 
90°C, 30s) 
Stability of kaempferol, 
quercetin and myricetin. 
10% increase of anthocyanins 
content (90°C, 60s) 
Odriozola-





Flash pasteurization (85°C) 
Increase of Catechins in cold-
pressed juice 
Decrease of Catechins in hot-
pressed juice 






Heating for (10,70, 130 
min) to 150°C then 
steaming (0.35 MPa, 20 
min) 
Increase of rutin and isovitexin 















Heating at 100°C for 300 
min under pH 5 and 8 with 
air or nitrogen perfusion 
Quercetin is more sensitive to 
heat under weak basic pH 
The presence of oxygen 
accelerates the degradation of 
quercetin and rutin 





Heating at 97°C for 240min 
under pH 8 
Quercetin is more sensitive to 
heat than rutin 
The presence of oxygen 
accelerates the degradation of 





Heating at 100°C for 300 or 
360min 
Heating at 180°C for 120 or 
180min 
Flavonoids are generally stable 
at 100°C 
Luteolin is more stable to heat 







Heating at 97°C for 240min 
under pH 8 
Quercetin is more sensitive to 
heat than rutin 
The presence of oxygen 
accelerates the degradation of 
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Food product Processing 
conditions 
Impact on flavonoids 
content 
References 








Potatoes Cutting Induction of flavonol 
biosynthesis 
Tudela et al., 2002 
Asparagus Chopping 18.5% decrease of 
rutin content 
Makris and Rossiter, 
2001 
Onions Peeling, trimming Losses of 39% Ewald et al., 1999 



















Boiling (60min) A 20.5% decrease in total 
flavonoid content in onion 
bulbs 
A 43.9% decrease in total 




Onions Sautéing (5min) Increase of quercetin 
conjugates and total flavonoid 
contents 
Lombard et 
al., 2005 Baking (15min, 176°C)
Boiling (5min) A 18.8% decrease of total 
flavonoid content 
Onions Boiling (3min) Boiling gave limited reduction 
in flavonoids content 
Ewald et al., 








Boiling (20min) A 14.3% loss of quercetin 
conjugates 
Price et al., 
1997 
A 2 1.9% loss of quercetin 
conjugates 
Frying (5min, 15min) 23-29% Losses of  quercetin 
conjugates 
Onions Boiling (5min) A 20% loss of total flavonoids Lee et al., 2008 
Microwaving (1min, 
High heat) 
No significant effect on total 
flavonoid content 
Sautéing (3min) No significant effect on total 
flavonoid content 
Table 7. Effects of domestic treatment on phenol content. 
reported that such a process has no damage on these compounds. In 2009, the same study 
was led on tomatoes’ juice; pulsed electric field has no effect on phenol content and led to a 
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better conservation during the storage (Odriozola-Serrano et al, 2009). The use of high 
pressure, instead pasteurisation, on fruit smoothies is better to keep phenolic content 
constant (Keenan et al., 2011). Suarez-Jacobo et al. (2011) found the same results for an apple 
juice, phenolic content and antioxidant activity remain constant. 
Few studies deal with filtration, Pap et al. (2010) recommended for blackcurrant juice 
filtration an enzymatic pre-treatment instead a reverse osmosis process, since it results in a 
juice concentrates highest in anthocyanins and flavonols.  Hartman et al. (2008) also used an 
enzymatic treatment for strawberry mash; no loss of phenolic compounds was noticed. 
3.3 Mechanical processes 
Processes studied in literature concern essentially peeling, trimming, chopping, slicing, 
crushing, pressing and sieving of flavonoid-rich foods (Table 6). Processing is expected to 
affect content, activity and availability of bioactive compounds (Nicoli et al., 1999). 
According to authors, major losses of flavonoids took place during the pre-processing step 
when parts of product was removed: onions peeling and trimming resulted in 39% 
flavonoids losses (Ewald, et al., 1999) and asparagus chopping yielded a 18.5% decrease of 
rutin content (Makris & Rossiter, 2001). Great losses are also noticed for the peeling and the 
dicing of tomatoes (Valverdú-Queralt et al., 2011).  
Slicing significantly affected the rutin content of asparagus (Makris & Rossiter, 2001). 
However, cutting increased flavonol content in fresh cut-potatoes (Tudela, et al., 2002) and 
fresh-cut onions (Pérez-Gregorio et al., 2011).  In fact, wounding enhances flavonol 
biosynthesis through the induction of phenylalanine ammonia-lyase enzyme which is 
related to the wound-healing process in order to fight pathogen attack after tissue 
wounding (Tudela, et al., 2002). 
3.4 Domestic processes 
Several studies simulated food home preparation conditions in order to investigate their 
effects on flavonoid degradation (Table 7). Common domestic processes such as boiling, 
frying, baking, sautéing, steam-cooking and microwaving were studied.  
Boiling resulted in flavonoids losses which are leached in cooking water, 43.9% for 
asparagus spears and 20.5% for onions (Makris & Rossiter, 2001). Similar losses in onions 
were reported (Lee et al., 2008; Lombard et al., 2005; Price et al., 1997). Microwaving does 
not markedly affect flavonoid content in onions (Ewald et al., 1999; Lee, et al., 2008; 
Lombard, et al., 2005; Price, et al., 1997; Tudela et al., 2002).  As regards sautéing operations, 
contradictory findings were reported. Lee et al. (2008) reported a decrease of flavonoid 
content at almost of 21% whereas Lombard et al. (2005) showed an increase of the total 
flavonoid of 25% in onions (Lombard, et al., 2005).   
Frying is reported to decrease onion flavonoid content between 25 and 33% (Lee, et al., 2008; 
Price, et al., 1997).Steaming and baking do not significantly affect the flavonoid content of 
onions (Lee, et al., 2008). Conversely, baking is found to increase  quercetin conjugate and 
total flavonol content (7%) in onions as these compounds were concentrated in the tissues, 
as water and other volatiles were lost during cooking (Lombard, et al., 2005). 
These contradictory results can be attributed easily to the diversity of food products used 
and the lack of the standardization of domestic processes. 
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Food product Processing 
conditions 
Impact on flavonoids 
content 
References 








Potatoes Cutting Induction of flavonol 
biosynthesis 
Tudela et al., 2002 
Asparagus Chopping 18.5% decrease of 
rutin content 
Makris and Rossiter, 
2001 
Onions Peeling, trimming Losses of 39% Ewald et al., 1999 



















Boiling (60min) A 20.5% decrease in total 
flavonoid content in onion 
bulbs 
A 43.9% decrease in total 




Onions Sautéing (5min) Increase of quercetin 
conjugates and total flavonoid 
contents 
Lombard et 
al., 2005 Baking (15min, 176°C)
Boiling (5min) A 18.8% decrease of total 
flavonoid content 
Onions Boiling (3min) Boiling gave limited reduction 
in flavonoids content 
Ewald et al., 








Boiling (20min) A 14.3% loss of quercetin 
conjugates 
Price et al., 
1997 
A 2 1.9% loss of quercetin 
conjugates 
Frying (5min, 15min) 23-29% Losses of  quercetin 
conjugates 
Onions Boiling (5min) A 20% loss of total flavonoids Lee et al., 2008 
Microwaving (1min, 
High heat) 
No significant effect on total 
flavonoid content 
Sautéing (3min) No significant effect on total 
flavonoid content 
Table 7. Effects of domestic treatment on phenol content. 
reported that such a process has no damage on these compounds. In 2009, the same study 
was led on tomatoes’ juice; pulsed electric field has no effect on phenol content and led to a 
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better conservation during the storage (Odriozola-Serrano et al, 2009). The use of high 
pressure, instead pasteurisation, on fruit smoothies is better to keep phenolic content 
constant (Keenan et al., 2011). Suarez-Jacobo et al. (2011) found the same results for an apple 
juice, phenolic content and antioxidant activity remain constant. 
Few studies deal with filtration, Pap et al. (2010) recommended for blackcurrant juice 
filtration an enzymatic pre-treatment instead a reverse osmosis process, since it results in a 
juice concentrates highest in anthocyanins and flavonols.  Hartman et al. (2008) also used an 
enzymatic treatment for strawberry mash; no loss of phenolic compounds was noticed. 
3.3 Mechanical processes 
Processes studied in literature concern essentially peeling, trimming, chopping, slicing, 
crushing, pressing and sieving of flavonoid-rich foods (Table 6). Processing is expected to 
affect content, activity and availability of bioactive compounds (Nicoli et al., 1999). 
According to authors, major losses of flavonoids took place during the pre-processing step 
when parts of product was removed: onions peeling and trimming resulted in 39% 
flavonoids losses (Ewald, et al., 1999) and asparagus chopping yielded a 18.5% decrease of 
rutin content (Makris & Rossiter, 2001). Great losses are also noticed for the peeling and the 
dicing of tomatoes (Valverdú-Queralt et al., 2011).  
Slicing significantly affected the rutin content of asparagus (Makris & Rossiter, 2001). 
However, cutting increased flavonol content in fresh cut-potatoes (Tudela, et al., 2002) and 
fresh-cut onions (Pérez-Gregorio et al., 2011).  In fact, wounding enhances flavonol 
biosynthesis through the induction of phenylalanine ammonia-lyase enzyme which is 
related to the wound-healing process in order to fight pathogen attack after tissue 
wounding (Tudela, et al., 2002). 
3.4 Domestic processes 
Several studies simulated food home preparation conditions in order to investigate their 
effects on flavonoid degradation (Table 7). Common domestic processes such as boiling, 
frying, baking, sautéing, steam-cooking and microwaving were studied.  
Boiling resulted in flavonoids losses which are leached in cooking water, 43.9% for 
asparagus spears and 20.5% for onions (Makris & Rossiter, 2001). Similar losses in onions 
were reported (Lee et al., 2008; Lombard et al., 2005; Price et al., 1997). Microwaving does 
not markedly affect flavonoid content in onions (Ewald et al., 1999; Lee, et al., 2008; 
Lombard, et al., 2005; Price, et al., 1997; Tudela et al., 2002).  As regards sautéing operations, 
contradictory findings were reported. Lee et al. (2008) reported a decrease of flavonoid 
content at almost of 21% whereas Lombard et al. (2005) showed an increase of the total 
flavonoid of 25% in onions (Lombard, et al., 2005).   
Frying is reported to decrease onion flavonoid content between 25 and 33% (Lee, et al., 2008; 
Price, et al., 1997).Steaming and baking do not significantly affect the flavonoid content of 
onions (Lee, et al., 2008). Conversely, baking is found to increase  quercetin conjugate and 
total flavonol content (7%) in onions as these compounds were concentrated in the tissues, 
as water and other volatiles were lost during cooking (Lombard, et al., 2005). 
These contradictory results can be attributed easily to the diversity of food products used 
and the lack of the standardization of domestic processes. 
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Table 8 summarizes the possible evolution of phenolic antioxidants and their antioxidant 
activities according to the data collected in this chapter. 
 
Phenolic Antioxidants Antioxidant activity 












- Better extraction of 
phenolic compounds. 
- A stress inducing phenol 








- No degradation. 
- Compensation of an 












- Degradation products have 
an antioxidant activity. 
- Increase of the total phenol 
content. 
- Positive Synergies occur 
between phenolic 
antioxidants. 
- Degradation of the 
phenolic antioxidants. 
- Negative synergies occur 
between phenolic 
antioxidants 
- No degradation of the 
phenol antioxidants. 
- Compensation of an 
increase and a decrease. 
Table 8. Possible evolutions of phenolic antioxidants content and their antioxidant activity 
during food transformations. 
4. Conclusion 
Phenolic antioxidants have a great importance in human food diet: (i) they are widely 
widespread in raw foods as fruit and vegetables, tea, coffee, cocoa, (ii) they gather numerous 
properties beneficial for human health as anti-oxidant, anti-inflammatory, anti-allergic, 
antimicrobial and anticancer properties and (iii) they can be preserved during food 
transformation by using adapted process conditions and also nonaggressive processes. 
However, provide to consumers enriched food products in antioxidants is not so easy; 
indeed, despite the number of studies on the effect of food processes on the degradation of 
phenolic antioxidants and their antioxidant activities, it is difficult to generalize results. 
Many factors influence the evolution of these parameters: (i) the kind of raw food (genotype, 
cultivation method), (ii) the lack of standardization of measurement methods: phenolic 
content, antioxidant activity by ABTS, DPPH, ORAC, (iii) the influence of the food matrix: 
existence of interactions between molecules and iv) the lack of standardization of processes 
applied (conditions, materials).  
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Increasing Recombinant  
Protein Production in E. coli by  
an Alternative Method to Reduce Acetate 
Hendrik Waegeman and Marjan De Mey 
Ghent University, Centre of Expertise-Industrial Biotechnology and Biocatalysis, 
Belgium 
1. Introduction  
Since the development of recombinant DNA technology (Cohen et al., 1973), it became 
possible to express heterologous genes in pro- or eukaryotic hosts, i.e. genes which they 
naturally not express. This development enabled the production of all kinds of products of 
which the high-added value recombinant proteins, became increasingly important and as 
such boosted biopharmaceutical and industrial enzyme applications. Up to now, the FDA 
(Food and Drug Administration) and EMEA (European Medicines Agency) have licensed 
the application of more than 150 recombinant proteins to be used as a pharmaceutical 
(Ferrer-Miralles et al., 2009). Global sales of biopharmaceuticals are estimated to account for 
US$70–80 Billion today (Walsh, 2010). Industrial enzymes (e.g. proteases, amylases, lipases, 
cellulases, pullulanases, pectinases) are used in various industrial segments and the 
industrial enzyme market is still expanding, estimated to reach US$ 3.74 Billion by the year 
2015 (Global Industry Analysts, 2011). To date, the majority of this industrial enzyme 
market value is generated by recombinant processes (Hodgson, 1994; Demain & Vaishnav, 
2009). 
It is clear that recombinant protein production has evolved to one of the most important 
branches in modern biotechnology, representing a billion-dollar business, both in the 
production of biopharmaceuticals and industrial enzymes.  
A pivotal choice in the design of a recombinant protein bioprocess is the selection of a 
suitable host strain. This selection is influenced by different factors: (i) ease of cultivation 
and growth characteristics, (ii) ease of genetic manipulation and availability of molecular 
tools, (iii) ability of post-translational modifications (e.g. glycosylation patterns, disulfide 
bond formation), (iv) downstream processing, and (v) regulatory aspects (generally 
regarded as safe, SAFE (Lotti et al., 2004; Sahdev et al., 2008; Durocher & Butler, 2009). 
These aspects will determine whether the designed recombinant protein bioprocess will end 
up in an economical viable bioprocess which can compete with the present process.  
In contrast to biopharmaceuticals, industrial enzyme bioprocesses are only economical 
viable as a low production cost is assured. This implies that higher yields, titres and 
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production rates are necessary which can only be obtained by fast growing organisms. This 
is reflected by the distribution of the most commonly used organisms in these two 
industries. Whereas slow growing organisms as plants and animals are used as host in half 
of the biopharmaceutical processes, they count only for 12% of the processes in the 
industrial enzyme market (Demain & Vaishnav, 2009; Ferrer-Miralles et al., 2009). Bacteria 
on the other hand, have a market share of 30% in both industries. However, yeasts and 
molds, which grow much faster in comparison with higher eukaryotes, are used in 58 % of 
the cases in the industrial enzyme market and only in 18% of the cases in the in the 
biopharmaceutical market. 
Several bacteria have been explored as host for recombinant protein production. Recently, 
much interest is raised in the use of Bacillus strains as host for recombinant protein 
production because of their advantageous features as gram-positive (Terpe, 2006). However, 
till today Escherichia coli remains a very popular and predominantly used bacterium for 
recombinant protein production. This is primarily because this well-characterised organism 
can easily and rapidly grow on cheap substrates and can be simply modified through a 
broad variety of molecular tools. But even more, the further exploration of other potential 
microbial hosts are often restricted due to limited information about genetics and 
metabolism and/or the availability of molecular tools. 
2. Escherichia coli for recombinant protein production 
Besides the advantage of many available molecular tools, the easily cultivable and 
genetically and metabolically well-known Escherichia coli can be grown to high biomass 
concentrations in high cell density cultures allowing the production of high amounts of 
heterologous protein (Makrides, 1996). Nonetheless, E. coli suffers from some major 
drawbacks as well.  
i. The production of heterologous proteins to high titres concurs mostly with the initiation 
of a stress response and/or metabolic burden, both associated with the use of multi-
copy plasmids, resulting in misfolding and degradation of the heterologous protein and 
formation of inclusion bodies (Noack et al., 1981; Parsell & Sauer, 1989; Bentley et al., 
1990; Gill et al., 2000; Hoffmann & Rinas, 2004; Ventura & Villaverde, 2006). 
ii. As prokaryotic, Escherichia coli lacks the ability to perform enhanced post-translational 
modifications making the production of more complex eukaryotic proteins in E. coli 
challenging. This inability to form disulfide bonds or to execute glycosylation results in 
the production of instable and non-functional proteins. 
iii. Secretory production of recombinant proteins into the culture medium includes several 
advantages, especially in cases of toxic recombinant proteins. However, compared to 
other hosts, E. coli does not naturally secrete proteins in high amounts. Nonetheless, E. 
coli possesses different secretions systems for the transport of proteins from the 
cytoplasmic to the perisplasmic or extracellular environment (Tseng et al., 2009). 
Crucial hereby is the signal peptide which is linked to the protein allowing recognition 
and transport by the secretion system.  
iv. The main difficulty when using E. coli as host is the production of acetate as by-product 
during fermentations as a result of overflow metabolism occurring when cells grow 
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rapidly and cannot metabolise the delivered carbon source fast enough (Andersen & 
von Meyenburg, 1980; Holms, 1986). It is generally observed that even low 
concentrations of acetate can hamper growth and obstruct the production of 
recombinant proteins (Jensen & Carlsen, 1990; Nakano et al., 1997).  
Many efforts have been made to overcome these hurdles and hence to increase recombinant 
protein production in E. coli or to express more complex proteins in this host. These 
engineering attempts are summarized in Fig. 1. 
 
Fig. 1. Overview of different engineering approaches to increase recombinant protein 
production in Escherichia coli 
The primarily used approach to produce recombinant proteins is to clone the gene of 
interest on a multi-copy plasmid under the control of a strong promoter in order to achieve 
high transcription rates and hence high recombinant protein concentrations. However, 
problems such as metabolic burden, segregational instability, misfolding and proteolytic 
breakdown or aggregation in inclusion bodies, and difficulties in controlling gene 
expression are usually associated with multi-copy plasmids and the use of strong promoters 
(Noack et al., 1981; Parsell & Sauer, 1989; Bentley et al., 1990; Dong et al., 1995; Kurland & 
Dong, 1996; Gill et al., 2000; Hoffmann & Rinas, 2004; Ventura & Villaverde, 2006). Most 
engineering strategies to tackle these problems focus on prevention of misfolding, 
neutralisation of increased protease activity or stress response (Chou, 2007). An elaborated 
review of these efforts is given in (Waegeman & Soetaert, 2011). 
Two post-translational modifications which are pivotal for the stability and activity of 
many more complex eukaryotic proteins are disulfide bonds and glycosylation. The 
former is being facilitated in E. coli by secreting the recombinant protein into the more 
oxidizing perisplasmic space using the Sec or Tat secretion system, by altering the redox 
state of the cytoplasm through modifications in the thioredoxin reductase gene (trxB) and 
gluthatione reductase genes (gor) or by cytoplasmic overexpression of periplasmic 
disulfide oxidoreductases (such as DsbC) which enhance the rate of disulfide 
isomerisation. An excellent review of these engineering strategies can be found in (de 
Marco, 2009). 
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Besides the proper formation of disulfide bonds, E. coli also lacks the ability of glycosylation. 
In order to make E. coli produce N-linked glycoproteins the gene cluster pgl, responsible for 
glycosylation in Campylobacter jejuni (Szymanski et al., 1999; Abu-Qarn et al., 2008) was 
successfully transferred (Wacker et al., 2002). Moreover, combination of the pgl system with 
a simple, genetically encoded glycosylation tag, expands the glycosylation possibilities of E. 
coli (Fisher et al., 2011). 
The secretory production of recombinant proteins into the fermentation broth includes 
several advantages compared to cytoplasmic production. Although E. coli has different 
secretion systems for transport of proteins, secretion of recombinant proteins is rather 
complex. Many research efforts focus on the utilisation of these existing transport routes for 
the secretion of heterlogous proteins (Choi & Lee, 2004; Jong et al., 2010) including selection 
and modification of the signal peptide, coexpression of proteins that assist in translocation 
and folding, improvement of periplasmic release when transport occurs in two steps or 
protection of the target protein from degradation and contamination (Abdallah et al., 2007). 
3. An alternative approach to reduce acetate production and improve 
recombinant protein production in Escherichia coli 
Throughout the years, various Escherichia coli strains with different genotypes have been 
examined for their potential to produce recombinant proteins in high titres. A 
comprehensive overview of all E. coli strains used in recombinant protein production 
processes and their characteristics is given in (Waegeman & Soetaert, 2011). Although E. coli 
B and E. coli K12 strains are equally used as host for recombinant protein production (47% 
and 53%, respectively), E. coli BL21 is by far the most commonly used strain (35%) in 
academia. In industry, this number is probably even much higher. 
Escherichia coli BL21 displays higher biomass yields compared to E. coli K12 resulting in 
substantially lower acetate amounts which in return has a positive effect on the recombinant 
protein production (El-Mansi & Holms, 1989; Shiloach et al., 1996). The second reason of the 
extensive use of E. coli BL21 as microbial host for recombinant protein production is that this 
strain is deficient in the proteases Lon and OmpT, which decreases the breakdown of 
recombinant protein and result in higher yields (Gottesman, 1989; Gottesman, 1996). 
However, until recently the genome sequence of E. coli BL21 was not available making 
genetically modifications not always straightforward and therefore challenging. 
Consequently, still a lot of attention and effort is going towards E. coli K12-derived strains as 
most favourable E. coli strain for recombinant protein production (Ko et al., 2010; Ryu et al., 
2010; Striedner et al., 2010). 
Many different strategies have been applied to increase recombinant protein formation and 
decrease acetate formation in E. coli K12 strains including optimisation of the bioprocess 
conditions as metabolic engineering of the production host (De Mey et al., 2007b). These 
approaches comprise attempts which can be categorised in 3 classes: (i) deletion of acetate 
pathway genes, (ii) avoiding overflow metabolism by limiting the glucose uptake system 
through alteration of the carbon source, applying elaborate feeding strategies, or 
engineering the glucose uptake system, and (iii) avoiding overflow metabolism by 
redirecting central metabolic fluxes and preserving sufficient precursors of the amino acids, 
the building blocks of proteins (Fig. 2). 
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Fig. 2. Strategies to reduce acetate formation in Escherichia coli (adapted from Waegeman & 
Soetaert, 2011): (i) blocking the acetate pathway by knocking out genes that encode for acetate 
pathway enzymes, (ii) reducing the glucose uptake rate, and (iii) redirecting central metabolic 
fluxes. PPP, pentose phosphate pathway; aceA, isocitrate lyase; aceB, malate synthase; ackA, 
acetate kinase; acn, aconitase; acs, acetyl-CoA synthase; adhCEP, ethanol dehydrogenase; adhE, 
aldehyde dehydrogenase; fumABCD, fumarase; galP, galactose permease; glk, glucokinase; icd, 
isocitrate dehydrogenase; ilvBG2HIMN, acetolacetate decarboxylase; ldhA, lactate 
dehydrogenase; maeAB, malic enzyme; mdh, malate dehydrogenase; pck, phosphoenolpyruvate 
carboxykinase; pdh, pyruvate dehydrogenase; pflB, tdcE, pyruvate formate lyase; poxB, 
pyruvate oxidase; ppc, phosphoenolpyruvate carboxylase; pps, phosphoenolpyruvate synthase; 
pta, acetylphosphotransferase; pyk, pyruvate kinase; sdhABCD, succinate dehydrogenase; 
sucAB, a-ketoglutarate dehydrogenase; sucCD, succinate thiokinase. 
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The first, rational effort to decrease acetate production is to block the acetate pathway by 
knocking out genes that encode for acetate pathway enzymes, e.g. ackA (acetate kinase), pta 
(phosphate acetyltransferase) and poxB (pyruvate oxidase) (Diaz-Ricci et al., 1991; Yang et 
al., 1999; Contiero et al., 2000; Dittrich et al., 2005; De Mey et al., 2007a). These attempts 
resulted in a considerably decrease of acetate production but in return pyruvate, lactate or 
formate formation, which are also undesired by-products, increased to a large extent. 
A second widely followed approach to minimise acetate formation during high cell density 
fermentations is to limit rapid uptake of glucose causing overflow metabolism. Overflow 
metabolism occurs when high glycolytic fluxes, due to rapid glucose uptake, are not further 
processed in the TCA cycle developing a bottleneck at the pyruvate node and consequently 
pyruvate is converted to acetate.  
Strategies based on optimising the bioprocess conditions to reduce the glucose uptake rate 
comprise applying specific glucose feeding patterns, the application of alternative substrates, 
the addition of supplements to the medium, the control of a range of fermentation parameters 
and the application of systems to remove acetate from the fermentation broth (Farmer & Liao, 
1997; Nakano et al., 1997; Akesson et al., 1999; Akesson et al., 2001b; Akesson et al., 2001a; 
Fuchs et al., 2002  ; Chen et al., 2005; Eiteman & Altman, 2006). Although all these attempts 
were in many cases successful to reduce acetate production, they imply a severe lower growth 
rate and they do not utilise the full potential of the microbial host.  
Engineering of the glucose uptake system is being successfully applied as well to overcome 
overflow metabolism. By deleting one of the phosphotransferase system genes, e.g. ptsG, 
ptsH or ptsI, the uptake through the major glucose transporter is several impeded, resulting 
in a reduced glycolytic flux and reduced acetate pathway (Chou et al., 1994; Siguenza et al., 
1999; De Anda et al., 2006; Wong et al., 2008). To restore the strong reduction in growth rate 
as consequence of hampering the main glucose transporter De Anda et al. (2006) 
overexpressed the alternative glucose transporter gene galP (coding for a galactose 
permease) and exploited the native glucose kinase (Glk) transporter. The resulting strain E. 
coli W3110 ΔptsH galP+ displayed a very low acetate yield and a significantly increased 
recombinant protein yield compared to the E. coli W3110 wild-type, without reduction in 
growth rate. Wong et al (2008) restored glucose transport by co-expressing the gene glf, 
encoding for a passive glucose transporter of Zymomonas mobilis. However, this only 
resulted in a decreased acetate formation in M9 minimal media, not in LB media. 
A third approach to overcome overflow metabolism is to redirect the fluxes around the 
bottleneck, the phosphoenolpyruvate-pyruvate-oxaloacetate node, instead of restricting the 
glucose uptake. Farmer & Liao (1997) increased anaplerotic and glycolate fluxes by 
overexpressing phosphenolpyruvate carboxylase (encoded by ppc) and by deleting the FadR 
regulator. This notable strategy resulted in a more than 75% decrease in acetate yield 
compared to its wild type. Alternatively, another important success was achieved by the 
overexpression of a heterologous anaplerotic pyruvate carboxylase from Rhizobium etli 
resulting in a 57% reduction in acetate formation and a 68% increase in recombinant protein 
production (March et al., 2002). Similarly, De Mey et al. (2010) achieved an increase in 
recombinant protein production by deleting the genes coding for acetate pathway enzymes 
combined with the overexpression of ppc. 
Increasing of Recombinant Protein Production  
in E. Coli by an Alternative Method to Reduce Acetate 
 
133 
An alternative approach to enhance recombinant protein production is mimicking the E. coli 
BL21 phenotype in E. coli K12 by interfering on the regulatory level of gene expression 
instead of targeting genes directly involved in the conversion of metabolites in the acetate 
pathway our around the phosphoenolpyruvate-pyruvate-oxaloacetate node. 13C metabolic 
flux analysis showed that the low acetate production in E. coli BL21(DE3) is caused by 
activation of the glyoxylate pathway (Noronha et al., 2000), a pathway which is normally 
not activated under glucose excess in E. coli K12 strains. Furthermore, acetate assimilation 
pathways are more active in E. coli BL21 compared to in E. coli K12 (Phue et al., 2005). 
3.1 Influence of transcriptional regulators ArcA and IclR on Escherichia coli 
phenotypes 
Regulation of gene expression is very complex and transcriptional regulators can be 
subdivided in global and local regulators depending on the number of operons they control. 
Global regulators control a vast number of genes, which must be physically separated on the 
genome and belong to different metabolic pathways (Gottesman, 1984). According to 
EcoCyc (Keseler et al., 2011) E. coli K12 MG1655 contains 40 master regulators and sigma 
factors. Nonetheless, only seven global regulators control the expression of 51% of all genes: 
ArcA, Crp, Fis, Fnr, Ihf, Lrp and NarL. In contrast to global regulators, local regulators 
control only a few genes, e.g. 20% of all transcriptional regulators control the expression of 
only one or two genes (Martinez-Antonio & Collado-Vides, 2003). 
The global regulator ArcA (anaerobic redox control) was first discovered in 1988 by Iuchi 
and Lin and the regulator seemed to have an inhibitory effect on expression of aerobic TCA 
cycles genes under anaerobic conditions (Iuchi & Lin, 1988). Later on, it was unravelled that 
ArcA is a component of the dual-component regulator ArcAB, in which ArcA is the 
regulatory protein and ArcB acts as sensory protein (Iuchi et al., 1990).  
Acording to EcoCyc (Keseler et al., 2011) ArcA is involved in the regulation of 168 genes and 
itself is regulated by 2 regulators (FnrR, RpoD). Statistical analysis of gene expression data 
(Salmon et al., 2005) showed that ArcA regulates the expression of a wide variety of genes 
involved in the biosynthesis of small macromolecules, transport, carbon and energy 
metabolism, cell structure, etc. The regulatory activity of ArcA is dependent on the oxygen 
concentration in the environment. The most profound effects of ArcA are noticed under 
microaerobic conditions (Alexeeva et al., 2003) but recently it was reported that also under 
aerobic conditions ArcA has an effect on central metabolic fluxes (Perrenoud & Sauer, 2005). 
Similarly to the global transcriptional regulator ArcA, the local transcriptional regulator 
isocitrate lyase regulator IclR has a reductive effect on the flux through the TCA cycle 
(Rittinger et al., 1996). IclR represses the expression of the aceBAK operon, which codes for the 
glyoxylate pathway enzymes isocitrate lyase (encoded by aceA), malate synthase (encoded by 
aceB), and isocitrate dehydrogenase kinase/phosphatise (encoded by aceK) (Yamamoto & 
Ishihama, 2003). The last enzyme phosphorylates the TCA cycle enzyme isocitrate 
dehydrogenase (Icd) controlling the switch between the flux through the TCA cycle and the 
glyoxylate pathway. It is reported that when IclR levels are low or when IclR is inactivated, i.e. 
for cells growing on acetate (Cortay et al., 1991; Cozzone, 1998; El-Mansi et al., 2006), or in slow 
growing glucose utilising cultures (Fischer & Sauer, 2003; Maharjan et al., 2005), repression on 
glyoxylate genes is released and the glyoxylate pathway is activated.  
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As both transcriptional regulators, ArcA and IclR, are involved in controlling the flux 
through the TCA cycle and glyoxylate pathway, they are interesting targets for metabolic 
engineering for mimicking the E. coli BL21 phenotype in E. coli K12.  
To investigate their effect, single knockouts as a knockout combination were made in E. coli 
MG1655 (K12-strain). The different mutants and wild type were cultivated in a 2L stirred 
tank bioreactor under glucose abundant (batch cultivation) conditions in order to precisely 
determine extracellular fluxes and growth rates and consequently to evaluate the 
physiological and metabolic consequences of arcA and iclR deletions on E. coli MG1655. In 
order to evaluate if these effects are corresponding with the characteristics of E. coli BL21, 
this E. coli strain was also tested. The growth rates and the average carbon and redox 
balances of the different strains are shown in Table 1. 
 
E. coli strain μmax (h-1) Carbon (%) Redox (%) 
MG1655 0.66 ± 0.02 97 101 
MG1655 ΔarcA 0.60 ± 0.01 96 94 
MG1655 ΔiclR 0.61 ± 0.02 95 95 
MG1655 ΔarcA ΔiclR 0.44 ± 0.03 99 101 
BL21(DE3) 0.59 ± 0.02 93 99 
Table 1. Average maximum growth rate, carbon balance and redox balance for batch 
cultures of the investigated strains 
The arcA and iclR single knockouts strains have a slightly lower maximum growth rate. In 
contrary the combined arcA-iclR double knockout strain in E. coli MG1655 exhibits a 
substantial reduction of 38% in μmax. Fig. 3 shows the effect of these mutations on various 
product yields under abundant glucose conditions. The corresponding average redox and 
carbon balances close very well (Table 1). 
Product yields in c-mole/c-mole glucose for E. coli MG1655, MG1655 ΔarcA, MG1655 ΔiclR, 
MG1655 ΔarcA ΔiclR and BL21 under glucose abundant conditions. Oxygen yield is shown 
as a positive number for a clear representation, but O2 is actually consumed during 
experiments. The values represented in the graph are the average of at least two separate 
experiments and the errors are standard deviations calculated on the yields. 
Both the arcA and iclR knockout strains show an increased biomass yield in E. coli MG1655. 
When combining these deletions in E. coli MG1655 the yield is further increased to 0.063 ± 
0.01 c-mole/c-mole glucose, which approximates the theoretical biomass yield of 0.65 c-
mole/c-mole glucose (assuming a P/O-ratio of 1.4) (Varma et al., 1993a; Varma et al., 1993b) 
and slightly higher compared to the E. coli BL21(DE3) wild-type. The higher biomass yield 
in E. coli  MG1655 ΔarcA ΔiclR is accompanied by a 70% and 16% reduction in acetate and 
CO2 yields, respectively. This reduction in CO2 yield could indicate that the glyoxylate 
pathway is more active in the double knock-out mutant as is observed in E. coli BL21 
(Noronha et al., 2000).  
The deletion of local transcriptional regulator iclR reduces the acetate formation with 50% in 
E. coli MG1655. When the global transcriptional regulator arcA is additionally deleted, the 
acetate yield is even further decreased to a comparable value of E. coli BL21(DE3). 
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Fig. 3. Product yields of the different E. coli strains in batch cultures.  
13C-metabolic flux analysis confirmed our hypothesis that the deletion of both arcA and iclR 
in E. coli MG1655 alters central metabolism fluxes profoundly (Fig. 4). A higher flux at the 
entrance of the TCA cycle was observed due to arcA deletion resulting in a reduced 
production of acetate and less carbon loss. Due to the iclR deletion, the glyoxylate pathway 
is activated resulting in a redirection of 30% of the isocitrate molecules directly to succinate 
and malate without CO2 production.  
Moreover, similar central metabolic fluxes were observed in the combined arcA-iclR double 
knockout in E. coli MG1655 as in E. coli BL21(DE3). These results suggest that the expression 
levels of arcA and iclR are low in E. coli BL21. We could confirm that deletion of both arcA 
and iclR in E. coli BL21 had no severe implications on the phenotype (Waegeman et al., 
2011c). Only a slight decrease in growth rate was observed. Thus, this proves that ArcA and 
IclR are poorly active in E. coli BL21 whereas in E. coli K12 both regulators play an important 
role. This can be explained by mutations in the promoter region of iclR and a less efficient 
codon usage of arcA in E. coli BL21 (Waegeman et al., 2011a). 
Thus, by deletion of a local and global transcriptional regulator, ArcA and IclR respectively, 
we could mimic the physiological and metabolic properties of E. coli BL21 in an E. coli K12 
strain. Furthermore, only a small part of the tremendously elevated biomass yield was 
attributed to increased glycogen content (Waegeman et al., 2011a) making this strain an 
attractive candidate for recombinant protein production. 
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Fig. 4. Metabolic Flux distribution in E. coli MG1655, its derivate single knockout strains 
ΔarcA and ΔiclR, and the double knockout strain ΔarcA ΔiclR, and E. coli BL21 cultivated in 
glucose abundant conditions. More specific details about the metabolic flux calculations can 
be found in (Waegeman et al., 2011a) 
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3.2 Escherichia coli MG1655 ΔarcA ΔiclR as potential candidate for recombinant 
protein production 
Our previous research has shown that similar metabolic and physiological characteristics as 
E. coli BL21 can be achieved in E. coli K12 by combined deletion of the global transcriptional 
regulator ArcA and the local transcriptional regulator IclR. 
To investigate whether these metabolic alterations in E. coli MG1655 also beneficially 
influence recombinant protein production, we compared the recombinant protein 
production of the metabolically engineered strain to E. coli BL21(DE3) using GFP (Green 
Fluorescent Protein)  as a biomarker (Fig. 5). 
Batch cultures were performed in 2L stirred tank bioreactors. Yields are calculated by 
dividing GFP and biomass concentrations during the cultivation phase when biomass 
concentrations are higher than 2 gL-1. The values represented in the graph are the average of 
at least two separate experiments and the errors are the standard deviations calculated on 
the yields. 
 
Fig. 5. Overall GFP yields of the different strains in batch cultures. 
To our regret, the combined arcA-iclR double knockout mutant did not perform as we 
anticipated. Although the increased biomass yield and decreased acetate yield in the double 
knockout beneficially influence recombinant protein production as a higher GFP yield was 
observed to its wild type E. coli MG1655 (30% increase in the double knockout strain), still a 
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striking difference of more than 40% was detected compared to E. coli Bl21. Additionally, we 
observed that at higher cell densities (>2gL-1 CDW) the GFP concentrations decreases again 
suggesting proteases activity (Waegeman et al., 2011b).  
Proteases play an important role in the degradation of foreign proteins (Gottesman & 
Maurizi, 1992) and it is generally believed that recombinant proteins are better produced in 
E. coli BL21 and his derivates because these strains lack the cytoplasmic ATP-dependent 
protease Lon (Gottesman, 1989) and the periplasmic OmpT (Gottesman, 1996).  
Although also other proteases are known for the degradation of proteins, but in a lesser 
extent towards recombinant proteins (Jürgen et al., 2010) and since E. coli BL21 lacks the 
proteases Lon and OmpT, these proteases were also deleted in the E. coli MG1655 ΔarcA 
ΔiclR strain. 
The additional deletion of the proteases Lon and OmpT, resulting in the quadruple 
knockout strain E. coli MG1655 ΔarcA ΔiclR Δlon ΔompT, could impede the breakdown of 
GFP at higher cell densities. The GFP yield obtained at the end of the glucose growth phase 
in bioreactor experiments approximates the GFP yield of E. coli BL21 (DE3). 
4. Conclusion 
To date, recombinant protein production has evolved to one of the most important branches 
in modern biotechnology, representing a billion-dollar business, both in the production of 
biopharmaceuticals and industrial enzymes. Although many organisms have been used as 
host, Escherichia coli is predominantly utilised as microbial host, representing 30% of the 
bioprocesses in both industries. 
Although, E. coli strains are popular because they are fast growers, metabolically and 
genetically well characterised, and many molecular tools are available, these strains display 
several drawbacks. Besides problems related to stress response, post-transcriptional 
modification and secretion of recombinant proteins, a major drawback is the formation of 
acetate in aerobic cultures which retards growth and impedes protein production. 
Logically, many endeavours have been reported to decrease acetate formation and increase 
recombinant protein production in this host. However, among the different E. coli strains, E. 
coli BL21 and his derivates show a significant low acetate formation compared to E. coli K12 
strains, making BL21 a standard host in industrial recombinant protein production 
bioprocesses. Though, E. coli BL21 is not the optimal host due to plasmid instability and, 
until recently, unknown genome sequence making genetic modifications challenging. 
Traditionally, acetate formation in E. coli K12 strains is tackled by blocking the acetate 
pathways or avoiding overflow metabolism through limiting the glucose uptake rate or 
redirecting the fluxes around the bottleneck, the phosphoenolpyruvate-pyruvate-
oxaloacetate node. Alternatively, we propose to copy similar physiological and metabolic 
properties of E. coli BL21 in E. coli K12. This was achieved by combined deletion of the 
global transcriptional regulator ArcA and the local regulator IclR. Albeit this metabolically 
engineered E. coli K12 derivate displayed higher biomass yield and lower acetate yield 
resulting in a substantially increase in recombinant protein yield, the protein yield was still 
considerably lower than the yield observed in E. coli BL21. This difference in recombinant 
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protein production is caused by proteolytic activity in E. coli K12, which does not occur in E. 
coli BL21 due to absence of the proteases Lon and OmpT. Additional deletion of these 
proteases in our combined arcA-iclR double knockout strain, hampered this proteolytic 
activity yielding recombinant protein levels similar to E. coli BL21. 
In conclusion, by deleting only four genes, i.e. arcA, iclR, lon, and ompT it was possible to 
mimic the phenotype of E. coli BL21 in E. coli K12. The metabolically engineered quadruple 
knockout strain exhibited not only a tremendous increase in biomass yield and severe 
decrease in acetate yield, the recombinant protein production increased by a factor 2, 
resulting in a strain that can compete with E. coli BL21 for the industrial production of 
recombinant proteins. These results are incentive to further optimization of E. coli as 
microbial host making E. coli an often-chosen host in industrial bioprocesses. 
5. Acknowledgment 
The research of Hendrik Waegeman was financially supported by the Special Research Fund 
(BOF) of Ghent University 
6. References 
Abdallah, A.M., van Pittius, N.C.G., Champion, P.A.D., Cox, J., Luirink, J., Vandenbroucke-
Grauls, C.M.J.E., Appelmelk, B.J.& Bitter, W. (2007). Type VII secretion-
mycobacteria show the way. Nat Rev Microbiol, Vol. 5,  pp. 883-891 
Abu-Qarn, M., Eichler, J.& Sharon, N. (2008). Not just for Eukarya anymore: protein 
glycosylation in Bacteria and Archaea. Curr Opin Struct Biol, Vol. 18,  pp. 544-550 
Akesson, M., Hagander, P.& Axelsson, J.P. (2001a). Avoiding acetate accumulation in 
Escherichia coli cultures using feedback control of glucose feeding. Biotechnology and 
Bioengineering, Vol. 73,  pp. 223-230 
Akesson, M., Hagander, P.& Axelsson, J.P. (2001b). Probing control of fed-batch cultivations: 
analysis and tuning. Control Engineering Practice, Vol. 9,  pp. 709-723 
Akesson, M., Karlsson, E.N., Hagander, P., Axelsson, J.P.& Tocaj, A. (1999). On-line 
detection of acetate formation in Escherichia coli cultures using dissolved oxygen 
responses to feed transients. Biotechnology and Bioengineering, Vol. 64,  pp. 590-598 
Alexeeva, S., Hellingwerf, K.J.& de Mattos, M.J.T. (2003). Requirement of ArcA for redox 
regulation in Escherichia coli under microaerobic but not anaerobic or aerobic 
conditions. J Bacteriol, Vol. 185,  pp. 204-209 
Andersen, K.B.& von Meyenburg, K. (1980). Are growth rates of Escherichia coli in batch 
cultures limited by respiration? J Bacteriol, Vol. 144,  pp. 114-123 
Bentley, W.E., Mirjalili, N., Andersen, D.C., Davis, R.H.& Kompala, D.S. (1990). Plasmid-
encoded protein: the principal factor in the "metabolic burden" associated with 
recombinant bacteria. Biotechnol Bioeng, Vol. 35,  pp. 668-681 
Chen, X., Cen, P.& Chen, J. (2005). Enhanced production of human epidermal growth factor 
by a recombinant Escherichia coli integrated with in situ exchange of acetic acid by 
macroporous ion-exchange resin. Journal of Bioscience and Bioengineering, Vol. 100,  
pp. 579-581 
Choi, J.H.& Lee, S.Y. (2004). Secretory and extracellular production of recombinant proteins 
using Escherichia coli. Appl Microbiol Biotechnol, Vol. 64,  pp. 625-635 
 
Advances in Applied Biotechnology 
 
138 
striking difference of more than 40% was detected compared to E. coli Bl21. Additionally, we 
observed that at higher cell densities (>2gL-1 CDW) the GFP concentrations decreases again 
suggesting proteases activity (Waegeman et al., 2011b).  
Proteases play an important role in the degradation of foreign proteins (Gottesman & 
Maurizi, 1992) and it is generally believed that recombinant proteins are better produced in 
E. coli BL21 and his derivates because these strains lack the cytoplasmic ATP-dependent 
protease Lon (Gottesman, 1989) and the periplasmic OmpT (Gottesman, 1996).  
Although also other proteases are known for the degradation of proteins, but in a lesser 
extent towards recombinant proteins (Jürgen et al., 2010) and since E. coli BL21 lacks the 
proteases Lon and OmpT, these proteases were also deleted in the E. coli MG1655 ΔarcA 
ΔiclR strain. 
The additional deletion of the proteases Lon and OmpT, resulting in the quadruple 
knockout strain E. coli MG1655 ΔarcA ΔiclR Δlon ΔompT, could impede the breakdown of 
GFP at higher cell densities. The GFP yield obtained at the end of the glucose growth phase 
in bioreactor experiments approximates the GFP yield of E. coli BL21 (DE3). 
4. Conclusion 
To date, recombinant protein production has evolved to one of the most important branches 
in modern biotechnology, representing a billion-dollar business, both in the production of 
biopharmaceuticals and industrial enzymes. Although many organisms have been used as 
host, Escherichia coli is predominantly utilised as microbial host, representing 30% of the 
bioprocesses in both industries. 
Although, E. coli strains are popular because they are fast growers, metabolically and 
genetically well characterised, and many molecular tools are available, these strains display 
several drawbacks. Besides problems related to stress response, post-transcriptional 
modification and secretion of recombinant proteins, a major drawback is the formation of 
acetate in aerobic cultures which retards growth and impedes protein production. 
Logically, many endeavours have been reported to decrease acetate formation and increase 
recombinant protein production in this host. However, among the different E. coli strains, E. 
coli BL21 and his derivates show a significant low acetate formation compared to E. coli K12 
strains, making BL21 a standard host in industrial recombinant protein production 
bioprocesses. Though, E. coli BL21 is not the optimal host due to plasmid instability and, 
until recently, unknown genome sequence making genetic modifications challenging. 
Traditionally, acetate formation in E. coli K12 strains is tackled by blocking the acetate 
pathways or avoiding overflow metabolism through limiting the glucose uptake rate or 
redirecting the fluxes around the bottleneck, the phosphoenolpyruvate-pyruvate-
oxaloacetate node. Alternatively, we propose to copy similar physiological and metabolic 
properties of E. coli BL21 in E. coli K12. This was achieved by combined deletion of the 
global transcriptional regulator ArcA and the local regulator IclR. Albeit this metabolically 
engineered E. coli K12 derivate displayed higher biomass yield and lower acetate yield 
resulting in a substantially increase in recombinant protein yield, the protein yield was still 
considerably lower than the yield observed in E. coli BL21. This difference in recombinant 
Increasing of Recombinant Protein Production  
in E. Coli by an Alternative Method to Reduce Acetate 
 
139 
protein production is caused by proteolytic activity in E. coli K12, which does not occur in E. 
coli BL21 due to absence of the proteases Lon and OmpT. Additional deletion of these 
proteases in our combined arcA-iclR double knockout strain, hampered this proteolytic 
activity yielding recombinant protein levels similar to E. coli BL21. 
In conclusion, by deleting only four genes, i.e. arcA, iclR, lon, and ompT it was possible to 
mimic the phenotype of E. coli BL21 in E. coli K12. The metabolically engineered quadruple 
knockout strain exhibited not only a tremendous increase in biomass yield and severe 
decrease in acetate yield, the recombinant protein production increased by a factor 2, 
resulting in a strain that can compete with E. coli BL21 for the industrial production of 
recombinant proteins. These results are incentive to further optimization of E. coli as 
microbial host making E. coli an often-chosen host in industrial bioprocesses. 
5. Acknowledgment 
The research of Hendrik Waegeman was financially supported by the Special Research Fund 
(BOF) of Ghent University 
6. References 
Abdallah, A.M., van Pittius, N.C.G., Champion, P.A.D., Cox, J., Luirink, J., Vandenbroucke-
Grauls, C.M.J.E., Appelmelk, B.J.& Bitter, W. (2007). Type VII secretion-
mycobacteria show the way. Nat Rev Microbiol, Vol. 5,  pp. 883-891 
Abu-Qarn, M., Eichler, J.& Sharon, N. (2008). Not just for Eukarya anymore: protein 
glycosylation in Bacteria and Archaea. Curr Opin Struct Biol, Vol. 18,  pp. 544-550 
Akesson, M., Hagander, P.& Axelsson, J.P. (2001a). Avoiding acetate accumulation in 
Escherichia coli cultures using feedback control of glucose feeding. Biotechnology and 
Bioengineering, Vol. 73,  pp. 223-230 
Akesson, M., Hagander, P.& Axelsson, J.P. (2001b). Probing control of fed-batch cultivations: 
analysis and tuning. Control Engineering Practice, Vol. 9,  pp. 709-723 
Akesson, M., Karlsson, E.N., Hagander, P., Axelsson, J.P.& Tocaj, A. (1999). On-line 
detection of acetate formation in Escherichia coli cultures using dissolved oxygen 
responses to feed transients. Biotechnology and Bioengineering, Vol. 64,  pp. 590-598 
Alexeeva, S., Hellingwerf, K.J.& de Mattos, M.J.T. (2003). Requirement of ArcA for redox 
regulation in Escherichia coli under microaerobic but not anaerobic or aerobic 
conditions. J Bacteriol, Vol. 185,  pp. 204-209 
Andersen, K.B.& von Meyenburg, K. (1980). Are growth rates of Escherichia coli in batch 
cultures limited by respiration? J Bacteriol, Vol. 144,  pp. 114-123 
Bentley, W.E., Mirjalili, N., Andersen, D.C., Davis, R.H.& Kompala, D.S. (1990). Plasmid-
encoded protein: the principal factor in the "metabolic burden" associated with 
recombinant bacteria. Biotechnol Bioeng, Vol. 35,  pp. 668-681 
Chen, X., Cen, P.& Chen, J. (2005). Enhanced production of human epidermal growth factor 
by a recombinant Escherichia coli integrated with in situ exchange of acetic acid by 
macroporous ion-exchange resin. Journal of Bioscience and Bioengineering, Vol. 100,  
pp. 579-581 
Choi, J.H.& Lee, S.Y. (2004). Secretory and extracellular production of recombinant proteins 
using Escherichia coli. Appl Microbiol Biotechnol, Vol. 64,  pp. 625-635 
 
Advances in Applied Biotechnology 
 
140 
Chou, C.H., Bennett, G.N.& San, K.Y. (1994). Effect of modified glucose uptake using genetic 
engineering techniques on high-level recombinant protein production in Escherichia 
coli dense cultures. Biotechnol Bioeng, Vol. 44,  pp. 952-960 
Chou, C.P. (2007). Engineering cell physiology to enhance recombinant protein production 
in Escherichia coli. Appl Microbiol Biotechnol, Vol. 76,  pp. 521-532 
Cohen, S.N., Chang, A.C., Boyer, H.W.& Helling, R.B. (1973). Construction of biologically 
functional bacterial plasmids in vitro. Proc Natl Acad Sci U S A, Vol. 70,  pp. 3240-
3244 
Contiero, J., Beatty, C., Kumari, S., DeSanti, C., Strohl, W.& Wolfe, A. (2000). Effects of 
mutations in acetate metabolism on high-cell-density growth of Escherichia coli. J Ind 
Microbiol Biotechnol, Vol. 24,  pp. 421-430 
Cortay, J.C., Nègre, D., Galinier, A., Duclos, B., Perrière, G.& Cozzone, A.J. (1991). 
Regulation of the acetate operon in Escherichia coli: purification and functional 
characterization of the IclR repressor. EMBO J, Vol. 10,  pp. 675-679 
Cozzone, A.J. (1998). Regulation of acetate metabolism by protein phosphorylation in enteric 
bacteria. Annu Rev Microbiol, Vol. 52,  pp. 127-164 
De Anda, R., Lara, A.R., Hernández, V., Hernández-Montalvo, V., Gosset, G., Bolívar, F.& 
Ramírez, O.T. (2006). Replacement of the glucose phosphotransferase transport 
system by galactose permease reduces acetate accumulation and improves process 
performance of Escherichia coli for recombinant protein production without 
impairment of growth rate. Metab Eng, Vol. 8,  pp. 281-290 
de Marco, A. (2009). Strategies for successful recombinant expression of disulfide bond-
dependent proteins in Escherichia coli. Microb Cell Fact, Vol. 8,  pp. 26 
De Mey, M., Lequeux, G.J., Beauprez, J.J., Maertens, J., Van Horen, E., Soetaert, W.K., 
Vanrolleghem, P.A.& Vandamme, E.J. (2007a). Comparison of different strategies to 
reduce acetate formation in Escherichia coli. Biotechnol Prog, Vol. 23,  pp. 1053-1063 
De Mey, M., Lequeux, G.J., Beauprez, J.J., Maertens, J., Waegeman, H.J., Van Bogaert, I.N., 
Foulquie-Moreno, M.R., Charlier, D., Soetaert, W.K., Vanrolleghem, P.A.& 
Vandamme, E.J. (2010). Transient metabolic modeling of Escherichia coli MG1655 
and MG1655 DeltaackA-pta, DeltapoxB Deltapppc ppc-p37 for recombinant beta-
galactosidase production. J Ind Microbiol Biotechnol, Vol. 37,  pp. 793-803 
De Mey, M., Maeseneire, S.D., Soetaert, W.& Vandamme, E. (2007b). Minimizing acetate 
formation in E. coli fermentations. J Ind Microbiol Biotechnol, Vol. 34,  pp. 689-700 
Demain, A.L.& Vaishnav, P. (2009). Production of recombinant proteins by microbes and 
higher organisms. Biotechnol Adv, Vol. 27,  pp. 297-306 
Diaz-Ricci, J.C., Regan, L.& Bailey, J.E. (1991). Effect of alteration of the acetic acid synthesis 
pathway on the fermentation pattern of Escherichia coli. Biotechnol Bioeng, Vol. 38,  
pp. 1318-1324 
Dittrich, C.R., Vadali, R.V., Bennett, G.N.& San, K.-Y. (2005). Redistribution of metabolic 
fluxes in the central aerobic metabolic pathway of E. coli mutant strains with 
deletion of the ackA-pta and poxB pathways for the synthesis of isoamyl acetate. 
Biotechnol Prog, Vol. 21,  pp. 627-631 
Dong, H., Nilsson, L.& Kurland, C.G. (1995). Gratuitous overexpression of genes in 
Escherichia coli leads to growth inhibition and ribosome destruction. J Bacteriol, Vol. 
177,  pp. 1497-1504 
Increasing of Recombinant Protein Production  
in E. Coli by an Alternative Method to Reduce Acetate 
 
141 
Durocher, Y.& Butler, M. (2009). Expression systems for therapeutic glycoprotein 
production. Curr Opin Biotechnol, Vol. 20,  pp. 700-707 
Eiteman, M.A.& Altman, E. (2006). Overcoming acetate in Escherichia coli recombinant 
protein fermentations. Trends in Biotechnology, Vol. 24,  pp. 530-533 
El-Mansi, E.M.& Holms, W.H. (1989). Control of carbon flux to acetate excretion during 
growth of Escherichia coli in batch and continuous cultures. J Gen Microbiol, Vol. 135,  
pp. 2875-2883 
El-Mansi, M., Cozzone, A.J., Shiloach, J.& Eikmanns, B.J. (2006). Control of carbon flux 
through enzymes of central and intermediary metabolism during growth of 
Escherichia coli on acetate. Curr Opin Microbiol, Vol. 9,  pp. 173-179 
Farmer, W.R.& Liao, J.C. (1997). Reduction of aerobic acetate production by Escherichia coli. 
Appl Environ Microbiol, Vol. 63,  pp. 3205-3210 
Ferrer-Miralles, N., Domingo-Espín, J., Corchero, J.L., Vázquez, E.& Villaverde, A. (2009). 
Microbial factories for recombinant pharmaceuticals. Microb Cell Fact, Vol. 8,  pp. 17 
Fischer, E.& Sauer, U. (2003). A novel metabolic cycle catalyzes glucose oxidation and 
anaplerosis in hungry Escherichia coli. J Biol Chem, Vol. 278,  pp. 46446-46451 
Fisher, A.C., Haitjema, C.H., Guarino, C., Çelik, E., Endicott, C.E., Reading, C.A., Merritt, 
J.H., Ptak, A.C., Zhang, S.& DeLisa, M.P. (2011). Production of secretory and 
extracellular N-linked glycoproteins in Escherichia coli. Appl Environ Microbiol, Vol. 
77,  pp. 871-881 
Fuchs, C., Koster, D., Wiebusch, S., Mahr, K., Eisbrenner, G.& Markl, H. (2002  ). Scale-up of 
dialysis fermentation for high cell density cultivation of Escherichia coli. Journal of 
Biotechnology, Vol. 93,  pp. 243-251 
Gill, R.T., Valdes, J.J.& Bentley, W.E. (2000). A comparative study of global stress gene 
regulation in response to overexpression of recombinant proteins in Escherichia coli. 
Metab Eng, Vol. 2,  pp. 178-189 
Global Industry Analysts, I. (February 09, 2011). Global Industrial Enzymes, In: PRWeb, July 
20, 2011,  Available from:  
 http://www.prweb.com/releases/industrial_enzymes/proteases_carbohydrases/
prweb8121185.htm. 
Gottesman, S. (1984). Bacterial regulation: global regulatory networks. Annu Rev Genet, Vol. 
18,  pp. 415-441 
Gottesman, S. (1989). Genetics of proteolysis in Escherichia coli. Annu Rev Genet, Vol. 23,  pp. 
163-198 
Gottesman, S. (1996). Proteases and their targets in Escherichia coli. Annu Rev Genet, Vol. 30,  
pp. 465-506 
Gottesman, S.& Maurizi, M.R. (1992). Regulation by proteolysis: energy-dependent 
proteases and their targets. Microbiol Rev, Vol. 56,  pp. 592-621 
Hodgson, J. (1994). The changing bulk biocatalyst market. Nat Biotechnol, Vol. 12,  pp. 789-
790 
Hoffmann, F.& Rinas, U. (2004). Stress induced by recombinant protein production in 
Escherichia coli. Adv Biochem Eng Biotechnol, Vol. 89,  pp. 73-92 
Holms, W.H. (1986). The central metabolic pathways of Escherichia coli: relationship between 
flux and control at a branch point, efficiency of conversion to biomass, and 
excretion of acetate. Curr Top Cell Regul, Vol. 28,  pp. 69-105 
 
Advances in Applied Biotechnology 
 
140 
Chou, C.H., Bennett, G.N.& San, K.Y. (1994). Effect of modified glucose uptake using genetic 
engineering techniques on high-level recombinant protein production in Escherichia 
coli dense cultures. Biotechnol Bioeng, Vol. 44,  pp. 952-960 
Chou, C.P. (2007). Engineering cell physiology to enhance recombinant protein production 
in Escherichia coli. Appl Microbiol Biotechnol, Vol. 76,  pp. 521-532 
Cohen, S.N., Chang, A.C., Boyer, H.W.& Helling, R.B. (1973). Construction of biologically 
functional bacterial plasmids in vitro. Proc Natl Acad Sci U S A, Vol. 70,  pp. 3240-
3244 
Contiero, J., Beatty, C., Kumari, S., DeSanti, C., Strohl, W.& Wolfe, A. (2000). Effects of 
mutations in acetate metabolism on high-cell-density growth of Escherichia coli. J Ind 
Microbiol Biotechnol, Vol. 24,  pp. 421-430 
Cortay, J.C., Nègre, D., Galinier, A., Duclos, B., Perrière, G.& Cozzone, A.J. (1991). 
Regulation of the acetate operon in Escherichia coli: purification and functional 
characterization of the IclR repressor. EMBO J, Vol. 10,  pp. 675-679 
Cozzone, A.J. (1998). Regulation of acetate metabolism by protein phosphorylation in enteric 
bacteria. Annu Rev Microbiol, Vol. 52,  pp. 127-164 
De Anda, R., Lara, A.R., Hernández, V., Hernández-Montalvo, V., Gosset, G., Bolívar, F.& 
Ramírez, O.T. (2006). Replacement of the glucose phosphotransferase transport 
system by galactose permease reduces acetate accumulation and improves process 
performance of Escherichia coli for recombinant protein production without 
impairment of growth rate. Metab Eng, Vol. 8,  pp. 281-290 
de Marco, A. (2009). Strategies for successful recombinant expression of disulfide bond-
dependent proteins in Escherichia coli. Microb Cell Fact, Vol. 8,  pp. 26 
De Mey, M., Lequeux, G.J., Beauprez, J.J., Maertens, J., Van Horen, E., Soetaert, W.K., 
Vanrolleghem, P.A.& Vandamme, E.J. (2007a). Comparison of different strategies to 
reduce acetate formation in Escherichia coli. Biotechnol Prog, Vol. 23,  pp. 1053-1063 
De Mey, M., Lequeux, G.J., Beauprez, J.J., Maertens, J., Waegeman, H.J., Van Bogaert, I.N., 
Foulquie-Moreno, M.R., Charlier, D., Soetaert, W.K., Vanrolleghem, P.A.& 
Vandamme, E.J. (2010). Transient metabolic modeling of Escherichia coli MG1655 
and MG1655 DeltaackA-pta, DeltapoxB Deltapppc ppc-p37 for recombinant beta-
galactosidase production. J Ind Microbiol Biotechnol, Vol. 37,  pp. 793-803 
De Mey, M., Maeseneire, S.D., Soetaert, W.& Vandamme, E. (2007b). Minimizing acetate 
formation in E. coli fermentations. J Ind Microbiol Biotechnol, Vol. 34,  pp. 689-700 
Demain, A.L.& Vaishnav, P. (2009). Production of recombinant proteins by microbes and 
higher organisms. Biotechnol Adv, Vol. 27,  pp. 297-306 
Diaz-Ricci, J.C., Regan, L.& Bailey, J.E. (1991). Effect of alteration of the acetic acid synthesis 
pathway on the fermentation pattern of Escherichia coli. Biotechnol Bioeng, Vol. 38,  
pp. 1318-1324 
Dittrich, C.R., Vadali, R.V., Bennett, G.N.& San, K.-Y. (2005). Redistribution of metabolic 
fluxes in the central aerobic metabolic pathway of E. coli mutant strains with 
deletion of the ackA-pta and poxB pathways for the synthesis of isoamyl acetate. 
Biotechnol Prog, Vol. 21,  pp. 627-631 
Dong, H., Nilsson, L.& Kurland, C.G. (1995). Gratuitous overexpression of genes in 
Escherichia coli leads to growth inhibition and ribosome destruction. J Bacteriol, Vol. 
177,  pp. 1497-1504 
Increasing of Recombinant Protein Production  
in E. Coli by an Alternative Method to Reduce Acetate 
 
141 
Durocher, Y.& Butler, M. (2009). Expression systems for therapeutic glycoprotein 
production. Curr Opin Biotechnol, Vol. 20,  pp. 700-707 
Eiteman, M.A.& Altman, E. (2006). Overcoming acetate in Escherichia coli recombinant 
protein fermentations. Trends in Biotechnology, Vol. 24,  pp. 530-533 
El-Mansi, E.M.& Holms, W.H. (1989). Control of carbon flux to acetate excretion during 
growth of Escherichia coli in batch and continuous cultures. J Gen Microbiol, Vol. 135,  
pp. 2875-2883 
El-Mansi, M., Cozzone, A.J., Shiloach, J.& Eikmanns, B.J. (2006). Control of carbon flux 
through enzymes of central and intermediary metabolism during growth of 
Escherichia coli on acetate. Curr Opin Microbiol, Vol. 9,  pp. 173-179 
Farmer, W.R.& Liao, J.C. (1997). Reduction of aerobic acetate production by Escherichia coli. 
Appl Environ Microbiol, Vol. 63,  pp. 3205-3210 
Ferrer-Miralles, N., Domingo-Espín, J., Corchero, J.L., Vázquez, E.& Villaverde, A. (2009). 
Microbial factories for recombinant pharmaceuticals. Microb Cell Fact, Vol. 8,  pp. 17 
Fischer, E.& Sauer, U. (2003). A novel metabolic cycle catalyzes glucose oxidation and 
anaplerosis in hungry Escherichia coli. J Biol Chem, Vol. 278,  pp. 46446-46451 
Fisher, A.C., Haitjema, C.H., Guarino, C., Çelik, E., Endicott, C.E., Reading, C.A., Merritt, 
J.H., Ptak, A.C., Zhang, S.& DeLisa, M.P. (2011). Production of secretory and 
extracellular N-linked glycoproteins in Escherichia coli. Appl Environ Microbiol, Vol. 
77,  pp. 871-881 
Fuchs, C., Koster, D., Wiebusch, S., Mahr, K., Eisbrenner, G.& Markl, H. (2002  ). Scale-up of 
dialysis fermentation for high cell density cultivation of Escherichia coli. Journal of 
Biotechnology, Vol. 93,  pp. 243-251 
Gill, R.T., Valdes, J.J.& Bentley, W.E. (2000). A comparative study of global stress gene 
regulation in response to overexpression of recombinant proteins in Escherichia coli. 
Metab Eng, Vol. 2,  pp. 178-189 
Global Industry Analysts, I. (February 09, 2011). Global Industrial Enzymes, In: PRWeb, July 
20, 2011,  Available from:  
 http://www.prweb.com/releases/industrial_enzymes/proteases_carbohydrases/
prweb8121185.htm. 
Gottesman, S. (1984). Bacterial regulation: global regulatory networks. Annu Rev Genet, Vol. 
18,  pp. 415-441 
Gottesman, S. (1989). Genetics of proteolysis in Escherichia coli. Annu Rev Genet, Vol. 23,  pp. 
163-198 
Gottesman, S. (1996). Proteases and their targets in Escherichia coli. Annu Rev Genet, Vol. 30,  
pp. 465-506 
Gottesman, S.& Maurizi, M.R. (1992). Regulation by proteolysis: energy-dependent 
proteases and their targets. Microbiol Rev, Vol. 56,  pp. 592-621 
Hodgson, J. (1994). The changing bulk biocatalyst market. Nat Biotechnol, Vol. 12,  pp. 789-
790 
Hoffmann, F.& Rinas, U. (2004). Stress induced by recombinant protein production in 
Escherichia coli. Adv Biochem Eng Biotechnol, Vol. 89,  pp. 73-92 
Holms, W.H. (1986). The central metabolic pathways of Escherichia coli: relationship between 
flux and control at a branch point, efficiency of conversion to biomass, and 
excretion of acetate. Curr Top Cell Regul, Vol. 28,  pp. 69-105 
 
Advances in Applied Biotechnology 
 
142 
Iuchi, S.& Lin, E.C. (1988). arcA (dye), a global regulatory gene in Escherichia coli mediating 
repression of enzymes in aerobic pathways. Proc Natl Acad Sci U S A, Vol. 85,  pp. 
1888-1892 
Iuchi, S., Matsuda, Z., Fujiwara, T.& Lin, E.C. (1990). The arcB gene of Escherichia coli 
encodes a sensor-regulator protein for anaerobic repression of the arc modulon. 
Mol Microbiol, Vol. 4,  pp. 715-727 
Jensen, E.B.& Carlsen, S. (1990). Production of recombinant human growth hormone in 
Escherichia coli: expression of different precursors and physiological effects of 
glucose, acetate, and salts. Biotechnol Bioeng, Vol. 36,  pp. 1-11 
Jong, W.S.P., Saurí, A.& Luirink, J. (2010). Extracellular production of recombinant proteins 
using bacterial autotransporters. Curr Opin Biotechnol, Vol. 21,  pp. 646-652 
Jürgen, B., Breitenstein, A., Urlacher, V., Büttner, K., Lin, H., Hecker, M., Schweder, T.& 
Neubauer, P. (2010). Quality control of inclusion bodies in Escherichia coli. Microb 
Cell Fact, Vol. 9,  pp. 41 
Keseler, I.M., Collado-Vides, J., Santos-Zavaleta, A., Peralta-Gil, M., Gama-Castro, S., 
Muniz-Rascado, L., Bonavides-Martinez, C., Paley, S., Krummenacker, M., Altman, 
T., Kaipa, P., Spaulding, A., Pacheco, J., Latendresse, M., Fulcher, C., Sarker, M., 
Shearer, A.G., Mackie, A., Paulsen, I., Gunsalus, R.P.& Karp, P.D. (2011). EcoCyc: a 
comprehensive database of Escherichia coli biology. Nucleic Acids Research, Vol. 39,  
pp. D583-D590 
Ko, C.-H., Tsai, C.-H., Lin, P.-H., Chang, K.-C., Tu, J., Wang, Y.-N.& Yang, C.-Y. (2010). 
Characterization and pulp refining activity of a Paenibacillus campinasensis cellulase 
expressed in Escherichia coli. Bioresour Technol, Vol.,   
Kurland, C.G.& Dong, H. (1996). Bacterial growth inhibition by overproduction of protein. 
Mol Microbiol, Vol. 21,  pp. 1-4 
Lotti, M., Porro, D.& Srienc, F. (2004). Recombinant proteins and host cell physiology. J 
Biotechnol, Vol. 109,  pp. 1-2 
Maharjan, R.P., Yu, P.-L., Seeto, S.& Ferenci, T. (2005). The role of isocitrate lyase and the 
glyoxylate cycle in Escherichia coli growing under glucose limitation. Res Microbiol, 
Vol. 156,  pp. 178-183 
Makrides, S.C. (1996). Strategies for achieving high-level expression of genes in Escherichia 
coli. Microbiol Rev, Vol. 60,  pp. 512-538 
March, J.C., Eiteman, M.A.& Altman, E. (2002). Expression of an anaplerotic enzyme, 
pyruvate carboxylase, improves recombinant protein production in Escherichia coli. 
Appl Environ Microbiol, Vol. 68,  pp. 5620-5624 
Martinez-Antonio, A.& Collado-Vides, J. (2003). Identifying global regulators in 
transcriptional regulatory networks in bacteria. Curr Opin Microbiol, Vol. 6,  pp. 
482-489 
Nakano, K., Rischke, M., Sato, S.& Märkl, H. (1997). Influence of acetic acid on the growth of 
Escherichia coli K12 during high-cell-density cultivation in a dialysis reactor. Appl 
Microbiol Biotechnol, Vol. 48,  pp. 597-601 
Noack, D., Roth, M., Geuther, R., Muller, G., Undisz, K., Hoffmeier, C.& Gaspar, S. (1981). 
Maintenance and genetic stability of vector plasmids pBR322 and pBR325 in 
Escherichia coli K12 strains grown in a chemostat. Mol Gen Genet, Vol. 184,  pp. 121-
124 
Increasing of Recombinant Protein Production  
in E. Coli by an Alternative Method to Reduce Acetate 
 
143 
Noronha, S.B., Yeh, H.J., Spande, T.F.& Shiloach, J. (2000). Investigation of the TCA cycle 
and the glyoxylate shunt in Escherichia coli BL21 and JM109 using (13)C-NMR/MS. 
Biotechnol Bioeng, Vol. 68,  pp. 316-327 
Parsell, D.A.& Sauer, R.T. (1989). Induction of a heat shock-like response by unfolded 
protein in Escherichia coli: dependence on protein level not protein degradation. 
Genes Dev, Vol. 3,  pp. 1226-1232 
Perrenoud, A.& Sauer, U. (2005). Impact of global transcriptional regulation by ArcA, ArcB, 
Cra, Crp, Cya, Fnr, and Mlc on glucose catabolism in Escherichia coli. J Bacteriol, Vol. 
187,  pp. 3171-3179 
Phue, J.-N., Noronha, S.B., Ritabrata, Wolfe, A.J.& Shiloach, J. (2005). Glucose metabolism at 
high density growth of E. coli B and E. coli K: differences in metabolic pathways are 
responsible for efficient glucose utilization in E. coli B as determined by 
microarrays and Northern blot analyses. Biotechnol Bioeng, Vol. 90,  pp. 805-820 
Rittinger, K., Negre, D., Divita, G., Scarabel, M., Bonod-Bidaud, C., Goody, R.S., Cozzone, 
A.J.& Cortay, J.C. (1996). Escherichia coli isocitrate dehydrogenase 
kinase/phosphatase. Eur J Biochem, Vol. 237,  pp. 247-254 
Ryu, K., Kim, K.-H., Yoo, S.-Y., Lee, E.-Y., Lim, K.-H., Min, M.-K., Kim, H., Choi, S.I.& 
Seong, B.L. (2010). Production and characterization of active hepatitis C virus RNA-
dependent RNA polymerase. Protein Expr Purif, Vol. 71,  pp. 147-152 
Sahdev, S., Khattar, S.K.& Saini, K.S. (2008). Production of active eukaryotic proteins 
through bacterial expression systems: a review of the existing biotechnology 
strategies. Mol Cell Biochem, Vol. 307,  pp. 249-264 
Salmon, K.A., Hung, S.-p., Steffen, N.R., Krupp, R., Baldi, P., Hatfield, G.W.& Gunsalus, R.P. 
(2005). Global gene expression profiling in Escherichia coli K12: effects of oxygen 
availability and ArcA. J Biol Chem, Vol. 280,  pp. 15084-15096 
Shiloach, J., Kaufman, J., Guillard, A.S.& Fass, R. (1996). Effect of glucose supply strategy on 
acetate accumulation, growth, and recombinant protein production by Escherichia 
coli BL21 ($\lambda$DE3) and Escherichia coli JM109. Biotechnol Bioeng, Vol. 49,  pp. 
421-428 
Siguenza, R., Flores, N., Hernandez, G., Mart\'inez, A., Bolivar, F.& Valle, F. (1999). Kinetic 
characterization in batch and continuous culture of Escherichia coli mutants affected 
in phosphoenolpyruvate metabolism: differences in acetic acid production. World J 
Microbiol Biotechnol, Vol. 15,  pp. 587-592 
Striedner, G., Pfaffenzeller, I., Markus, L., Nemecek, S., Grabherr, R.& Bayer, K. (2010). 
Plasmid-free T7-based Escherichia coli expression systems. Biotechnol Bioeng, Vol. 
105,  pp. 786-794 
Szymanski, C.M., Yao, R., Ewing, C.P., Trust, T.J.& Guerry, P. (1999). Evidence for a system 
of general protein glycosylation in Campylobacter jejuni. Mol Microbiol, Vol. 32,  pp. 
1022-1030 
Terpe, K. (2006). Overview of bacterial expression systems for heterologous protein 
production: from molecular and biochemical fundamentals to commercial systems. 
Appl Microbiol Biotechnol, Vol. 72,  pp. 211-222 
Tseng, T.-T., Tyler, B.M.& Setubal, J.C. (2009). Protein secretion systems in bacterial-host 
associations, and their description in the Gene Ontology. BMC Microbiol, Vol. 9,  pp. 
S2 
 
Advances in Applied Biotechnology 
 
142 
Iuchi, S.& Lin, E.C. (1988). arcA (dye), a global regulatory gene in Escherichia coli mediating 
repression of enzymes in aerobic pathways. Proc Natl Acad Sci U S A, Vol. 85,  pp. 
1888-1892 
Iuchi, S., Matsuda, Z., Fujiwara, T.& Lin, E.C. (1990). The arcB gene of Escherichia coli 
encodes a sensor-regulator protein for anaerobic repression of the arc modulon. 
Mol Microbiol, Vol. 4,  pp. 715-727 
Jensen, E.B.& Carlsen, S. (1990). Production of recombinant human growth hormone in 
Escherichia coli: expression of different precursors and physiological effects of 
glucose, acetate, and salts. Biotechnol Bioeng, Vol. 36,  pp. 1-11 
Jong, W.S.P., Saurí, A.& Luirink, J. (2010). Extracellular production of recombinant proteins 
using bacterial autotransporters. Curr Opin Biotechnol, Vol. 21,  pp. 646-652 
Jürgen, B., Breitenstein, A., Urlacher, V., Büttner, K., Lin, H., Hecker, M., Schweder, T.& 
Neubauer, P. (2010). Quality control of inclusion bodies in Escherichia coli. Microb 
Cell Fact, Vol. 9,  pp. 41 
Keseler, I.M., Collado-Vides, J., Santos-Zavaleta, A., Peralta-Gil, M., Gama-Castro, S., 
Muniz-Rascado, L., Bonavides-Martinez, C., Paley, S., Krummenacker, M., Altman, 
T., Kaipa, P., Spaulding, A., Pacheco, J., Latendresse, M., Fulcher, C., Sarker, M., 
Shearer, A.G., Mackie, A., Paulsen, I., Gunsalus, R.P.& Karp, P.D. (2011). EcoCyc: a 
comprehensive database of Escherichia coli biology. Nucleic Acids Research, Vol. 39,  
pp. D583-D590 
Ko, C.-H., Tsai, C.-H., Lin, P.-H., Chang, K.-C., Tu, J., Wang, Y.-N.& Yang, C.-Y. (2010). 
Characterization and pulp refining activity of a Paenibacillus campinasensis cellulase 
expressed in Escherichia coli. Bioresour Technol, Vol.,   
Kurland, C.G.& Dong, H. (1996). Bacterial growth inhibition by overproduction of protein. 
Mol Microbiol, Vol. 21,  pp. 1-4 
Lotti, M., Porro, D.& Srienc, F. (2004). Recombinant proteins and host cell physiology. J 
Biotechnol, Vol. 109,  pp. 1-2 
Maharjan, R.P., Yu, P.-L., Seeto, S.& Ferenci, T. (2005). The role of isocitrate lyase and the 
glyoxylate cycle in Escherichia coli growing under glucose limitation. Res Microbiol, 
Vol. 156,  pp. 178-183 
Makrides, S.C. (1996). Strategies for achieving high-level expression of genes in Escherichia 
coli. Microbiol Rev, Vol. 60,  pp. 512-538 
March, J.C., Eiteman, M.A.& Altman, E. (2002). Expression of an anaplerotic enzyme, 
pyruvate carboxylase, improves recombinant protein production in Escherichia coli. 
Appl Environ Microbiol, Vol. 68,  pp. 5620-5624 
Martinez-Antonio, A.& Collado-Vides, J. (2003). Identifying global regulators in 
transcriptional regulatory networks in bacteria. Curr Opin Microbiol, Vol. 6,  pp. 
482-489 
Nakano, K., Rischke, M., Sato, S.& Märkl, H. (1997). Influence of acetic acid on the growth of 
Escherichia coli K12 during high-cell-density cultivation in a dialysis reactor. Appl 
Microbiol Biotechnol, Vol. 48,  pp. 597-601 
Noack, D., Roth, M., Geuther, R., Muller, G., Undisz, K., Hoffmeier, C.& Gaspar, S. (1981). 
Maintenance and genetic stability of vector plasmids pBR322 and pBR325 in 
Escherichia coli K12 strains grown in a chemostat. Mol Gen Genet, Vol. 184,  pp. 121-
124 
Increasing of Recombinant Protein Production  
in E. Coli by an Alternative Method to Reduce Acetate 
 
143 
Noronha, S.B., Yeh, H.J., Spande, T.F.& Shiloach, J. (2000). Investigation of the TCA cycle 
and the glyoxylate shunt in Escherichia coli BL21 and JM109 using (13)C-NMR/MS. 
Biotechnol Bioeng, Vol. 68,  pp. 316-327 
Parsell, D.A.& Sauer, R.T. (1989). Induction of a heat shock-like response by unfolded 
protein in Escherichia coli: dependence on protein level not protein degradation. 
Genes Dev, Vol. 3,  pp. 1226-1232 
Perrenoud, A.& Sauer, U. (2005). Impact of global transcriptional regulation by ArcA, ArcB, 
Cra, Crp, Cya, Fnr, and Mlc on glucose catabolism in Escherichia coli. J Bacteriol, Vol. 
187,  pp. 3171-3179 
Phue, J.-N., Noronha, S.B., Ritabrata, Wolfe, A.J.& Shiloach, J. (2005). Glucose metabolism at 
high density growth of E. coli B and E. coli K: differences in metabolic pathways are 
responsible for efficient glucose utilization in E. coli B as determined by 
microarrays and Northern blot analyses. Biotechnol Bioeng, Vol. 90,  pp. 805-820 
Rittinger, K., Negre, D., Divita, G., Scarabel, M., Bonod-Bidaud, C., Goody, R.S., Cozzone, 
A.J.& Cortay, J.C. (1996). Escherichia coli isocitrate dehydrogenase 
kinase/phosphatase. Eur J Biochem, Vol. 237,  pp. 247-254 
Ryu, K., Kim, K.-H., Yoo, S.-Y., Lee, E.-Y., Lim, K.-H., Min, M.-K., Kim, H., Choi, S.I.& 
Seong, B.L. (2010). Production and characterization of active hepatitis C virus RNA-
dependent RNA polymerase. Protein Expr Purif, Vol. 71,  pp. 147-152 
Sahdev, S., Khattar, S.K.& Saini, K.S. (2008). Production of active eukaryotic proteins 
through bacterial expression systems: a review of the existing biotechnology 
strategies. Mol Cell Biochem, Vol. 307,  pp. 249-264 
Salmon, K.A., Hung, S.-p., Steffen, N.R., Krupp, R., Baldi, P., Hatfield, G.W.& Gunsalus, R.P. 
(2005). Global gene expression profiling in Escherichia coli K12: effects of oxygen 
availability and ArcA. J Biol Chem, Vol. 280,  pp. 15084-15096 
Shiloach, J., Kaufman, J., Guillard, A.S.& Fass, R. (1996). Effect of glucose supply strategy on 
acetate accumulation, growth, and recombinant protein production by Escherichia 
coli BL21 ($\lambda$DE3) and Escherichia coli JM109. Biotechnol Bioeng, Vol. 49,  pp. 
421-428 
Siguenza, R., Flores, N., Hernandez, G., Mart\'inez, A., Bolivar, F.& Valle, F. (1999). Kinetic 
characterization in batch and continuous culture of Escherichia coli mutants affected 
in phosphoenolpyruvate metabolism: differences in acetic acid production. World J 
Microbiol Biotechnol, Vol. 15,  pp. 587-592 
Striedner, G., Pfaffenzeller, I., Markus, L., Nemecek, S., Grabherr, R.& Bayer, K. (2010). 
Plasmid-free T7-based Escherichia coli expression systems. Biotechnol Bioeng, Vol. 
105,  pp. 786-794 
Szymanski, C.M., Yao, R., Ewing, C.P., Trust, T.J.& Guerry, P. (1999). Evidence for a system 
of general protein glycosylation in Campylobacter jejuni. Mol Microbiol, Vol. 32,  pp. 
1022-1030 
Terpe, K. (2006). Overview of bacterial expression systems for heterologous protein 
production: from molecular and biochemical fundamentals to commercial systems. 
Appl Microbiol Biotechnol, Vol. 72,  pp. 211-222 
Tseng, T.-T., Tyler, B.M.& Setubal, J.C. (2009). Protein secretion systems in bacterial-host 
associations, and their description in the Gene Ontology. BMC Microbiol, Vol. 9,  pp. 
S2 
 
Advances in Applied Biotechnology 
 
144 
Varma, A., Boesch, B.W.& Palsson, B.O. (1993a). Biochemical production capabilities of 
Escherichia coli. Biotechnol Bioeng, Vol. 42,  pp. 59-73 
Varma, A., Boesch, B.W.& Palsson, B.O. (1993b). Stoichiometric interpretation of Escherichia 
coli glucose catabolism under various oxygenation rates. Appl Environ Microbiol, 
Vol. 59,  pp. 2465-2473 
Ventura, S.& Villaverde, A. (2006). Protein quality in bacterial inclusion bodies. Trends 
Biotechnol, Vol. 24,  pp. 179-185 
Wacker, M., Linton, D., Hitchen, P.G., Nita-Lazar, M., Haslam, S.M., North, S.J., Panico, M., 
Morris, H.R., Dell, A., Wren, B.W.& Aebi, M. (2002). N-linked glycosylation in 
Campylobacter jejuni and its functional transfer into E. coli. Science, Vol. 298,  pp. 
1790-1793 
Waegeman, H., Beauprez, J., Moens, H., Maertens, J., De Mey, M., Foulquie-Moreno, M.R., 
Heijnen, J.J., Charlier, D.& Soetaert, W. (2011a). Effect of iclR and arcA knockouts 
on biomass formation and metabolic fluxes in Escherichia coli K12 and its 
implications on understanding the metabolism of Escherichia coli BL21 (DE3). BMC 
Microbiol, Vol. 11,  pp. 70 
Waegeman, H., De Lausnay, S., Beauprez, J., Maertens, J., De Mey, M.& Soetaert, W. (2011b). 
Increasing recombinant protein production in Escherichia coli K12 through 
metabolic engineering. New Biotechnology,  submitted   
Waegeman, H., Maertens, J., Beauprez, J., De Mey, M.& Soetaert, W. (2011c). Effect of iclR 
and arcA deletion on physiology and metabolic fluxes in Escherichia coli BL21(DE3). 
Biotechnology Progress, in press  
Waegeman, H.& Soetaert, W. (2011). Increasing recombinant protein production in 
Escherichia coli through metabolic and genetic engineering. Journal of Industrial 
Microbiology and Biotechnology, accepted   
Walsh, G. (2010). Post-translational modifications of protein biopharmaceuticals. Drug 
Discov Today, Vol. 15,  pp. 773-780 
Wong, M.S., Wu, S., Causey, T.B., Bennett, G.N.& San, K.-Y. (2008). Reduction of acetate 
accumulation in Escherichia coli cultures for increased recombinant protein 
production. Metab Eng, Vol. 10,  pp. 97-108 
Yamamoto, K.& Ishihama, A. (2003). Two different modes of transcription repression of the 
Escherichia coli acetate operon by IclR. Mol Microbiol, Vol. 47,  pp. 183-194 
Yang, Y.T., Aristidou, A.A., San, K.Y.& Bennett, G.N. (1999). Metabolic flux analysis of 
Escherichia coli deficient in the acetate production pathway and expressing the 




Improvement of Heterologous  
Protein Secretion by Bacillus subtilis 
Hiroshi Kakeshita1,2, Yasushi Kageyama1, 
Katsuya Ozaki1, Kouji Nakamura2 and Katsutoshi Ara1 
1Biological Science Laboratories,  
Kao Corporation, 
2Graduate School of Life and Environmental Sciences,  
University of Tsukuba,   
Japan  
1. Introduction  
The Gram-positive bacterium, Bacillus subtilis and related species are widely used as hosts 
for the extracellular production of industrially worthy enzymes, such as amylases, 
proteases, xylanase, and lipases (Braun et al., 1999; Tjalsma et al., 2000; Westers et al., 2004). 
These species possess a very high capacity for secreting a variety of exoenzymes into the 
growth medium, thereby reducing downstream purification processes. In addition, many of 
these are generally regarded as safe (GRAS) microorganisms, and do not produce 
endotoxins. Therefore, the secretion system of these species presents many advantages in 
terms of production capacity, structural authenticity, product purification, and safety. 
Nevertheless, the secretion of heterologous proteins from eukaryotes by these species is 
frequently inefficient (Table1). Hence, these species are never selected as the best cell factory 
for pharmaceutical proteins (Westers et al., 2004).  
In pharmaceutical industry, the production of recombinant proteins in Escherichia coli is well 
established. In many cases, proteins are produced in cytoplasm of E. coli, and therefore, the 
production of recombinant proteins involves refolding and purification from inclusion 
bodies. However, the production of soluble recombinant proteins is relatively more cost-
effective and less time-consuming. In fact, many studies have been performed regarding 
methods to overcome the problem of inclusion bodies and to improve protein solubility for 
the expression of heterologous proteins (Kapust & Waugh, 1999; Baneyx & Mujacic, 2004; 
Sørensen & Mortensen, 2005; Rabhi-Essafi et al., 2007). Therefore, developing human protein 
producing hosts is a major challenge in the field of biotechnology and protein production in 
Bacilli.  
In B. subtilis, one long-standing major problem is the presence of high levels of extracellular 
protease for the production of heterologous proteins. In recent years, many proteases have 
been identified via the completed genome sequence of B. subtilis (Kunst et al., 1997; Westers 
et al., 2004), thereby allowing the construction of many protease-depleted strains for the 
production of heterologous proteins. 
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In addition, considerable efforts have been targeted at developing B. subtilis as a host for the 
production of heterologous proteins (Wu & Wong, 2002; Li et al., 2004; Westers et al., 2004; 
Kodama et al., 2007a, 2007b). However, many problems still remain for the secretion of 
human proteins, and these should be analyzed from the complementary perspectives of 
both the target protein and the secretion pathway, in order to improve human protein 
secretion. 
We have used human interferon-α and interferon-β as heterologous model proteins to 
investigate the effects of B. subtilis secretion.  
In this report, the knowledge which has become available in recent years aimed at 
improving heterologous protein secretion is discussed, and co-production of a Tat system is 




Table 1. Protein products from B. subtilis  
2. Signal peptide and propeptide 
The major of Bacterial secreted proteins are translocated across the cytoplasmic membrane 
via the Sec pathway (Antelmann et. al. 2004). Secretory proteins are identified by a signal 
peptide at the protein’s N-terminus. A signal peptide consists of a positively charged N-
domain, a hydrophobic H domain, and a C domain containing a specific cleavage site. Most 
signal peptides are Sec dependent signal peptides, which are cleaved by a type I signal 
peptidase at the AXA cleavage site (Tjalsma et al., 2000), as an example, B. subtilis α-amlyase 
(AmyE) (Fig. 1). 
2.1 Signal peptide 
For the production of a heterologous protein in the culture medium of B. subtilis, it is 
necessary to use a signal peptide that directs the protein very efficiently to the translocase. 
However, heterologous protein secretion often results in inefficient and unsatisfyingly low 
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yields. The relationship between signal peptides and target proteins remains unknown. 
Accordingly, previous studies have indicated the need for individually optimal signal 
peptides for every heterologous secretion target.  
Recently, Brockmeier et al. (2006) established a new strategy for the optimization of 
heterologous protein secretion in B. subtilis, by screening a library of all natural signal 
peptides of the strain. Accordingly, the best signal peptide for the secretion of one target 
protein is not automatically the best, or even sufficient, for the secretion of a different target 
protein (Brockmeier et al., 2006).  
In our study, human interferon- (hIFN-) was used as a heterologous model protein, to 
investigate the secretion of the B. subtilis several major signal peptides. (Fig. 2). We found 
that for the secretion production of hIFN-α, the AmyE signal peptide is one of the best 
signal peptides (unpublished data).  
 
Fig. 1. The amino acid sequence of N-terminus-pre-pro AmyE. The putative SPase 
cleavage site is indicated by a closed arrowhead, and the post-secretory processing site is 
indicated by an open arrowhead, as described in the references (Takase et al., 1988; 
Sasamoto et al., 1989). Numbers above the AmyE amino acid sequence refer to the 
locations of the encoded amino acid residues of AmyE (adapted from Kakeshita et al., 
2011a).  
2.2 Propeptide 
Some secreted bacterial proteins have cleavage propeptides located between their signal 
peptide and the mature protein. The propeptide is processed after translocation. Long 
propeptides (60 to 200 residues) are present for most bacterial extracellular proteases, which 
are auto-catalytically cleaved and possess intramolecular chaperon activities, for example,  
B. subtilis AprE (Braun et al., 1996; Ikemura & Inouye, 1998; Wang et al., 1998; Yabuta et al., 
2001; Yabuta et al., 2002; Zhu et al., 1989). On the other hand, short propeptides (with fewer 
than 60 residues) are present for a few secreted proteins, including B. subtilis α-amylase 
(AmyE) (Davis et al., 1977; Mezes et al., 1983; Takase et al., 1998) (Fig. 1). In B. subtilis, the 
AmyE propeptide is cleaved by unknown proteins, and is dispensable for secretion, folding, 
and stability (Takase et al., 1998; Sasamoto et al., 1989).  
However, the secretion efficiency of the Staphylococcus aureus nuclease (Nuc) was found to 
be enhanced by a propeptide in E. coli (Suciu & Inouye 1996) and Lactococcus lactis (Le Loir et 
al., 1998). In addition, in L. lactis, the nine-residue synthetic propeptide, LEISSTCDA, which 
is fused immediately after the signal peptide cleavage site, is known to enhance 
heterologous protein secretion (Le Loir et al., 1998; Le Loir et al., 2005; Zhuang et al., 2008; 
Zhang et al., 2010). Therefore, we evaluated whether the fusion of the AmyE signal peptide 
and the propeptide could improve the secretion of hIFNα-2b, compared to that with only 
AmyE signal peptide.  
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Fig. 2. Construction of plasmids for production and secretion of heterologous proteins. The 
restriction sites used for each construction are indicated. PxylA, promoter of xylA; RBS, 
ribosome binding site; SP, signal peptide; Pro, propeptide. 
 
Fig. 3. Western blot analysis of hIFN-α production by B. subtilis Dpr8 with pHKK3101 
(AmyE SP-hIFN-α) or pHKK3201 (AmyE SP-Pro-hIFN-α). Samples were collected at 20 h 
after xylose induction, separated by 15% SDS-PAGE, and stained with Western blotting 
using anti hIFN-α2b polyclonal antibodies. Dpr8 with pHKK3101 (lanes 1 and 2); Dpr8 with 
pHKK3201 (lanes 3 and 4); 0.6% xylose induced (lanes 1 and 3), none induced (lanes 2 and 
4), and commercially purified hIFN-α 10 ng (lane 5). Arrowheads indicate the positions of 
the Pro-hIFN-α2b and hIFN-α2b. (adapted from Kakeshita et al., 2011a)  
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We showed that the secretion production and activity of hIFN-α2b with propeptide 
increased by more than 3-fold, compared to that without propeptide. The amount of 
secreted hIFN-α2b with propeptide was 15mg /L. This result indicated that the propeptide 
of AmyE enhanced the secretion of hIFNα-2b (Fig. 3, Kakeshita et al., 2011a).  
 
Fig. 4. Western blot analysis of hIFN-β production by B. subtilis Dpr8 with pHKK3111 
(AmyE SP-hIFN-β) or pHKK3211 (AmyE SP-Pro hIFN-β). Samples were collected at 20 h 
after xylose induction, separated by 15% SDS-PAGE, and stained with Western blotting 
using anti hIFN-β polyclonal antibodies. Dpr8 with pHKK3111 (lanes 1 and 2); Dpr8 with 
pHKK3211 (lanes 3 and 4); 0.6% xylose induced (lanes 1 and 3), none induced (lanes 2 and 
4), and commercially purified hIFN-β 50 ng (lane 5). Arrowheads indicate the positions of 
the Pro-hIFN-β and hIFN-β. (adapted from Kakeshita et al., 2011b) 
In L. lactis, directed mutagenesis experiments demonstrated that the positive effect of 
LEISSTCDA on protein secretion was due to the insertion of negatively charged residues in 
the N-terminus of the mature moiety (Le Loir et al., 2001). In hIFN-α2b with AmyE 
propeptide, the first 10 amino acid residues of this mature protein have a net charge of -1. 
On the other hand, hIFN-α2b without propeptide has a net charge of 0. In addition, we 
demonstrated that propeptide mutants of neutral or positive charge resulted in a reduction 
in the amount of secreted hIFN-α2b, compared with propeptides of negative charge. This 
result suggested that negative charges in the mature protein can enhance the secretion of 
hIFN-α2b (Kakeshita et al., 2011a).  
We then indicated that the AmyE propeptide enhanced the secretion of the hIFN-β protein 
from B. subtilis, as well. The secretion production and activity of hIFN-β with propeptide 
increased by more than 4-fold (Fig. 4, Kakeshita et al., 2011b). The amount of secreted hIFN- 
 




Fig. 2. Construction of plasmids for production and secretion of heterologous proteins. The 
restriction sites used for each construction are indicated. PxylA, promoter of xylA; RBS, 
ribosome binding site; SP, signal peptide; Pro, propeptide. 
 
Fig. 3. Western blot analysis of hIFN-α production by B. subtilis Dpr8 with pHKK3101 
(AmyE SP-hIFN-α) or pHKK3201 (AmyE SP-Pro-hIFN-α). Samples were collected at 20 h 
after xylose induction, separated by 15% SDS-PAGE, and stained with Western blotting 
using anti hIFN-α2b polyclonal antibodies. Dpr8 with pHKK3101 (lanes 1 and 2); Dpr8 with 
pHKK3201 (lanes 3 and 4); 0.6% xylose induced (lanes 1 and 3), none induced (lanes 2 and 
4), and commercially purified hIFN-α 10 ng (lane 5). Arrowheads indicate the positions of 
the Pro-hIFN-α2b and hIFN-α2b. (adapted from Kakeshita et al., 2011a)  
 
Improvement of Heterologous Protein Secretion by Bacillus subtilis 
 
149 
We showed that the secretion production and activity of hIFN-α2b with propeptide 
increased by more than 3-fold, compared to that without propeptide. The amount of 
secreted hIFN-α2b with propeptide was 15mg /L. This result indicated that the propeptide 
of AmyE enhanced the secretion of hIFNα-2b (Fig. 3, Kakeshita et al., 2011a).  
 
Fig. 4. Western blot analysis of hIFN-β production by B. subtilis Dpr8 with pHKK3111 
(AmyE SP-hIFN-β) or pHKK3211 (AmyE SP-Pro hIFN-β). Samples were collected at 20 h 
after xylose induction, separated by 15% SDS-PAGE, and stained with Western blotting 
using anti hIFN-β polyclonal antibodies. Dpr8 with pHKK3111 (lanes 1 and 2); Dpr8 with 
pHKK3211 (lanes 3 and 4); 0.6% xylose induced (lanes 1 and 3), none induced (lanes 2 and 
4), and commercially purified hIFN-β 50 ng (lane 5). Arrowheads indicate the positions of 
the Pro-hIFN-β and hIFN-β. (adapted from Kakeshita et al., 2011b) 
In L. lactis, directed mutagenesis experiments demonstrated that the positive effect of 
LEISSTCDA on protein secretion was due to the insertion of negatively charged residues in 
the N-terminus of the mature moiety (Le Loir et al., 2001). In hIFN-α2b with AmyE 
propeptide, the first 10 amino acid residues of this mature protein have a net charge of -1. 
On the other hand, hIFN-α2b without propeptide has a net charge of 0. In addition, we 
demonstrated that propeptide mutants of neutral or positive charge resulted in a reduction 
in the amount of secreted hIFN-α2b, compared with propeptides of negative charge. This 
result suggested that negative charges in the mature protein can enhance the secretion of 
hIFN-α2b (Kakeshita et al., 2011a).  
We then indicated that the AmyE propeptide enhanced the secretion of the hIFN-β protein 
from B. subtilis, as well. The secretion production and activity of hIFN-β with propeptide 
increased by more than 4-fold (Fig. 4, Kakeshita et al., 2011b). The amount of secreted hIFN- 
 
Advances in Applied Biotechnology 
 
150 
β with propeptide was 3.7mg /L. These results indicated that the propeptide of AmyE 
enhanced the secretion and extracellular production of a heterologous protein in B. subtilis. 
2.3 Deletion of the C-terminus of SecA  
In B. subtilis, most secreted proteins are translocated across the cytoplasmic membrane via 
the Sec system (Tjalsma et al., 2000; Tjalsma et al., 2004; Yamane et al., 2004). Nearly all of 
the components of the Sec system identified in E. coli have also been identified in B. subtilis 
and are biochemically well-characterized (van Wely et al., 2001; Harwood et al., 2008). 
Among these components, the peripheral membrane protein, SecA is considered to play a 
pivotal role in secretion. The SecYEG complex acts as a receptor for SecA, and functions as a 
preprotein conducting channel (Hartl et al., 1990; Fekkes et al., 1997). In E. coli, SecB is a 
molecular chaperone that functions in the post-translational protein translocation pathway, 
and binds to the C-terminal SecB binding site of E. coli SecA. In B. subtilis, this region of SecA 
is highly conserved. However, genome sequencing revealed that SecB is absent in B. subtilis 
(Kunst et al., 1997). B. subtilis Ffh interacts directly with SecA, and promotes the formation of 
soluble SecA-preprotein complexes (Bunai et al., 1999). These results suggest that the signal 
recognition particle (SRP) of B. subtilis not only acts as a targeting factor in co-translational 
translocation, but also stimulates the process of post-translocation across the membrane 
(Harwood & Cranenburgh, 2008; Ling et al., 2007; Tjalsma et al., 2000; Yamane et al., 2004). 
In additon, it has been shown that SecB binding site of B. subtilis SecA is not essential for 
viability and protein secretion (van Wely et al., 2000). The SecB binding site is connected by 
a C-terminal Linker (CTL) with the α-helical scaffold domain (HSD) in SecA. A cross-species 
comparison of the amino acid sequence of SecA revealed that the CTL is not well-conserved 
between B. subtilis and other species, including E. coli. We examined the effects of modifying 
the C-terminal region of SecA on growth and the extracellular production of heterologous 
proteins in B. subtilis, and demonstrated that the C-terminal domain (CTD) of SecA is not 
essential for viability or protein secretion. Furthermore, we showed that the productivity of 
hINF-α2b increased by 2.2-fold, compared to wild type SecA (Kakeshita et al., 2010). The 
crystal structure of B. subtils SecA indicated that CTL binds to the surface of NBF-I. The 
CTL-binding grove is a highly conserved and hydrophobic surface, and this grove is 
predicted to be one of the mature preprotein binding sites in SecA (Hunt et al., 2002). 
Therefore, deletion of the CTL of SecA is likely to affect SecA - preprotein interaction, and 
likely caused an increase in the secretion of heterologous proteins. 
2.4 Co-expression of PrsA 
PrsA is essential for viability and protein secretion. In protein secretion, PrsA is suggested to 
mediate protein folding at the late stage of secretion (Konitinen et al., 1991; Kontinen & 
Sarvas, 1993; Vitikainen et al., 2001). We examined the effect of co-expression of an extra-
cytoplasmic molecular chaperone, PrsA. It is known that co-expression of an extra-
cytoplasmic molecular chaperone, PrsA enhances the secretion of several model proteins: α -
amylase, Single-chain antibody (SCA), and recombinant Protective antigen (rPA) (Kontinen 
& Sarvas, 1993; Vitikainen et al., 2001; Wu et al., 1998; Williams et al., 2003).  
We demonstrated that co-expression of PrsA can act in concert with the AmyE propeptide to 
enhance the secretion production of hIFN-β. The amount of secreted hIFN-β with 
propeptide was 5.5mg /L.  (Fig. 5, Kakeshita et al., 2011b). 
 




Fig. 5. Comparison of the amounts of secreted hIFN-β from B. subtilis D8C and D8PA, PrsA 
co-expressing strains. (a) Schematic representation of the gene structure around the amyE 
locus in the B. subtilis mutant strains D8PA and D8C. PspoVG and prsA represent the B. subtilis 
spoVG promoter and B. subtilis PrsA, respectively. Pcat and Cmr represent the 
chloramphenicol-resistant gene promoter and coding region, respectively. (b) Western blot 
analysis of PrsA protein from B. subtilis D8C, D8PA, and Dpr8. (c) Western blot analysis of 
hIFN-β production by B. subtilis D8C, D8PA, and Dpr8. D8C with pHKK3211 (lane 1); D8PA 
with pHKK3211 (lane 2); Dpr8 with pHKK3211 (lane 3). Arrowheads indicate the positions 
of Pro-IFN-β. (Adapted from Kakeshita et al., 2011b). 
3. Tat pathway 
The majority of bacterial secreted proteins are translocated across the cytoplasmic 
membrane via the Sec pathway, which acts on unfolded proteins using the energy provided 
by ATP hydrolysis (Tajalsma et al., 2000; Antelman et al., 2000). Recently, a novel and 
different secretion protein translocation pathway, the twin-arginine translocation (Tat) 
pathway was discovered (Santini et al., 1998; Berks et al., 2000; van Dijl et al., 2002). The 
bacterial twin-arginine translocation (Tat) machinery is able to transport folded proteins 
across the cytoplasmic membrane (Robinson et al., 2001). The Tat pathway might have 
advantages over the Sec pathway for the production of heterologous proteins, because many 
proteins fold tightly before they reach the Sec machinery, and thus cannot engage with it for 
translocation across the cytoplasmic membrane.  
B. subtilis contains two substrate specific Tat systems, TatAyCy and TatAdCd. The TatAyCy 
translocase is required for translocation of YwbN. On the other hand, a TatAdCd translocase 
translocates the phosphodiesterase PhoD (Jongbloed JD et al., 2002; Pop et al., 2002). 
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3.1 Twin-arginine signal peptide  
Proteins are targeted to the Tat pathway by tripartite N-terminal signal peptides, the amino-
terminal portion (n region) of which contain a conserved twin-arginine (RR) motif (R-R-X-#-
#, where # is a hydrophobic residue). 
In a previous study by Jongbloed et al., a database search for the presence of this motif in 
amino-terminal protein sequences identified a total number of 27 putative RR-signal 
peptides.  
 
Fig. 6. Schematic representation of the signal sequences used for secretion of human 
Interferon-α in B. subtilis. Schematic structure of the proteins encoded by each indicated 
plasmid. The twin-arginine motif is boxed, and the residues at positions -3 to -1 relative to 
the predicted SPase I cleavage site are underlined. The six base pairs of the KpnI site add the 
amino acids Gly–Thr to the end of each signal peptide coding sequence; therefore, in the 
table, each sequence ends with GT. Numbers under the signal peptides refer to the 
respective locations of the encoded amino acid residues.  
We therefore selected six candidate Tat signal peptides, shown in Fig. 6, from the list 
generated by Jongbloed et al. for testing in the hIFN-α secreted assay. To determine the 
secretion ability for hINF-α2b, the six signal peptide genes considered to belong to the Tat 
pathway of B. subtilis were PCR-amplified. The PCR-amplified signal peptide genes were 
inserted upstream of the hIFN-α mature peptide gene in pHKK3101, yielding six secretion 
expression vectors. pHKK3101 expressing hIFN-α with the AmyE signal peptide, as the 
Sec-type signal peptide, was used as the control plasmid. The resultant recombinants 
were transformed into B. subtilis Dpr8, respectively, and the secretion expression of hIFN-
α mediated by these signal peptides was detected by immunoblotting analysis. The hIFN-
α was expressed in these strains and hIFN-α production was induced with the addition of 
0.6% of xylose to the exponentially growing cultures (OD660 = 0.3), and both culture 
supernatants and intracellular lysates were analyzed as described in Kakeshita et al. 
(2010). As shown in Fig. 7a, in the extracellular fraction, only one band corresponding to 
mature protein (16 kDa) was detected for the samples of B. subtilis Dpr8 cells harboring 
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pHKK3101 (AmyE signal), pHKK4004 (WprA), pHKK4005 (LipA), and pHKK4006 
(WapA) by Western blot and immunoblot. This result suggested that the obtained three 
signal peptides (WprA, LipA, WapA) directed efficient secretion expression.  
 
 
Fig. 7. Comparison of the amounts of secreted hIFN-α using the Twin arginine signal 
peptides from B. subtilis Dpr8. (a) Western blot analysis of hIFN-α production in B. subtilis 
Dpr8 harboring seven recombinants. Cells were grown at 30 °C in 2xL medium. Samples 
were collected at 20 h after xylose induction, separated by 15% SDS-PAGE, and subjected to 
Western blotting using anti hIFN-β polyclonal antibodies. Protein samples present in the 
supernatant (lanes 1, 2, 3, 4, 5, and 6) and cell fractions (lanes 7, 8, 9, 10, 11, and 12) of 
stationary-phase cultures were prepared by centrifugation, analyzed by SDS-PAGE, and 
immunodetected with anti-hIFN-α antibodies. Dpr8/pHKK3101 (lanes 1 and 8); 
Dpr8/pHKK4001 (lanes 2 and 9); Dpr8/pHKK4002 (lanes 3 and 10); Dpr8/pHKK4003 (lanes 
4 and 11); Dpr8/pHKK4004 (lanes 5 and 12); Dpr8/pHKK4005 (lanes 6 and 13); 
Dpr8/pHKK4006 (lanes 7 and 14); precursor, pre hIFN-α; mature, hIFN-α. S, supernatant; C, 
cell fractions. (b) Quantification of secreted hIFN-α mature form in the culture medium and 
cell fraction. The hIFN-α production corresponding to the supernatant of B. subtilis Dpr8 
carrying pHKK3101 (AmyE signal peptide) was set as 100%. Data represent the mean of 
three experiments, and error bars represent standard error. 
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Especially, WapA demonstrated the highest efficiency of hIFN-α secretion expression, 
which was 1.5-fold as high as the Sec dependent signal peptide, AmyE (Fig. 7b).  
However, No hIFN-α was detected in the supernatants of Dpr8/pHKK4001 (YvhJ), 
Dpr8/pHKK4002 (YwbN), or Dpr8/pHKK4003 (PhoD). In the intracellular lysates of 
Dpr8/pHKK3101, Dpr8/pHKK4004, Dpr8/pHKK4005, and Dpr8/pHKK4006, two bands 
were detected. As deduced from the molecular mass of each band, these bands ware 
assigned to the unprocessed precursor (17 kDa) and the mature protein (16 kDa), 
respectively. On the other hand, only one band corresponding to the unprocessed protein 
was detected for the samples of Dpr8/pHKK4001 (YvhJ), Dpr8/pHKK4002 (YwbN), and 
Dpr8/pHKK4003 (PhoD).  
These results suggested that the three obtained signal peptides, YvhJ, YwbN, and PhoD 
cannot be secreted hIFN-α2b into the supernatant.  
3.2 Co-expression of the tat system 
We examined the effect of co-expression of the Tat-machinary, TatAd/Cd or TatAy/Cy. To 
examine the effects of the co-expression of B. subtilis tat genes on hIFN-α secretion, we 
constructed TatAd/TatCd and TatAy/TatCy under the control of the spoVG promoter in 
plasmids. It is known that the spoVG promoter is a powerful promoter (Zuber & Losick 
1983). The resulting constructs were subsequently integrated into the chromosome of B. 
subtilis strain Dpr8 via a double crossover event at the amyE locus, leaving the native tat 
genes intact (Fig. 8a).  
The resultant strains, D8tatD and D8tatY were transformed with pHKK3101, pHKK4001, 
pHKK4002, pHKK4003, pHKK4004, pHKK4005, and pHKK4006 for expression of hIFN-α.  
As shown in Fig. 8b and c, when the LipA signal peptide was fused to hIFN-α, a densitometric 
analysis of the western blotting demonstrated that the amounts of hIFN-α secreted by D8tatD 
and D8tatY were increased by roughly 2-fold, compared with that in strain Dpr8 (Fig. 8c). 
When the WprA signal peptide was fused to hIFN-α, in D8tatD, the amount of secreted hIFN-
α was increased by 71% compared with that in the parental strain, Dpr8, whereas the 
enhanced production of hIFN-α increased by 29%. On the other hand, When the WapA signal 
peptide was fused to hIFN-α, the amounts of hIFN-α secreted by D8tatD and D8tatY were 
increased by only 10-20%, compared with that in strain Dpr8 (Fig. 8c). Then, when the AmyE 
signal peptide was fused to hIFN-α, the amounts of hIFN-α secreted by D8tatD and D8tatY 
were increased by 37% and 25%, respectively compared with that in strain Dpr8 (Fig. 8c). 
Therefore, WapA signal peptide and AmyE signal peptide are not able to enhance of secretion 
by co–expression of Tat system. In addition, when the YvhJ, YwbN, and PhoD signal peptides, 
respectively were fused to hIFN-α, the bands of hIFN-α secreted by D8tatD and D8tatY could 
not be detected in the resulting supernatants (data not shown). 
We demonstrated that co-expression of TatAd/Cd or TatAy/Cy with LipA signal peptide 
can act in concert to enhance the secretion production of hIFN-α. In addition, WprA signal 
peptide was enhanced the secretion production of hIFNα by co-expression of TatAd/Cd, 
not TatAy/Cy. On the other hands, AmyE signal peptide and WapA peptide are Tat 
pathway independent.  
 




Fig. 8. Comparison of the amounts of secreted hIFN-α from B. subtilis Dpr8 and Tat 
overexpressing strains. (a) Schematic representation of the gene structure around the amyE 
locus in the B. subtilis D8tatD and D8tatY mutant strain genomes. Construction of strains 
D8tatD and D8tatY was by double crossover integration of plasmids pHKK2001 (tatAd-Cd) 
and pHKK2002 (tatAy-Cy) into the amyE locus of B. subtilis Dpr8. The resulting strain 
contains the native phoD-tatAd-tatCd locus, as well as one copy of tatAd-Cd and tatAy-Cy 
under the control of the PspoVG promoter. The stem-loop structures and the bent arrows 
indicate the putative Rho-independent terminators and promoters, respectively. (b) Western 
blot analysis of hIFN-α production by B. subtilis Dpr8, D8tatD, and D8tatY (carrying 
pHKK3101, pHKK4004, pHKK4005, or pHKK4006) was performed in the same manner as 
for hIFN-α. (c) Quantification of secreted hIFN-α in mature form in the culture medium. 
The hIFN-α production corresponding to the B. subtilis Dpr8 strain was set as 100%. Data 
represent the mean of three experiments, and error bars represent standard error. 
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In recent years, considerable efforts have been targeted at developing B. subtilis as a host for 
the production of heterologous proteins. However, the secretion of heterologous proteins 
from eukaryotes by these species produces small yields and is frequently inefficient. 
Initially, we considered the major problem to be the presence of high levels of extracellular 
protease in B. subtilis. Nevertheless, even after obtaining many depleted protease strains, the 
problem of inefficient secretion was not resolved. Currently, it is considered that the largest 
problem is the detection of the pre-mature form of human protein in cell lysate, when 
human proteins with signal peptide are over expressed in B. subtilis (Fig. 7a). Normally, the 
pre-mature forms of target secretion proteins are not detected in cell lysates. If the pre-
mature form of target a secretion protein is detected, it indicates a problem in the secretion 
pathway, for example, non-functional or depleted SecA, SecY, Ffh, or FtsY (Sadaie et al. 
1991; Takamatsu et al., 1992; Honda et al., 1993; Oguro et al., 1995; Tjalsma et al., 2000; 
Tjalsma et al., 2004; Yamane et al., 2004). Therefore, we must solve this primary problem, 
which is the accumulation of the precursor of human proteins in B. subtilis cells.  
We indicated that the propeptide of AmyE enhanced the secretion of the extracellular 
production of a heterologous protein in B. subtilis. In L. lactis, the nine-residue synthetic 
propeptide, LEISSTCDA, which is fused immediately after the signal peptide cleavage site, 
is known to enhance heterologous protein secretion (Le Loir et al., 1998). In addition, 
LEISSTCDA enhances secretion efficiency (Le Loir et al., 2001). Therefore, it is considered 
that a short type propeptide may be one answer to improve the accumulation of precursor.  
On the other hand, we indicated that the deletion of the C-terminal domain of SecA 
enhanced the secretion of heterologous proteins. secA is an essential gene, and SecA is 
considered to play a pivotal role in secretion (Sadaie et al. 1991; Takamatsu et al., 1992; 
Tjalsma et al., 2000; Tjalsma et al., 2004; Yamane et al., 2004). In addition, we exhibited that 
the co-expression of PrsA or the Tat system can be able to enhance the secretion production.  
In the future, it may be necessary to modify the components of the secretion machinery for 
higher secretion efficiency.  
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1. Introduction  
Bacillus subtilis is a Gram-positive, nonpathogenic organism which is widely used as a host 
for enzyme production, due to its ability to secrete large amounts of proteins into the 
growth medium (Simonen et al., 1993; Westers et al., 2004). The secretion of a target protein 
leads to the natural separation of the product from cell components, which simplifies 
downstream processing of the protein. Accordingly, there has been a great deal of research 
performed regarding protein production in B. subtilis (Simonen et al., 1993; Westers et al., 
2004). Nevertheless, the yields of heterologous protein obtained from this organism are 
often insufficient (Harwood, 1992). Several bottlenecks in the B. subtilis secretion pathway 
have been reported, including poor targeting to the translocase, degradation of the secretory 
protein, and incorrect folding (Westers et al., 2004). One of the major bottlenecks involves 
the degradation of the produced protein by extracellular proteases; therefore, inactivation of 
extracellular proteases is essential for improvement of protein production with B. subtilis as 
the host. 
2. Inhibition of proteolysis of heterologous and nature proteins after the 
translocation process by inactivation of multiple proteases 
Eight extracellular proteases have been identified in B. subtilis to date, which are encoded by 
the following genes: aprE (Stahl et al., 1984; Wong et al., 1984), bpr (Sloma et al., 1990b; Wu et 
al., 1990), epr (Bruckner et al., 1990; Sloma et al., 1988), mpr (Rufo et al., 1990; Sloma et al., 
1990a), nprB (Tran et al., 1991), nprE (Yang et al., 1984), vpr (Sloma et al., 1991), and wprA 
(Margot et al., 1996). Deletions in the aprE (encoding subtilisin, alkaline protease) and nprE 
(encoding neutral protease) genes were the first such mutations, whose mutants show lower 
activities of extracellular proteases (Sloma et al., 1991). In addition, a deletion mutation in 
the epr gene resulted in low protease activity in the culture supernatant. wprA encodes a 96-
kDa protein that is processed to the CWBP23 propeptide and CWBP52 mature protease, 
forming a complex associated with the cell wall (Margot et al., 1996). This complex was also 
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al., 1990), epr (Bruckner et al., 1990; Sloma et al., 1988), mpr (Rufo et al., 1990; Sloma et al., 
1990a), nprB (Tran et al., 1991), nprE (Yang et al., 1984), vpr (Sloma et al., 1991), and wprA 
(Margot et al., 1996). Deletions in the aprE (encoding subtilisin, alkaline protease) and nprE 
(encoding neutral protease) genes were the first such mutations, whose mutants show lower 
activities of extracellular proteases (Sloma et al., 1991). In addition, a deletion mutation in 
the epr gene resulted in low protease activity in the culture supernatant. wprA encodes a 96-
kDa protein that is processed to the CWBP23 propeptide and CWBP52 mature protease, 
forming a complex associated with the cell wall (Margot et al., 1996). This complex was also 
 
 






Fig. 1. Strategy for construction of a ∆epr mutant. (A) Construction of a chloramphenicol-
resistance (Cmr) plasmid, pUC118-Cmr∆epr. Fragment 3 was amplified with fragment a 
(containing the repU promoter of pUB110) and fragment b (containing the chloramphenicol 
resistance gene of pC194), and primers 7 and 8. Fragment 4 was amplified with fragments 1, 
2, 3, and primers 5 and 6. The amplified fragment 4 was prepared by blunting and kination, 
and then cloned into the SmaI site of pUC118 to generate pUC118-Cmr∆epr. (B) Construction 
of the ∆epr mutant. B. subtilis 168 cells were transformed with pUC118-Cmr∆epr, followed 
by selection for chloramphenicol resistance, obtaining Cmr∆epr. To obtain a ∆epr mutant 
(deleted chloramphenicol-resistance cassette), the ampicillin concentration method was used 
(Kodama et al., 2007a). The chloramphenicol-sensitive (Cms) ∆epr mutant was confirmed by 
PCR using primers 5 and 4. 
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found in the culture supernatant of B. subtilis WB600 (Babe et al., 1998; Wu et al., 1991). 
Whether it is present in the cell wall or in the culture medium is therefore a critical factor in 
the degradation of heterologous proteins (Lee et al., 2000). Strains with deletion mutations in 
multiple extracellular proteases have since been constructed with extracellular protease 
activities of less than 0.5%, compared to the parental strain (Wu et al., 1991). It was recently 
reported that an eight protease-deficient strain, WB800, was a useful host for the production 
of various heterologous proteins (Murashima et al., 2002; L. Westers et al., 2006). However, 
the use of B. subtilis as a host has remained limited to bulk industrial enzyme production. 
Further optimization is necessary to develop production systems for heterologous proteins. 
This chapter focuses on the inhibition of proteolysis of secreted proteins after the 
translocation process by inactivation of multiple proteases which are extracellular (AprE, 
Bpr, Epr, Mpr, NprB, NprE, Vpr, and WprA), leaked outside from intracellular (AprX), and 
membrane-bound (HtrA and HtrB). 
2.1 The intracellular protease, AprX is involved in degradation of a heterologous 
protein 
In B.  subtilis, extracellular protease-deficient mutants have been used in attempts to increase 
the productivity of heterologous proteins. We detected the protease activity of AprX using 
protease zymography in the culture medium at the late stationary growth phase. 
Construction of multiple-protease-deficient mutant without antibiotic-resistance markers 
and the effect of AprX on the heterologous protein production are descrived in detail in the 
following sections. 
2.1.1 Construction of an eight-extracellular-protease-deficient mutant by marker-free 
deletion in B. subtilis  
Antibiotic-resistance marker genes were used to create new bacterial strains. However, the 
number of markers available for use in B. subtilis and other bacteria is limited. We used the 
“ampicillin concentration” method for the creation of eight-extracellular-protease-deficient 
mutant with marker-free deletion (Fig. 1, Kodama et al., 2007a). Recently, several useful 
methods were developed to produce unmarked mutations in B. subtilis (Liu et al., 2008; 
Morimoto et al., 2008; Morimoto et al., 2009). These systems are more convenient for the 
introduction of multiple mutations. 
2.1.2 Detection of AprX activity in the culture supernatant with protease zymography 
Zymography has been used to detect proteolytic enzymes after electrophoretic separation in 
gels. Recently, the activities of some proteases, including Vpr have been detected by fibrin 
zymography of the extracellular proteins of B. subtilis (Murashima et al., 2002; L. Westers et 
al., 2006). The supernatant proteins of B. subtilis culture in modified 2xL broth (Kodama et 
al., 2007b) at 8 h (exponential growth phase), 25 h (early stationary phase), 50 h (mid-
stationary phase), and 75 h (late stationary phase) (Fig. 2A) were analyzed by gelatin 
zymography (Fig. 2B). The resulting zymogram shows the protease activities as clear bands 
(or zones). In the exponential growth phase (8 h), no protease activity was detected (Fig. 2B, 
lane 1). However, protease activity increased during the stationary phase, and was highest 
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of various heterologous proteins (Murashima et al., 2002; L. Westers et al., 2006). However, 
the use of B. subtilis as a host has remained limited to bulk industrial enzyme production. 
Further optimization is necessary to develop production systems for heterologous proteins. 
This chapter focuses on the inhibition of proteolysis of secreted proteins after the 
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Bpr, Epr, Mpr, NprB, NprE, Vpr, and WprA), leaked outside from intracellular (AprX), and 
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mutant with marker-free deletion (Fig. 1, Kodama et al., 2007a). Recently, several useful 
methods were developed to produce unmarked mutations in B. subtilis (Liu et al., 2008; 
Morimoto et al., 2008; Morimoto et al., 2009). These systems are more convenient for the 
introduction of multiple mutations. 
2.1.2 Detection of AprX activity in the culture supernatant with protease zymography 
Zymography has been used to detect proteolytic enzymes after electrophoretic separation in 
gels. Recently, the activities of some proteases, including Vpr have been detected by fibrin 
zymography of the extracellular proteins of B. subtilis (Murashima et al., 2002; L. Westers et 
al., 2006). The supernatant proteins of B. subtilis culture in modified 2xL broth (Kodama et 
al., 2007b) at 8 h (exponential growth phase), 25 h (early stationary phase), 50 h (mid-
stationary phase), and 75 h (late stationary phase) (Fig. 2A) were analyzed by gelatin 
zymography (Fig. 2B). The resulting zymogram shows the protease activities as clear bands 
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at 75 h of the late stationary phase (Fig. 2B, lane 4). We examined the zymogram profile of 
the supernatant from the eight-extracellular-protease-deficient mutant (Dpr8) at 75 h, and 
found one clear band in the zymogram (Fig. 2C, lane 2). Protease activity disappeared in the 
aprX mutant at 75 h (Fig. 2C, lane 3). All of the protease activities completely disappeared in 
the KA8AX strain, in which nine genes (eight extracellular protease genes and aprX) were 
disrupted (Fig. 2C, lane 4). These results support the idea that the protease is serine protease 
AprX. To determine the serine and metal protease activities of this protease by zymography, 
PMSF and EDTA (2 mM each) were added to the supernatant of the 75 h culture of Dpr8 
(Fig. 2D). EDTA decreased the activity of the protease slightly, whereas 2 mM PMSF 
completely inhibited the protease activity (Fig. 2D). These results suggest that the gelatin-
degrading protease from the supernatant of Dpr8 culture is AprX. To determine whether 
AprX is the gelatin-degrading protease in the supernatant of the Dpr8 culture at 75 h, the 
AprX-FLAG fusion protein was constructed. The fusion gene was expressed with the 
original promoter and ribosomal binding site. On a zymographic gel, the activity bands 
corresponding to AprX-FLAG from both 168/AprX-FLAG and Dpr8/AprX-FLAG strains 
were located at slightly larger positions in size than those of AprX (Fig. 3). The size of the 
band corresponded to the size of the FLAG peptide. These results indicate that the activity 
of AprX is detectable as a single band by gelatin zymography of the supernatant of a 75 h 
culture of B. subtilis strains. 
 
 
Fig. 2. (A) Cells from the wild-type were cultured in modified 2xL broth at 30ºC. (B) 
Protein samples were prepared from the supernatants of the wild-type, cultured for 
various incubation times.  Lane 1, 8 h culture; lane 2, 25 h; lane 3, 50 h; lane 4, 75 h. (C). 
Protein samples were prepared from the supernatants of the protease-deficient mutants 
after a 75 h culture. Lane 1, 168; lane 2, Dpr8; lane 3, AprXdd; lane 4, KA8AX. (D) PMSF or 
EDTA (2 mM each) was added to the supernatants of Dpr8 after a 75 h culture. Lane 1, 
Control (no addition); lane 2, addition of 2 mM PMSF; lane 3, addition of 2 mM EDTA. 
The samples were analyzed on SDS-12% polyacrylamide gels with 0.1% (w/v) gelatin. 
Proteins from the culture supernatants (equivalent to 0.3 µl) were applied to each lane for 
panels B, C, and D. 
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Fig. 3. Zymography of AprX-FLAG proteases. (A) Lane 1, 168; lane 2, 168/AprX-FLAG. (B) 
Lane 1, Dpr8; lane 2, Dpr8/AprX-FLAG. Proteins from the supernatants of the 75-h cultures 
(equivalent to 0.3 µl) were applied to the lanes for panels A and B. Arrowheads indicate the 
positions of AprX (closed symbol) and AprX-FLAG (open symbol). 
2.1.3 Intracellular AprX leaked to the culture medium during the late stationary phase 
It has been supposed that AprX is a serine protease belonging to the subtilase superfamily, 
and that it is an intracellular protease, because a canonical signal sequence for secretion has 
not been found in this protease (Valbuzzi et al.; 1999). However, AprX was detected in the 
culture medium by gelatin zymography (Fig. 3). aprX is transcribed during the stationary 
phase, and the regulator of SinR exerts negative effect on its transcription directly or 
indirectly (Valbuzzi et al.; 1999). However, aprX is not essential for either growth or 
sporulation (Valbuzzi et al.; 1999). As a result, the function of AprX has remained poorly 
understood. The Western blotting of AprX-FLAG from the intracellular fraction showed that 
the expression of AprX-FLAG began at 25 h, and that the expression level markedly 
increased after 50 h (Fig. 4). Our results agreed with a previous report that aprX is 
transcribed during the stationary phase. In contrast, a weak AprX-FLAG expression was 
detected in the supernatant only in the late stationary phase at 75 h (Fig. 4). This result 
agreed with the zymogram pattern of wild-type AprX (Fig. 2B). A slight decrease in cell 
density was observed after 50 h for the wild-type (Fig. 2A) and 168/AprX-FLAG strains 
(data not shown). The bands corresponding to AprX-FLAG from both the intra- and 
extracellular fractions were located at the same position. This result suggests that there is 
insufficient secretion of AprX, due to the absence of an obvious signal sequence. These 
observations also suggest that AprX is localized intracellularly by nature, and is leaked to 
the culture medium during the late stationary phase due to cell lysis. 
 
Fig. 4. Western blot analysis of AprX-FLAG. Western blot analysis was carried out to detect 
AprX-FLAG in the 168/AprX-FLAG strain with the anti-FLAG antibody. Proteins of cells 
(lanes 1-3) and supernatants (lanes 4-6) from 168/AprX-FLAG (0.02 OD600 units) were 
prepared as described in Materials and Methods. The arrowhead indicates the position of 
AprX-FLAG. The times of harvest of cells and supernatants are shown at the top. 
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2.1.4 AprX involved in degradation of the α-amylase-A522-PreS2 hybrid protein 
AprX in the supernatant was able to degrade gelatin. Therefore, we considered that AprX 
may affect the production of secreted proteins. pTUBE522-preS2 has already been 
developed for the extracellular production of small peptides of the human hepatitis B virus 
preS2 antigen (42 amino acids) fused with B. subtilis α-amylase (deleting the C-terminal 
region to construct a peptide carrier) (Honda et al., 1993). To confirm the effect of AprX on 
the degradation of heterologous proteins, we examined the production of α-amylase-A522-
PreS2 as a model of heterologous proteins, in multiple-protease-deficient B. subtilis strains. 
Cells carrying pTUBE522-preS2 were cultured in modified 2xL broth for 25, 50, and 75 h. α-
amylase-A522-PreS2 in the supernatants from the cultures of Dpr7, Dpr8, and KA8AX 
strains was analyzed by Western blotting with the anti-PreS2 antibody (Fig. 5A). The Dpr7 
strain lacked seven extracellular proteases (AprE deficiency excluded). No positive band 
corresponding to α-amylase-A522-PreS2 was detected at any phase for Dpr7 (pTUBE522-
preS2) (Fig. 5A, lanes 1-3). Dpr8 (pTUBE522-preS2) produced α-amylase-A522-PreS2 at 
detectable levels, and production of the hybrid protein attained high levels after 50 h (Fig. 
5A, lane 5). However, when AprX was produced in the supernatant of Dpr8 (pTUBE522-
preS2) at 75 h, the amount of α-amylase-A522-PreS2 decreased markedly (Fig. 6A, lane 6). 
As expected, the degradation of α-amylase-A522-PreS2 was markedly inhibited in KA8AX 
(pTUBE522-preS2) at 75 h, with the relative amount of the hybrid protein produced by this 
strain being 1.8-times higher than that of Dpr8 at 50 h (Fig. 5A, lanes 5 and 9; Fig. 5B). 
KA8AX produced α-amylase-A522-PreS2 up to 80 mg/L, which is at least eightfold higher 
than the amount produced by the improved strain in a previous study (Lee et al., 2000; Fig. 
5, lane 9). We also examined the degradation of α-amylase-A522-PreS2 by AprX protease. 
First, we prepared AprX protease from KA8AX (pDG-AprX) that was grown in a medium 
containing 1 mM IPTG for 4 h. The overexpression of AprX was confirmed by gelatin 
zymography (Fig. 6A, lane 2). Afterwards, the α-amylase-A522-PreS2 protein prepared from 
the supernatant of KA8AX (pTUBE522-preS2) at 75 h was mixed with AprX protease, and 
the mixture was incubated at 37ºC for 60 min. The degradation of α-amylase-A522-PreS2 
was analyzed by Western blotting using the anti-PreS2 antibody. H2O and intracellular 
proteins extracted from KA8AX (pDG-AprX) cells cultured without IPTG did not decrease 
the amount of the α-amylase-A522-PreS2 protein (Figs. 6B, C, lanes 2 and 4), but 
intracellular proteins extracted from KA8AX (pDG-AprX) cells cultured with 1 mM IPTG 
decreased the amount to 70% (Figs. 6B, C, lanes 5 and 6).  
These results indicate that the AprX protease directly degraded the α-amylase-A522-PreS2 
protein. One bottleneck of the production of α-amylase-A522-PreS2 was partially solved by 
the disruption of eight extracellular proteases and AprX, as shown in this chapter. However, 
the supernatant from the KA8AX culture at 75 h contained not only a small amount of α-
amylase-A522-PreS2, but also a large amount of α-amylase protein (determined by Western 
blotting with the anti-α-amylase antibody; data not shown). On other hand, no PreS2 
peptide was detected by Western blotting with the anti-PreS2 antibody (Fig. 5A). These 
results indicate that the degradation of α-amylase-A522-PreS2 was not inhibited completely 
in the KA8AX strain, and that there were as yet unidentified protease(s) involved in the 
proteolysis of the PreS2 region. Therefore, there is still room for improving the inhibition of 
hybrid protein degradation. It has been reported that IspA (Isp) was identified as a major 
intracellular serine protease (Koide et al., 1986). We evaluated the inhibition of the 
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degradation of α-amylase-A522-PreS2 by the inactivation of IspA in the KA8AX strain. 
However, the productivity of α-amylase-A522-PreS2 in the ten-protease deficient mutant 
was almost same as that in the KA8AX strain. A search in the GenoList database for B. 
subtilis 168 genome (http://genodb.pasteur.fr/cgi-bin/WebObjects/GenoList) of proteases 
and peptidases revealed the presence of 31 known and 11 putative proteases, and 38 known 
and 12 putative peptidases, respectively. Section 2.2 describes the investigation of 
membrane-bound proteases involved in protein degradation. 
 
Fig. 5. Western blot analysis of the α-amylase-A522-PreS2 hybrid protein in the extracellular 
fractions of Dpr7, Dpr8, and KA8AX. (A) Western blot analysis was carried out to detect α-
amylase-A522-PreS2 with the anti-PreS2 antibody. Culture supernatants from Dpr7 (lanes 1-3), 
Dpr8 (lanes 4-6), and KA8AX (lanes 7-9) were collected after 25, 50 h, and 75 h of cultivation, 
and subjected to Tricine-SDS-PAGE and Western blotting, as described in the Materials and 
Methods. Proteins from the culture supernatants (equivalent to 1 µl) were applied to each lane. 
The arrowhead indicates the position of α-amylase-A522-PreS2. The times of harvest of 
supernatants are shown at the top. (B) The relative α-amylase-A522-PreS2 protein amounts 
were compared on the basis of band intensities on Western blots (the amount of α-amylase-
A522-PreS2 at 50 h in the Dpr8 strain was set to 100%). The presented results are the average of 
three individual experiments. Error bars correspond to the standard errors of the means 
(SEM). Lane numbers in panel A correspond to those in panel B. 
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proteolysis of the PreS2 region. Therefore, there is still room for improving the inhibition of 
hybrid protein degradation. It has been reported that IspA (Isp) was identified as a major 
intracellular serine protease (Koide et al., 1986). We evaluated the inhibition of the 
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degradation of α-amylase-A522-PreS2 by the inactivation of IspA in the KA8AX strain. 
However, the productivity of α-amylase-A522-PreS2 in the ten-protease deficient mutant 
was almost same as that in the KA8AX strain. A search in the GenoList database for B. 
subtilis 168 genome (http://genodb.pasteur.fr/cgi-bin/WebObjects/GenoList) of proteases 
and peptidases revealed the presence of 31 known and 11 putative proteases, and 38 known 
and 12 putative peptidases, respectively. Section 2.2 describes the investigation of 
membrane-bound proteases involved in protein degradation. 
 
Fig. 5. Western blot analysis of the α-amylase-A522-PreS2 hybrid protein in the extracellular 
fractions of Dpr7, Dpr8, and KA8AX. (A) Western blot analysis was carried out to detect α-
amylase-A522-PreS2 with the anti-PreS2 antibody. Culture supernatants from Dpr7 (lanes 1-3), 
Dpr8 (lanes 4-6), and KA8AX (lanes 7-9) were collected after 25, 50 h, and 75 h of cultivation, 
and subjected to Tricine-SDS-PAGE and Western blotting, as described in the Materials and 
Methods. Proteins from the culture supernatants (equivalent to 1 µl) were applied to each lane. 
The arrowhead indicates the position of α-amylase-A522-PreS2. The times of harvest of 
supernatants are shown at the top. (B) The relative α-amylase-A522-PreS2 protein amounts 
were compared on the basis of band intensities on Western blots (the amount of α-amylase-
A522-PreS2 at 50 h in the Dpr8 strain was set to 100%). The presented results are the average of 
three individual experiments. Error bars correspond to the standard errors of the means 
(SEM). Lane numbers in panel A correspond to those in panel B. 
 




Fig. 6. The α-amylase-A522-PreS2 hybrid protein was degraded by AprX. (A) Zymography 
of supernatants from the KA8AX(pDG-AprX) strain. Lane 1, without IPTG; lane 2, with 
IPTG. (B) Western blot analysis of degradation of α-amylase-A522-PreS2 by AprX. AprX 
from KA8AX (pDG-AprX) mutant cells, cultured for 4 h with or without 1 mM IPTG was 
prepared as described in the Material and Methods. α-Amylase-A522-PreS2 from 10 µl 
supernatants of the KA8AX (pTUBE522-preS2) mutant (at 75 h cultivation) was mixed with 
10 µl of AprX solution. After incubation at 37ºC for 60 min, PMSF (final concentration, 10 
mM) was added to the samples to stop the reaction. Western blot analysis was carried out to 
detect α-amylase-A522-PreS2 with the anti-PreS2 antibody; +, addition of 1 mM IPTG 
(AprX); -, no addition. The reaction mixture (equivalent to 1 µl) was applied to each lane. 
The arrowhead indicates the position of α-amylase-A522-PreS2. (C) The relative amounts of 
α-amylase-A522-PreS2 were obtained by comparing the band intensities on Western blots 
(the α-amylase-A522-PreS2 amount in lane 1 was set as 100%). Lanes 1 to 6 in panel C 
correspond to lanes 1 to 6 in panel B. 
2.2 The effect of HtrA and HtrB on the degradation of secreted proteins 
In this section we describe the effects of membrane-bound proteases and a two-component 
system on degradation of secreted proteins, and transcriptional regulation of the membrane-
bound protease genes. 
2.2.1 Cell envelope-associated quality control proteases 
In B. subtilis, the accumulation of misfolded proteins at the membrane-cell wall interface is 
sensed by the CssR–CssS two-component system, which consists of the membrane-
embedded sensor kinase, CssS and the response regulator, CssR (Hyyryläinen et al., 2001). 
This system responds to general protein secretion stresses, which can be triggered by either 
homologous (e.g., overproduction of LipA) or heterologous (e.g., overproduction of AmyQ 
and hIL-3) proteins, and consequently activates the transcription of the monocistronic htrA 
and htrB genes (Darmon et al., 2002; H. Westers et al., 2006; Hyyryläinen et al., 2007). HtrA 
and HtrB are membrane-bound serine proteases that are responsible for the degradation of 
misfolded proteins, and can thereby rescue the cell from a lethal accumulation of misfolded 
proteins in the cell envelope. In addition, HtrA has a dual localization, because it can be 
detected in the membrane-associated cellular fraction as well as the growth medium. 
Therefore, HtrA has a chaperone-like activity that might assist misfolded proteins in 
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recovering their conformation, while also targeting unsuccessful protein for degradation 
(Antelmann et al., 2003). Induction of htrA and htrB expressions is responsive to secretion 
stress in a manner dependent on the CssRS two-component system. In addition, htrA and 
htrB expressions are negatively autoregulated and reciprocally cross-regulated (Noone et al., 
2000, Noone et al., 2001). Therefore, the absence of HtrA leads to the increased synthesis of 
HtrB, and vice versa (Noone et al., 2001). 
2.2.2 High-level lipase A (LipA) production in eleven proteases mutant 
We examined the production of lipase A (LipA) of B. subtilis (van Pouderoyen et al., 2001), as a 
valuable model for industrial enzyme production, in a nine-protease-deficient B. subtilis strain. 
Therefore, we constructed the pHLApm plasmid, in which LipA with the promoter and 
ribosomal binding site of an alkaline cellulase gene, egl-237 (Hakamada et al., 2000) was cloned 
into pHY300PLK (Takara, Japan). LipA was overproduced in B. subtilis. Cells carrying 
pHLApm were cultured in modified 2xL broth for 12, 24, 36, 48, 60, and 75 h. The productivity 
of LipA in the supernatants from cultures of the 168 and Dpr9 (in which nine genes encoding 
eight extracellular proteases and AprX were precisely and completely deleted from the 
chromosome) strains was calculated based on the activity of LipA (Fig. 7). In 24 h cultivation, 
the production level of the LipA in 168 and Dpr9 could be obtained at 860 mg/L, an excellent 
yield which is 1.4-times higher than that of previously reported (Lesuisse et al., 1993). After 24 
h, the amount of LipA markedly decreased in the 168 strain (Fig. 7). In contrast, degradation of 
LipA in the Dpr9 was effectively inhibited, compared with the 168 strain. However, after 36 h, 
the production of LipA in Dpr9 was reduced by approximately 10% (Fig. 7). These results 
showed that LipA was also degraded in the Dpr9 strain. Overproduction of both homologous 
(LipA) and heterologous (AmyQ and hIL-3) proteins induces the expression of htrA and htrB 
by the CssRS system (Darmon et al., 2002; H. Westers et al., 2006). From the currently available 
data, it seems most likely that limitation of both proteases of HtrA and HtrB improved the 
yield of heterologous proteins (Vitikainen, M., H. L. et al., 2005). To confirm the effect of HtrA 
and HtrB on the degradation of secreted proteins, we examined the production of LipA of B. 
subtilis in the htrA and/or htrB deficient B. subtilis strains. We constructed Dpr9∆htrA, 






















Fig. 7. Time course of LipA activity in the Dpr9 mutant. Cells were cultured in modified 2xL 
broth at 30ºC. The accumulation of LipA in the culture medium was measured at various 
incubation times. Open circles, wild type strain; closed triangles, Dpr9 mutant.  
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LipA in the Dpr9 was effectively inhibited, compared with the 168 strain. However, after 36 h, 
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(LipA) and heterologous (AmyQ and hIL-3) proteins induces the expression of htrA and htrB 
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Fig. 7. Time course of LipA activity in the Dpr9 mutant. Cells were cultured in modified 2xL 
broth at 30ºC. The accumulation of LipA in the culture medium was measured at various 
incubation times. Open circles, wild type strain; closed triangles, Dpr9 mutant.  
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Dpr9∆htrB, and Dpr9∆htrA/B (with eleven inactivated proteases), and evaluated each strain 
for the production of LipA. No effect on LipA production was observed in Dpr9∆htrA and 
Dpr9∆htrB. However, the production of LipA by the Dpr9∆htrA/B strain was at 1100 mg/L, 
which is 1.2-times higher than that of the Dpr9 strain (Fig. 8). These results suggest that 
inactivation of both htrA and htrB, as well as the nine proteases, has improved the 
productivity of B. subtilis for the production of LipA. 
 
Fig. 8. Enhanced productivity of LipA in the absence of both htrA and htrB. Cells were 
cultured in modified 2xL broth at 30ºC. The accumulation of LipA in the culture medium 
was measured at 48 h. The relative activities of LipA are shown (the amount of Dpr9 was set 
to 100%). 
2.2.3 Transcriptional regulation of htrB and htrA by reciprocal cross regulation 
We predicted that there was no difference between the productivities of LipA in the 
Dpr9∆htrA and Dpr9∆htrB strains, because the inactivation of either htrA or htrB results in a 
compensating overexpression of the other gene (Noone et al., 2001). To confirm that the 
overexpressions of htrA and htrB are caused by the inactivation of the other gene, we 
examined the level of expression of the htrB-lacZ fusion for the Dpr9∆htrA mutant, as well 
as the similar expression of the htrA-lacZ fusion for the Dpr9∆htrB mutant. Cells carrying 
pHY300PLK (control) and pHLApm (LipA overexpression) were cultured in modified 2xL 
broth for 48 h. As shown in Table 1, Dpr9∆htrA cells harboring pHLApm transcribed htrB-
lacZ at a 4-fold increased level, compared with Dpr9 harbouring pHLApm (from 0.51 to 2.30 
U). Similarly, a 10-fold increase in the htrA-lacZ expression level was observed in the 
Dpr9∆htrB mutant (from 0.41 to 4.26 U). The expressions of htrB-lacZ and htrA-lacZ also 
demonstrated reciprocal cross regulation in cells carrying pHY300PLK. These observations 
suggest that the overexpression of htrB in Dpr9∆htrA and of htrA in Dpr9∆htrB might affect 
LipA production. The expression level of htrB-lacZ in LipA-producing Dpr9 was 2.4-times 
higher than that of non-LipA-producing Dpr9 (Table 1). There was almost no change in the 
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expression level of htrA-lacZ, between Dpr9 cells harboring pHLApm and Dpr9 cells 
harbouring pHY300PLK. The expression of the htrB-lacZ reporter gene fusion has previously 
been shown to be more sensitive to secretion stress than the htrA-lacZ reporter gene fusion 
(Hyyryläinen et al., 2001). These results suggest that Dpr9 produced LipA in weak response 
to secretion stress.  
Expressed gene  Strain  Plasmid   Expression a 
htrB-lacZ  Dpr9  pHY300PLK  0.22±0.01 
   Dpr9∆htrA pHY300PLK  1.46± 0.11  
   Dpr9  pHYLApm  0.51± 0.11  
   Dpr9∆htrA pHYLApm  2.30± 0.02 
htrA-lacZ  Dpr9  pHY300PLK  0.38± 0.03 
   Dpr9∆htrB pHY300PLK  1.29± 0.01  
   Dpr9  pHYLApm  0.41± 0.03 
   Dpr9∆htrB pHYLApm  4.26± 0.02 
a One activity unit is defined as 1 nmol of O-nitrophenyl-ß-D-galactopyranoside hydrolysed per min per 
µg of OD600. The results presented are the average of three individual experiments. Plus/minus values 
represent standard deviations. 
Table 1. Expression of transcriptional fusions between the htrA and htrB promoters and lacZ 
reporter gene in various genetic backgrounds. 
3. Conclusion 
This chapter focused on biotechnological approaches to optimization of heterologous 
protein and enzyme production by multiple protease-deficient mutations in B. subtilis. 
Section 2.2 described the identification of AprX protease using gelatin zymography and the 
effects of AprX on heterologous protein production. The nine-protease-deficient KA8AX 
strain (lacking nine genes encoding eight extracellular proteases and AprX) effectively 
prevented proteolysis of α-amylase-A522-PreS2 [PreS2 antigen of human hepatitis B virus 
(HBV) fused with the N-terminal 522 amino acids of B. subtilis α-amylase] in the late 
stationary growth phase and improved the yield of the fusion protein. In addition, AprX 
was detected in the culture medium due to leakage on cell lysis during the late stationary 
growth phase. Section 2.3 described that the inactivation of nine-proteases and both htrA 
and htrB (resulting the Dpr9∆htrA/B mutant) improved the productivity of LipA in B. 
subtilis. In particular, the productivity of the LipA in the Dpr9∆htrA/B strain was 1100 
mg/L, an optimal yield which is 1.8-times higher than that of previously reported. There 
was no difference in the productivities of LipA in the Dpr9∆htrA and Dpr9∆htrB strains, 
compared with that of Dpr9. Because the transcriptions of htrA and htrB are controlled by 
reciprocal cross regulation, overexpression of htrB in the Dpr9∆htrA strain and of htrA in the 
Dpr9∆htrB strain might affect LipA production. The previous approach for effective protein 
production was to generate a strain which has the inactivation of eight extracellular 
proteases in B. subtilis as the host. We reported that AprX leaked outside of cells, and 
HtrA/HtrB membrane-bond proteases of B. subtilis were also key proteases involved in the 
degradation of natural and heterologous proteins. In addition, nine- or eleven-protease-
deficient strains of B. subtilis were helpful in improving protein productivity. Our findings, 
described in this chapter should contribute to the generation of hosts to be further optimized 
for protein production. 
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to 100%). 
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broth for 48 h. As shown in Table 1, Dpr9∆htrA cells harboring pHLApm transcribed htrB-
lacZ at a 4-fold increased level, compared with Dpr9 harbouring pHLApm (from 0.51 to 2.30 
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Dpr9∆htrB mutant (from 0.41 to 4.26 U). The expressions of htrB-lacZ and htrA-lacZ also 
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1. Introduction  
There is a little doubt that increasing developments of protein synthesis are in high demand. 
Not only proteins are participants in all biochemical processes of the living cell, continually 
accelerating advances in proteomics, (i.e. the science of proteins and their reciprocal 
interactions in the cell) are increasingly underscoring the need to perfect techniques that 
facilitate the production of specified proteins at an industrial scale that meets the necessary 
standards of purification (Kim and Kim 2009). Investigations that have built the foundation 
for such protein production have largely originated from discoveries in the middle of the 
last century. Such advances firstly elucidated new cellular environments of protein 
production. Subsequent developments focused on the specificity of protein synthesis and 
the general efficiency of production has been developed largely by genomic analysis and 
genetic recombination. 
Several in vitro systems of protein synthesis are commercially available worldwide. Many of 
these methods are categorized according to the derivation of their extracts, from either 
prokaryotic cells such as Escherichia coli (E. coli) or, alternatively, eukaryotic cells such as 
wheat germ or rabbit reticulocytes. While such extracts can be enriched by cofactors that 
enhance the efficacy of protein biosynthesis, there are obvious limitations to such systems.  
An important criterion involves also simplicity of the system and its potential application: 
(1) simple systems, such as synthesis of phenylalanine homopolymer (poly(U)-dependent 
poly(Phe) expression) are generally applied in studies that analyze protein biosynthesis itself 
and on factors which block the process, i.e. antibiotics. This is in contrast to (2) the complex 
systems that are able to link transcription and translation into a single system. 
The most advanced cell-free system based on the application of semi-permeable membrane 
allowing the concentration of reaction compartment during the work with ribosomes. Such 
membrane separates the feeding compartment where energy-rich molecules are deposed 
and can be moved to the reaction compartment with a simple diffusion. Moreover, such a 
feeding compartment is a suitable space where by-products potentially interfering with the 
biosynthesis can be deposed.  
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biosynthesis can be deposed.  
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Recently, many of different cell-free based systems are available and the customer can select 
the most suitable for the specific application. Here, we described the most popular systems 
and we demonstrated how these systems can be utilized to study interactions between 
antibiotics and the ribosome. 
1.1 The beginning of cell-free protein synthesis 
In 1950s, several research teams independently demonstrated that protein biosynthesis can 
take place even after disintegration of the cell membrane (Siekievitz and Zamecnik 1951; 
Borsook et al. 1950; Winnick 1950; Gale and Folkes 1954). Thus, the isolated cytoplasm has 
been found to comprise the entire set of components necessary to conduct protein 
biosynthesis. As first, Zamecnik prepared fully active cell-free system based on 
mitochondrium-isolated ribosomes from an animal (Littlefield et al. 1955; Keller and 
Littlefield 1957). The team further demonstrated that the reactions were dependent on the 
supply of high energy molecules, such as ATP and GTP. The first in vitro systems of protein 
synthesis based on isolated bacterial ribosomes were designed independently by two teams, 
German (Schachtschabel and Zillig 1959) and American (Lamborg and Zamecnik 1960). 
However, both of them were only capable of translating endogenous mRNAs, what was 
their main limitation. Nevertheless, this discovery provided a proof that extracellular 
biosynthesis was possible at all and consequently it provided a new approach to synthesize 
proteins and to study  molecular mechanisms of protein biosynthesis. An open nature of the 
in vitro systems was very attractive especially to the latter approach. 
The discovery of protein expression systems on the template of exogenous mRNA 
molecules significantly extended applications of extracellular protein biosynthesis. The 
achievement took place in 1961 in the laboratory of Nirenberg and Matthaei (Nirenberg 
and Matthaei 1961). A short incubation at the physiological temperature of around 37ºC 
proved sufficient to remove endogenous mRNA molecules from ribosomes. Free 
ribosomes obtained from the procedure were subsequently used for protein synthesis on 
the template of exogenous mRNA molecules. Of great importance, the ribosomes could be 
"programmed" by synthetic mRNA molecules. The technique of Nirenberg became the 
classical system of extracellular protein synthesis and, taking advantage of it, its 
originator deciphered the genetic code, for which he received the Nobel prize in 1968. In 
the subsequent systems, additional procedures of purifying ribosomes from endogenous 
mRNA molecules were applied to DEAE cellulose, permitting the separation ribosomes 
from free nucleic acids via chromatography.  
Incubation of ribosomes, preceding the proper protein biosynthesis and conducted in the 
same manner as in the technique of Nirenberg, was later successfully applied in 
eukaryotic in vitro systems. Extracts of animal cells enriched with purified ribosomes 
conducted efficient protein biosynthesis. The technique was again successful using the 
template of exogenous mRNA molecules (Schreier and Staehelin 1973). During 
approximately the same timeframe, investigators applied this capacity to extracts of 
wheat germs and, of great interest, found that the endogenous as opposed to exogenous 
expression of mRNA molecules manifested naturally low levels of protein (Marcus, Efron, 
and Weeks 1974; Roberts and Paterson 1973; Anderson, Straus, and Dudock 1983). Other 
techniques of eliminating endogenous mRNA were based on application of calcium ion-
dependent bacterial RNAse, used to augment the efficiency of protein expression system 
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in lysates of erythrocytes (Jackson and Hunt 1983; Merrick 1983; Pelham and Jackson 
1976) as well as in other lysates originating from animal cells (Henshaw and Panniers 
1983). In the 1980s, it was subsequently found that bypassing the expression of 
endogenous mRNA molecules significantly improved the efficiency of extracellular 
protein expression systems. 
1.2 Simple systems based on synthesis of protein homopolymers 
In such systems, the principal homopolymeric system involves synthesis of polyalanine on 
the template of poly(U) chain (poly(U)-dependent poly(Phe) synthesis). A buffered medium 
containing free ribosomes and the remaining components necessary for a translation 
reaction with the template of poly(U), the polyuridine homopolymer is added. The poly(U) 
template has the capacity to bind a ribosome without involvement of the Shine-Dalgarno 
sequence (sequence on mRNA which binds to the region of 16S rRNA) also has the ability to 
"program" the ribosome for synthesis of poly(Phe). Efficiency of the optimised systems of 
polyphenyloalanine synthesis may reach 300 amino acid incorporations per ribosome, 
which represents a significant achievement allowing for a unitemporal and complete 
analysis of all protein biosynthesis components (Szaflarski et al. 2008). In contrast, the first 
attempts of the type, performed in 1950s and 1960s resulted in merely 2-5 amino acid 
incorporations per ribosome.  
The homopolymeric system was prepared by isolation of two cellular fractions, which were 
subsequently enriched in high-energy molecules, free amino acides and poly(U)-mRNA, 
providing the template. The fractions were obtained from bacterial extracts, which were 
fractionated by centrifugation (for a detailed description of ribosome isolation see (Blaha et 
al. 2000)). The so-called fraction S30 (obtained by centrifugation at approximately 30,000 
rpm for 24 h) was rich in ribosomes and was used to purify free ribosome subunits in a 
sucrose gradient (centrifugation at around 45,000-60,000 rpm for 15 h). Ribosomes prepared 
in this manner were incubated at the temperature of 37ºC in a buffer containing, for 
instance, Mg2+ ions at the concentration of 4.5 mM in order to obtain complete correct 70S 
ribosome structure capable of performing protein synthesis.  
S100 fraction was obtained from supernatant of the S30 fraction and it provides the source of 
protein factors indispensable to conduct translation (i.a., initiation factors: IF1, IF2, IF3, 
specific aminoacyl-tRNA synthetases, elongation factors: EF-Tu, EF-G, EF-Tu). 
The reaction of polyphenylanaline synthesis represents a simple and widely used technique 
in several varieties. Instead of a poly(U) template, a poly(A) template can be used, enabling 
the synthesis of polylysine. Unfortunately, however, the polymer was poorly soluble in 
water; this property markedly restricts applicability of the system at a broader scale. 
Nevertheless, application of certain detergents permits its application in studies as seen in 
previous experiments conducted with the functional analysis of two antibiotics (pactamycin 
and edein), representing inhibitors of protein synthesis (Dinos et al. 2004). Here, the 
incorporation of near-cognate lysine instead of phenylalanine on the template of poly(U) can 
be precisely measured using double radioisotope labeling. If any antibiotic impacts on the 
translation accuracy (for example aminoglycoside paromomycin) it can be confirmed by 
detection of higher incorporation of lysine. Followed that technique edein was found to be 
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an error-prone antibiotic in contrast to pactamycin which did not induce any miscoding 
(Dinos et al. 2004). 
1.3 Biosynthesis of protein in a couple transcription-translation system 
Nirenberg and Matthaei (Matthaei and Nirenberg 1961) again were the first to describe the 
DNA dependence of the bacterial extracellular synthesis of protein. The dependence was 
corroborated by synthesis of a protein on the template of endogenous DNA molecules. 
Another group of investigators extended synthesis of endogenous proteins by application of 
exogenous DNA, which originated from a bacteriophage (Byrne et al. 1964; Wood and Berg 
1962). Unfortunately, the systems manifested a relatively poor efficiency using either 
endogenous or viral DNA. Moreover, they were accompanied by a non-specific expression 
of cellular and bacteriophage proteins. However, the continuing improvements of the joint 
transcription and translation system resulted in its dissemination; with it ultimately 
becoming a significant laboratory tool (Lederman and Zubay 1967; DeVries and Zubay 
1967).  
In the improved system, suggested by Zubay, a preliminary bacterial extract was subjected 
to incubation in order to degrade mRNA and DNA molecules by cellular nucleases (Zubay 
1973). The system gained popularity due to the ease of its preparation, stability of 
components and a relatively high efficiency. In the system designed by Gold and Schweiger 
ribosomes were isolated from cellular extracts to their homogenous form and so prepared 
ribosomes were supplemented with a cytoplasmic fraction, cleared of nucleic acids by ion-
exchange chromatography (Schweiger and Gold 1969, 1969, 1970). Such a preparation of 
components for extracellular protein synthesis produced a remarkable reduction in the non-
specific expression of protein. The troublesome procedure, however, remained the 
disadvantage of the system. 
2. Contemporary systems of the cell-free protein expression 
The 1980s and 1990s witnessed development of the in vitro systems in the form of 
optimization of cellular extracts, including the application of bacterial strains lacking the 
genes that code enzymes of endonuclease type (RNases) (Zaniewski, Petkaites, and 
Deutscher 1984). Such reaction mixes allowed researchers to keep bacteria in the reactive 
mix for a much longer period of time. Contemporary systems are characterized by a high 
mRNA level even after 24 h of the reaction (Iskakova et al. 2006). In 1990s the developing 
methods of genetic engineering and bioinformatics produced tremendous advances inside 
in vitro systems. One tremendous achievement was the ability to obtain data on structure of 
mRNA transcripts and on the effect of the structure on the efficiency of biosynthesis. The 
spatial structure of mRNA and primarily the sequence located at the 5’ terminus, proved to 
be very important (Graentzdoerfer et al. 2002) due to its ability to fold secondary structures 
covering Shine-Dalgarno sequence. 
The several years of studies on structure and function of individual elements of mRNA 
sequence resulted in a design of the optimum expression vector for the in vitro protein 
expression systems. This has been exemplified by pIVEX (In Vitro EXpression) plasmid 
(Betton 2003). This plasmid is characterized by its ability to form secondary structures at the 
level of mRNA, particularly within the Shine-Dalgarno system and AUG initiation codon. 
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Due to this, both fragments of mRNA sequence are exposed and they easily bind to a 
ribosome. An integral part of the vector also includes the sequence of the bacteriophage 
promoter, T7, which permits transcription of a given gene using T7 polymerase. Two types 
of vectors are commercially available, including: (1) those containing His-tag sequences and 
(2) Strep-tag, located on the amine or carboxylic terminus of the protein, which allows for an 
easy and rapid purification of the biosynthesis products. 
2.1 In vitro systems based on application of a semipermeable membrane 
At present, the in vitro expression systems enjoy wide application due to the ease of 
performing the reaction without the need to apply sophisticated equipment. However, 
they exhibit low efficiency, not exceeding few tens of product nanograms in 50 µl reaction. 
The solution which markedly increased protein expression level involved application of a 
semipermeable membrane, used for the first time by Spirin (Baranov and Spirin 1993). 
This produced a significant increase volume of the so-called feeding mix, containing free 
amino acids, ribonucleotides and high energy molecules (mainly ATP and GTP), securing 
in parallel high concentration of ribosomes with the yield produced in the reaction 
compartment (Fig. 1, A and B). Application of a semipermeable membrane further 
enabled a significant extension of the biosynthetic reaction since it could be continuously 
supplied by inflow of indispensable reactants from the feeding mix (Fig. 1B). The 
maximum duration of conducting the reaction averaged at approximately 30-50 h, with 
plateau of reaction product being reached following around 30 h at 30°C. The system 
produced a remarkable yield. For the first time milligram quantities of protein per 1 ml of 
the reaction were obtained. The example involved expression of GFP (Green Fluorescence 
Protein), the synthesis of which reached the level of around 5 mg in the course of a single 
24 h (Fig. 2 A and B) reaction using the RTS (Rapid Translation System) (Iskakova et al. 
2006). RTS is manufactured by Roche company and it has been designed in the basis of A. 
Spirin’s patent (U.S. Pat. No. 5,478,730).  
The RTS is based not only on the ingenious application of a semipermeable membrane but 
also coupling the transcription and translation reactions, used also in the earlier designed 
systems (Fig. 1A). Such an approach markedly abbreviated duration of the process and 
reduced formation of nonspecific products since only the gene present in the expression 
vector was undergoing transcription and, then, translation.  
2.2 Advantages and drawbacks of RTS 
The RTS system manifests several advantages. Due to release of ribosomes from the cell and 
provision of appropriate conditions for the translation reaction, toxic proteins can be 
produced. If using in vivo conditions, such toxicities factors would surely block living 
processes in the cell. Enrichment of free amino acids with their radioactively labeled 
substitutes permitted the effective labeling of nascent polypeptides. 
The open nature of  RTS systems and other in vitro techniques provided a handy tool for 
studies on protein biosynthesis itself and on molecules such as antibiotics, which would 
otherwise, of course block protein production. An interesting approach within RTS involves 
screening analysis of known or potential antibiotics. Such an approach allows for a very 
rapid determination of the inhibitory concentration of a given antibiotic (determination of 
IC50) or preliminary analysis of the mechanism of antibiotic action. 
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Fig. 1. Production of proteins in RTS system. (A) Principles of the process; coupled 
transcription-translation reaction runs on one of three templates in the reaction 
compartment supplied by energy rich-components and amino acids from the feeding 
compartment. (B) RTS reaction chamber with the semipermeable membrane separating 
reaction and feeding compartments. 
A typical marker protein used in studies on in vitro systems is GFP protein, due to the ease 
of estimating the total product quantity and the fraction of active molecules (the 
phenomenon of fluorescence). The GFP protein is almost ideal for this purpose since it 
manifests a characteristic structure (Fig. 2A). The structure involves a barrel formed by 11 β 
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structures and an active centre, the chromophore, located inside the molecule. The β 
structures serve to protect the chromophore from the access of water molecules that could 
otherwise block the fluorescence of the reaction (Yang, Moss, and Phillips 1996). The 
appearance of inappropriate amino acids in GFP disturbs its structure and allows for 
penetration of its interior by water molecules.  
Using this system, it was possible to demonstrate that the in vitro system fully confirmed the 
role of aminoglycosides as inducers of translation errors (Szaflarski et al. 2008). In the 
presence of one of the aminoglycosides (streptomycin) expression of total GFP and active 
fraction (i.e. GFP molecules inducing fluorescence) were followed by SDS polyacrylamide 
gel electrophoresis (SDS PAGE) and native PAGE, respectively. The relations between 
results read by these two techniques determined whether antibiotic (e.g. streptomycin) 
impacted on the fidelity of translation reaction. If the active fraction of GFP decreases faster 
than the total expression it means that full-size polypeptide chains are produced on the 
ribosome however their protein folding failed due to increasing number of wrong amino 
acids in the GFP and this protein was inactive (Fig. 2C). In view of the literature on 
aminoglycoside character, this provided evidence for introduction of erroneous amino acids 
to GFP molecule. This technique was demonstrated to be suitable to discriminate opposite 
effects of edeine and pactamycin acting on the ribosome (Dinos et al. 2004).  
Aminoglycosides were also tested in another in vitro synthesis system: the poly(U)-
dependent translation of polyphenylalanine (Szaflarski et al. 2008). In contrast to results 
obtained in the RTS system, they failed to block the ribosome. However, following addition 
of an additional leucine, it was found to be introduced to the polyphenylalanine chain 
already at low concentration of streptomycin (around 1 µM). This reflected the similarity of 
leucine codon and phenylalanine codon (UUC vs. UUU) and, thereafter, in situations 
inducing elevated probability of translation errors, leucine was introduced instead of 
phenylalanine. Thus, the observation did not allow a direct comparison between the two in 
vitro translation systems. The RTS system resembles more closely the natural conditions 
and, therefore, is more sensitive to action of antibiotics due to higher number of potential 
targets.  
Nevertheless, extracellular protein biosynthesis is linked to disadvantages which for several 
years have been successively eliminated. In the course of studies the systems such as RTS 
was found to support expression of relatively high amounts of protein but around half of 
the proteins were found to be biologically inactive (Iskakova et al. 2006). However, 
application of specific translation factors as EF-4 allowed reaching 100% efficiency of RTS 
system (Qin et al. 2006). 
The causes of lowered activity of proteins inside in vitro systems may be multiple but the 
most probable one involves application of the bacteriophage polymerase T7, which is 
exceedingly rapid. The transcription and translation are strictly interrelated during in vivo 
conditions with elimination of the free space on mRNA between polymerase and the 
ribosome. This prevents against development of spatial structures in mRNA molecule and it 
does not allow for a precocious termination of translation. Application of T7 polymerase 
disturbs the natural interrelationship between the polymerase and the ribosome, which may 
lead to errors at the level of translation or to incorporation of inappropriate amino acids to 
the growing polypeptide chain. The solution worked out by involved genetic recombination 
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fraction (i.e. GFP molecules inducing fluorescence) were followed by SDS polyacrylamide 
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impacted on the fidelity of translation reaction. If the active fraction of GFP decreases faster 
than the total expression it means that full-size polypeptide chains are produced on the 
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of the polymerase T7 of such a type that the enzyme contained two point mutations that 
decreased the rate of activity (He et al. 1997). The results proved that despite the lowered 
efficiency of the total biosynthesis the content of active proteins increased to almost 100%. A 
similar effect was obtained decreasing temperature of the reaction. Most probably this 
reflected the fact that, as compared to ribosomes, polymerase is much more temperature 
sensitive, producing a slower rate of transcription and a similar pace of translation (Lewicki 
et al. 1993). 
3. Energy consumption and its regeneration inside in vitro systems 
Protein biosynthesis represents a process of particular energetic requirements. In biological 
systems the energy is obtained from hydrolysis of high energy bonds. For introduction of a 
single amino acid to the growing polypeptide chain, the cell sacrifices as many as 10 high 
energy bonds which is equivalent to hydrolysis of 10 molecules of ATP or GTP, each 
characterized by bonding energy of ΔG0 = -6 kcal/mol. The extreme energetic requirement 
of a cell supporting protein biosynthesis explains development of sophisticated systems 
which control energy loss. However, the systems retain the Achilles heel of contemporary 
systems of protein biosynthesis in vitro in which their output remains seriously restricted by 
excessive uncontrolled leaks of energy: usually not more than 5% of energy is expended to 
support current protein biosynthesis while the remaining energy is wasted in uncontrolled 
biochemical reactions. It should be borne in mind that injuring the cell we introduce an 
extreme chaos to its metabolism. In contrast to in vitro conditions, in the in vivo conditions in 
a bacterial cell as much as 70% of energy can be directed to support protein biosynthesis 
(Szaflarski and Nierhaus 2007). 
Therefore, in the techniques of protein biosynthesis in vitro a continuous replenishment of 
high energy compounds (i.a. ATP and GTP), necessary for efficacious transcription and 
translation reactions, continues to pose an enormous challenge. The earliest to be 
designed system of replenishing the high energy compounds involved enrichment of the 
cellular extract with millimolar concentrations of phosphoenolpyruvate (PEP), a 
derivative of pyruvic acid, and with pyruvate kinase, which catalyzes transfer of a 
phosphate group from phosphoenolpyruvate to AMP and ADP, yielding ADP and ATP, 
respectively. Also GMP and GDP represent substrates for the kinase. PEP is distinguished 
among all biologically active compounds by its content of the energetically most valuable 
bond: the phosphoester bond contained in the compound carries the energy of ΔG0=-12 
kcal/mol. Nevertheless, the PEP-based system carries also an extreme disadvantage: the 
by-product formed during regeneration of the high energy molecules involves 
orthophosphoric acid. The acid lowers pH of the reaction and, which is even more 
important, it binds magnesium ions (Mg2+), markedly reducing their level in the reaction. 
Mg2+ stabilizes ribosome structure by its interaction with rRNA, therefore their reduced 
level results in a disturbed ribosome structure and a reduced efficiency of protein 
biosynthesis. 
One of the ways in which the lowered concentration of Mg2+ ions can be avoided involves 
transformation of orthophosphoric to acetylphosphate using pyruvate oxidase and a 
defined prosthetic group (TPP or FAD). The reaction requires an access of molecular 
oxygen, the availability of which is restricted inside in vitro systems, particularly when the 
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reaction is conducted in a few milliliter volumes. Nevertheless, the application of pyruvate 
oxidase has significantly extend  the duration of the effective protein biosynthesis reaction 
which has markedly increased efficiency (Kim and Swartz 2000). 
However, the above approach still hardly can be considered ideal. First of all, the restricted 
access of molecular oxygen markedly reduces the potential for utilization of the system on a 
larger scale. At present, the solution widely applied involves application of a combined 
system, based on the traditional PEP/pyruvate kinase approach with acetyl phosphate 
synthesis by acetyl-CoA, which allows for an effective elimination of free phosphoric acid 
during synthesis of acetylphosphate from acetyl-CoA (Jewett and Swartz 2004). Application 
of the system provided a breakthrough and permitted milligram quantities of the produced 
protein in a volume of just one milliliter (Iskakova et al. 2006). 
 
Fig. 2. Expression of GFP as a reporter protein in the presence of antibiotic streptomycin. (A) 
The molecular structure of GFP with the internal chromophore as red (coordinates based on 
PDB acc. no. 2B3Q). (B) The luminescence of GFP seen under UV lamp. (C) Parallel analysis 
of GFP total expression (SDS PAGE) and its activity measured as its luminescence (native 
PAGE). The graph demonstrates the fidelity (red line) of translation as the ratio  between 
total expression of GFP (blue dashed line) and the active fraction of GFP (green dotted line). 
Increasing concentrations of streptomycin caused dramatic decrease in the ratio of the active 
GFP to the total protein. Techniqual and experimental details see in Dinos et al. 2004; 
Szaflarski et al. 2008; Qin et al. 2006. 
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4. Biotechnological application of extracellular protein synthesis systems 
4.1 Efficient expression of several proteins and their screening analysis in parallel 
The extracellular protein expression provided the base for many automated techniques of 
high-throughput expression and screening of several proteins in parallel (Angenendt et al. 
2004; Spirin 2004). In such a system, using a single 96- or 384-well plate, multiple genes can 
be copied, transcribed and translated in parallel, providing substrates for subsequent high-
throughput analysis of protein functions. The extensive scale of expression as well as the 
rate of analysis warrant that the technique deserves to be considered in proteomics and 
protein engineering based on screening analysis of gene and protein libraries as well as of 
entire genomes and proteomes (He and Taussig 2007, 2008). The in vitro systems of protein 
expression permit synthesis of protein population in a single reaction, which represents an 
ideal and economic solution in complete screening analysis of proteins within a given gene 
library (Chandra and Srivastava).  
Such solutions can be proved by the technology known as in vitro expression cloning (IVEC) 
(King et al. 1997). In the technique a large genomic library is preliminarily subcloned to 
groups each containing 50-100 plasmids placed in the standard 96-well plate. They provide 
a template for expression in an in vitro system. The plasmid-containing genes which yield 
protein products are subsequently transferred by cloning to expression vectors, which allow 
for synthesis of milligram quantities of proteins in RTS type in vitro systems.  
The IVEC technique can further be improved by combining it with gene cloning and 
amplification using the PCR reaction, thus eliminating the time-consuming cloning of the 
genes to plasmids (Gocke and Yu 2009). Preparation of the appropriate primers containing 
promoter sequences and  Shine-Dalgarno sequences has facilitated protein synthesis directly 
from products of the PCR reaction (Rungpragayphan, Nakano, and Yamane 2003). The 
example includes an application of extracellular protein expression system for screening 
analysis of the entire Arabidopsis thaliana genome in order to identify new genes and 
products of their expression (Sawasaki et al. 2002). 
Systems of in vitro translation have found application also in medical studies. The protein 
truncated test (PTT) has been worked out in order to identify open reading frames (ORF) 
(Roest et al. 1993). Detection of precocious translation termination within an ORF may reflect 
mutation at the level of  DNA, which provides grounds for distinguishing another genetically-
conditioned disease. Other applications are linked to production and analysis inside in vitro 
systems of potential vaccines which, even if obtained on bacterial or animal ribosomes, 
manifest the same immunological variables as those obtained in cultures of human cells 
(Kanter et al. 2007). At present, new proteins representing potential anti-malaria vaccines have 
been fully worked out in the systems of extracellular protein expression (Tsuboi et al. 2008). 
Also the expression of virus-like particles (VLP) has been characterized inside in vitro systems 
The examples include the phage protein, MS2 and C-terminal fragment of the protein core in 
the hepatitis B virus (HBV), the biological activity of which has been identical to the forms 
obtained in vivo (Bundy, Franciszkowicz, and Swartz 2008).  
4.2 Production of proteins ”resistant” to expression 
Considering the open character of in vitro systems due to the absence of biological 
membranes, the systems could have been applied with excellent results for production of 
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toxic or membraneous proteins, which manifest poor expression in in vivo systems (Jackson 
et al. 2004). At present the in vitro systems allow for expression at a large scale of 
membraneous proteins in modified extracts of  E. coli (Klammt et al. 2006). Due to 
application in the in vitro systems of techniques allowing for formation of disulphide 
bridges, production of antibodies also has become possible. The example involves 
immunoglobulin G (IgG), which when obtained in the system has proven to be fully 
biologically active, manifesting affinity to antigen and stability identical to the natural 
antibody (Frey et al. 2008). 
4.3 Analysis of molecular interactions 
Extracellular protein expression systems markedly facilitate the molecular analysis of 
interactions between protein and X substance, where X may involve another protein, DNA, 
RNA or a ligand (Jackson et al. 2004). In order to identify the interaction, one of the reactants 
must be labeled (a protein, nucleotide or ligand) and placed in a system in which protein, 
the other reactant is synthesized. Then, the arising complex is isolated from the reaction mix 
using immunoprecipitation (Derbigny et al. 2000) or it may be directly analyzed in agarose 
or polyacrylamide gels (Lee and Chang 1995).  
4.4 Protein display technologies 
The essence of protein display technologies involves establishing a link between genetic 
information (genotype) and function of an unknown protein (phenotype) in the protein 
library. The principal technique involves a ribosome display (He and Taussig 1997; Hanes 
and Pluckthun 1997). Elimination of the STOP codon in mRNA permitted to obtain stable 
complexes of mRNA-ribosome-protein. Thus, a kind of a frozen structure was obtained, 
from the threshold of genetic world and proteomics. Subsequently, binding of the protein 
formed on the ribosome to a defined ligand (which may involve also DNA or RNA) resulted 
in development of an informational link between a given ligand and the sequence of protein 
mRNA. Then, a given mRNA-ribosome-protein-ligand complex can be isolated by affinity 
chromatography from the medium containing also other ligands while mRNA sequences 
are identified by reverse transcription and DNA sequencing. In order to amplify efficacy of 
the system, the process is conducted in a cyclic manner, i.e., the isolated mRNAs are 
independently amplified and added again to the mixture of ribosomes and ligands, enabling 
a more effective selection of an individual specific ligand. In combination with methods of 
genetic engineering, including mutagenesis, the protein display technologies can be applied 
not only in proteomics but also in molecular evolution studies. Now, the processes of 
interactions between DNA, RNA and protein, which took millions of years of evolution may 
be analyzed in the laboratory and their rate may be multiplied by selective amplification of 
DNA. 
5. Conclusion 
Cell-free systems will be optimized and improved according to their expression yield, 
protein specificity (“difficult proteins”) and protein folding. They will be more broadly 
applied in protein microarrays technology where can be utilized for the analysis of protein-
protein interaction. Furthermore, protein technologies based on cell-free biosynthesis will be 
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applied for protein engineering in order to synthesis specific antibodies or enzymes, as well 
as for production of proteins for crystallisation.  
The “post-genome” research requires comprehensive tool which will allow determination of 
structure, function and specific location of the proteins in the network of proteomes. It has 
to be performed effectively, quickly and on the multiple platform where large number of 
proteins can be analyzed in the same time. Based on cell-free systems such analysis is 
possible especially in the comparison to traditional cell-based systems where their 
miniaturization is rather impossible. 
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applied for protein engineering in order to synthesis specific antibodies or enzymes, as well 
as for production of proteins for crystallisation.  
The “post-genome” research requires comprehensive tool which will allow determination of 
structure, function and specific location of the proteins in the network of proteomes. It has 
to be performed effectively, quickly and on the multiple platform where large number of 
proteins can be analyzed in the same time. Based on cell-free systems such analysis is 
possible especially in the comparison to traditional cell-based systems where their 
miniaturization is rather impossible. 
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Synthetic approaches are widely employed in the emerging research field of systems and 
synthetic biology, to learn the living organisms in a physical and systematic manner, such 
as, cellular dynamics and network interactions. Synthetic gene circuits potentially offer the 
insights into nature’s underlying design principles (Hasty et al, 2002), and genetic 
reconstructions will give better understanding of naturally occurring functions (Sprinzak 
and Elowitz, 2005). Technical improvements in synthetic biology will provide not only 
engineering novelty for applications in biotechnology (McDaniel and Weiss, 2005) but also 
the fundamental understanding of living systems.  
It is well-known that a library of the parts comprised in the gene circuits, which can be 
found in MIT Parts Registry (http://parts.mit.edu/), provides a variety for genetic 
reconstruction. As well, a new born organization (http://biobricks.org/) provides a 
platform (BioBrickTM parts) for scientists and engineers to work together. Current pioneer 
studies provided the successful examples of synthetic circuits working in the living cells, 
such as, the mutual inhibitory circuits functionally constructed in bacterial cells (Gardner et 
al, 2000), and with newly introduced biological functions (Kashiwagi et al, 2006). However, 
the reported cases generally do not include the vast majority of many failures. After 
defining a conceptual design as specifying how individual components are connected to 
accomplish the desired function, the next step is constructing the well-designed foreign 
circuit in living cells. So far, the strategies for construction of synthetic gene circuits are 
more of an art form than a well-established engineering discipline, mostly, in a “Plug and 
Play” manner (Haseltine and Arnold, 2007).  
Carriers (vector) used for genetic construction are commonly limited in the plasmid, due to the 
advantageous of its efficiency and easy manipulation. Successful constructions have been 
reported to mimic a toggle switch in bacterial cells (Gardner et al, 2000), to build a synthetic 
predator-prey ecosystem (Balagadde et al, 2008), to address the dynamical property of positive 
feedback system (Maeda and Sano, 2006), to study the behaviour of the synthetic circuit under 
complex conditions: unregulated, repressed, activated, simultaneously repressed and activated 
(Guido et al, 2006). However, noise due to the copy number variation in plasmids is inevitable. 
As know, copy number variation is an important and widespread component within and 
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between cell populations. For example, CNV can cause statistically significant changes in 
concentrations of RNA associated with growth rate changes in bacteria (Klappenbach et al, 
2000; Stevenson and Schmidt, 2004); as well as, small-scale copy number variation can cause a 
dramatic, nonlinear change in gene expression from the theoretical study on various genetic 
modules (network motifs) (Mileyko et al, 2008). Thus, low-copy plasmids are utilized for 
generation of cellular function in the studies of demonstrating that negative auto-regulation 
speeds the response times of transcription networks (Rosenfeld et al, 2002), identifying 
heuristic rules for programming gene expression with combinatorial promoters (Cox et al, 
2007), studying the biological networks and produce diverse phenotypes (Guet et al, 2002), etc. 
As well, combination of low-copy plasmid and genome has been applied to analyze the 
multistablity in lactose operon in bacterial (Ozbudak et al, 2004), to evaluate the fluctuation in 
gene regulation at the single cell level (Rosenfeld et al, 2005), and to study noise propagation 
(Pedraza and van Oudenaarden, 2005), and so on. Nevertheless, neither controlling the copy 
number of plasmid in a living cell nor keeping a constant copy number of plasmid in a 
growing cell population is easy. 
Difficulties in synthetic approaches of genetic constructions are faced, in particular, as the fact 
that a stable construction is essential for steady phenotypic quantification. Practical 
methodology is required for the stable maintenance of the synthetic gene circuits in growing 
cells. As the genome is the most stable genetic circuit in living cells, insertion synthetic circuit 
into the genome will promise a best solution. Short fragment genome recombination of a 
reporter gene is widely applied, particularly, such as, the accurate prediction of the behaviour 
of gene circuits from component properties (Rosenfeld et al, 2007), and the study on intrinsic 
and extrinsic noise in a single cell level (Elowitz et al, 2002). It is becoming aware of the 
importance of genome integration of the synthetic gene networks. 
Though the single copy of genome is the best choice for carrying the synthetic circuit stable 
along with the cell division and propagation, building a complex synthetic circuit, commonly 
comprised of a few genetic parts, into genome is not an easy job due to the flowing reasons. 
Inducing these parts into the genome one by one is time consuming, and the frequently 
repeated genomic construction process can potentially result in unexpected mutagenesis or 
stress-induced genomic recombination. The modified method introduced here reduces the 
frequency of recombination, and provides a time-saving approach for efficient synthetic 
construction on the bacterial genome. The availability of long insertions allows the easy 
artificial reconstruction of complicated networks on the genome. The examples of synthetic 
circuits constructing in Escherichia coli cells using the refined methods are described in detail. 
An assortment of synthetic circuits integrated into the genome working as design principles 
are shown. The switch-like response of the synthetic circuit sensitive to nutritional conditions 
is specially presented. Constructing synthetic gene circuits integrated in bacterial genome is to 
form a stable built-in artificial structure, and provides a powerful tool for the studies not only 
on the field of synthetic and systems biology based on bacteria but also on the applications 
potential for genetic engineering to achieve metabolic reconstruction. 
2. Methodology: Genome-integration of foreign DNA sequences  
As the classic methods for genome recombination, a number of general allele replacement 
methods have been used to inactivate bacterial chromosomal genes (Dabert and Smith, 1997; 
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Kato et al, 1998; Link et al, 1997; Posfai et al, 1999). These methods all require creating the 
gene disruption on a suitable plasmid before recombining it onto the chromosome, leading 
to its complexity in the methodology. A relatively simple method was developed by 
Wanner’s group, a simple and highly efficient method to disrupt chromosomal genes in 
Escherichia coli in which PCR primers provide the homology to the targeted genes (Datsenko 
and Wanner, 2000). The procedure is based on the Red system that promotes a greatly 
enhanced rate of recombination over that exhibited by recBC, sbcB, or recD mutants when 
using linear DNA. 
Elegant applications of Wanner’s method have been reported, such as, the construction of 
single-gene knock-out mutants (Baba et al, 2006), construction of targeted single copy of lac 
fusions (Ellermeier et al, 2002), produce insertion alleles for about 2,000 genes systematic 
mutagenesis of Escherichia coli genome (Kang et al, 2004). Because of the limitation on the 
insertion length, the optimization on transformation procedure was performed to produce 
recombinant prophages carrying antibiotic resistance genes (Serra-Moreno et al, 2006). 
Wanner’s method is very efficient on deletion mutation, even for quite long genome segments, 
whereas, insertion is limited within 2-3 Kbs technically. The requirement on constructing 
complicated networks is facing to the technical problem on the length limitation.  
The methodology of genetic construction was recently published as the research article on 
a new protocol for more efficient integration of larger genetic circuits into the Escherichia 
coli chromosome. Complex synthetic circuits are commonly comprised of a few genetic 
parts. Inducing these parts into the genome one by one is time consuming, and the 
frequently repeated genomic construction process can potentially result in unexpected 
mutagenesis or stress-induced genomic recombination. The refined procedure introduced 
here shows the availability of the efficient artificial reconstruction of complex networks on 
the Escherichia coli genome, and provides a powerful tool for complex studies and analysis 
in synthetic and systems biology. Comparison between the genome integrated and the 
plasmid incorporated genes, reduced cell-to-cell variation was clearly observed in genome 
format. The method demonstrated that the integrated circuits show more stable gene 
expression than those on plasmids and so we feel this technique is an essential one for 
microbiologists to use. 
2.1 Refined method 
The method has been modified including medium, temperature, transformation, and 
selection, as described elsewhere (Ying et al, 2010). The synthetic sequences need to be 
wholly constructed on a plasmid in advance. Following PCR amplification and purification 
of the linear target sequence, transformation (electroporation) for genome replacement is 
performed, to introduce it into competent cells. To distinguish genomic recombinants from 
the original plasmid carriers, the target synthetic sequence encodes a different antibiotic 
resistant gene from the original plasmid. False transformants (i.e., transformed colony) 
carrying the plasmid grow on both antibiotic plates; genomic recombinants grow only on 
the plate carrying the antibiotic whose resistant gene is encoded in the circuit, but not the 
one encoded in the plasmid. Dual antibiotics selection for positive transformants reduces the 
labour and cost of large-scale screening, and uncovers a high ratio of positive candidates on 
the colony PCR check. The steps of the refined method are described as follows, along with 
the schematic illustration of the process (Figure 1). 
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frequently repeated genomic construction process can potentially result in unexpected 
mutagenesis or stress-induced genomic recombination. The refined procedure introduced 
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in synthetic and systems biology. Comparison between the genome integrated and the 
plasmid incorporated genes, reduced cell-to-cell variation was clearly observed in genome 
format. The method demonstrated that the integrated circuits show more stable gene 
expression than those on plasmids and so we feel this technique is an essential one for 
microbiologists to use. 
2.1 Refined method 
The method has been modified including medium, temperature, transformation, and 
selection, as described elsewhere (Ying et al, 2010). The synthetic sequences need to be 
wholly constructed on a plasmid in advance. Following PCR amplification and purification 
of the linear target sequence, transformation (electroporation) for genome replacement is 
performed, to introduce it into competent cells. To distinguish genomic recombinants from 
the original plasmid carriers, the target synthetic sequence encodes a different antibiotic 
resistant gene from the original plasmid. False transformants (i.e., transformed colony) 
carrying the plasmid grow on both antibiotic plates; genomic recombinants grow only on 
the plate carrying the antibiotic whose resistant gene is encoded in the circuit, but not the 
one encoded in the plasmid. Dual antibiotics selection for positive transformants reduces the 
labour and cost of large-scale screening, and uncovers a high ratio of positive candidates on 
the colony PCR check. The steps of the refined method are described as follows, along with 
the schematic illustration of the process (Figure 1). 
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Fig. 1. Scheme of homologous recombination. The numbering steps are corresponding to the 
listed procedure of the refined method. Modified from the original paper (Ying et al, 2010). 
• Construction of the synthetic sequence on a plasmid (often containing an AmpR gene). 
• PCR amplification of the target foreign DNA sequence, with the homogenous region 
corresponding to the recombination site. 
• Clean-up (buffer exchange or gel extraction) using commercial kits.  
• Digestion by the enzyme DpnI at 37C for 2 h to remove the trace amount of the original 
plasmid. 
• Clean-up and condensation of the target sequence. Any commercial kit is convenient. 
• Transformation to the host strain containing the plasmid of pKD46, encoding the 
recombinase. Electroporation is crucial. 
• Culturing in the rich medium (SOC) with 1 mM of arabinose, at 37C for 2 h. Quiet 
incubation often increases the efficiency of transformation. 
• Plating for antibiotic selection, incubation overnight at 37C. Once using a slow growth 
strain, the additional incubation time is required. 
• Strike the single colonies onto two plates, each with a different antibiotic, and incubate 
overnight at 37C. 
• Selection based on the difference of the clones between the two plates: positive 
candidates exhibited fast growth on the GeneR (the antibiotics resistant gene different 
from AmpR) plate, and slow or no growth on the AmpR plate. This dual antibiotics 
screening on the plates promoted the final positive selection by colony PCR. 
• Colony PCR for final confirmation. This step is essential to make sure that no 
unexpected recombination occurred in genome, particularly repeated homologous 
recombination have been performed. 
2.2 High efficiency of recombination 
Synthetic DNA sequences of various lengths (1 ― 10 Kbs) have been inserted into the 
different sites on genome, such as, intC, argG, glnA, leuB, ilvE, hisC and galK. Comparatively 
short insertions result in accurate genome replacement. In contrast, longer insertions 
generally lead to fewer transformants and a worse outcome (i.e., fewer positive colonies); 
nevertheless, usually there are still sufficient transformants for further selection (Table 1). 
Genome location (gene site) dependent efficiency of homologous recombination was noticed 
(unpublished data). The site of galK always gave the best score of successful recombination, 
regardless of the length of inserted sequences. The efficiency of successful recombination, 
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based on the positive ratio of the colony PCR, depended on the insertion length. Previous 
studies provide myriad examples of short DNA fragment recombinations (Elowitz et al, 
2002), but none of long ones. The ability of this methodology to successfully recombine a 
foreign DNA fragment of 9 to 10 Kbs indicates that it is possible to construct a complex 
synthetic gene circuit of a considerable length onto the bacterial genome.  





GeneR (cat) for deletion <1.5 hundreds ~100%
Gene A-GeneR 2-3 hundreds 70-100%
Gene A-Gene B-GeneR 3-4 20-100 70-100%
Gene A-Gene B-Gene C-GeneR 4-5 20-100 50-80%
Gene A-Gene B-…-GeneR 9-10 10-30 30-50%
 
Table 1. Recombination efficiency. Genes A, B, C, etc. represent an assortment of genes 
incorporated into the synthetic circuits. GeneR indicates the antibiotic resistance gene. 
1Number of clones grown on an agar plate plated with 300 μL of SOC transformation 
mixture. 2Ratio of the number of positive clones to the total number of clones applied in the 
colony PCR test, for final confirmation. Modified from the original paper (Ying et al, 2010). 
In addition, the homologous sequences of various lengths have been evaluated for the 
transformation efficiency at the identical genome location. In general, a 100-bp overlap, 
which can be easily generated by PCR amplification, could enable reasonably high genome 
recombination efficiency. Thought longer homologous sequences are supposed to give 
higher recombination efficiency, our test showed that length dependency was only present 
when the homologous sequence ranged from 50 to 150 bps, as an overlap of 300 to 500 bps 
decreased the number of transformants (Ying et al, 2010). We assume that the accessibility of 
the secondary structure, caused by the complex conformation of genome, for annealing 
possibly plays a role in successful recombination. According to the reported studies, genome 
integration has been generally carried out for 1 or 2 genes for each recombination step. If a 
relatively large fragment comprising 4 to 8 genes, four cycles of genome recombination 
procedure are needed. The reduced repetition of homologous recombination procedure of 
this refined protocol allows long DNA segments exchange at once. It greatly saves time and 
labour, and is supposed to contribute to the microbiological engineering.  
2.3 Reduced cell-to-cell variation 
Copy number variation in genetic materials can cause large variation within and between 
cell populations. As reported, it caused significant changes in RNA concentrations 
associated with growth rate changes (Klappenbach et al, 2000; Stevenson et al, 2004), as well 
as dramatic differences in gene expression compared to theory in various genetic modules 
(network motifs) (Mileyko et al, 2008). It is why combination of low-copy plasmids and 
genomes is currently applied in the studies on fluctuations in living cells (Ozbudak et al, 
2004; Rosenfeld et al, 2005).  
The relation between the copy number of the plasmid and the cell-to-cell variation in gene 
expression has been evaluated by an assortment of experiments using the flow cytometry, as 
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previously reported (Ito et al, 2009). The results showed that the copy number of the plasmid 
was correlated to the protein abundance, which indicated that the variable in DNA copy 
number contributed to the cell-to-cell variation in gene expression. The copy number issue is 
important to be considered, when discussing the property of the target gene and its 
expression fluctuation. Genomic recombination seems to be the best choice for the studies 
on biological noise and phenotypic fluctuation, as the genome is a stable carrier of the 
constant copy number. 
The comparison between the plasmid and the genome clearly verified this statement. Identical 
synthetic sequence, comprising a reporter gene gfp (green fluorescence protein, GFP) and an 
antibiotic resistant gene kanR, has been transformed into the host Escherichia coli cells, either in a 
low-copy plasmid (~ 20 copies per cell) or onto the genome. Once both cell types were induced 
to display similar green fluorescent intensities (i.e., the same averaged concentration of GFP), 
the variance of the cellular GFP concentration obtained from plasmid carriers was much larger 
than that from genomic carriers (Ying et al, 2010). It demonstrates that the variety of gene 
expression levels among the cells carrying the synthetic sequence in plasmid format is much 
larger than that in the genomic format. Using a very low-copy plasmid (< 5 copies per cell) 
reduced the cell-to-cell variation but still showed larger variance than the genome format 
(unpublished data). It greatly suggests that it is noise in the gene copy number that increases 
the variation in a genetically identical population. In addition, less heterogeneous in the 
transformant phenotypes and longer generations were often observed in genome-integrated 
carriers than those of plasmid insertion (personal communication). Taken together, 
construction of a synthetic gene circuit on the genome will greatly improve the stability of the 
genetic structure itself and reduce the biological noise from copy number variation. 
3. Applications: Synthetic gene circuits work as design principles 
An applicable protocol for solid and efficient genome recombination is described above. An 
assortment of well-designed synthetic circuits built-in Escherichia coli cells are going to be 
introduced as successful applications. Precise reconstruction of synthetic gene circuits to 
mimic gene expression and regulation is generally employed in a plasmid with a 
chromosomal reporter gene (Blake et al). Using the modified method, we successful 
integrated a variety of gene circuits into the bacterial genome. First of all, a relatively long 
genetic loop of mutual inhibitory structure displayed a strong hysteric expression pattern 
was successfully constructed, which was assumed to be resulted from the decreased 
fluctuation due to the genome recombination. Applying the mutual inhibitory design, a 
bistable dual function genetic switch was built in the genome. Selective expression of the 
genome integrated genetic switch sensitive to the environmental transition was clearly 
observed, which suggested that the synthetic circuits could show physiological activity in 
living cells and play an important role in population adaptation. 
3.1 Mutual inhibitory construct behaved as design principles 
Mutual inhibitory structure has been successfully constructed in bacterial cells on the 
plasmids (Gardner et al, 2000; Kashiwagi et al, 2006), and the pretty work of this structure in 
genome format was firstly reported using the refined method (Ying et al, 2010). As shown in 
Figure 2A, the mutual inhibitory structure, which was integrated into the genome and 
showed the expected features, was finally acquired using the method described here. The 
Escherichia coli DH1 cells were used as hosts for the construct. To prevent disturbance of the 
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expression from the promoter Plac by the endogenous level of LacI protein, the native lacI 
gene and the related genes lacY and lacZ were deleted from the genome. The reporter genes, 
gfp and rfp, were employed as two different visible phenotypes and were used for 
quantitative evaluation of the protein levels of the two repressor proteins, TetR and LacI. 
The two antibiotic resistant genes were used as selection markers during genetic 
construction. According to the design principle, when the two expression units (i.e., gfp-lacI-
kanR and rfp-tetR-catR), which are regulated by the promoters Plac and Ptet, respectively, are 
expressed, they will inhibit each other, and the cells will show a “red” or “green” 
phenotype. The gfp-lacI-kanR unit is highly induced (“green” phenotype) when the chemical 
inducer, doxycycline (Dox), is added. Similarly, the rfp-tetR-catR unit is greatly induced 
(“red” phenotype) by isopropyl β-D-1-thiogalactopyranoside (IPTG).  
The engineered Escherichia coli cells carrying this mutual inhibitory structure (Figure 2A) 
displayed either green or red fluorescent intensity (Figure 2B), representing the two discrete 
phenotypes of highly induced expression of either unit. As known, the positive feedback 
structure could accelerate the expression of any of the two expression units occasionally 
showing slightly higher expression level, while the mutual inhibitory structure would 
suppress expression of the other unit, leading to a fixation effect of the expressed unit 
(Gardner et al, 2000; Kashiwagi et al, 2006; Ozbudak et al, 2004). The discrete expression of 












Fig. 2. Escherichia coli cells carrying the mutual inhibitory circuit. A. Genetic construction of 
the mutual inhibitory structure. B. Immerged image of the Escherichia coli cells observed 
under fluorescent microscope. Cells carrying the synthetic circuit as illustrated in A were 
grown in the minimal medium with induced conditions. 
Following preliminary incubation in a doxycycline-free or doxycycline-supplemented (40 
nM) medium, Escherichia coli cells carrying the mutual inhibitory structure were cultured in 
various concentrations of doxycycline (i.e., 0, 5, 10, 15, 20, 30 and 40 nM) to induce the 
expression of gfp-lacI-kanR, the “green” unit. Due to the different initial states, that is, the 
“green” or “red” induced expression level, the gfp expression levels varied even under the 
same condition, for instance, in the presence of 5 nM doxycycline, cells with high expression 
of the “red” unit at preincubation (doxycycline-free condition) showed an induced 
expression of rfp after incubation (Figure 3, upper panel), while those with high expression 
of “green” unit in preincubation (doxycycline-supplemented condition) showed an induced 
expression of gfp after incubation (Figure 3, bottom panel). The hysteresis in gene expression 
was clearly observed in the engineered Escherichia coli cells, under the inductions of 5 ― 15 
nM doxycycline, and kept for several days undergoing serial transfer, equal to approximate 
30 to 50 generations. It indicated that the applicable synthetic approach of building genome 
integrated gene circuits successfully presenting the designed principles.  
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previously reported (Ito et al, 2009). The results showed that the copy number of the plasmid 
was correlated to the protein abundance, which indicated that the variable in DNA copy 
number contributed to the cell-to-cell variation in gene expression. The copy number issue is 
important to be considered, when discussing the property of the target gene and its 
expression fluctuation. Genomic recombination seems to be the best choice for the studies 
on biological noise and phenotypic fluctuation, as the genome is a stable carrier of the 
constant copy number. 
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to display similar green fluorescent intensities (i.e., the same averaged concentration of GFP), 
the variance of the cellular GFP concentration obtained from plasmid carriers was much larger 
than that from genomic carriers (Ying et al, 2010). It demonstrates that the variety of gene 
expression levels among the cells carrying the synthetic sequence in plasmid format is much 
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construction of a synthetic gene circuit on the genome will greatly improve the stability of the 
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Figure 2A, the mutual inhibitory structure, which was integrated into the genome and 
showed the expected features, was finally acquired using the method described here. The 
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expression from the promoter Plac by the endogenous level of LacI protein, the native lacI 
gene and the related genes lacY and lacZ were deleted from the genome. The reporter genes, 
gfp and rfp, were employed as two different visible phenotypes and were used for 
quantitative evaluation of the protein levels of the two repressor proteins, TetR and LacI. 
The two antibiotic resistant genes were used as selection markers during genetic 
construction. According to the design principle, when the two expression units (i.e., gfp-lacI-
kanR and rfp-tetR-catR), which are regulated by the promoters Plac and Ptet, respectively, are 
expressed, they will inhibit each other, and the cells will show a “red” or “green” 
phenotype. The gfp-lacI-kanR unit is highly induced (“green” phenotype) when the chemical 
inducer, doxycycline (Dox), is added. Similarly, the rfp-tetR-catR unit is greatly induced 
(“red” phenotype) by isopropyl β-D-1-thiogalactopyranoside (IPTG).  
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displayed either green or red fluorescent intensity (Figure 2B), representing the two discrete 
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structure could accelerate the expression of any of the two expression units occasionally 
showing slightly higher expression level, while the mutual inhibitory structure would 
suppress expression of the other unit, leading to a fixation effect of the expressed unit 
(Gardner et al, 2000; Kashiwagi et al, 2006; Ozbudak et al, 2004). The discrete expression of 












Fig. 2. Escherichia coli cells carrying the mutual inhibitory circuit. A. Genetic construction of 
the mutual inhibitory structure. B. Immerged image of the Escherichia coli cells observed 
under fluorescent microscope. Cells carrying the synthetic circuit as illustrated in A were 
grown in the minimal medium with induced conditions. 
Following preliminary incubation in a doxycycline-free or doxycycline-supplemented (40 
nM) medium, Escherichia coli cells carrying the mutual inhibitory structure were cultured in 
various concentrations of doxycycline (i.e., 0, 5, 10, 15, 20, 30 and 40 nM) to induce the 
expression of gfp-lacI-kanR, the “green” unit. Due to the different initial states, that is, the 
“green” or “red” induced expression level, the gfp expression levels varied even under the 
same condition, for instance, in the presence of 5 nM doxycycline, cells with high expression 
of the “red” unit at preincubation (doxycycline-free condition) showed an induced 
expression of rfp after incubation (Figure 3, upper panel), while those with high expression 
of “green” unit in preincubation (doxycycline-supplemented condition) showed an induced 
expression of gfp after incubation (Figure 3, bottom panel). The hysteresis in gene expression 
was clearly observed in the engineered Escherichia coli cells, under the inductions of 5 ― 15 
nM doxycycline, and kept for several days undergoing serial transfer, equal to approximate 
30 to 50 generations. It indicated that the applicable synthetic approach of building genome 
integrated gene circuits successfully presenting the designed principles.  
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Fig. 3. Memory effect of the mutual inhibitory structure. Cells populations growing under the 
different induced conditions were measured using flow cytometry (FC500, Beckman). Each 
dot spot represents a single cell. Every 10 000 cells were collected and shown in the density 
maps here. GFP FI and RFP FI represent the green and red fluorescence intensity, respectively. 
The success of the synthetic design was due to the easy genomic construction method. 
Construction of a simple toggle switch on a plasmid and transformation into bacterial cells 
was previously reported (Gardner et al, 2000). A genomic version of the similar toggle 
switch is introduced here. It could be steadily maintained along with propagation and cell 
division. Note that, to optimize this structure (i.e., for strong hysteresis of gene expression), 
the “green” unit (i.e., gfp-lacI-kanR) was fixed and the regulatory region of the “red” one (i.e., 
rfp-tetR-catR) was flexible, by using various operators or promoters. As differences in the 
sequence of promoters and the number of operators could strongly influence the binding 
affinity of the repressor proteins, regardless of the identical promoter, the operator 
sequences have been adjusted to amend the expression level of the repressors. The 
promoters and operators have been optimized for the enhanced binding affinity with the 
repressors, strong hysteresis (memory effect) was clearly observed in this construction. 
Owing to the greatly reduced copy number of the genome integrated synthetic construct, 
the changes in binding affinity of operator and repressor were clearly observed. The final 
construct of the satisfying promoter and operator sequences was decided by means of the 
“Plug and Play” strategy (Haseltine et al, 2007). Thus, optimization of the genetic construct 
in genome becomes practical, as the modification of the method reduces the steps and 
increases the efficiency of genome recombination. 
3.2 Synthetic switch sensitive to environmental transitions 
An assortment of synthetic circuits of varied genetic designs has been successfully 
constructed into the Escherichia coli genome (Kashiwagi et al, 2009; Ying et al, 2010). 
Experimental investigation demonstrated that these synthetic circuits were functional in 
living cells and could survive cells from starvation (Tsuru et al, 2011; Shimizu et al, in 
revision). Among these constructs, a relatively complex circuit of mutual inhibitory 
structure (Matsumoto et al, 2011) is introduced here. 
3.2.1 Design principles 
As described, bistability can be easily introduced into the genetic design of the synthetic 
circuit to produce two discrete stable states, “red” and “green”, as shown in Figure 2B. Once 
the biological functions, for instance, which are crucial for cell growth, are introduced to the 
synthetic circuit, the two stable states will represent two phenotypes of physiological 
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activities. For instance, two additional genes, geneA and geneB, can be inserted into the two 
expression units, “red” and “green”, as shown in Figure 4. The geneA and geneB encode the 
proteins (e.g., enzymes) that catalyze the biological reactions promoting the two 
independent physiological pathways (Figure 4, Function A and Function B), respectively. 
Switching between the two expression units is supposed to have selective activation of the 
two pathways, resulting in growth recovery of cell population and/or causing improved 
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Fig. 4. Synthetic circuit designed for physiological functions. Dual functions are introduced in 
the mutual inhibitory structure. Induced expression of geneA and geneB represent the 
















Fig. 5. Discrete phenotypes designed for the synthetic circuit. Induced expression of either 
“red” or “green” unit is supposed to be decided by the growing environment, either 
condition A (e.g., leucine-free medium) or condition B (e.g., histidine-free medium). 
Selectively induced expression of the two units is shown in red or green. 
Such synthetic gene circuit was finally designed as described elsewhere (Matsumoto et al, 
2011) and constructed as follows (Figure 4 and Figure 5). The two expression units, “red” 
and “green”, representing a dual-function synthetic switch, were built in the Escherichia coli 
genome by homologous recombination as described in 2.1. The “red” unit contained three 
genes, rfp, tetR and leuB, encoding a red fluorescent protein (RFP), a repressor protein (i.e., 
TetR) for blocking expression of the “green” unit (the promoter Ptet) and an enzyme 
contributing to leucine biosynthesis, respectively. The “green” unit consisted of three genes, 
gfp, lacI and hisC, encoding a green fluorescent protein (GFP), a repressor protein (i.e., LacI) 
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switch is introduced here. It could be steadily maintained along with propagation and cell 
division. Note that, to optimize this structure (i.e., for strong hysteresis of gene expression), 
the “green” unit (i.e., gfp-lacI-kanR) was fixed and the regulatory region of the “red” one (i.e., 
rfp-tetR-catR) was flexible, by using various operators or promoters. As differences in the 
sequence of promoters and the number of operators could strongly influence the binding 
affinity of the repressor proteins, regardless of the identical promoter, the operator 
sequences have been adjusted to amend the expression level of the repressors. The 
promoters and operators have been optimized for the enhanced binding affinity with the 
repressors, strong hysteresis (memory effect) was clearly observed in this construction. 
Owing to the greatly reduced copy number of the genome integrated synthetic construct, 
the changes in binding affinity of operator and repressor were clearly observed. The final 
construct of the satisfying promoter and operator sequences was decided by means of the 
“Plug and Play” strategy (Haseltine et al, 2007). Thus, optimization of the genetic construct 
in genome becomes practical, as the modification of the method reduces the steps and 
increases the efficiency of genome recombination. 
3.2 Synthetic switch sensitive to environmental transitions 
An assortment of synthetic circuits of varied genetic designs has been successfully 
constructed into the Escherichia coli genome (Kashiwagi et al, 2009; Ying et al, 2010). 
Experimental investigation demonstrated that these synthetic circuits were functional in 
living cells and could survive cells from starvation (Tsuru et al, 2011; Shimizu et al, in 
revision). Among these constructs, a relatively complex circuit of mutual inhibitory 
structure (Matsumoto et al, 2011) is introduced here. 
3.2.1 Design principles 
As described, bistability can be easily introduced into the genetic design of the synthetic 
circuit to produce two discrete stable states, “red” and “green”, as shown in Figure 2B. Once 
the biological functions, for instance, which are crucial for cell growth, are introduced to the 
synthetic circuit, the two stable states will represent two phenotypes of physiological 
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activities. For instance, two additional genes, geneA and geneB, can be inserted into the two 
expression units, “red” and “green”, as shown in Figure 4. The geneA and geneB encode the 
proteins (e.g., enzymes) that catalyze the biological reactions promoting the two 
independent physiological pathways (Figure 4, Function A and Function B), respectively. 
Switching between the two expression units is supposed to have selective activation of the 
two pathways, resulting in growth recovery of cell population and/or causing improved 
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Fig. 5. Discrete phenotypes designed for the synthetic circuit. Induced expression of either 
“red” or “green” unit is supposed to be decided by the growing environment, either 
condition A (e.g., leucine-free medium) or condition B (e.g., histidine-free medium). 
Selectively induced expression of the two units is shown in red or green. 
Such synthetic gene circuit was finally designed as described elsewhere (Matsumoto et al, 
2011) and constructed as follows (Figure 4 and Figure 5). The two expression units, “red” 
and “green”, representing a dual-function synthetic switch, were built in the Escherichia coli 
genome by homologous recombination as described in 2.1. The “red” unit contained three 
genes, rfp, tetR and leuB, encoding a red fluorescent protein (RFP), a repressor protein (i.e., 
TetR) for blocking expression of the “green” unit (the promoter Ptet) and an enzyme 
contributing to leucine biosynthesis, respectively. The “green” unit consisted of three genes, 
gfp, lacI and hisC, encoding a green fluorescent protein (GFP), a repressor protein (i.e., LacI) 
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inhibiting expression of the “red” unit (the promoter Plac) and an enzyme involved in 
histidine biosynthesis, respectively. That is, the geneA and geneB were replaced by leuB and 
hisC, and leucine and histidine biosynthesis represented the Function A and B, respectively 
(Figure 4). By the way, to oblige the cells to use the genes, hisC and leuB, within the synthetic 
switch, the native regulation of Leu and His operons was disturbed by removing leuB and 
hisC from their native chromosomal locations. Thus, the expression of leuB and hisC only 
inside the “red” and “green” units were reported by the red and green fluorescence, 
respectively. Thus, a synthetic switch based on a mutual inhibitory structure showing two 
discrete physiological states, the induced leucine (red) and histidine (green) productions, 
was constructed as designed (details in Matsumoto et al, 2011). 
Rewiring of the stress-stringent genes (i.e., leuB and hisC) to the synthetic circuit allows us 
not only to investigate the unknown survival strategy in living systems but also to search 
the possibility of metabolism reconstitution. As genome recombination promises a stable 
genetic carrier, this synthetic dual-function circuit can be applied to mimic cellular 
behaviour. According to the design principle, the Escherichia coli cells carrying this synthetic 
switch are able to show two different phenotypes, “red” and “green”, representing the 
induced expression of leuB and hisC, and related to two physiological functions, i.e., leucine 
and histidine biosynthesis, respectively (Figure 5). Bistability, resulting from the mutual 
inhibitory structure, was assumed to confer the “memory effect” on the cells carrying this 
structure, as shown in Figure 3, where the same promoter and repressor cassette is used. 
That is, the cells are thought to be able to show two distinct phenotypes under identical 
culture conditions due to the diverse histories (induction) of gene expression.  
Here, two diverse biological functions leucine and histidine biosynthesis are designed, both 
of which result in a fitness recovery depending on the external conditions (Figure 5). For 
instance, it is the cells only showing an induced expression level of the “red” unit, which 
contacting the gene leuB essential for leucine biosynthesis that could survive under leucine-
depleted conditions (i.e., Condition A). In general, Escherichia coli cells use the Leu operon 
and His operon to respond to starvation (Keller and Calvo, 1979; Searles et al, 1983; Wessler 
and Calvo, 1981). Depletion of leucine will lead to the induced expression of structural 
genes in the Leu operon; similarly, histidine depletion will cause an increase in expression of 
proteins encoded within the His operon (Henkin and Yanofsky, 2002; Keller et al, 1979). leuB 
and hisC, which are located within the Leu and His operons (Gama-Castro et al, 2008), are 
responsible for leucine and histidine biosynthesis, respectively. Rewiring these stringent 
starvation genes to the synthetic circuit not only introduces physiological activities to the 
synthetic design but also disturbs the original native regulation.  
3.2.2 Experimental investigation 
Firstly, whether the constructed synthetic circuit was functional was examined. The addition 
of IPTG induced the expression of the “red” unit that comprising leuB greatly improved the 
cell growth under the leucine-depleted conditions; similarly, the addition of doxycycline 
(Dox) induced the expression of hisC within the “green” unit, and allowed the cells to grow 
in histidine-depleted conditions (Table 2). Obviously, the selective full induction of the two 
expression units enabled the cells to grow under starved conditions. These results verified 
the following points: 1) the rewired genes, leuB and hisC, were biologically active, regardless 
of the chromosomal replacement; 2) the repressor-promoter interactions involved in the 
mutual inhibitory structure were strong; 3) the synthetic circuit was genetically stable and 
functional in the living cells. 
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No add. +IPTG +Dox
+Leu 0.24 0.07 0.25
+His 0.10 0.35 0.10
Both AA 0.37 0.40 0.40
No add. +IPTG +Dox
+Leu hisC leuB hisC
+His hisC leuB hisC
Both AA hisC leuB hisC
Cell growth Gene Expression
 
Table 2. Cell growth and gene expression under varied conditions. +Leu, +His and Both AA 
indicate the addition of leucine, histidine and both amino acids, respectively. +IPTG, +Dox 
and No add. indicate the addition of IPTG, doxycycline, and in the absence of inducers, 
respectively. Cell growth is shown in the growth rate (h-1), and gene expression is marked as 
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Fig. 6. Population shift in response to environmental transition. The distributions of newly 
formed populations (from 0 to 10 h or 33 h) are shown from light to dark grey, respectively. 
Green fluorescence intensity (GFP FI) and forward scattering (FSC) represent the 
abundances of GFP expressed in single cells and the relative cell size, respectively. GFP 
FI/FSC indicates the expression level of the “green” unit (i.e., hisC) in cells. The figures are 
partially modified from the original paper (Matsumoto et al, 2011). 
Subsequently, whether the synthetic circuit comprised of the rewired genes can be used by 
the Escherichia coli cells as a functional genetic switch in response to environmental 
transition was investigated. Under the hysteretic conditions, exponentially growing cells 
were transferred to the fresh media without the essential amino acid, leucine or histidine, for 
growth. Temporal changes in population dynamics were analyzed using flow cytometry, as 
described somewhere else (Matsumoto et al, in submission). When the “red” cell population 
of repressed expression of hisC was transferred to histidine-free conditions, the composition 
of the cell population changed gradually. More and more “green” cells of induced 
expression of hisC were born within the population, resulted in the population transition 
from “red” to “green” (Figure 6, left). Similarly, once the “green” cell population of 
repressed expression of leuB was transferred to leucine-free conditions, the “red” cells of 
induced expression of leuB were born and the fast growth allowed the “red” cells to take 
over the whole population, leading to the distribution shift from “green” to “red” (Figure 6, 
right). Note that in the rich medium, both “red” and “green” populations kept their 
distributions as initial expression level. Taken together, the Escherichia coli cells carrying this 
synthetic circuit formed the new population in accordance with the nutritional status. 
Furthermore, the relation between cell growth and expression of the synthetic circuit was 
evaluated. The temporal trajectory of the relation between cell growth and relative 
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inhibiting expression of the “red” unit (the promoter Plac) and an enzyme involved in 
histidine biosynthesis, respectively. That is, the geneA and geneB were replaced by leuB and 
hisC, and leucine and histidine biosynthesis represented the Function A and B, respectively 
(Figure 4). By the way, to oblige the cells to use the genes, hisC and leuB, within the synthetic 
switch, the native regulation of Leu and His operons was disturbed by removing leuB and 
hisC from their native chromosomal locations. Thus, the expression of leuB and hisC only 
inside the “red” and “green” units were reported by the red and green fluorescence, 
respectively. Thus, a synthetic switch based on a mutual inhibitory structure showing two 
discrete physiological states, the induced leucine (red) and histidine (green) productions, 
was constructed as designed (details in Matsumoto et al, 2011). 
Rewiring of the stress-stringent genes (i.e., leuB and hisC) to the synthetic circuit allows us 
not only to investigate the unknown survival strategy in living systems but also to search 
the possibility of metabolism reconstitution. As genome recombination promises a stable 
genetic carrier, this synthetic dual-function circuit can be applied to mimic cellular 
behaviour. According to the design principle, the Escherichia coli cells carrying this synthetic 
switch are able to show two different phenotypes, “red” and “green”, representing the 
induced expression of leuB and hisC, and related to two physiological functions, i.e., leucine 
and histidine biosynthesis, respectively (Figure 5). Bistability, resulting from the mutual 
inhibitory structure, was assumed to confer the “memory effect” on the cells carrying this 
structure, as shown in Figure 3, where the same promoter and repressor cassette is used. 
That is, the cells are thought to be able to show two distinct phenotypes under identical 
culture conditions due to the diverse histories (induction) of gene expression.  
Here, two diverse biological functions leucine and histidine biosynthesis are designed, both 
of which result in a fitness recovery depending on the external conditions (Figure 5). For 
instance, it is the cells only showing an induced expression level of the “red” unit, which 
contacting the gene leuB essential for leucine biosynthesis that could survive under leucine-
depleted conditions (i.e., Condition A). In general, Escherichia coli cells use the Leu operon 
and His operon to respond to starvation (Keller and Calvo, 1979; Searles et al, 1983; Wessler 
and Calvo, 1981). Depletion of leucine will lead to the induced expression of structural 
genes in the Leu operon; similarly, histidine depletion will cause an increase in expression of 
proteins encoded within the His operon (Henkin and Yanofsky, 2002; Keller et al, 1979). leuB 
and hisC, which are located within the Leu and His operons (Gama-Castro et al, 2008), are 
responsible for leucine and histidine biosynthesis, respectively. Rewiring these stringent 
starvation genes to the synthetic circuit not only introduces physiological activities to the 
synthetic design but also disturbs the original native regulation.  
3.2.2 Experimental investigation 
Firstly, whether the constructed synthetic circuit was functional was examined. The addition 
of IPTG induced the expression of the “red” unit that comprising leuB greatly improved the 
cell growth under the leucine-depleted conditions; similarly, the addition of doxycycline 
(Dox) induced the expression of hisC within the “green” unit, and allowed the cells to grow 
in histidine-depleted conditions (Table 2). Obviously, the selective full induction of the two 
expression units enabled the cells to grow under starved conditions. These results verified 
the following points: 1) the rewired genes, leuB and hisC, were biologically active, regardless 
of the chromosomal replacement; 2) the repressor-promoter interactions involved in the 
mutual inhibitory structure were strong; 3) the synthetic circuit was genetically stable and 
functional in the living cells. 
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Fig. 6. Population shift in response to environmental transition. The distributions of newly 
formed populations (from 0 to 10 h or 33 h) are shown from light to dark grey, respectively. 
Green fluorescence intensity (GFP FI) and forward scattering (FSC) represent the 
abundances of GFP expressed in single cells and the relative cell size, respectively. GFP 
FI/FSC indicates the expression level of the “green” unit (i.e., hisC) in cells. The figures are 
partially modified from the original paper (Matsumoto et al, 2011). 
Subsequently, whether the synthetic circuit comprised of the rewired genes can be used by 
the Escherichia coli cells as a functional genetic switch in response to environmental 
transition was investigated. Under the hysteretic conditions, exponentially growing cells 
were transferred to the fresh media without the essential amino acid, leucine or histidine, for 
growth. Temporal changes in population dynamics were analyzed using flow cytometry, as 
described somewhere else (Matsumoto et al, in submission). When the “red” cell population 
of repressed expression of hisC was transferred to histidine-free conditions, the composition 
of the cell population changed gradually. More and more “green” cells of induced 
expression of hisC were born within the population, resulted in the population transition 
from “red” to “green” (Figure 6, left). Similarly, once the “green” cell population of 
repressed expression of leuB was transferred to leucine-free conditions, the “red” cells of 
induced expression of leuB were born and the fast growth allowed the “red” cells to take 
over the whole population, leading to the distribution shift from “green” to “red” (Figure 6, 
right). Note that in the rich medium, both “red” and “green” populations kept their 
distributions as initial expression level. Taken together, the Escherichia coli cells carrying this 
synthetic circuit formed the new population in accordance with the nutritional status. 
Furthermore, the relation between cell growth and expression of the synthetic circuit was 
evaluated. The temporal trajectory of the relation between cell growth and relative 
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expression level in the cell population showed that the growth rate decreased significantly 
under conditions of leucine or histidine depletion but recovered gradually, accompanied by 
a gradual increase in leuB (“red” unit) or hisC (“green” unit) expression level. The growth 
recovery and population transition due to histidine depletion were faster than those due to 
leucine depletion. The “green” unit (hisC) was much easier to induce than the “red” unit 
(leuB), possibly due to slight leakage of gene expression from Ptet, diverse essentiality in 
amino acid requirement, or as yet unknown synchronised expression changes in other 
related genes, etc. Further applications using other genes and amino acids are required to 
determine the universality of the capacity of the synthetic circuit to respond to external 
perturbations and to function as genetic switch sensitive to surroundings. 
The experiments demonstrated that bacterial cells carrying this synthetic circuit formed 
diverse populations in response to the nutritional conditions and survived under conditions 
of nutrient depletion. A genome-integrated dual-function synthetic circuit sensitive to an 
environmental transition was successfully acquired. It strongly suggested that the synthetic 
design of proto-operons sensitive to external perturbations is practical for native cells. In 
summary, the method of genetic engineering and the application studies introduced here 
provides an efficient constructive approach for the studies or analysis in bacterial systems 
biology. Here, the genes involved in physiological functions responsive to external changes 
are introduced into the two expression units, the selective expression of the two units in 
cells can be considered a synthetic operon contributing to survival and/or adaptation. 
4. Conclusion 
A modified method for the integration of complicated genetic circuits into the Escherichia coli 
genome is introduced. The methodology provides an efficient synthetic approach for the 
dynamic and stochastic study of genetic networks. Linear artificial sequences as long as ~ 9 
Kbps can be easily integrated into the bacterial genome at one time. The applications clearly 
showed accurate phenotypic behavior of the genome-integrated synthetic gene circuits 
corresponding to the design principle, which confirmed that the improved method allows 
the efficient construction of a single copy of a complicated genetic circuit in cells. As the 
genome recombination generally minimizes the copy number noise in the genetic circuit, it 
allows the precise design and interpretation of the cellular network. The availability of long-
fragment insertions allows the easy reconstruction of complicated networks on the genome, 
and provides a powerful tool for synthetic and systems biology. Furthermore, the Escherichia 
coli cells carrying the synthetic circuit showed selective expression pattern in accordance 
with the environmental conditions, demonstrated the successful application of the genome-
integrated synthetic circuit in cells. The applications owing to the simplified protocol 
demonstrated that the synthetic construct in the genome could be physiologically functional 
and sensitive to environmental transition. Synthetic approaches not only leads to the 
technical evolution for industrial use, but also can be employed to observe novel 
phenomena in living organisms. Further applications and improvement may bring us the 
completely synthetic genome functionally works in protocells.  
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1. Introduction 
The gastrointestinal tract (GTI) is the organ with the largest surface area in the human body, 
having in an adult between 150 and 200 m2 (Holzapfel et al., 1998). Interesting in this context 
is the fact that a huge number of microorganisms live and interact with the host in the 
stomach and gut. The GIT of an adult human is estimated to harbour about 1013–1014  viable 
bacteria, i.e. 10 times the total number of eukaryotic cells in all tissues of man's body 
(Holzapfel et al., 1998; Velez et al., 2007). In the gastrointestinal tract, the bacteria are 
affected both by the physiological conditions (such as low pH, bile salt and enzymes) and by 
other microorganisms which exist in the GIT. Because of the presence of enzymes, salts and 
acids in the gastric juice, the environmental conditions in the stomach are destructive to a 
number of microorganisms (Holzapfel et al., 1998). The microbial community in the 
gastrointestinal tract is complex and consists of several hundred species, of which lactic acid 
bacteria constitute a minor proportion. Lactic acid bacteria (LAB) are Gram-positive bacteria 
which excrete lactic acid as a main fermentation product into the medium. This biochemical 
definition associates lactic acid bacteria of different phylogenetic branches of bacterial 
evolution: the “low GC” taxa, e.g. Enterococcus, Lactobacillus, Lactococcus, Leuconostoc, 
Pediococcus and Streptococcus, and the “high GC” genus Bifidobacterium. Species of these 
genera can be found in gastrointestinal tract of man and animal (Klaenhammer et al., 2005; 
Klein et al., 1998; Mathur & Singh, 2005). They have also been involved since time 
immemorial in food processing and food preservation, and are applied in particular for the 
manufacturing of dairy products, fermented meat, vegetables, bread and ensilage (Pouwels 
et al., 1998). Several lactic acid bacteria have the potential to promote the health of the host 
or to prevent and treat diseases. Such bacteria are referred to as probiotic, meaning ‘for life’ 
(Latin pro=for and biotic=life) (Herich & Levkut, 2002; Marteau & Rambaud, 2002; Mercenier 
et al., 2002; Ouwehand et al., 2003). The strains of LAB used as probiotics usually belong to 
species of the genera Lactobacillus, Enterococcus, and Bifidobacterium (Klein et al., 1998). The 
effects of probiotic microorganisms on the host have been discussed extensively in the 
literature. It has been proposed that probiotics possess several advantageous properties, 
such as antagonistic actions, production of antimicrobial substances, modulation of immune 
responses, and impact on the metabolic activities of the gut (Marteau & Rambaud, 2002; 
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immemorial in food processing and food preservation, and are applied in particular for the 
manufacturing of dairy products, fermented meat, vegetables, bread and ensilage (Pouwels 
et al., 1998). Several lactic acid bacteria have the potential to promote the health of the host 
or to prevent and treat diseases. Such bacteria are referred to as probiotic, meaning ‘for life’ 
(Latin pro=for and biotic=life) (Herich & Levkut, 2002; Marteau & Rambaud, 2002; Mercenier 
et al., 2002; Ouwehand et al., 2003). The strains of LAB used as probiotics usually belong to 
species of the genera Lactobacillus, Enterococcus, and Bifidobacterium (Klein et al., 1998). The 
effects of probiotic microorganisms on the host have been discussed extensively in the 
literature. It has been proposed that probiotics possess several advantageous properties, 
such as antagonistic actions, production of antimicrobial substances, modulation of immune 
responses, and impact on the metabolic activities of the gut (Marteau & Rambaud, 2002; 
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O'Toole & Cooney, 2008; Sanders & Klaenhammer, 2001). In vitro and animal studies have 
further shown inhibitory effects of probiotic bacteria to be mediated by their interference 
with the adhesion of gastrointestinal pathogens or with toxins produced by the pathogenic 
microorganisms (O'Toole & Cooney, 2008; Sullivan & Nord, 2002). However, beneficial 
influence of probiotics has been demonstrated in clinical studies (De Roos & Katan, 2000; 
Kos et al., 2008; Mishra et al., 2008; O'Toole & Cooney, 2008; Park et al., 2008; Resta-Lenert & 
Barrett, 2003; Sanders & Klaenhammer, 2001). Some possible health effects include immune 
system stimulation, cholesterol lowering, prevention and treatment of diarrhea, prevention 
of cancer recurrence, improvement in lactose intolerance, and reduction of allergy (De Roos 
& Katan, 2000; Mercenier et al., 2002; Reid, 1999; Sanders & Klaenhammer, 2001). The most 
common probiotic strains belong to two genera, Lactobacillus and Bifidobacterium (Sanders & 
Klaenhammer, 2001; Sullivan & Nord, 2002). Some strains of Lactobacillus are found as 
natural commensals of the GIT, the oral cavity and the female uro-genital tract of animals 
and humans (Pouwels et al., 1998). Also, Lactobacilli are of considerable technological and 
commercial importance because of their role in the manufacturing and preservation of many 
fermented food products (Schar-Zammaretti et al., 2005). Lactobacillus acidophilus is one of 
the major species of the genus Lactobacillus found in human and animal intestines (Frece et 
al., 2005). Nowadays, Lactobacillus acidophilus strains are commonly used as probiotic 
(Sanders & Klaenhammer, 2001), and marketed as capsules, powders, enriched yogurts, 
yogurt-like products, and milk (De Roos & Katan, 2000). Adhesion to intestinal epithelial 
cells is an important prerequisite for colonization of probiotic strains in the gastrointestinal 
tract (Altermann et al., 2004; Kos et al., 2003). This is mediated either non-specifically by 
physico-chemical factors (such as hydrophobicity) or, specifically, by adhesive bacterial 
surface molecules and epithelial receptor molecules (such as S-layer, fibronectin and mucin-
binding proteins) (Holzapfel et al., 1998). 
2. Probiotics and stress 
In the intestinal tracts of mammals and avians, species of the genera Lactobacillus, 
Enterococcus, Streptococcus and Bifidobacterium are the dominant indigenous lactic micro-
biota. Commonly recovered Lactobacillus isolates from the human gastrointestinal tract 
include L. acidophilus, L. salivarius, L. casei, L. plantarum, L. fermentum, L. brevis and L. reuteri. 
The findings that colonization by lactobacilli and other lactic acid bacteria improves 
infection resistance of the host have led to the production and consumption of probiotics 
(Kosin & Rakshit, 2006). The probiotics must resist multiple stresses including the GIT 
conditions and food processing. An important attribute for certain probiotic bacteria 
functions are survival and growth in the intestinal tract (Sanders & Klaenhammer, 2001). 
The gastric juice contains hydrochloric acid, which induces an extremely low pH. The 
fasting pH in the stomach is approximately 1.5, while the pH increases to between 3.0 and 
5.0 when food is eaten (Cotter & Hill, 2003). In the intestine, the conditions are less extreme 
because of in the intestine pH is higher than the stomach, but the bacteria still have to 
endure bile and pancreatic juices (intestinal fluids). Other factors affecting microbial life in 
this environment are immunoglobulins, defensins, a continuously regenerating epithelium, 
peristaltic movement of intestinal content, and a viscous mucus layer (Dunne et al., 2001; 
Tannock et al., 1999). Moreover, probiotics used in food technology are exposed to various 
adverse conditions during processing, such as temperature changes, acidity, osmotic and 
oxidative stress (Kosin & Rakshit, 2006). Such stresses may reduce the physiological activity 
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of the cells and readily kill the cells. Once the cells have survived the stresses, they can 
colonize and grow to adequate numbers to provide the beneficial effect to the host. Survival 
mechanisms exhibited by bacteria when confronted with stress are generally referred to as 
the stress response (De Angelis & Gobbetti, 2004; Jan et al., 2001; Kim et al., 2001). However, 
the ability to survive passage through the intestinal tract and potentially establish residence 
there is considered as an important feature. The degree of retention is likely dependent on 
the ability of the bacteria to interact with eukaryotic cell surfaces or with the mucosal layer 
surrounding these cells (Altermann et al., 2004). Several factors contribute to the interaction 
of Lactobacilli with the host tissues, such as cell surface hydrophobicity (Vadillo-Rodriguez 
et al., 2005; Van der Mei et al., 2003), autoaggregation (Kos et al., 2003), lipoteichoic acids 
(Granato et al., 1999) and external surface proteins (such as S-layer, fibronectin and mucin-
binding proteins) (Altermann et al., 2004; Avall-Jaaskelainen & Palva, 2005; Frece et al., 2005; 
Kos et al., 2003; Kosin & Rakshit, 2006; Pouwels et al., 1998; Velez et al., 2007; Ventura et al., 
2002). Surface layer (S-layer) has been identified as the outermost structure of cell envelope 
in numerous organisms from the domains Bacteria (in both Gram-positive and Gram-
negative Eubacteria) and Archaea  (Debabov, 2004; Sara & Sleytr, 2000). S-layer proteins are 
non-covalently bound to the cell wall and assemble into surface layers with high degrees of 
positional order often completely covering the cell wall, and can be disintegrated into 
monomers by denaturing agents such as urea or guanidine hydrochloride (Avall-
Jaaskelainen & Palva, 2005; Engelhardt & Peters, 1998; Lortal et al., 1992; Sleytr et al., 2001). 
The S-layer has been detected in a few species of the genus Lactobacillus (Avall-Jaaskelainen 
& Palva, 2005). Lactobacilli surface layer proteins (S-layers) are generally monomolecular 
crystalline arrays exhibiting a morphologically similar, oblique lattice structure and 
representing 10-15% of the total protein content of the bacterial cell wall (Avall-Jaaskelainen 
& Palva, 2005; Jakava-Viljanen et al., 2002). Several reports have appeared in which 
functions of S-layer are described or assumed (Boot et al., 1993; Jakava-Viljanen et al., 2002; 
Sara & Sleytr, 2000). However, no general function has been identified for S-layer proteins, 
but several lactobacillar S-layers have been identified as putative adhesions with affinity for 
intestinal epithelial cells, extracellular matrices and/ or to lipoteichoic acid (LTA) of other 
bacterial species (Avall-Jaaskelainen & Palva, 2005; Buck et al., 2005; Frece et al., 2005; 
Garrote et al., 2004; Hynonen et al., 2002; Kos et al., 2003; Velez et al., 2007; Vidgren et al., 
1992). Of the various roles proposed for the bacterial S-layer, it is a protective sheath against 
hostile environment (Avall-Jaaskelainen & Palva, 2005; Frece et al., 2005; Khaleghi et al., 
2010, 2011; Kos et al., 2003; Schar-Zammaretti et al., 2005). Adhesive S-layers have a role in 
inhibition of adhesiveness of pathogenic bacteria and thus can contribute to probiotic effects 
of lactobacilli. To date, several lactobacilli S-layer protein-encoding genes have been cloned, 
sequenced and deposited in GenBank (Avall-Jaaskelainen & Palva, 2005; Velez et al., 2007). 
The presence of multiple S-layer protein genes seems to be quite common for bacteria 
(Avall-Jaaskelainen & Palva, 2005; Ben-Jacob et al., 2000; Boot & Pouwels, 1996; Jakava-
Viljanen et al., 2002). Multiple S-layer genes have been identified in the genomes of L. 
acidophilus, L. amylovorus, L. gallinarum, L. crispatus, L. brevis, L. gasseri and L. johnsonii (Avall-
Jaaskelainen & Palva, 2005; Boot & Pouwels, 1996; Jakava-Viljanen et al., 2002; Ventura et al., 
2002). There is also increasing evidence that S-layer-carrying bacteria may use S-layer 
variation, by expressing alternative S-layer protein genes, for adaptation to different stress 
factors such as the immune response of the host for pathogens and drastic changes in the 
environmental conditions for nonpathogens (Boot & Pouwels, 1996; Frece et al., 2005; 
Jakava-Viljanen et al., 2002; Pouwels et al., 1998; Sara & Sleytr, 2000). According to Pouwels’ 
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O'Toole & Cooney, 2008; Sanders & Klaenhammer, 2001). In vitro and animal studies have 
further shown inhibitory effects of probiotic bacteria to be mediated by their interference 
with the adhesion of gastrointestinal pathogens or with toxins produced by the pathogenic 
microorganisms (O'Toole & Cooney, 2008; Sullivan & Nord, 2002). However, beneficial 
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& Katan, 2000; Mercenier et al., 2002; Reid, 1999; Sanders & Klaenhammer, 2001). The most 
common probiotic strains belong to two genera, Lactobacillus and Bifidobacterium (Sanders & 
Klaenhammer, 2001; Sullivan & Nord, 2002). Some strains of Lactobacillus are found as 
natural commensals of the GIT, the oral cavity and the female uro-genital tract of animals 
and humans (Pouwels et al., 1998). Also, Lactobacilli are of considerable technological and 
commercial importance because of their role in the manufacturing and preservation of many 
fermented food products (Schar-Zammaretti et al., 2005). Lactobacillus acidophilus is one of 
the major species of the genus Lactobacillus found in human and animal intestines (Frece et 
al., 2005). Nowadays, Lactobacillus acidophilus strains are commonly used as probiotic 
(Sanders & Klaenhammer, 2001), and marketed as capsules, powders, enriched yogurts, 
yogurt-like products, and milk (De Roos & Katan, 2000). Adhesion to intestinal epithelial 
cells is an important prerequisite for colonization of probiotic strains in the gastrointestinal 
tract (Altermann et al., 2004; Kos et al., 2003). This is mediated either non-specifically by 
physico-chemical factors (such as hydrophobicity) or, specifically, by adhesive bacterial 
surface molecules and epithelial receptor molecules (such as S-layer, fibronectin and mucin-
binding proteins) (Holzapfel et al., 1998). 
2. Probiotics and stress 
In the intestinal tracts of mammals and avians, species of the genera Lactobacillus, 
Enterococcus, Streptococcus and Bifidobacterium are the dominant indigenous lactic micro-
biota. Commonly recovered Lactobacillus isolates from the human gastrointestinal tract 
include L. acidophilus, L. salivarius, L. casei, L. plantarum, L. fermentum, L. brevis and L. reuteri. 
The findings that colonization by lactobacilli and other lactic acid bacteria improves 
infection resistance of the host have led to the production and consumption of probiotics 
(Kosin & Rakshit, 2006). The probiotics must resist multiple stresses including the GIT 
conditions and food processing. An important attribute for certain probiotic bacteria 
functions are survival and growth in the intestinal tract (Sanders & Klaenhammer, 2001). 
The gastric juice contains hydrochloric acid, which induces an extremely low pH. The 
fasting pH in the stomach is approximately 1.5, while the pH increases to between 3.0 and 
5.0 when food is eaten (Cotter & Hill, 2003). In the intestine, the conditions are less extreme 
because of in the intestine pH is higher than the stomach, but the bacteria still have to 
endure bile and pancreatic juices (intestinal fluids). Other factors affecting microbial life in 
this environment are immunoglobulins, defensins, a continuously regenerating epithelium, 
peristaltic movement of intestinal content, and a viscous mucus layer (Dunne et al., 2001; 
Tannock et al., 1999). Moreover, probiotics used in food technology are exposed to various 
adverse conditions during processing, such as temperature changes, acidity, osmotic and 
oxidative stress (Kosin & Rakshit, 2006). Such stresses may reduce the physiological activity 
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of the cells and readily kill the cells. Once the cells have survived the stresses, they can 
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The presence of multiple S-layer protein genes seems to be quite common for bacteria 
(Avall-Jaaskelainen & Palva, 2005; Ben-Jacob et al., 2000; Boot & Pouwels, 1996; Jakava-
Viljanen et al., 2002). Multiple S-layer genes have been identified in the genomes of L. 
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2002). There is also increasing evidence that S-layer-carrying bacteria may use S-layer 
variation, by expressing alternative S-layer protein genes, for adaptation to different stress 
factors such as the immune response of the host for pathogens and drastic changes in the 
environmental conditions for nonpathogens (Boot & Pouwels, 1996; Frece et al., 2005; 
Jakava-Viljanen et al., 2002; Pouwels et al., 1998; Sara & Sleytr, 2000). According to Pouwels’ 
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study (1998), phase variation or antigenic variation, as a result of inversion of the slp 
segment, might enable Lactobacillus acidophilus bacteria to better adhere to specific regions of 
the mucosa. Variation in S-layer gene expression as a response to environmental changes 
has also been described in Geobacillus stearothermophilus, Bacillus anthracis, and Campylobacter 
fetus (Boot & Pouwels, 1996; Mignot et al., 2002).  
There is some evidence that the surface properties of microorganisms are dependent on the 
growth conditions and the composition of the fermentation medium (Schar-Zammaretti et 
al., 2005; Waar et al., 2002; Dufrene & Rouxhet, 1996; Millsap et al., 1997). Schar-Zammaretti 
(2005) suggested that S-layer protein is preferentially expressed under different 
fermentation media. Furthermore, it has been shown that the S-layer production is changed 
with the change in medium (such as bile salt, penicillin G) (Khaleghi et al., 2010, 2011). 
The aim of this study was to gain more knowledge about S-layer production and slpA gene 
expression in different growth conditions (pH and temperature) in Lactobacillus acidophilus 
ATCC 4356. Moreover, the reassembly of S-layer subunits was studied under these stresses.  
2.1 S-layer protein, slpA expression and stresses 
The S-layer proteins of Lactobacilli are relatively small, 25 kDa to 71 kDa in size (Avall-
Jaaskelainen & Palva, 2005), whereas the molecular masses of S-layers in other bacterial 
species range up to 200 kDa (Sara & Sleytr, 2000). The Lactobacillar S-layers are highly basic 
proteins with calculated isoelectric point values ranging from 9.35 to 10.4. Yet, all the other 
S-layer proteins characterized are weakly acidic (Avall-Jaaskelainen & Palva, 2005). 
Evidence shows that the S-layer protein is important for Lactobacillus acidophilus (Frece et al., 
2005; Khaleghi et al., 2010, 2011; Kim et al., 2001; Toba et al., 1995).  
Lactobacillus acidophilus strains isolated from humans and animals, which belong to DNA 
homology groups A, are reported to possess a slpA gene, while the strains which belong to 
the DNA homology groups B appear not to have an slpA gene (Boot et al., 1993). According 
to Boots' study (1995, 1996, 1996c), there are two S-layer protein encoding genes, slpA and 
slpB, in Lactobacillus acidophilus ATCC 4356; of the two, slpA is active and slpB is silent in 
normal growth conditions. The two S-protein genes are located 6-kb apart on the 
chromosome, in a reverse orientation relative to each other. The slpA gene is interchanged 
with the slpB gene through inversion of a chromosomal fragment in a fraction of a culture 
(0.3% of the cell growth under laboratory conditions). Thus, it seems that S-layer variation of 
non-pathogenic lactobacilli has the same function as S-layer variation for pathogenic 
organisms such as Campylobacter fetus, namely to circumvent an immune response of the 
infected host (Boot & Pouwels, 1996; Boot et al., 1995, 1996b, 1996c). 
Therefore, the present study investigated the effects of some stresses on the S-layer 
production, reassembly of S-layer subunits, and slpA gene expression. 
2.1.1 Materials and methods 
2.1.1.1 Stress conditions 
To study the effect of heat and pH stresses on S-layer production and slpA gene expression, 
the Lactobacillus acidophilus ATCC 4356 was cultivated in MRS broth (Merck) for heat stress 
(30, 45, 50 and 55 oC) (Kim et al., 2001); for pH stress, MRS broth was adjusted to pH 3-7 
(adjusted with HCl and NaOH) (Jan et al., 2001; Lorca et al., 1998). The pH and temperature 
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of the control culture (MRS broth) were 6.5 and 37 oC, respectively, according to 
manufacturer's recommendation and as described previously (Boot et al., 1993; Silva et al., 
2005; Smit et al., 2001).  
2.1.1.2 Isolation of S-layer 
Lactobacillus acidophilus ATCC 4356 was obtained from the Germany Type Culture Collection 
and was cultivated anaerobically (in jar with Anaerocult A-strip, Merck) in MRS broth 
(Merck) at 37 oC (Boot et al., 1993; Smit et al., 2001). Lactobacillus casei ATCC 393 was used as 
negative control for isolation of S-layer. 
For isolation of S-layer and total RNA, the recommended optical density is 0.7 at 695 nm 
(the end of log phase) (Boot et al., 1993; Smit et al., 2001) and 0.2-0.4 at 600 nm (mid-log 
phase), respectively (Boot et al., 1995). But in this study, we compared slpA gene expression 
and S-layer production at the same time. In addition, the S-layer production was compared 
in OD600= 0.4 and OD600= 0.7.  Therefore, S-layer protein and total RNA were isolated in 
exponentially growing cells (OD600 ≈ 0.4). Also, S-layer protein was extracted at OD600= 0.7. 
For extraction of S-layer, Lactobacillus acidophilus ATCC 4356 was cultivated anaerobically in 
MRS broth at 37 oC. In general, 100 ml of pre-warmed MRS medium (under stress 
conditions and control) was inoculated 1: 100 (v/v) with an overnight culture and cultivated 
until the optical density at 600 nm reached 0.4 and 0.7. Cells were harvested by 
centrifugation at 15000 ×g for 15 min at 4 oC. The cells were washed twice with 100 ml of ice-
cold water. The cell pellet was extracted with 0.1 volume of 4 M guanidine hydrochloride 
(pH 7) for one hour at 37 oC and centrifuged at 18000 ×g for 15 min. The supernatant, 
containing S-layer protein monomers, was dialyzed against water at 4 oC for 16-24 h (Boot et 
al., 1993). The dialyzed extracts were analyzed by SDS-PAGE (Smit et al., 2001). SDS-PAGE 
of protein samples was carried out using Precision Plus Protein Standard [low molecular 
weight marker (10-250 kDa) - Biorad]. The samples were run on 12% polyacrylamide gel at 
100 V. Protein bands were visualized by Coomassie blue staining. Protein concentration was 
determined according to Bradford's method (Bradford, 1976). For normalization of the 
measured absorption values, BSA (Merck) was used.  
2.1.1.3 Reassembly of S-layer monomers and transmission electron microscopy (TEM) 
S-layer self-assembly subunits were studied by the negative staining technique. To prepare 
the TEM samples, several droplets of the dialyzed protein were pipetted onto the carbon-
coated grids and left for 1-16 h to immobilize the proteinaceous structures. Samples were 
washed once with distilled water and then stained with 2% uranyl acetate for two minutes 
(Avall-Jaaskelainen et al., 2002; Smit et al., 2001). The grids were dried by nitrogen flow and 
studied by Zeiss/CEM 902 a transmission electron microscopy (TEM) at 60 kV. 
2.1.1.4 Isolation of total RNA 
For isolation of total RNA, L. acidophilus ATCC 4356 cells were grown in MRS broth (under 
stress conditions and control) until they reached an optical density of approximately 
OD600=0.4. The cells were subsequently harvested by centrifugation (5000 ×g for 10 min at 
4°C) and washed with an ice-cold TE buffer (Boot et al., 1995). The total RNA was isolated 
using a protective RNeasy Minikit (Qiagen) according to the manufacturer’s 
recommendations, and then treated with deoxyribonuclease I (DNase I, RNase-free; 
Fermentas) at 37°C for 30 min according to manufacturer’s recommendations.  
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The reverse transcription (RT) of the RNA samples was performed with 150 ng of total RNA 
and 0.5 µg of Oligo dT primer using a First Strand cDNA Synthesis kit (Fermentas) at 42°C 
for 60 min, as recommended by the manufacturer. Forward and reverse primers were 
designed for the slpA gene of Lactobacillus acidophilus ATCC 4356 as follows: slpA forward 
(5'-TGG CCG TTC TTG AAT GTG TA-3') and slpA reverse (5'-ACA TCA ACG CTG CAA 
ACA TC-3'). These primers generated a 154 bp PCR product in the PCR reaction.  
16S rRNA was used as the internal control gene based on previously reported primers 
(Trotha et al., 2001) that generate a 370 bp PCR product. 
The final volume of the PCR reaction was 25 µl with the following components: 1 µl cDNA  
(≈ 7.5 ng), 1 µl (100 pmol/µl) from each primer, 0.5 µl dNTPs mix, 0.5 µl MgCl2, and 0.25 µl (5 
U/µl) Taq DNA polymerase (Fermentas). The Mastercycler (Eppendorf) was programmed as 
follows: initial denaturation for 5 min at 94°C; 30 cycles at 94°C for 45 sec, 54°C for 30 sec, 72°C 
for 30 sec, and a final extension at 72°C for 8 min. The PCR products (and 50 bp DNA ladder, 
Fermentas) were separated on a 1% agarose gel and visualized by ethidium bromide staining. 
2.1.1.6 Statistical assessment 
All the experiments and measurements were repeated at least three times. All the statistical 
analyses were performed using SPSS and Excel 2003 software. All the experimental results 
were analyzed using mean descriptive statistics, the correlation coefficient, and a single-
factorial analysis of variance. A value of P<0.05 was regarded as statistically significant.  
2.1.2 Results 
The growth curve of Lactobacillus acidophilus ATCC 4356 showed that it took approximately 
8 h to reach OD600= 0.4 and approximately 14 h to reach OD600= 0.7 (Data not shown). It is 
important to know that Lactobacillus acidophilus ATCC 4356 was live and grew after 14 h 
under stress conditions. However, the results indicated that Lactobacillus acidophilus was not 
live in 50 oC, 55 oC, pH 3 and 4 after 14 h (Table 1). In this study, pH 5, 6, and 7, as well as 
temperatures 30 oC and 45 oC were chosen as the stress conditions.  
 
Culture condition Cell count (CFU/ml) 
Control* 9.6 × 109
pH 3 No growth
pH 4 No growth
pH 5 8.38 × 106
pH 6 7.24 × 108
pH 7 9.03 × 109
30 oC 8.98 × 108
45 oC 3.63 × 107
50 oC No growth
55 oC No growth
* pH 6.5 & 37 oC.
Table 1. Viable cell counts of Lactobacillus acidophilus ATCC 4356 under stress conditions and 
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The surface proteins of Lactobacills acidophilus ATCC 4356 were extracted by treatment of 
whole cells with 4M guanidine hydrochloride, and analyzed by SDS-PAGE. One dominant 
band of 43-46 kDa, which is known as the S-protein (Boot et al., 1993; Smit et al., 2001) and a 
few faint bands were visible on gel (Fig. 1b). In the mid-log-phase (OD600=0.4), S-protein 
production was low in control group, so the 43-46 kDa band was not seen on gel clearly (Fig. 
1a, c; lane 1). However, in the control group with OD600=0.7, a 43-46 kDa band was visible 
on SDS-PAGE gel (Fig. 1b, d; lane 1).  
Under stress conditions (OD600=0.4 & 0.7), S-protein band was visible and the band became 
sharper in pH 5 and 45 oC (Fig. 1). It seemed that S-protein bands were not different in pH 6, 
7 and the control (Fig. 1b).  
No protein bands (43-46 kDa) were visible on SDS-PAGE gel from isolated protein of 
Lactobacillus casei ATCC 393. 
To determine the total proteins, the Bradford method was used. The total proteins were 
compared between the control and the group under stress conditions. In the case of pH 5 and 
45 oC, total protein content was higher than others (Fig. 2). Moreover, the total protein 
production level was lowest at 30 oC (p< 0.001). In pH 6, 7 and control, the protein content was 
almost similar. After comparing the results of total protein analysis under stress and control 
conditions, the range of difference in protein content was similar in OD600 = 0.4 and 0.7. 
 
Fig. 1. SDS-PAGE gel (12% polyacrylamide) analysis of isolated surface proteins of 
Lactobacillus acidophilus ATCC 4356 at: a) mid-log phase (OD600= 0.4) and b) exponential 
growth phase (OD600= 0.7) under pH stress (lane 1, control; lane 2, pH 5; lane 3, pH 6; lane 4, 
pH 7). c) mid-log phase (OD600= 0.4) and d) exponential growth phase (OD600= 0.7) under 
heat stress (lane 1, control; lane 2, 30 ºc; lane 3, 45 ºc). M, Protein marker. 
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Fig. 2. Extracted surface proteins (extracted in mid-log phase) were compared in control and 
the group under stress conditions by Bradford method. (a) Control (pH 6.5 & 37 oC); (b) pH 
5; (c) pH 6; (d) pH 7; (e) 30 oC; (f) 45 oC. Error bars represent standard deviations of the mean 
values of results from three independent experiments. 
To assess the change in S-layer protein content of the cell wall under stress conditions by 
transmission electron microscopy (TEM), we chose 45 oC in which S-layer production was 
highest (Fig. 2). In the electron microscopy study, the presence of the S-layer on the outer 
surface of Lactobacillus acidophilus ATCC 4356 was clearly demonstrated (Fig. 3). In 
particular, the bacterial surface was completely covered with an S-layer in the control (Fig. 
3a, b), but an excess of S-layer protein was found at the both ends of the bacterial cell under 
stress condition (Fig. 3c, d).  
 
Fig. 3. Electron microscopic images of Lactobacillus acidophilus ATCC 4356. a, b: Lactobacillus 
acidophilus ATCC 4356 was completely covered by the S-layer in the control. c, d: an excess 
of S-layer was found at the both ends of the bacterial cell at 45ºc. S-layer protein was 
indicated by black arrow (scale bar (a, c) = 2.5 μm and scale bar (b, d) = 0.6 μm). 
The crystallization of S-layer was investigated by TEM. S-protein, which was isolated by 
guanidine hydrochloride, aggregated readily upon removal of the salt by dialysis, and 
formed a white precipitate. Analysis of these precipitates by TEM showed that they were 
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composed exclusively of crystalline lattice (Fig. 4). It seems that the reassembly of S-layer 
subunits was similar in the group under stress condition (45ºc) and control. The results 
indicated that S-layer has two-fold (p2) symmetry with a periodicity of 11.3 and 5.5 nm in 
the control. After comparing the lattice parameters, we found that they were similar (under 
stress condition and control).   
 
Fig. 4. Negatively stained TEM image of isolated S-layer from Lactobacillus acidophilus ATCC 
4356. a) The control (37 ºc); b) 45 ºc (scale bar = 100nm). 
The results indicated that the stress influenced slpA gene expression. Interestingly, the slpA 
gene expression increased in pH 5 and 45 oC. Under pH stress, comparison of the slpA gene 
expression showed that in the pH 6 and 7, the slpA gene expression was lower than that in 
the control (Fig. 5a) (p< 0.001). In addition, the slpA gene expression decreased at 30 oC, and 
the slpA gene expression was highest at 45 oC (Fig. 5b) (p< 0.001). However, major 
differences in the slpA gene expression were observed between the control and the group 
under stress conditions (Fig. 5).  
 
Fig. 5. Comparison of slpA gene expression under control and stress conditions (a: pH stress; 
b: heat stress) as compared to expression of housekeeping gene (16S RNA) in the same 
reaction to normalize the data. Error bars represent standard deviations of the mean values 
of results from three independent experiments. 
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To investigate the effects of pH and heat stresses on S-layer production and slpA gene 
expression (OD600 = 0.4 and 0.7) in Lactobacillus acidophilus ATCC 4356, we studied the survival 
of bacteria under stress conditions for 14 h. It was found that in pH 3, 4 and the temperatures 
50-55 oC, Lactobacillus acidophilus ATCC 4356 could not survive. Then, pH 5, 6, and 7, as well as 
temperatures 30 oC and 45 oC were chosen as the stress conditions. SDS-PAGE gel (12% 
polyacrylamide) of S-layer protein showed that a single dominant band (43-46 kDa) was 
visible (Fig. 1). According to the previous studies, Lactobacillus acidophilus ATCC 4356 has S-
layer protein with 43 kDa molecular weight (Boot et al., 1993; Smit et al., 2001). Also, 
Lactobacillus acidophilus ATCC 4356 has been used as positive control for S-layer protein in 
other studies (Fitzsimons et al., 2003; Frece et al., 2005). In our study, S-layer extraction was 
carried out according to Boot's method (Boot et al., 1993) in Lactobacillus acidophilus ATCC 4356 
and Lactobacillus casei ATCC 393 (as negative control), and the results were compared together. 
As S-layer is the outermost structure of cell envelope in Lactobacillus acidophilus ATCC 4356, the 
extracted protein was only from cell wall without lysis of bacterial cells. In SDS-PAGE gel, 
there was one dominant band of 43-46 kDa and a few faint bands which were not 43 kDa. But 
there was no protein band in negative control. Therefore, we confirmed that these proteins are 
S-layer proteins. The S-layer protein was isolated with 4 M guanidine hydrochloride. During 
the mid-log phase (OD600 = 0.4), the S-layer protein production was low in the control group, 
but it was clearly visible in OD600 = 0.7 (Fig. 1, lane 1). Under stress conditions, the production 
of S-layer protein increased at pH 5 and 45oC. However, the increase in S-protein production 
was found in OD600 = 0.4 and 0.7 (Fig. 1, 2). Evidence showed that S-layer production was 
increased under stress conditions (Khaleghi et al., 2010, 2011) and medium components (Schar-
Zammaretti et al., 2005). It was found that S-layer proteins were present during all growth 
phases of Lactobacillus acidophilus M92 under heat stress (Frece et al., 2005). This suggested that 
the S-layer protein is preferentially expressed under conditions which are not optimal for 
bacterial growth. It has been proposed that S-layer plays a role as a protective sheath in 
Lactobacillus acidophilus ATCC 4356. In addition, some studies identified that the S-layer 
proteins of Lactobacilli were important for hydrophobicity, autoaggregation and adherence of 
this bacteria to different host surfaces (Frece et al., 2005; Greene & Klaenhammer, 1994; 
Hynonen et al., 2002; Kos et al., 2003; Pelletier et al., 1997; Sillanpaa et al., 2000; Toba et al., 
1995; Vadillo-Rodriguez et al., 2004, 2005; Van der Mei et al., 2003).    
Transmission electron microscopic analysis showed that Lactobacillus acidophilus ATCC 4356 
was completely covered by S-layer at 37 oC. Also, S-layer covered the bacterial cells at 45 oC, 
but an excess of S-protein was found at the both ends of the bacterial cell (Fig. 3). It seems 
that the S-layer protein has a protective role for Lactobacillus acidophilus ATCC 4356. 
Previously, the excess of S-layer was found at the site of separation of the two daughter cells 
in Clostridium thermosaccharolyticum, which prevented the exposure of the newly synthesized 
parts of the cell wall to the environment. It has been proposed that several bacteria produce 
an excess of S-protein to ensure complete coverage of the cell wall during cell division, and 
either store excess S-layer protein in the peptidoglycan layer or secrete it into the 
environment (Boot & Pouwels, 1996).   
Because of the adhesion role of S-layer to the epithelial cells in Lactobacilli, it is important to 
investigate of the self-assembly ability of S-protein monomers under stress conditions. One 
of these stresses is heat stress that Lactobacillus is encountered it during food processing. 
According to the investigation, the TEM images showed that dialyzed S-protein monomers 
were able to recrystalized at 45 oC as same as 37 oC. The S-layer structure was an oblique 
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lattice with p2 symmetry, and its parameters were respectively 11.3 and 5.5 nm. This finding 
was corresponded to the lattice parameters in Lactobacillus acidophilus ATCC 4356 (Smit et 
al., 2001), Lactobacillus helveticus ATCC 12046 (Lortal et al., 1992) and Lactobacillus brevis 
ATCC 14869 (Jakava-Viljanen et al., 2002).  
According to the investigation of slpA gene expression, it was found that the slpA gene 
expression increased at 45 oC and pH 5. It proves that S-layer is very important for Lactobacillus 
acidophilus ATCC 4356, and is a protective sheath for the bacteria. In the pH 6, 7 and 37 oC, the 
slpA gene expression was lower than that in the control. It is not known why the slpA gene 
expression was different from the S-protein production in pH 6 and 7. It has been suggested 
that, either a little inversion has happened on slpA and slpB in unfavorable growth conditions 
or the presence of HCl and NaOH, used for adjusting of pH, can influence or block slpA gene 
expression. Another explanation could be that the S-layer mRNA has a relatively long half-life 
of 15 min and it can be repeatedly translated. As S-layer proteins represent 10-15% of the total 
amount of proteins in Lactobacillus cells, their transcription and secretion mechanisms must be 
efficient and tightly regulated. Multiple promoters precede several S-layer genes (Boot & 
Pouwels, 1996) including S-layer genes of Lactobacillus acidophilus (Boot et al., 1996a) and 
Lactobacillus brevis (Vidgren et al., 1992) and are likely to ensure efficient transcription of these 
genes. Also, the half-lives of mRNA-encoding lactobacillar S-layer proteins are relatively high, 
approximately 15 min, which enables efficient protein translation (Boot et al., 1996a). In 
addition to the actively transcribed S-layer protein gene (slpA), Lactobacillus acidophilus has also 
the silent slpB gene. The inversion of the slp segment causes an interchange of the active and 
the silent S-layer genes, which resembles a mechanism of phase variation in expression of 
bacterial surface antigen (Avall-Jaaskelainen & Palva, 2005; Boot & Pouwels, 1996; Boot et al., 
1996b; Pouwels et al., 1998). It was found that the frequency of inversion was high (1/300), yet 
all attempts to demonstrate expression of the slpB gene have so far been unsuccessful (Boot et 
al., 1996b; Pouwels et al., 1998). Phase variation or antigenic variation, as a result of inversion 
of the slp segment, might enable Lactobacillus acidophilus bacteria to better adhere to specific 
regions of mucosa (Pouwels et al., 1998).  
4. Conclusion  
In conclusion, we found that environmental conditions influenced the S-layer protein and 
slpA gene expression. Nevertheless, it seems that high temperature (45 oC) did not influence 
the self-assembly of S-layer monomers.  
For future investigations, the slpB gene expression and adhesion of Lactobacillus acidophilus 
to the epithelial cells should be studied under stress and control conditions.   
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1. Introduction 
The biosynthesis of saccharides is important because these diverse molecules mediate 
various functions from structure and storage to signaling. The biosynthesis of 
oligosaccharides, polysaccharides and glycoconjugates involves glycosyltransferases (EC 
2.4), which transfer a sugar moiety from a nucleotide-activated donor sugar onto acceptors 
(Breton et al., 2006).  
L-rhamnose is found widely in bacteria and plants (Giraud & Naismith, 2000). It is a 
common component of the cell wall and the capsule of many pathogenic bacteria, and has 
been indicated to play an essential role in many pathogenic bacteria (Giraud & Naismith, 
2000). L-rhamnose is also found in the cytoplasmic membrane of archaea (Sprott et al., 1983), 
while pathogenic archaea have not been identified (Eckburg et al., 2003).    
The nucleotide-activated L-rhamnose, dTDP-L-rhamnose, is synthesized from dTTP and 
glucose-1-phosphate (G-1-P) by a conserved four-step reaction. In the first reaction, RmlA 
(G-1-P thymidylyltransferase, EC 2.7.7.24) transfers the thymidylmonophosphate nucleotide 
to G-1-P. RmlB (dTDP-D-glucose 4,6-dehydratase, EC 4.2.1.46) then catalyzes oxidation of 
the C4 hydroxyl group of the sugar, followed by dehydration. Third, RmlC (dTDP-4-
dehydrorhamnose 3,5-epimerase, EC 5.1.3.13) catalyzes an unusual double epimerization 
reaction at positions C3 and C5. Finally, RmlD (dTDP-4-dehydrorhamnose reductase, EC 
1.1.1.133) reduces the C4 keto group to generate the final product, dTDP-L-rhamnose 
(Giraud & Naismith, 2000).  
Thermal instability of the Rml enzymes has been raised as an issue (Graninger et al., 1999, 
2002). Thus far, the highest reported temperature for the dTDP-L-rhamnose synthesis 
reaction is around 50 °C using thermophilic bacterial enzymes (Graninger et al., 2002; 
Novotny et al., 2004). The presence of dTDP-L-rhamnose has not been reported in archaea. 
 
Advances in Applied Biotechnology 
 
224 
Smit, E., Oling, F., Demel, R., Martiez, B. & Pouwels, P. H. (2001). The S-layer protein of 
Lactobacillus acidophilus ATCC 4356: Identification and characterization of domains 
responsible for S-protein assembly and cell wall binding. Journal of Molecular 
Biology, Vol. 305, No. 2, (January 2001), pp. 245-257, ISSN 0022-2836 
Sullivan, A. & Nord, C. E. (2002). Probiotics in human infections. Journal of Antimicrobial 
Chemotherapy, Vol. 50, No. 5, (October 2002), pp. 625-627, ISSN 0305-7453 
Tannock, G. W., Tilsala-Timisjarvi, A., Rodtong, S., Ng, J., Munro, K. & Alatossava, T. (1999). 
Identification of Lactobacillus isolates from the gastrointestinal tract, silage, and 
yoghort by 16S-23S rRNA gene intergenic spacer region sequence comparisons. 
Applied and Environmental Microbiology, Vol. 65, No. 9, (September 1999), pp. 4264-
4267, ISSN 0099-2240 
Toba, T., Virkola, R., Westerlund, B., Bjorkman, Y., Sillanpaa, J., Vartio, T., Kalkkinen, N. & 
Korhonen, T. K. (1995). A collagen-binding S-layer protein in Lactobacillus crispatus. 
Applied and Environmental Microbiology, Vol. 61, No. 7, (July 1995), pp. 2467-2471, 
ISSN 0099-2240 
Trotha, R., Konig, T. H. W. & Konig, B. (2001). Rapid ribosequencing-an effective diagnostic 
tool for detecting microbial infection. Infection, Vol. 29, No. 1, (January-February 
2001), pp. 12-16, ISSN 0019-9567 
Vadillo-Rodriguez, V., Busscher, H. J., Norde, W., De Vries, J. & van der Mei, H. C. (2004). 
Dynamic cell surface hydrophobicity of Lactobacillus strains with and without 
surface layer proteins. The Journal of Bacteriology, Vol. 186, No. 19, (July 2004), pp. 
6647-6650, ISSN 0021-9193 
Vadillo-Rodriguez, V., Busscher, H. J., van der Mei, H. C., De Vries, J. & Norde, W. (2005). 
Role of Lactobacillus cell surface hydrophobicity as probed by AFM in adhesion to 
surfaces at low and high ionic strength. Colloids and Surfaces B: Biointerfaces, Vol. 41, 
No. 1, (March 2005), pp. 33-41, ISSN 0144-8617 
Van der Mei, H. C., Van der Belt-Gritter, B., Pouwels, P. H., Martinez, B. & Busscher, H. 
J.(2003). Cell surface hydrophobicity is conveyed by S-layer proteins - a study in 
recombinant lactobacilli. Colloids and Surfaces B: Biointerfaces, Vol. 28, No. 2-3, (April 
2003), pp. 127-134, ISSN 0144-8617 
Velez, M. P., De Keersmaecker, S. C. J. & Vanderleyden, J. (2007). Adherence factors of 
Lactobacillus in the human gastrointestinal tract. FEMS. Microbiology Letters, Vol. 
276, No. 2, (September 2007), pp. 140-148, ISSN 1574-6968 
Ventura, M., Jankovic, I., Walker, D. C., Pridmore., R. D. & Zink, R. (2002). Identification and 
characterization of novel surface proteins in Lactobacillus johnsonii and Lactobacillus 
gasseri. Applied and Environmental Microbiology, Vol. 68, No.12, (December 2002), pp. 
6172-6181, ISSN 0099-2240 
Vidgren, G., Palva, I., Pakkanen, R., Lounatmaa, K. & Palva, A. (1992). S-layer protein gene 
of Lactobacillus brevis: cloning by polymerase chain reaction and determination of 
the nucleotide sequence. The Journal of Bacteriology, Vol. 174, No. 22, (November 
1992), pp. 7419-7427, ISSN 0021-9193 
Waar, K., van der Mei, H. C., Harmsen, H. J. M., Degener, J. E. & Busscher, H. J. (2002). 
Adhesion to bile drain materials and physicochemical surface propertise of 
Enterococcus faecalis strains growth in the presence of bile. Applied and Environmental 
Microbiology, Vol. 68, No. 8, (August 2002), pp. 3855-3858, ISSN 0099-2240 
 
12 
The Thermostable Enzyme Genes of 
the dTDP-L-Rhamnose Synthesis 
Pathway (rmlBCD) from a 
Thermophilic Archaeon 
Maki Teramoto1, Zilian Zhang1, Motohiro Shizuma2, Takashi Kawasaki1, 
Yutaka Kawarabayasi1 and Noriyuki Nakamura1 
1National Institute of Advanced Industrial Science and Technology (AIST),  
Amagasaki, Hyogo 
2Osaka Municipal Technical Research Institute (OMTRI), 
Joto-ku, Osaka,  
Japan 
1. Introduction 
The biosynthesis of saccharides is important because these diverse molecules mediate 
various functions from structure and storage to signaling. The biosynthesis of 
oligosaccharides, polysaccharides and glycoconjugates involves glycosyltransferases (EC 
2.4), which transfer a sugar moiety from a nucleotide-activated donor sugar onto acceptors 
(Breton et al., 2006).  
L-rhamnose is found widely in bacteria and plants (Giraud & Naismith, 2000). It is a 
common component of the cell wall and the capsule of many pathogenic bacteria, and has 
been indicated to play an essential role in many pathogenic bacteria (Giraud & Naismith, 
2000). L-rhamnose is also found in the cytoplasmic membrane of archaea (Sprott et al., 1983), 
while pathogenic archaea have not been identified (Eckburg et al., 2003).    
The nucleotide-activated L-rhamnose, dTDP-L-rhamnose, is synthesized from dTTP and 
glucose-1-phosphate (G-1-P) by a conserved four-step reaction. In the first reaction, RmlA 
(G-1-P thymidylyltransferase, EC 2.7.7.24) transfers the thymidylmonophosphate nucleotide 
to G-1-P. RmlB (dTDP-D-glucose 4,6-dehydratase, EC 4.2.1.46) then catalyzes oxidation of 
the C4 hydroxyl group of the sugar, followed by dehydration. Third, RmlC (dTDP-4-
dehydrorhamnose 3,5-epimerase, EC 5.1.3.13) catalyzes an unusual double epimerization 
reaction at positions C3 and C5. Finally, RmlD (dTDP-4-dehydrorhamnose reductase, EC 
1.1.1.133) reduces the C4 keto group to generate the final product, dTDP-L-rhamnose 
(Giraud & Naismith, 2000).  
Thermal instability of the Rml enzymes has been raised as an issue (Graninger et al., 1999, 
2002). Thus far, the highest reported temperature for the dTDP-L-rhamnose synthesis 
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Novotny et al., 2004). The presence of dTDP-L-rhamnose has not been reported in archaea. 
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However, putative rmlABCD genes have been identified in the genomes of thermophilic 
archaea, including Pyrococcus horikoshii (Kawarabayasi et al., 1998), Archaeoglobus fulgidus 
(Klenk et al., 1997), Sulfolobus solfataricus (She et al., 2001) and Sulfolobus tokodaii 
(Kawarabayasi et al., 2001). Their rml genes possibly encode thermostable enzymes, and 
could thus greatly contribute to the thermostability of the Rml enzymes by in vitro protein 
evolution techniques such as family shuffling (Kikuchi et al., 2000). S. tokodaii 7 grows 
optimally at 80°C (Suzuki et al., 2002), and thus its putative rmlABCD genes were 
functionally and biochemically analyzed in this study.  
2. Materials and methods 
2.1 Sequence analysis 
Sequences were compared to those in the SWISS-PROT protein sequence database (Bairoch 
& Apweiler, 2000) using BLAST (Altschul et al., 1990).  
2.2 Vector construction  
The four genes rmlCDAB (genes ST1969 to ST1972; DDBJ accession number BA000023) were 
PCR-amplified with each of the following sets of primers designed to introduce an NdeI site 
(overlapping the initiating ATG codon) and a downstream HindIII or XhoI site (the restriction 
sites are underlined): 5’-GGAATTCCATATGCCTTTTGAATTCGAAAATCTGGG-3’ (forward; 
contains the NdeI site) and 5’-GCGGCCGCAAGCTTTTAATCAAAGACTTCAGCCTTTTC-3’ 
(reverse; contains the HindIII site) for rmlC (gene ST1969); 5’- 
GGAATTCCATATGCGAACACTAATAACTGGTGC-3’ (forward; contains the NdeI site) and 
5’-GGTGCTCGAGCACCACCATACCGTCTAGATCC-3’ (reverse; contains the XhoI site) for 
rmlD (gene ST1970) (His tag at the C terminal); 5’-
GGAATTCCATATGGAGGCGGTAATTTTACAC-3’ (forward; contains the NdeI site) and 5’- 
GGTGCTCGAGTCATAATATCACCGAAGAATTCTC-3’ (reverse; contains the XhoI site) for 
rmlA (gene ST1971); 5’-GGAATTCCATATGATAATTATTGGTGGTGCTGG-3’ (forward; 
contains the NdeI site) and 5’-GGTGCTCGAGTTTACTAACTTTTACTTTCCAAGGC-3’ 
(reverse; contains the XhoI site) for rmlB (gene ST1972) (His tag at the C terminal). PCR was 
performed in 50 μl of standard PCR mixture with 1 unit of KOD-plus DNA polymerase 
(Toyobo, Japan), 10 ng of S. tokodaii 7 genomic DNA (NITE Biological Resource Center, 
Chiba, Japan) and 100 pmol of each primer. The amplification program was as follows: (i) 
94°C for 2 min; (ii) 25 cycles of 94°C for 30 sec, X°C for 30 sec (X = 55 for rmlCDB; X = 58 for 
rmlA) and 68°C for 1 min. PCR products were digested at the restriction sites in the primers 
described above and ligated into the same restriction sites of the pET21(b) expression vector 
(Novagen). Nucleotide sequences of the resultant plasmids were confirmed after 
transformation of Escherichia coli DH5α (Takara, Japan) with the resultant plasmids and 
purification of the plasmids from the E. coli (QIAprep Spin Miniprep kit; Qiagen). The 
resultant plasmids to express rmlC, rmlD, rmlA and rmlB were designated pSTC, pSTD, 
pSTA and pSTB, respectively.           
2.3 Preparation of supernatants containing the expressed proteins  
E. coli BL21-Codon Plus (DE3)-RIL cells (Stratagene) were transformed with either pSTC, 
pSTD, pSTA or pSTB. The transformed E. coli was cultured at 37°C in 600 ml LB medium 
supplemented with 100 μg ml-1 ampicillin and 20 μg ml-1 chloramphenicol to an OD600 of X 
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(X = 0.49 for RmlC; X = 0.56 for RmlD; X = 0.12 for RmlA; X = 0.60 for RmlB). Isopropyl β-D-
thiogalactopyranoside was then added to the culture at a final concentration of 0.1 mM, and 
the culture was grown at 16°C overnight. The culture was then harvested by centrifugation, 
washed twice with 50 mM Tris-HCl buffer (pH 7.5), and resuspended in 2.5 ml of the 50 mM 
Tris-HCl buffer. The suspension was sonicated on ice for 4 min with a UD-201 ultrasonic 
disruptor (output, 6; duty, 50%; Tomy Seiko, Japan), heated at 80°C for 20 min, and 
centrifuged at 20,000 g for 10 min at 4°C. The resultant supernatant (2.5 ml) was desalted 
through a PD10 Sephadex G-25 column (GE Healthcare) with the 50 mM Tris-HCl buffer as 
the elution buffer. The resultant supernatant (3.5 ml) containing the expressed protein was 
stored at 4°C.  
2.4 SDS-PAGE  
Eight μl of each supernatant was analyzed on an E-R12.5L polyacrylamide gel (ATTO, 
Japan) at 30 mA constant current together with 10 μl of the broad range molecular weight 
standards (Bio-rad), and visualized with Coomassie Brilliant Blue R-250. The gel was 
photographed with a luminescent image analyzer Las-4000 mini (Ver 2.1; Fuji film, Japan). 
The amount of expressed protein was determined using MultiGauge software (Ver 3.2; Fuji 
film) in comparison to the molecular weight standards.   
2.5 Reaction of the expressed protein  
The reaction to detect G-1-P thymidylyltransferase activity of RmlA was performed at 80°C 
for 3 h in 50 mM Tris-HCl buffer (pH 7.5), 2 mM MgCl2, 10 mM dTTP, 10 mM UTP and 10 
mM G-1-P with the RmlA supernatant (40 μl of the supernatant, which contained 4 μg 
RmlA, was added to the reaction mixture for a total volume of 100 μl). UTP was also used as 
a substrate candidate because a product of a rmlA homolog (ST0452) from S. tokodaii 7 shows 
the G-1-P thymidylyltransferase activity (RmlA activity) as well as G-1-P uridylyltransferase 
activity (Zhang et al., 2005).  
The reaction to determine substrate specificity of RmlB was performed at 80°C for 3 h in 50 
mM Tris-HCl buffer (pH 7.5), 2 mM MgCl2, 10 mM dTDP-D-glucose, and 10 mM UDP-D-
glucose with the RmlB supernatant (40 μl of the supernatant, which contained 4 μg RmlB, 
was added to the reaction mixture for a total volume of 100 μl). To serve as controls, this 
reaction was performed with the RmlC supernatant or the RmlD supernatant (40 μl of the 
supernatant, which contained 20 μg of RmlC or RmlD, was added to the reaction mixture for 
a total volume of 100 μl) instead of the RmlB supernatant. Optimal reaction temperature for 
RmlB was determined in the same way as just described above except that UDP-D-glucose 
was not included in the reaction mixture and the reaction was preformed at the indicated 
temperature for 2 h. The reaction to characterize the thermostability of RmlB was carried out 
in the same way as described above for determining the optimal temperature except that the 
reaction was performed at 80°C for the indicated time period.  
The dTDP-L-rhamnose synthetic reaction was performed at 80°C for 3 h in 50 mM Tris-HCl 
buffer (pH 7.5), 2 mM MgCl2, 10 mM dTDP-D-glucose, 5 mM NADPH, and 5 mM NADH 
with a combination of the supernatants (4 μgs each of RmlB, RmlC and/or RmlD were 
added to the reaction mixture for a total volume of 100 μl). Each reaction was stopped by 
adding ten times the reaction volume of 500 mM KH2PO4.  
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However, putative rmlABCD genes have been identified in the genomes of thermophilic 
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GGAATTCCATATGCGAACACTAATAACTGGTGC-3’ (forward; contains the NdeI site) and 
5’-GGTGCTCGAGCACCACCATACCGTCTAGATCC-3’ (reverse; contains the XhoI site) for 
rmlD (gene ST1970) (His tag at the C terminal); 5’-
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(X = 0.49 for RmlC; X = 0.56 for RmlD; X = 0.12 for RmlA; X = 0.60 for RmlB). Isopropyl β-D-
thiogalactopyranoside was then added to the culture at a final concentration of 0.1 mM, and 
the culture was grown at 16°C overnight. The culture was then harvested by centrifugation, 
washed twice with 50 mM Tris-HCl buffer (pH 7.5), and resuspended in 2.5 ml of the 50 mM 
Tris-HCl buffer. The suspension was sonicated on ice for 4 min with a UD-201 ultrasonic 
disruptor (output, 6; duty, 50%; Tomy Seiko, Japan), heated at 80°C for 20 min, and 
centrifuged at 20,000 g for 10 min at 4°C. The resultant supernatant (2.5 ml) was desalted 
through a PD10 Sephadex G-25 column (GE Healthcare) with the 50 mM Tris-HCl buffer as 
the elution buffer. The resultant supernatant (3.5 ml) containing the expressed protein was 
stored at 4°C.  
2.4 SDS-PAGE  
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Japan) at 30 mA constant current together with 10 μl of the broad range molecular weight 
standards (Bio-rad), and visualized with Coomassie Brilliant Blue R-250. The gel was 
photographed with a luminescent image analyzer Las-4000 mini (Ver 2.1; Fuji film, Japan). 
The amount of expressed protein was determined using MultiGauge software (Ver 3.2; Fuji 
film) in comparison to the molecular weight standards.   
2.5 Reaction of the expressed protein  
The reaction to detect G-1-P thymidylyltransferase activity of RmlA was performed at 80°C 
for 3 h in 50 mM Tris-HCl buffer (pH 7.5), 2 mM MgCl2, 10 mM dTTP, 10 mM UTP and 10 
mM G-1-P with the RmlA supernatant (40 μl of the supernatant, which contained 4 μg 
RmlA, was added to the reaction mixture for a total volume of 100 μl). UTP was also used as 
a substrate candidate because a product of a rmlA homolog (ST0452) from S. tokodaii 7 shows 
the G-1-P thymidylyltransferase activity (RmlA activity) as well as G-1-P uridylyltransferase 
activity (Zhang et al., 2005).  
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reaction was performed at 80°C for the indicated time period.  
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with a combination of the supernatants (4 μgs each of RmlB, RmlC and/or RmlD were 
added to the reaction mixture for a total volume of 100 μl). Each reaction was stopped by 
adding ten times the reaction volume of 500 mM KH2PO4.  
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2.6 HPLC of the reaction  
A 50-μl aliquot of the reaction solution mixed with 500 mM KH2PO4 was subjected to HPLC 
using a LaChrom ELITE system with a L-2420 UV-VIS detector and a L-2130 pump (Hitachi) 
equipped with a Wakosil 5C18-200 column (4.6 x 250 mm; Wako, Japan). The 500 mM KH2PO4 
was run as the elution buffer at a constant flow rate of 1 ml min−1. The substrates and products 
were detected at 254 nm, and the peak area was used for calculation of the amount.      
2.7 Mass spectrometry (MS) of the reaction products 
The reaction samples for MS were prepared with a smaller amount of the substrate dTDP-D-
glucose (2 mM) and thus with 2 mM NADPH and 2 mM NADH to completely consume the 
dTDP-D-glucose (this reaction was otherwise performed in the same way as described 
above), as a standard sample dTDP-L-rhamnose (the predicted product; Genechem Inc., 
Taejon, Korea) was unable to be separated from dTDP-D-glucose by HPLC used for MS 
(described below). 
Reaction samples, to which 500 mM KH2PO4 was not added, were separated by HPLC (LC-
10AT, Shimadzu, Japan) performed on a Wakosil 5C18-200 column using a water/methanol/ 
acetic acid mixture (98.9/1.0/0.1, v/v/v) as the elution buffer at a flow rate of 1 ml min-1. Mass 
spectra of the peaks detected by the HPLC were then measured by an electrospray 
ionization/ion trapped mass spectrometer (LCQDECA, ThermoQuest, USA) connected to the 
HPLC under the following instrumental conditions: detection mode, negative; mass range, m/z 
100–1500; spray voltage, 5 kV; capillary temperature, 350°C; capillary voltage, -10 V; sheath gas 
flow, 100 units; auxiliary gas flow, 20 units (1 unit is roughly 0.025 L min-1).  
3. Results and discussion 
3.1 Putative dTDP-L-rhamnose synthesis gene cluster (rmlABCD) from the 
thermophilic archaeon S. tokodaii 7 
The rml genes from S. tokodaii 7 are clustered in the order of rmlCDAB, and the rmlC is 
oriented in a different direction from the others rmlDAB (Kawarabayasi et al., 2001). The 
RmlBCD were most similar to the dTDP-L-rhamnose synthesis enzymes (Table 1). However, 
the most similar homolog of the RmlA was UDP-N-acetylglucosamine 
pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase from Methanocaldococcus 
jannaschii (39% identity and 79% similarity; Q58501; Namboori & Graham, 2008), and its 
second closest homolog was RmlA from Streptococcus mutans (29% identity and 71% 
similarity; P95778; Tsukioka et al., 1997).  
The RmlA from S. tokodaii possessed a signature sequence for recognition of nucleoside 
triphosphate, GXGTRX8PK, and that of G-1-P, LVEKP (Thorson et al., 1994). RmlB contained 
motifs characteristic of dTDP-D-glucose 4,6-dehydratase, PSSPYSASKA and GGAGFIG 
(Allard et al., 2001). A region covering approximately 150 residues and conserved in dTDP-
4-dehydrorhamnose 3,5-epimerase for substrate binding (Giraud et al., 2000) was found in 
RmlC. RmlD possessed the PX3YX3KX3E motif, which is characteristic of a 
reductase/epimerase/dehydrogenase/dehydratase superfamily for L-rhamnose synthesis 
from G-1-P, and another motif, STDYVF, unique in RmlD sequences (Graninger et al., 1999). 
However, the conserved NAD(P) binding motif (Wierenga et al., 1985), GXGX2G, was not 
found in RmlD. 
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Table 1. The rmlBCD products from Sulfolobus tokodaii 7 and their homologs 
3.2 Activity of RmlA 
RmlA was expressed as a 35-kDa protein (data not shown), in agreement with the molecular 
weight (MW) of 38 kDa deduced from its nucleotide sequence. The predicted G-1-P 
thymidylyltransferase (RmlA) activity was assayed at 80°C with dTTP and G-1-P, but was 
not detected. RmlA may thus function as the UDP-N-acetylglucosamine 
pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase as deduced from its 
sequence similarity. This deserves further investigation. A product from another rmlA 
homolog, located away from the rmlABCD cluster in S. tokodaii 7, shows RmlA activity 
(Zhang et al., 2005). This is consistent with the reports that rmlABCD genes are not always 
found together (Cole et al., 1998; Giraud & Naismith, 2000).  
3.3 RmlB as a thermophilic dTDP-D-glucose 4,6-dehydratase 
RmlB was expressed as a 35-kDa protein (Fig. 1), which corresponded to the deduced MW 
(Table 1). The predicted activity (Table 1) was assayed at 80°C with dTDP-D-glucose and 
UDP-D-glucose (Fig. 2). UDP-D-glucose was also used as a substrate candidate because 
UDP-D-glucose as well as dTDP-D-glucose can be produced by the product from the 
another rmlA homolog (Zhang et al., 2005). As shown in Fig. 2, dTDP-D-glucose was used as 
a substrate by RmlB, whereas UDP-D-glucose was not. As controls, RmlC (Fig. 2) and RmlD 
(data not shown) did not use dTDP-D-glucose and UDP-D-glucose as the substrate. RmlB 
(+B) produced a broad peak in the mass chromatogram by the selected ion monitoring of the 
m/z 545 peak (data not shown; this broad peak was not obvious in Fig. 2, +B, 3h), which 
corresponded to the deprotonated molecule (M—H)— of the dTDP-D-glucose 4,6-
dehydratase (RmlB) product, dTDP-4-dehydro-6-deoxy-D-glucose (MW = 546). Consistent 
with this result, dTDP-4-dehydro-6-deoxy-D-glucose has previously been eluted as a broad 
peak from a C18 column (Nakano et al., 2000; Watt et al., 2004). Together with the sequence 
homology, these data indicate that RmlB from S. tokodaii was thermostable dTDP-D-glucose 
4,6-dehydratase (RmlB). Peaks 1 and 2, which became prominent by the addition of RmlB 
(Fig. 2), were indicated by MS to be from TMP and TDP, respectively (data not shown). It is 
unclear if RmlB degraded dTDP-D-glucose to TDP and TMP.  
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Fig. 1. SDS-PAGE analysis of RmlBCD. Eight μl of each cell-free supernatant from E. coli 
cells expressing rmlB (lane B), rmlC (lane C) or rmlD (lane D) was analyzed, and contained 
0.8, 4.0 or 4.0 μg, respectively, of the deduced product (indicated by arrows). M, molecular 
weight markers. 
 
Fig. 2. Substrate specificity of RmlB shown by HPLC. RmlB-containing supernatant was 
incubated with dTDP-D-glucose (TDP-G) and UDP-D-glucose (UDP-G) at 80°C for the 
indicated period (+B). RmlC-containing supernatant was also incubated in the same way 
instead of the RmlB supernatant as a control (+C). Relative amounts of TDP-G and UDP-G 
are indicated compared to the amounts of TDP-G and UDP-G in the +B sample at 0 h, 
respectively. Peaks 1 and 2 of the reaction products were indicated by MS to be from TMP 
and TDP, respectively. 
Temperature range for the dTDP-D-glucose-utilizing activity of RmlB was measured from 
60 to 99°C, and the optimal temperature was shown to be 80°C (Fig. 3A). Therefore, RmlB 
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from S. tokodaii was thermophilic; its optimal temperature for the activity coincided with the 
optimal growth temperature of 80C for its host S. tokodaii 7 (Suzuki et al., 2002). The activity 
of RmlB gradually diminished at 80°C over hours (Fig. 3B). Specific dTDP-D-glucose-
utilizing activity of RmlB was calculated to be 4.2 U/mg protein based on the data from the 
first 1 h of Fig. 3B. On the other hand, E. coli RmlB shows a high activity of approx. 3700 
U/mg protein (Marolda & Valvano, 1995).   
 
 
Fig. 3. Thermophilic TDP-D-glucose-utilizing activity of RmlB. (A) Optimal temperature of 
the activity. RmlB supernatant was incubated with TDP-D-glucose for 2 h at the indicated 
temperature. The amount of TDP-D-glucose used was shown as a percentage of the amount 
of TDP-D-glucose in the control sample incubated for 2 h at 80°C without supernatant (100% 
remained). (B) Thermostability of the activity at the optimal temperature of 80°C. RmlB 
supernatant was incubated with TDP-D-glucose at 80°C for the indicated period. The 
amount of TDP-D-glucose used was expressed as a percentage of the amount of TDP-D-
glucose in the sample at 0 h (100% remained). Each value is the mean ± standard error from 
two independent experiments. 
3.4 The dTDP-L-rhamnose synthesis reaction from dTDP-D-glucose at 80°C catalyzed 
by RmlBCD 
RmlC and RmlD were expressed as a 22-kDa protein and a 30-kDa protein, respectively (Fig. 
1), which corresponded to their respective deduced MWs (Table 1). The dTDP-L-rhamnose 
synthesis reaction catalyzed by RmlBCD, suspected based on their homology (Table 1), was 
analyzed at 80°C using dTDP-D-glucose and NAD(P)H as substrates (Fig. 4). A combination 
of RmlB plus RmlD produced peak 3 (+BCD and +BD in Fig. 4); the retention time and MS 
spectrum of this peak were identical to those of the standard sample dTDP-L-rhamnose. 
RmlB(C)D from S. tokodaii were thus shown to synthesize dTDP-L-rhamnose from dTDP-D-
glucose at 80°C (discussed in the next paragraph). Without NAD(P)H, peak 3 was not 
produced in the reaction (data not shown). RmlB plus RmlC (+BC in Fig. 4) did not yield 
peak 3. The broad m/z 545 peak produced by RmlB disappeared with the addition of RmlD  
(+BD and +BCD in Fig. 4; MS data not shown). Together with the results indicating that 
RmlB from S. tokodaii was dTDP-D-glucose 4,6-dehydratase (RmlB) and with the sequence 
homology, the results strongly suggest that RmlD from S. tokodaii was thermostable dTDP-4-
dehydrorhamnose reductase (RmlD).  
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(+BD and +BCD in Fig. 4; MS data not shown). Together with the results indicating that 
RmlB from S. tokodaii was dTDP-D-glucose 4,6-dehydratase (RmlB) and with the sequence 
homology, the results strongly suggest that RmlD from S. tokodaii was thermostable dTDP-4-
dehydrorhamnose reductase (RmlD).  
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It is possible that peak 3 produced by the combination of RmlB plus RmlD (+BD) could have 
been an epimer of dTDP-L-rhamnose produced without the possible epimerase RmlC (Table 
1). Addition of RmlC showed no effect on the broad m/z 545 peak produced by RmlB (+BC 
in Fig. 4; MS data not shown), which is consistent with the previous observation using a C18 
column (Watt et al., 2004). Therefore, unfortunately, the dTDP-4-dehydrorhamnose 3,5-
epimerase (RmlC) activity, predicted activity of RmlC from S. tokodaii, was unable to be 
detected with the system used.  
The concentrations of peak 3 (indicated from dTDP-L-rhamnose) and dTDP-D-glucose in 
the +BCD sample (Fig. 4) were determined to be 2.4 and 4.8 mM, respectively, showing that 
52% of the added dTDP-D-glucose was used and that 46% of the dTDP-D-glucose used was 
converted to dTDP-L-rhamnose in the reaction. Consequently, RmlB and RmlD were 
estimated to show their respective activities of at least 0.33 U/mg protein. 
 
Fig. 4. The dTDP-L-rhamnose synthesis reaction from TDP-D-glucose by RmlBCD shown by 
HPLC. Combinations of RmlB (B), RmlC (C) and RmlD (D) supernatants were incubated with 
TDP-D-glucose (TDP-G), NADPH and NADH for 3 h at 80°C. The sample treated in the same 
way without the supernatants is also shown as a control. Peaks 1, 2 and 3 of the reaction 
products were indicated to be from TMP, TDP and dTDP-L-rhamnose, respectively, by MS. 
4. Conclusions 
Genes for thermostable RmlB and RmlD of the dTDP-L-rhamnose synthesis pathway were 
functionally identified from a thermophilic archaeon S. tokodaii 7. S. tokodaii Rml enzymes 
were suggested to be functionally identical to the bacterial counterparts, and exhibited 
superior thermostability. The temperature level of 80°C that was tested in this study is the 
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highest value yet reported for the dTDP-L-rhamnose synthesis reaction from dTDP-D-
glucose. Therefore, S. tokodaii rml genes could confer thermostability on the high-activity 
Rml enzymes, including the E. coli RmlB (Marolda & Valvano, 1995), by in vitro protein 
evolution techniques such as family shuffling (Kikuchi et al., 2000), and are useful for a 
broad field of potential applications requiring Rml enzyme including production of 
rhamnose-containing antigens as vaccines (Hsu et al., 2006; Prakobphol & Linzer, 1980).  
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1. Introduction  
Iron oxide nanoparticles are responsible to magnetic eld allowing them to be manipulated, 
tracked, imaged and remotely heated. Such key features open up a wide eld of applications 
in medicine which includes cell separation, magnetic force-based tissue engineering, MRI 
tracking of transplanted cells, magnetic drug targeting and hyperthermia.  
In most applications reported in the literature, magnetic systems are typically composed of 
an inorganic core and an organic coating. Although cores have been made from different 
materials, iron oxide nanoparticles constituted of magnetite (Fe3O4) and maghemite (γ-
Fe2O3) are used at a great extent. While the core provide nanocontainers with magnetic 
properties, the shell functions to (i) protect against core agglomeration, (ii) provide chemical 
handles for the conjugation of drug molecules, and (iii) limit opsonization. Additionally, 
shell coatings have been engineered to enhance pharmacokinetics and tailor in vivo fate. 
Organic shells main comprise phospholipid bilayered membranes or polymeric coating of 
dextran, for instance. Magnetic system design with such different materials can be achieved 
via a number of approaches, including in situ coating, post-synthesis adsorption and end-
grafting. In fact, several methods have been proposed for their synthesis, coating, and 
stabilization, mainly comprising the precipitation route together with a surface 
functionalization step by means of polymers or surfactants. This point will be the focus of 
the next chapter section – “Producing magnetic particles.”  
Once produced, these magnetic carriers must meet certain criteria for use in the human 
body. For therapeutic purposes, magnetic carriers must be water-based, biocompatible, 
biodegradable, and nonimmunogenic. Besides, special care should be focused on the particle 
size, surface properties, magnetic properties, and administration route, as will be discussed 
in the third chapter section, entitled “Magnetic particles: concerns towards in vivo use.”  
The fourth chapter section comprises the applications of magnetic particles in the field of 
biotechnology. They can be divided into therapeutic and diagnostic ones. Chapter 
subsections will focus on both. Also discussed is a novel application of magnetic 
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nanoparticles – the use of magnetic force for tissue engineering, termed “magnetic force-
based Tissue Engineering (Mag-TE).” Since cells labeled with magnetic nanoparticles can be 
manipulated using magnets, this novel tissue engineering methodology using magnetic 
force and functionalized magnetic nanoparticles may hold great promise in reproducing in 
vitro patterned tissues for organ regeneration. 
The fifth and last section of this chapter provides concluding remarks while addressing 
future perspectives in regard to magnetic particles in biotechnology. 
2. Producing magnetic particles 
2.1 Synthesis of magnetic carriers 
In most applications reported in the literature, iron oxides, such as magnetite and 
maghemite, are the magnetic material of choice. The synthesis, coating, and stabilization of 
such particles will be discussed below. The most common synthetic route to produce 
magnetite (Fe3O4) is the coprecipitation of hydrated divalent and trivalent iron salts in an 
alkaline medium (A. K. Silva et al., 2008).  
Nanoreactors can be employed for the precipitation reaction. They provide a constrained 
domain, which limits the growth of the particles. This method offers numerous advantages 
over the previous ones when higher homogeneity of size and shape are concerned.  A 
discussion of these follows. 
Microemulsions are colloidal nano-dispersions of water in oil (or oil in water) stabilized by a 
surfactant film. The synthesis of magnetic particles by this means is carried out when water 
droplets interact and exchange their contents. Experimental results have confirmed that the 
microemulsion method allows good control of the particles by preventing their growth and 
providing particles small enough to get stable magnetic fluids. On the other hand, magnetic 
particles prepared by coprecipitation may undergo aggregation. Microemulsions, which are 
thermodynamically stable dispersions, can be considered as truly nanoreactors that can be 
used to carry out chemical reactions and, in particular, to synthesize nanomaterials. The 
main idea behind this technique is that by appropriate control of the synthesis parameters, 
these nanoreactors can produce smaller and more uniform particles than the ones produced 
by other standard methods. Particle size was found to depend on the molar ratios of water 
and surfactant (Lopez-Quintela, 2003).   
Liposomes are also used as nanoreactors for the precipitation as they provide a constrained 
domain, which limits the growth of the particles. Alternatively, encapsulation of magnetic 
particles into liposomes may be performed after synthesis (A. A. Kuznetsov et al., 2001). 
Magnetoliposomes have been found to be a promising approach that offers some unique 
advantages when the magnetic nanoparticles are applied in biological systems. Lipid 
systems present the advantage of low toxicity due to their composition, mainly 
physiological lipids, compared to the polymeric particles. In fact, encapsulation of the 
magnetic nanoparticles in liposomes increases their biocompatibility under physiological 
conditions, making them suitable for a large variety of biological applications. Furthermore, 
it is known that magnetic particles tend to agglomerate, and are chemically unstable with 
respect to oxidation in air. Encapsulation of the magnetic nanoparticles in liposomes 
protects them from aggregation and oxidation (Heurtault et al., 2003).  
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Concerning the production of polymer-based magnetic carriers, three different methods 
may be used. The emulsification/polymerization method has been successfully employed to 
produce magnetic microcapsules. In this process, particles are synthesized in the internal 
aqueous phase of an inverse emulsion/microemulsion. Afterwards, polymerization by a 
cross-linking agent takes place. In such microcapsules, the drug and the magnetic particles 
are in the inner compartment (Saravanan et al., 2004). Alternatively, polymer-covered 
magnetic particles can be produced by in situ precipitation of magnetic materials in the 
presence of a polymer that acts as a stabilizer.  
Magnetic polymer nanoparticles have been produced in the presence of water-soluble dextran, 
poly (vinyl alcohol), sodium poly (oxyalkylene di phosphonates), carboxymethyl starch, and 
amylose starch, just to name a few. In all cases, magnetic particles are surrounded by a 
hydrophilic polymer shell. Such systems are functionalized by the introduction of chemical 
groups so that they are able to bind active molecules. For instance, dextran-coated magnetic 
particles, which are highly hydrophilic, uniform, and nontoxic magnetic carriers, may be 
activated by the periodate oxidation method. Thus, magnetic polyaldehyde dextran is formed 
and may be conjugated to different molecules (Hong et al., 2004).  
Another method for producing magnetic polymer particles consists of separately 
synthesizing magnetic particles and polymer particles and then mixing them together to 
enable either physical or chemical adsorption of the polymer onto the magnetic material to 
be achieved (É. L. Silva et al., 2009). 
3. Magnetic particles: Concerns towards in vivo use 
For therapeutic purposes, magnetic carriers must be water-based, biocompatible, 
biodegradable, and nonimmunogenic (Häfeli, 2004; A. K. Silva et al., 2007a). Concerning the in 
vivo use, the following parameters are critical: (a) particle size, (b) surface characteristics of the 
particle, (c) concentration of the fluid, (d) volume of the fluid, (e) administration route, (f) 
duration/rate of the injection/infusion, (g) geometry and strength of the magnetic field, (h) 
duration of magnetic field application, (i) particle stability, and (j) magnetic properties. 
Physiological parameters of the patient organism are also important. They comprise: a) size, 
weight, and body surface, (b) blood volume, (c) cardiac output and systemic vascular 
resistance, d) circulation time, (e) tumor volume and location, (f) vascular content of target 
area, and (g) blood flow in that area (A. A. Kuznetsov et al., 1999; Lübbe et al., 1999).  
Markedly, size is a crucial factor. Large microspheres can physically irritate the surrounding 
tissue or even embolize small blood vessels and capillaries. Besides, stable suspensions of 
dense particles larger than 2μm are rarely prepared, and it is difficult to inject suspensions 
of such particles through a catheter. On the other hand, very small particles (less than 0.1 
μm in diameter) have a small magnetic moment. In such a case, magnetic forces may not be 
high enough to counteract the linear blood-flow rates in the tissue. As a consequence, the 
magnetic field may fail in successfully concentrating particles at the target organ, with also 
the possibility of a significant fraction of them accumulating in the liver (Häfeli, 2004; Lübbe 
et al., 2001).  
Surface charge is known to play an important role in blood half-lives of particles. It is 
generally agreed that highly positively and negatively charged particles present a decreased 
circulation time. In such a case, particles undergo phagocytosis, resulting in distribution 
mainly in the liver or spleen. The clearance from circulation is mediated by interaction with 
cells, especially those of the reticulo-endothelial system. Functional groups on cell surfaces 
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nanoparticles – the use of magnetic force for tissue engineering, termed “magnetic force-
based Tissue Engineering (Mag-TE).” Since cells labeled with magnetic nanoparticles can be 
manipulated using magnets, this novel tissue engineering methodology using magnetic 
force and functionalized magnetic nanoparticles may hold great promise in reproducing in 
vitro patterned tissues for organ regeneration. 
The fifth and last section of this chapter provides concluding remarks while addressing 
future perspectives in regard to magnetic particles in biotechnology. 
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such particles will be discussed below. The most common synthetic route to produce 
magnetite (Fe3O4) is the coprecipitation of hydrated divalent and trivalent iron salts in an 
alkaline medium (A. K. Silva et al., 2008).  
Nanoreactors can be employed for the precipitation reaction. They provide a constrained 
domain, which limits the growth of the particles. This method offers numerous advantages 
over the previous ones when higher homogeneity of size and shape are concerned.  A 
discussion of these follows. 
Microemulsions are colloidal nano-dispersions of water in oil (or oil in water) stabilized by a 
surfactant film. The synthesis of magnetic particles by this means is carried out when water 
droplets interact and exchange their contents. Experimental results have confirmed that the 
microemulsion method allows good control of the particles by preventing their growth and 
providing particles small enough to get stable magnetic fluids. On the other hand, magnetic 
particles prepared by coprecipitation may undergo aggregation. Microemulsions, which are 
thermodynamically stable dispersions, can be considered as truly nanoreactors that can be 
used to carry out chemical reactions and, in particular, to synthesize nanomaterials. The 
main idea behind this technique is that by appropriate control of the synthesis parameters, 
these nanoreactors can produce smaller and more uniform particles than the ones produced 
by other standard methods. Particle size was found to depend on the molar ratios of water 
and surfactant (Lopez-Quintela, 2003).   
Liposomes are also used as nanoreactors for the precipitation as they provide a constrained 
domain, which limits the growth of the particles. Alternatively, encapsulation of magnetic 
particles into liposomes may be performed after synthesis (A. A. Kuznetsov et al., 2001). 
Magnetoliposomes have been found to be a promising approach that offers some unique 
advantages when the magnetic nanoparticles are applied in biological systems. Lipid 
systems present the advantage of low toxicity due to their composition, mainly 
physiological lipids, compared to the polymeric particles. In fact, encapsulation of the 
magnetic nanoparticles in liposomes increases their biocompatibility under physiological 
conditions, making them suitable for a large variety of biological applications. Furthermore, 
it is known that magnetic particles tend to agglomerate, and are chemically unstable with 
respect to oxidation in air. Encapsulation of the magnetic nanoparticles in liposomes 
protects them from aggregation and oxidation (Heurtault et al., 2003).  
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Concerning the production of polymer-based magnetic carriers, three different methods 
may be used. The emulsification/polymerization method has been successfully employed to 
produce magnetic microcapsules. In this process, particles are synthesized in the internal 
aqueous phase of an inverse emulsion/microemulsion. Afterwards, polymerization by a 
cross-linking agent takes place. In such microcapsules, the drug and the magnetic particles 
are in the inner compartment (Saravanan et al., 2004). Alternatively, polymer-covered 
magnetic particles can be produced by in situ precipitation of magnetic materials in the 
presence of a polymer that acts as a stabilizer.  
Magnetic polymer nanoparticles have been produced in the presence of water-soluble dextran, 
poly (vinyl alcohol), sodium poly (oxyalkylene di phosphonates), carboxymethyl starch, and 
amylose starch, just to name a few. In all cases, magnetic particles are surrounded by a 
hydrophilic polymer shell. Such systems are functionalized by the introduction of chemical 
groups so that they are able to bind active molecules. For instance, dextran-coated magnetic 
particles, which are highly hydrophilic, uniform, and nontoxic magnetic carriers, may be 
activated by the periodate oxidation method. Thus, magnetic polyaldehyde dextran is formed 
and may be conjugated to different molecules (Hong et al., 2004).  
Another method for producing magnetic polymer particles consists of separately 
synthesizing magnetic particles and polymer particles and then mixing them together to 
enable either physical or chemical adsorption of the polymer onto the magnetic material to 
be achieved (É. L. Silva et al., 2009). 
3. Magnetic particles: Concerns towards in vivo use 
For therapeutic purposes, magnetic carriers must be water-based, biocompatible, 
biodegradable, and nonimmunogenic (Häfeli, 2004; A. K. Silva et al., 2007a). Concerning the in 
vivo use, the following parameters are critical: (a) particle size, (b) surface characteristics of the 
particle, (c) concentration of the fluid, (d) volume of the fluid, (e) administration route, (f) 
duration/rate of the injection/infusion, (g) geometry and strength of the magnetic field, (h) 
duration of magnetic field application, (i) particle stability, and (j) magnetic properties. 
Physiological parameters of the patient organism are also important. They comprise: a) size, 
weight, and body surface, (b) blood volume, (c) cardiac output and systemic vascular 
resistance, d) circulation time, (e) tumor volume and location, (f) vascular content of target 
area, and (g) blood flow in that area (A. A. Kuznetsov et al., 1999; Lübbe et al., 1999).  
Markedly, size is a crucial factor. Large microspheres can physically irritate the surrounding 
tissue or even embolize small blood vessels and capillaries. Besides, stable suspensions of 
dense particles larger than 2μm are rarely prepared, and it is difficult to inject suspensions 
of such particles through a catheter. On the other hand, very small particles (less than 0.1 
μm in diameter) have a small magnetic moment. In such a case, magnetic forces may not be 
high enough to counteract the linear blood-flow rates in the tissue. As a consequence, the 
magnetic field may fail in successfully concentrating particles at the target organ, with also 
the possibility of a significant fraction of them accumulating in the liver (Häfeli, 2004; Lübbe 
et al., 2001).  
Surface charge is known to play an important role in blood half-lives of particles. It is 
generally agreed that highly positively and negatively charged particles present a decreased 
circulation time. In such a case, particles undergo phagocytosis, resulting in distribution 
mainly in the liver or spleen. The clearance from circulation is mediated by interaction with 
cells, especially those of the reticulo-endothelial system. Functional groups on cell surfaces 
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alter the circulation time. A usual approach consists of grafting magnetic systems with PEG 
(polyethylene glycol), which may be achieved by the precipitation of the particles in the 
presence of this polymer. By such a technique, sterically stabilized carriers are produced due 
to the induced sterical hindrance, which avoids protein binding and macrophage 
recognition (Bulte et al., 1999).  
Since the particles must be effectively controlled by the applied magnetic field, their magnetic 
properties, their dispersion, and their degree of agglomeration are important. It has been 
observed that an increase in stability of the particles leads to a decrease in toxicity. Low 
coercive force will prevent aggregation of the particles prior to superimposition of the field. As 
a result, superparamagnetic particles seem to be ideal. Besides superparamagnetism, high 
magnetic susceptibility and high saturation magnetization allow the particles to be effectively 
controlled by a relatively weak field (A. A. Kuznetsov et al., 1999).  
The fate of magnetic particles also depends strongly on the administration route: 
3.1 Intravenous administration 
After intravenous administration, smaller particles are subject to rapid renal elimination or 
are removed by cells capable of endocytosis (i.e., by B and T lymphocytes), while larger ones 
undergo uptake by the liver, spleen, and bone marrow. The blood half-lives of many iron 
oxide nanoparticles administered in patients vary from 1 h to 24–36 h (Corot et al., 2006).  
Iron oxide particles present low toxicity and are well tolerated in the human body. Inside 
the cells, such systems are expected to be degraded relatively fast. In fact, degradation into 
iron (Fe) and oxygen is presumed to occur in intracellular lysosomes of macrophages under 
the influence of a variety of hydrolytic enzymes, low pH, and protein mobilization and 
utilization according to natural Fe pathways. The human body contains around 3–4 g of Fe, 
for example, in the proteins ferritin, hemosiderin, transferritin, and hemoglobin. As the 
magnetic nanoparticles start to break down, any soluble Fe becomes part of this normal Fe 
pool, which is then regulated by the body. A clinical dose would likely include just a few 
milligrams of Fe per kilogram of body weight, which is low compared to the total 
participating in Fe metabolism. Iron oxides have been shown to degrade in vivo and 
integrate Fe stores in the human body. Therefore, they are not expected to be toxic to the 
organism (Mornet et al., 2004). This assumption concerning the low toxicity was confirmed 
by the lethal dose LD50 of magnetic systems. For instance, the LD50 of dextran–iron oxide 
complex was found to be 2000–6000 mg of Fe kg–1 of body mass. Besides, the systemic 
safety of several iron oxide nanoparticles has been evaluated after injection in humans, 
indicating that these products have a satisfactory safety profile according to standard 
toxicological and pharmacological tests (Corot et al., 2006). 
3.2 Subcutaneous and intratumoral administration 
Small particles injected locally infiltrate into the interstitial space around the injection site and 
are gradually absorbed by the lymphatic capillaries into the lymphatic system. For this reason, 
subcutaneously or locally injected (intratumoral administration) nanoparticles can be used for 
lymphatic targeting, i.e., as a tool for chemotherapy against lymphatic tumors or metastases. In 
order to achieve a good uptake in regional lymph nodes following subcutaneous injection, 
colloidal carriers should be small (60 nm or smaller) and the surface of the particles should be 
neither too hydrophilic nor too hydrophobic. Concerning intratumoral administration, 
different studies indicate its feasibility (Hilger et al., 2002, 2005). 
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3.3 Oral administration 
Magnetic particles exhibit strong potential as externally modulated oral systems for both in 
vivo imaging and targeted drug delivery. In this approach, imaging agents or drugs can be 
localized to specific sites through the application of an external magnetic field. Similarly to the 
other routes of administration, the fate of the particles in the gastrointestinal tract is closely 
related to the particle size. Particles under 5 μm can be removed via lymphatic drainage, 
particles up to 500 nm can cross the membrane of epithelial cells through endocytosis, and 
particles less than 50 nm can achieve the paracellular passage between intestinal epithelial 
cells. The use of the magnetic force to delay the transit of orally administered drugs may 
become an attractive strategy for enhancing the efficacy of orally delivered systems. Despite 
the promising properties, magnetic particles may dissolve in acid media (Silva-Freitas et al., 
2011). Such possible particle loss could reduce the efficiency of the magnetic system used as a 
drug carrier.  In order to avoid it, magnetic particles may be coated using polymers to protect 
them from the gastric environment. Our recent studies have shown that xylan and  
Eudragit®S100 coatings are able to protect magnetite from the gastric pH, successfully 
preventing particle degradation   (A. K. Silva et al., 2007b; É. L. Silva et al., 2009).  
4. Applications of magnetic particles in the field of biotechnology 
4.1 The therapeutic applications 
4.1.1 Magnetic drug targeting 
One of the major problems related to drug administration is the difficulty in targeting a 
tissue or an area of the body. After administration, drugs tend to distribute to various 
organs in a process that occurs depending on the physicochemical properties of the 
molecule. In order to reach an acceptable therapeutic level at the desired site, large amounts 
of the drug must be administered. However, only a part of the dose will actually reach the 
intended tissue or disease site, while the other fraction can cause toxic side effects at non-
target organs (Häfeli, 2004; A. K. Silva et al., 2010). 
Magnetic drug targeting (MDT) presents a solution to this problem by using magnetic 
particles as controllable carriers of therapeutic agents which are either encapsulated or 
attached to the surface of these particles (Mangual et al., 2011). Due to its non-invasiveness, 
high efficiency, quick-impact, and reduced toxicity in the non-target regions, many 
researchers are engaging in this area (Cao et al., 2011). 
MDT typically uses an external magnetic field source to capture and retain magnetic drug 
carrier particles at a specific site after being administered in the body. The accumulation of 
the magnetic particles in the desired area depends on the interplay of the magnetic forces, 
fluid resistance, and diffusive motions (Cao et al., 2011).   
There are some significant limitations of MDT. One limitation is the gradient problem, once 
the retention of the magnetic particles is quite low due to the relatively weak nature of the 
magnetic force, which must overcome the hydrodynamic force (A. K. Silva et al., 2006). It 
can be difficult to use external magnets to target areas deep within the body by the fact that 
the strength of the magnetic field generated from a permanent magnet decreases sharply 
with distance (Mangual et al., 2011).  
An approach to overcome this limitation uses implant assisted-MDT that takes advantage of 
a magnetic implant placed inside the body that can become magnetized in the presence of 
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alter the circulation time. A usual approach consists of grafting magnetic systems with PEG 
(polyethylene glycol), which may be achieved by the precipitation of the particles in the 
presence of this polymer. By such a technique, sterically stabilized carriers are produced due 
to the induced sterical hindrance, which avoids protein binding and macrophage 
recognition (Bulte et al., 1999).  
Since the particles must be effectively controlled by the applied magnetic field, their magnetic 
properties, their dispersion, and their degree of agglomeration are important. It has been 
observed that an increase in stability of the particles leads to a decrease in toxicity. Low 
coercive force will prevent aggregation of the particles prior to superimposition of the field. As 
a result, superparamagnetic particles seem to be ideal. Besides superparamagnetism, high 
magnetic susceptibility and high saturation magnetization allow the particles to be effectively 
controlled by a relatively weak field (A. A. Kuznetsov et al., 1999).  
The fate of magnetic particles also depends strongly on the administration route: 
3.1 Intravenous administration 
After intravenous administration, smaller particles are subject to rapid renal elimination or 
are removed by cells capable of endocytosis (i.e., by B and T lymphocytes), while larger ones 
undergo uptake by the liver, spleen, and bone marrow. The blood half-lives of many iron 
oxide nanoparticles administered in patients vary from 1 h to 24–36 h (Corot et al., 2006).  
Iron oxide particles present low toxicity and are well tolerated in the human body. Inside 
the cells, such systems are expected to be degraded relatively fast. In fact, degradation into 
iron (Fe) and oxygen is presumed to occur in intracellular lysosomes of macrophages under 
the influence of a variety of hydrolytic enzymes, low pH, and protein mobilization and 
utilization according to natural Fe pathways. The human body contains around 3–4 g of Fe, 
for example, in the proteins ferritin, hemosiderin, transferritin, and hemoglobin. As the 
magnetic nanoparticles start to break down, any soluble Fe becomes part of this normal Fe 
pool, which is then regulated by the body. A clinical dose would likely include just a few 
milligrams of Fe per kilogram of body weight, which is low compared to the total 
participating in Fe metabolism. Iron oxides have been shown to degrade in vivo and 
integrate Fe stores in the human body. Therefore, they are not expected to be toxic to the 
organism (Mornet et al., 2004). This assumption concerning the low toxicity was confirmed 
by the lethal dose LD50 of magnetic systems. For instance, the LD50 of dextran–iron oxide 
complex was found to be 2000–6000 mg of Fe kg–1 of body mass. Besides, the systemic 
safety of several iron oxide nanoparticles has been evaluated after injection in humans, 
indicating that these products have a satisfactory safety profile according to standard 
toxicological and pharmacological tests (Corot et al., 2006). 
3.2 Subcutaneous and intratumoral administration 
Small particles injected locally infiltrate into the interstitial space around the injection site and 
are gradually absorbed by the lymphatic capillaries into the lymphatic system. For this reason, 
subcutaneously or locally injected (intratumoral administration) nanoparticles can be used for 
lymphatic targeting, i.e., as a tool for chemotherapy against lymphatic tumors or metastases. In 
order to achieve a good uptake in regional lymph nodes following subcutaneous injection, 
colloidal carriers should be small (60 nm or smaller) and the surface of the particles should be 
neither too hydrophilic nor too hydrophobic. Concerning intratumoral administration, 
different studies indicate its feasibility (Hilger et al., 2002, 2005). 
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3.3 Oral administration 
Magnetic particles exhibit strong potential as externally modulated oral systems for both in 
vivo imaging and targeted drug delivery. In this approach, imaging agents or drugs can be 
localized to specific sites through the application of an external magnetic field. Similarly to the 
other routes of administration, the fate of the particles in the gastrointestinal tract is closely 
related to the particle size. Particles under 5 μm can be removed via lymphatic drainage, 
particles up to 500 nm can cross the membrane of epithelial cells through endocytosis, and 
particles less than 50 nm can achieve the paracellular passage between intestinal epithelial 
cells. The use of the magnetic force to delay the transit of orally administered drugs may 
become an attractive strategy for enhancing the efficacy of orally delivered systems. Despite 
the promising properties, magnetic particles may dissolve in acid media (Silva-Freitas et al., 
2011). Such possible particle loss could reduce the efficiency of the magnetic system used as a 
drug carrier.  In order to avoid it, magnetic particles may be coated using polymers to protect 
them from the gastric environment. Our recent studies have shown that xylan and  
Eudragit®S100 coatings are able to protect magnetite from the gastric pH, successfully 
preventing particle degradation   (A. K. Silva et al., 2007b; É. L. Silva et al., 2009).  
4. Applications of magnetic particles in the field of biotechnology 
4.1 The therapeutic applications 
4.1.1 Magnetic drug targeting 
One of the major problems related to drug administration is the difficulty in targeting a 
tissue or an area of the body. After administration, drugs tend to distribute to various 
organs in a process that occurs depending on the physicochemical properties of the 
molecule. In order to reach an acceptable therapeutic level at the desired site, large amounts 
of the drug must be administered. However, only a part of the dose will actually reach the 
intended tissue or disease site, while the other fraction can cause toxic side effects at non-
target organs (Häfeli, 2004; A. K. Silva et al., 2010). 
Magnetic drug targeting (MDT) presents a solution to this problem by using magnetic 
particles as controllable carriers of therapeutic agents which are either encapsulated or 
attached to the surface of these particles (Mangual et al., 2011). Due to its non-invasiveness, 
high efficiency, quick-impact, and reduced toxicity in the non-target regions, many 
researchers are engaging in this area (Cao et al., 2011). 
MDT typically uses an external magnetic field source to capture and retain magnetic drug 
carrier particles at a specific site after being administered in the body. The accumulation of 
the magnetic particles in the desired area depends on the interplay of the magnetic forces, 
fluid resistance, and diffusive motions (Cao et al., 2011).   
There are some significant limitations of MDT. One limitation is the gradient problem, once 
the retention of the magnetic particles is quite low due to the relatively weak nature of the 
magnetic force, which must overcome the hydrodynamic force (A. K. Silva et al., 2006). It 
can be difficult to use external magnets to target areas deep within the body by the fact that 
the strength of the magnetic field generated from a permanent magnet decreases sharply 
with distance (Mangual et al., 2011).  
An approach to overcome this limitation uses implant assisted-MDT that takes advantage of 
a magnetic implant placed inside the body that can become magnetized in the presence of 
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an external magnet creating a localized magnetic field around the implant and increasing 
the magnetic force on nearby magnetic particles (Mangual et al., 2011).  
In addition, magnetic properties and the internalization of particles depend strongly on the 
size of the magnetic particles. Some hydrodynamic parameters, such as blood flow rate, 
particle concentration and infusion route play significant roles. Also, there are several forces 
acting on magnetic particles in a viscous environment and magnetic field, such as magnetic 
force due to all field sources, viscous drag force, inertia, gravity, thermal kinetics, particle 
fluid interactions and inter-particle effects such as magnetic dipole interactions, electric 
double layer interactions, and van der Waals force (Babincova & Babinec, 2009). 
The possibilities of MDT applications have drastically increased in recent years. In the 
clinical area of human medicine, these particles are being used as delivery systems for 
several drugs, mainly chemotherapy drugs. Such approach may represent a new method to 
treat cancer. Also, MDT has been used in radiotherapy and immunotherapy. Fig. 1 
demonstrates a schematic MDT model for cancer treatment (Alexiou et al., 2011). 
 
Fig. 1. Schematic drawing of MDT for tumor treatment. Reprinted from the Journal of 
Magnetism and Magnetic Materials, Vol 323, C Alexiou, R Tietze, E Schreiber, R Jurgons, H 
Richter, L Trahms, H Rahn, S Odenbach, S Lyer, Cancer therapy with drug loaded magnetic 
nanoparticles--magnetic drug targeting, 1404-1407, Copyright (2011), with permission from 
Elsevier. License number 2690150177916. 
Our research group has developed a new technology for oral delivery of drugs for the 
treatment of Helicobacter pylori infections. The focus of this work was the development of a 
stomach-specific formulation of amoxicillin based on drug-containing Eudragit®S100 
microparticles with a magnetite core. This could be the first attempt to prepare a magnetic 
system for local delivery of antibiotics, in particular for the treatment of H. pylori infections 
(É. L. Silva et al., 2009). 
4.1.2 Magnetofection  
Several systems, including viral and non-viral carriers, have been developed to transfer 
foreign genetic material into cells with the aim of enhancing gene transfer in vitro and in 
vivo. Viral vectors can provide a high transfection rate and a rapid transcription of the 
genetic material inserted in the viral genome. However, viral carriers present potential 
problems for patients, such as the immunogenicity of the viral proteins, lack of desired 
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tissue selectivity, potential for oncogenesis due to chromosomal integration, and generation 
of infectious viruses due to recombination.  
Non-viral vectors are less immunogenic, are easy to produce in large scale and capable of 
delivering large genetic material, exhibit enhanced biosafety, and can be associated with 
tissue targeting. However, unlike viral analogues that have evolved to overcome cellular 
barriers and immune defense mechanisms, non-viral gene carriers exhibit significantly 
lower transfection efficiency compared with the viral ones. Among the non-viral vectors, the 
most used compounds are cationic and biodegradable polymers, lipids, liposomes, and 
niosomes (He et al., 2010).  
In order to overcome those disadvantages, a new transfection method called magnetically 
guided gene transfection or magnetofection has been developed. Magnetofection employs 
magnetic nanoparticles combined with transfection agents to form magnetic gene vectors so 
that the vectors can be rapidly concentrated on the surface of target cells under the attraction 
of a magnetic field (Yunfeng, 2010). 
Since  the  first  reports on  magnetically  enhanced nucleic acid delivery, it has become a 
well-established method  and  has  been  predominantly  used to potentiate viral and  non-
viral gene delivery. The nucleic acids can be directly associated with magnetic nanoparticles 
in naked form or can be incorporated into a complex composed of magnetic particles and 
other components, e.g., cationic lipids and polymers. Fig. 2 shows the principle of 
magnetofection in vitro (Schillinger et al., 2005). 
 
Fig. 2. Illustration of magnetofection in cell culture. The magnetic force pulls magnetic 
nanoparticles with surface-bound gene vectors toward the cells and results in rapid kinetics 
and high efficiency nucleic acid delivery. Reprinted from the Journal of Magnetism and 
Magnetic Materials, Vol 293, U Schillinger, T Brill, C Rudolph, S Huth, S Gersting, F Krötz, J 
Hirschberger, C Bergemann, C Plank, Advances in magnetofection--magnetically guided 
nucleic acid delivery, 501-508, Copyright (2005), with permission from Elsevier. License 
number 2690150501010. 
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an external magnet creating a localized magnetic field around the implant and increasing 
the magnetic force on nearby magnetic particles (Mangual et al., 2011).  
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particle concentration and infusion route play significant roles. Also, there are several forces 
acting on magnetic particles in a viscous environment and magnetic field, such as magnetic 
force due to all field sources, viscous drag force, inertia, gravity, thermal kinetics, particle 
fluid interactions and inter-particle effects such as magnetic dipole interactions, electric 
double layer interactions, and van der Waals force (Babincova & Babinec, 2009). 
The possibilities of MDT applications have drastically increased in recent years. In the 
clinical area of human medicine, these particles are being used as delivery systems for 
several drugs, mainly chemotherapy drugs. Such approach may represent a new method to 
treat cancer. Also, MDT has been used in radiotherapy and immunotherapy. Fig. 1 
demonstrates a schematic MDT model for cancer treatment (Alexiou et al., 2011). 
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Our research group has developed a new technology for oral delivery of drugs for the 
treatment of Helicobacter pylori infections. The focus of this work was the development of a 
stomach-specific formulation of amoxicillin based on drug-containing Eudragit®S100 
microparticles with a magnetite core. This could be the first attempt to prepare a magnetic 
system for local delivery of antibiotics, in particular for the treatment of H. pylori infections 
(É. L. Silva et al., 2009). 
4.1.2 Magnetofection  
Several systems, including viral and non-viral carriers, have been developed to transfer 
foreign genetic material into cells with the aim of enhancing gene transfer in vitro and in 
vivo. Viral vectors can provide a high transfection rate and a rapid transcription of the 
genetic material inserted in the viral genome. However, viral carriers present potential 
problems for patients, such as the immunogenicity of the viral proteins, lack of desired 
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tissue selectivity, potential for oncogenesis due to chromosomal integration, and generation 
of infectious viruses due to recombination.  
Non-viral vectors are less immunogenic, are easy to produce in large scale and capable of 
delivering large genetic material, exhibit enhanced biosafety, and can be associated with 
tissue targeting. However, unlike viral analogues that have evolved to overcome cellular 
barriers and immune defense mechanisms, non-viral gene carriers exhibit significantly 
lower transfection efficiency compared with the viral ones. Among the non-viral vectors, the 
most used compounds are cationic and biodegradable polymers, lipids, liposomes, and 
niosomes (He et al., 2010).  
In order to overcome those disadvantages, a new transfection method called magnetically 
guided gene transfection or magnetofection has been developed. Magnetofection employs 
magnetic nanoparticles combined with transfection agents to form magnetic gene vectors so 
that the vectors can be rapidly concentrated on the surface of target cells under the attraction 
of a magnetic field (Yunfeng, 2010). 
Since  the  first  reports on  magnetically  enhanced nucleic acid delivery, it has become a 
well-established method  and  has  been  predominantly  used to potentiate viral and  non-
viral gene delivery. The nucleic acids can be directly associated with magnetic nanoparticles 
in naked form or can be incorporated into a complex composed of magnetic particles and 
other components, e.g., cationic lipids and polymers. Fig. 2 shows the principle of 
magnetofection in vitro (Schillinger et al., 2005). 
 
Fig. 2. Illustration of magnetofection in cell culture. The magnetic force pulls magnetic 
nanoparticles with surface-bound gene vectors toward the cells and results in rapid kinetics 
and high efficiency nucleic acid delivery. Reprinted from the Journal of Magnetism and 
Magnetic Materials, Vol 293, U Schillinger, T Brill, C Rudolph, S Huth, S Gersting, F Krötz, J 
Hirschberger, C Bergemann, C Plank, Advances in magnetofection--magnetically guided 
nucleic acid delivery, 501-508, Copyright (2005), with permission from Elsevier. License 
number 2690150501010. 
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The magnetofection process has substantial advantages over traditional transfection 
methods. The process time is substantially reduced; high transfection rates can be obtained 
with lower vector doses; an increase in the gene transfer efficiency can be reached; and gene 
delivery can be achieved with non-permissive cells. The association of gene vectors with 
superparamagnetic nanoparticles under a magnetic field can boost the efficiency of many 
vector types up to several hundred-fold and this technique is available for most gene 
vectors. The accumulation of the vectors in the target area and the dose–response 
relationship with a smaller amount of DNA required for sufficient gene expression can be 
enhanced by magnetofection methods (Holzbach et al., 2010). 
4.1.3 Magnetic embolization 
The conventional cancer treatment is based on chemotherapy and radiotherapy, which are 
effective treatment, but these systemic approaches typically have an effect on both healthy 
and disease tissues (Yang et al., 2011). Therefore, it is necessary to study novel strategies to 
eradicate cancer cells. An alternative approach to overcome these disadvantages is magnetic 
embolization, which is a new technique in cancer therapy presenting less toxicity than 
chemotherapy and less invasiveness than surgery.  
Magnetic embolization consists of injecting (in a blood vessel) a magnetorheological (MR) 
fluid, which is a suspension of micron-sized magnetizable particles such as Fe or iron oxide 
particles (e.g., magnetite). The microscopic structures of these fluids change in the presence 
of a magnetic field, which leads to a phase transition from a liquid to a solid. MR fluids 
solidify only under a magnetic field. A seal is formed, which mechanically blocks the tumor 
blood vessels, causing its death. Once the field is removed, thermal energy makes the fluid 
return to its original liquid state (J. Liu et al., 2001). 
Flores and Liu showed that blocking the fluid flow is possible within a single-tube system, 
simulating one blood vessel. They found that the seal remains stable even at pressures 
exceeding those found inside human arterioles and capillaries (Flores et al., 1999; J. Liu et al., 
2001). Despite some promising results, it is difficult to obtain selective embolization of small 
blood vessels when these are positioned at a large distance from the magnetic field source 
(e.g., approximately >3 cm inside the body of the patient). In this case, a suitable magnetic 
field intensity and gradient in the vicinity of the vessel is required (A. K. Silva et al., 2010). 
A possible solution to this problem may be obtained by a new approach referred to as 
magnetic resonance navigation (MRN). This has been proposed to steer and track in real time 
endovascular magnetic carriers in deep tissues to target areas of interest (Pouponneau et al., 
2010), and restrain the systemic carrier distribution. MRN is achieved with a clinical magnetic 
resonance imaging (MRI) scanner upgraded with an insert of steering coils. Therefore, MRN 
can overcome the problem of a weaker magnetic field in deep tissues observed with an 
external magnet. By controlling chemoembolic material distribution, MRN could improve 
embolization and drug concentration in the tumor area while limiting chemoembolization of 
healthy blood vessels and the hepatic complications (Kennedy et al., 2010).  
MRN significantly controlled the distribution of these therapeutic particles as compared to 
the control. More importantly, a decrease in the TMMC (Therapeutic Magnetic Microcarrier) 
levels in the untargeted lobe was obtained. Steering efficiency was higher with the left 
steering compared to the right steering. Therefore, MRN was more efficient in preserving 
the right liver lobe from the chemoembolization than left lobes. Only one-third of the 
TMMC dose reached the right lobe without steering because of the natural difference in 
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blood supply between the lobes (the right lobes have less weight than left lobes) 
(Pouponneau et al., 2011) (Fig. 3). Thus, further work is necessary to confirm the feasibility 
of MRN applied to magnetic embolization. 
 
Fig. 3. Representation of MRI targeting with PLGA microparticles loaded with the doxorubicin 
and magnetic FeCo nanoparticles for liver chemoembolization. Images A and C are 
fluoroscopy images of the rabbit hepatic artery with superposed images of the microparticle 
distribution without (A) and with (C) the MRI targeting. On image A, the microparticles are 
released from the catheter in the artery and distributed to both lobes. Image B illustrates a 
schematic representation of a cut of the microparticles loaded with an antitumor drug and 
magnetic nanoparticles embedded into a biodegradable matrix. Image C displays the MRI 
targeting of the left bifurcation using the magnetic force (Fmag) to preserve the right lobe from 
the chemoembolization. Reprinted from Biomaterials, Vol 32, P Pouponneau, J-C Leroux, G 
Soulez, L Gaboury, S Martel, Co-encapsulation of magnetic nanoparticles and doxorubicin into 
biodegradable microcarriers for deep tissue targeting by vascular MRI navigation, 3481-3486, 
Copyright (2011), with permission from Elsevier. License number 2690150825494. 
4.1.4 Tissue engineering 
Advances in cell therapy research gave rise to a fast-growing multidisciplinary field that 
integrates knowledge of engineering, biology and medicine. Tissue engineering (TE) is a 
promising technology for overcoming the organ transplantation limitations related to organ 
donor shortage. It consists of appropriately using cells, materials, and physics/biochemical 
processes to restore, maintain, or improve tissue function (Fig. 4). 
 
Fig. 4. Schematic picture of tissue engineering. The combination of a scaffold, cells and 
soluble factors facilitate the formation of structural and functional tissue units. 
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2010), and restrain the systemic carrier distribution. MRN is achieved with a clinical magnetic 
resonance imaging (MRI) scanner upgraded with an insert of steering coils. Therefore, MRN 
can overcome the problem of a weaker magnetic field in deep tissues observed with an 
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released from the catheter in the artery and distributed to both lobes. Image B illustrates a 
schematic representation of a cut of the microparticles loaded with an antitumor drug and 
magnetic nanoparticles embedded into a biodegradable matrix. Image C displays the MRI 
targeting of the left bifurcation using the magnetic force (Fmag) to preserve the right lobe from 
the chemoembolization. Reprinted from Biomaterials, Vol 32, P Pouponneau, J-C Leroux, G 
Soulez, L Gaboury, S Martel, Co-encapsulation of magnetic nanoparticles and doxorubicin into 
biodegradable microcarriers for deep tissue targeting by vascular MRI navigation, 3481-3486, 
Copyright (2011), with permission from Elsevier. License number 2690150825494. 
4.1.4 Tissue engineering 
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Fig. 4. Schematic picture of tissue engineering. The combination of a scaffold, cells and 
soluble factors facilitate the formation of structural and functional tissue units. 
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Despite successful efforts and results, tissue-engineered constructs lack structural 
complexity. Well-defined spatial cell organization is required in the attempt to reproduce 
living tissue complexity and succeed in creating functional tissue constructs.  In this regard, 
several cell patterning methods such as microcontact printing and lithography have been 
developed. However, these methods demand specialized surfaces to be used as substrates 
and fabrication is time consuming. In order to bypass these shortcomings, innovative active 
patterning approaches have been based on the use of an external force. This constraint may 
be generated by an electric field, as in the dielectrophoresis technique, or by an optical trap. 
Alternatively, Ino et al. (Ino et al., 2007, 2008) suggested the use of magnetic force to induce 
two-dimensional patterning of magnetically-labeled cells on submillimetric scales. 
This group developed a novel methodology for cell patterning using magnetic force and 
magnetite cationic liposomes (MCLs), which contain 10 nm magnetite nanoparticles. MCLs 
were used as carriers to introduce magnetite nanoparticles into target cells since the 
positively charged particle surface interacts with the negatively charged cell surface. Given 
that cells labeled with magnetic nanoparticles can be manipulated by using a magnet, they 
were able to  seed labeled cells onto a low-adhesive culture surface through the use of 
magnetic force to form a tissue construct (Ino et al., 2007). This technique was designated 
magnetic force-based tissue engineering (Mag-TE). By using it, complex cell patterns 
(curved, parallel, or crossing motifs) were successfully fabricated from several cell types (Ino 
et al., 2007). This group also showed that magnetically labeled keratinocytes were 
accumulated using a magnet, and stratification was promoted by a magnetic force to form a 
sheet-like 3D construct. Transmission electron microscopy revealed the presence of 
intercellular adhesion proteins, desmosomes, within keratinocyte sheets constructed by 
Mag-TE. This result indicated that the proposed method enabled intercellular contact and 
preserved adhesion proteins. For this reason, patterns were found to resist after magnetic 
force removal and manipulation was also feasible. 
Following a related approach, Frasca et al. applied magnetic forces to create a 3D cell 
assembly with tuneable size and controlled geometry. Cells were magnetically labeled using 
anionic citrate-coated iron oxide nanoparticles. Focalized magnetic force ensured an efficient 
entrapment of the cells at the magnet vicinity. This technology could be applied with no 
restriction regarding the physicochemical nature of the substrate, the cell type, or the 
geometry of the imposed magnetic constraint (Frasca et al., 2009). The same group 
demonstrated that magnetic force-assisted cell seeding provided effective cell seeding into 
3-D porous scaffolds. Moreover, precise spatial cellular organization inside the scaffold 
could be achieved by means of magnetic microtips that develop high magnetic forces. 
4.1.5 Magnetic hyperthermia  
Hyperthermia is a technique that increases the temperature of the local environment of a 
tumor, resulting in changing the physiology of diseased cells and finally leading to 
apoptosis. Depending on the degree of temperature rise, hyperthermia treatment can be 
classified into different types. In thermo ablation, a tumor is submitted to high temperatures 
of heat >46 °C (up to 56 °C), causing cells to undergo direct tissue necrosis, coagulation, or 
carbonization. Moderate hyperthermia (41 °C <T< 46 °C) has various effects both at the 
cellular and tissue levels. Diathermia uses lower temperatures (T<41 °C) for the treatment of 
rheumatic diseases in physiotherapy. 
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During moderate hyperthermia, which is traditionally termed hyperthermia treatment, cells 
undergo heat stress resulting in activation and/or initiation of many intra- and extracellular 
degradation mechanisms, including induction and regulation of apoptosis, signal 
transduction, multidrug resistance, and heat shock protein expression. The tissue-level 
effects include pH changes, perfusion, and oxygenation of the tumor microenvironment 
(Santos-Marques et al., 2006).  
Nevertheless, traditional hyperthermia treatment presents several challenges: 1) 
unavoidable heating of healthy tissue resulting in burns, blisters, and discomfort; 2) limited 
penetration of heat into body tissues; and 3) thermal under-dosage in the target region, a 
nearly unsolved problem in the case of bone of the pelvis or scull, which shields deep 
tissues, often yielding recurrent tumor growth (Tanaka et al., 2005).  
Improvements in this technique yielded the magnetic hyperthermia treatment, which has a 
number of advantages compared to conventional hyperthermia treatment: 1) cancer cells 
absorb magnetic nanoparticles (MNPs), therefore increasing the effectiveness of 
hyperthermia by delivering therapeutic heat directly to them; 2) MNPs can be targeted 
through cancer-specific binding agents, making the treatment much more selective and 
effective; 3) the frequencies of oscillating magnetic fields generally utilized pass harmlessly 
through the body and generate heat only in tissues containing MNPs; 4) MNPs can also 
cross the blood-brain barrier, and thus can be used for treating brain tumors; 5) effective and 
externally stimulated heating can be delivered at cellular levels through alternating 
magnetic fields; 6) stable MNPs can be administered through a number of drug delivery 
routes; 7) MNPs used for hyperthermia are only a few tens of nanometer in size and 
therefore allow easy passage into several tumors whose pore sizes are in the 380–780 nm 
range; 8) compared to macroscopic implants, MNP-based heat generation is much more 
efficient and homogeneous; 9) MNP-based hyperthermia treatment may induce antitumoral 
immunity (Ito et al., 2005); and 10) the last but most important aspect is that MNP-based 
hyperthermia can also be utilized for controlled delivery of drugs (Lu et al., 2005). This 
additional feature opens up possibilities for the development of multifunctional and multi-
therapeutic approaches for treating a number of diseases. 
For MNP-based hyperthermia, a general procedure involves the distribution of particles 
throughout the targeted tumor site, followed by generation of heat to the tumor using an 
external AMF. The absorption efficiency of any material to generate heat due to AMF is 
measured in terms of a specific absorption rate or specific loss of power. These terms are 
generally used to define the transformation of magnetic energy into heat. For a majority of 
applications, it is desirable to have higher temperature enhancement rates. 
Heat generation can be attributed to two different phenomena: relaxation and hysteresis 
loss. The relaxation is of two types: Brownian and Néel. Brownian relaxation is due to the 
physical rotation of particles within the medium in which they are placed (external 
dynamics) and is hindered by the viscosity that tends to counter the movement of particles 
in the medium. Heat generation through Néel relaxation is due to rapidly occurring changes 
in the direction of magnetic moments relative to crystal lattice (internal dynamics). This is 
hindered by the energy of anisotropy that tends to orient the magnetic domain in a given 
direction relative to crystal lattice. For intracellular magnetic fluid hyperthermia, Néel 
relaxation is the major contributor for heat release (Hergt & Dutz, 2007). 
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A number of types of magnetic nanomaterials have been investigated for magnetic 
hyperthermia. Some of the well-known hyperthermic agents based on iron oxide are 
magnetite and maghemite nanoparticles. Recently, a high heating performance of 1300–
1600W/g was reported based on FeCo metallic nanoparticles (Nojima et al., 2010). However, 
iron oxide-based MNPs continue to attract attention due to their lack of toxicity, excellent 
biocompatibility, and metabolization, which is carried out by heme oxygenase-1 to form 
blood hemoglobin and hence maintain Fe cell homeostasis in cells. In addition, magnetite 
was found to be superior to cobalt nanoparticles with respect to its high Curie temperature, 
saturation magnetization (90–98 emu/g), and lower toxicity in preclinical tests (Martina et 
al., 2008).  
In vivo studies using magnetic hyperthermia have been conducted by Matsuoka et al. 
(Matsuoka, 2004). They have developed magnetic cationic liposomes based on 
superparamagnetic iron oxide nanoparticles and investigated their in vivo efficacy for 
hyperthermia treatment of hamster osteosarcoma. Magnetoliposomes were injected directly 
into the osteosarcoma and then subjected to an alternating magnetic field. The tumor was 
heated above 42°C, and complete regression was observed in 100% of the treated hamsters. 
Therefore, these results demonstrate the feasibility of magnetic hyperthermia. 
4.2 The diagnostic uses 
4.2.1 MRI contrast agent 
MRI is a noninvasive and sensitive technique to obtain images by non-ionizing radiation. As 
it associates rapid in vivo acquisition of images, long effective imaging window, ne signal 
intensity contrast, high temporal and spatial resolution, and simultaneous information 
about physiology and anatomy of the desired area, MRI quickly became one of the major 
tomographic imaging modalities (G. Liu et al., 2011).  
The images formed are the result of several parameters such as proton density, relaxation 
times (T1, T2, T2*), water diffusion, nuclear alignment, radio frequency excitation, spatial 
encoding, etc., providing a digital representation of tissue characteristics. The relative 
difference between the signal intensity of two adjacent regions is called contrast, and this 
difference is translated using a color scale (normally the grey scale for MRI). The spin–lattice 
(1/T1 = R1) and spin–spin (1/T2 = R2) relaxation rates of the water protons in tissues, which 
are the most important intrinsic factors for contrast, are dependent upon the local 
environment of the protons, so that different tissues will relax at different rates (Yurt & 
Kazanci, 2008). However, for specific studies of evaluation at the molecular and cellular 
level, the MRI sensibility is lower, being necessary the use of a contrast agent or even a 
selective binding attached to a contrast agent, in order to differentiate the target area 
(Lalatonne, 2010). 
Contrast agents are normally dened based on their relaxation properties, their magnetic 
properties, and their biodistribution. When dening a contrast agent based on relaxation 
properties, the efficiency is described by the longitudinal and transverse relaxivity R1 and 
R2, respectively. The relaxivity reects the change in the relaxation rate as a function of the 
contrast agent concentration. The relaxivities are affected by the size and the composition of 
these particles (Yurt & Kazanci, 2008).  
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To design a contrast agent, the choice of core and monolayer material is a critical step 
because this composition determines the primary physical and chemical properties besides 
reactivity, solubility, and interfacial interactions. Most common core among the MRI 
contrast agents are paramagnetic lanthanide metals (gadolinium, manganese and 
dysprosium ion complexes) and superparamagnetic magnetite particles (iron oxides) (Yurt 
& Kazanci, 2008). Iron oxide particles are widely investigated in MRI applications as they 
alter the relaxation times of tissues in which they are present and due to the low toxicity 
when compared to gadolinium chelates (Lalatonne, 2010). In this context, the 
superparamagnetic particles, which can be superparamagnetic iron oxide (SPIO) particles, 
ultrasmall superparamagnetic iron oxide (USPIO) and oral magnetic particles (OMPs), 
appear as preferred materials because (a) they have magnetic characteristics, (b) they are 
composed of biodegradable Fe, (c) their coating can be functionalized with various ligands, 
(d) they provide the greatest signal changes per unit of metal, and (e) they are easily 
detectable by light and electron microscopy (Bulte & Kraitchman, 2004). 
Superparamagnetic iron oxides have substantially larger T2 relaxivity compared with 
gadolinium chelates in current clinical use, typically by an order of magnitude or more. This 
increase is confirmed by a superior magnetization. The T1-relaxivity can also be much 
higher for iron oxides than for gadolinium chelates. In addition, iron oxide nanoparticles 
may offer several advantages over existing agents due to their accumulation in 
macrophages combined with an intravascular distribution and higher relaxivity values 
(Bulte & Kraitchman, 2004).  
Another field of research in development aims to use superparamagnetic contrast agents in 
drug delivery applications for real-time monitoring of drug distribution to the target tissue, 
as well as to follow the effect of therapeutics on the progression of disease. 
4.2.2 Magnetic cell tracking  
There is a great need to develop improved means of monitoring transplanted cells in vivo. A 
recent methodology involves the use of magnetic particles for intracellular magnetic 
labeling of cells. This technique, called magnetic cell tracking, allows in vivo tracking of 
implanted cells via MRI. Magnetic cell tracking can be used as a non-invasive tool to 
provide unique information on the dynamics of cell movements within and away from 
tissues in vivo. Alternatively, magnetic cell tracking could be applied in the future to monitor 
cell therapy in patients. Both approaches require magnetic labeling of cells as well as 
methods for analysis and evaluation of cell labeling (Vuu et al., 2005). 
The magnetic cell tracking technique may overcome the limitations of individual in vivo 
imaging methods including low sensitivity, low resolution, or low soft tissue contrast. MRI 
provides excellent soft tissue contrast and due to its high resolution, MRI can be used for the 
visualization of single cells against a homogeneous background (Himmelreich & 
Dresselaers, 2009). 
Several methods have been developed to incorporate sufficient quantities of iron oxide 
nanoparticles into cells. These methods mainly concern the prolonged incubation of the cells 
with the particles resulting in their passive internalization. Another possibility is the 
introduction of functional ligands chemically linked to the particles, in order to increase the 
uptake by cells. Besides, the transient increase in the membrane permeability using a 
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magnetic field (magneto-electroporation) may result in a quick cytoplasmic accumulation of 
the magnetic particles (Dousset et al., 2008).  
Some other examples of magnetic cell tracking applications include labeling mesenchymal 
stem cells, haematopoietic progenitor cells, Schwann cell transplants, neural stem cells, and 
NK cells. 
4.2.3 Monitoring the gastrointestinal motility  
The evaluation of the large intestine motility is usually made by intraluminal manometry, 
radiology, or scintigraphy. Most of the current knowledge about motility of the large 
intestine was generated by intraluminal manometry. Despite its providing quantitative 
assessment, intraluminal manometry is obviously invasive and uncomfortable for patients. 
Radiology offers qualitative or, at best, semi-quantitative information, and carries the risk of 
significant radiation exposure. Gamma-scintigraphy also imposes radiation exposure and 
depends on the availability of expensive equipment (Ferreira et al., 2004). 
Among other methods, the investigation of intestinal movements by Magnetic Marker 
monitoring is considered to be a useful diagnostic tool. The colon exhibits complex motor 
patterns with variations of frequency and amplitude yielding compaction and movement of 
its contents along its extension. The arrival of a meal into the stomach is consistently 
associated with the unleashment of contractions of the large intestine, which causes 
movements of the colonic content, called gastrocolic reflex, and can be observed by an 
increase in the motor activity of the colon (Ferreira et al., 2004). 
The oral route is still by far the most common way used for the administration of 
pharmacologically active substances. This is mainly due to the ease of administration and 
the general acceptance by the patients. Knowledge about the performance of dosage forms 
in the gastrointestinal tract is essential for the choice of the optimal formulation technology 
(Weitschies et al., 2010). In order to overcome restrictions that are associated with the use of 
radioisotopes, an alternative method for the investigation of the behavior of solid dosage 
forms in the gastrointestinal tract was developed. It is based on the labeling of the dosage as 
a magnetic dipole by means of incorporation of trace amounts of ferromagnetic particles, 
recording of the magnetic dipole field using biomagnetic measurement equipment, and data 
evaluation applying techniques established in magnetic source imaging (MSI). This method 
is known as Magnetic Marker Monitoring (MMM) or Magnetic Moment Imaging (MMI). 
(Goodman et al., 2010; Weitschies et al., 1994). 
MMM is a new technique for the investigation of the gastrointestinal transit of magnetically 
marked solid drug dosage forms (Weitschies et al., 1999). The magnetic labeling of the 
dosage forms is achieved by the incorporation of small amounts of remanent ferromagnetic 
particles and their subsequent magnetization tracking. After ingestion of one magnetically 
marked dosage form, its magnetic dipole field is recorded during its gastrointestinal transit. 
Multichannel superconducting quantum interference devices (SQUID), developed for the 
detection of extremely weak biomagnetic fields, are employed for the measurement of the 
magnetic field (Drung, 1995). Finally, the parameters describing the magnetic dipole, i.e., its 
location r =(x, y, z) and its magnetic moment m=(mx, my, mz), are estimated from the 
recorded data by means of fitting procedures. After ingestion, their magnetic dipole field is 
recorded, and by means of fitting procedures, the location of the marked dosage form is 
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estimated from the recorded data.  The disintegration behavior is also assessed by this 
technique. The induction generated by the magnetic dipole moment of the oral dosage form 
during disintegration is used for the investigation of its mechanism and quantitative 
determination of the process (Weitschies et al., 2001a, 2001b). 
Additionally, MMM has been applied for the determination of the performance of 
disintegrating and non-disintegrating solid dosage forms such as tablets, capsules, and 
pellets in the gastrointestinal tract, as well as for the determination of the in vivo drug 
release from modified release products such as enteric-coated tablets and enhanced release 
tablets (Weitschies et al., 2005a).  
The combination of MMM with the pharmacokinetic measurements 
(pharmacomagnetography) enables the determination of in vitro–in vivo correlations and the 
delineation of absorption sites in the gastrointestinal tract (Weitschies et al., 2005b). The 
results obtained with MMM can also serve as a data base for the development of improved 
pharmacokinetic models. 
5. Conclusion and perspectives 
The use of magnetic particles in the medical field opens new prospect of selective 
treatment of local tissues where efficiency is increased through local concentrations while, 
at the same time, general side effects can be avoided. However, the use of magnetic 
carriers in the human body imposes several requirements on the magnetic carriers. 
Magnetic carriers must be water-based, biocompatible, biodegradable, and 
nonimmunogenic. Besides, special care should be focused on the particle size, surface 
properties, magnetic properties, and administration route, for example. In most of the 
reports in the literature, iron oxides are the material of choice for the development of 
magnetic systems for therapeutic purposes.  
Several methods have been proposed for their synthesis, coating, and stabilization. Magnetic 
systems produced by different methods have found many applications in biotechnology. 
The safety aspect, the non-invasiveness, and the high targeting efficiency are promising 
advantages for the use of magnetic particles in therapeutics. The current challenge still 
consists of totally controlling the biocompatibility, stability, biokinetics, and properties of 
the particles.  By incorporating advances in surface engineering, molecular imaging, and 
biotechnology, magnetic systems have great potential to enable physicians to diagnose and 
treat diseases with greater effectiveness than ever before. 
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1. Introduction 
The late 19th and, especially, the early 20th century were marked by the introduction of 
experimental approaches in various biological disciplines. The methods of accumulative and 
axenic microorganism cultures were already widely used in microbiology of that period; in 
animal and plant sciences, attempts were made to grow whole organisms, individual 
organs, tissues and/or individual cells under controlled laboratory conditions (Vochting, 
1892; Harrison, 1907). By the early 20th century, some results had already been achieved in 
cultivating animal tissues (Krontovsky, 1917 cited in Butenko, 1999), and, in the 1920s, plant 
and animal cells and tissues (Czech, 1927; Prat, 1927; Gautheret, 1932; White, 1932). An 
important step in plant tissue cultivation was the discovery of phytohormones and 
development of specialized cultivating media that allowed inducing, on the one hand, 
dedifferentiation and callus formation, or, on the other hand, cell differentiation. These 
achievements helped to solve a number of problems, both theoretical and applied 
(Street, 1977; Butenko, 1999). With time, the spectrum of organisms introduced in cultures 
was widening, the principal methods of growing plant cells in vitro  were developed, and 
the foundations were laid for microclonal propagation. 
The said period was also marked by the formation and development of the notion of 
symbiosis. The revolutionary works of A.S. Famintsyn (1865) and S. Schwendener (1867)  (as 
cited in Famintsyn, 1907) discovered the dual nature of lichens. The notion of symbiosis was 
formulated in 1879 by A. de Bary. In the early 20th century, K.S. Mereschkowski established 
the theory of symbiogenetic origin for the eukaryotic cell and formulated the notion of two 
"plasms" (Mereschkowski, 1907, 1909). 
Symbiosis is currently studied by a special scientific discipline, symbiology, and regarded as 
a stable super-organism system undergoing balanced growth and characterized by specific 
interrelations of components, and by unique biochemistry and physiology (Ahmadjian & 
Paracer, 1986; Paracer & Ahmadjian, 2000). 
It is noteworthy that the development of each of the above-mentioned fields of study has 
not been independent. Constantly intervening with each other, works in all these fields were 
conductive to the formation of a new branch, already within the new science of symbiology. 
In the 1990s, this new branch was termed experimental symbiology. 
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1. Introduction 
The late 19th and, especially, the early 20th century were marked by the introduction of 
experimental approaches in various biological disciplines. The methods of accumulative and 
axenic microorganism cultures were already widely used in microbiology of that period; in 
animal and plant sciences, attempts were made to grow whole organisms, individual 
organs, tissues and/or individual cells under controlled laboratory conditions (Vochting, 
1892; Harrison, 1907). By the early 20th century, some results had already been achieved in 
cultivating animal tissues (Krontovsky, 1917 cited in Butenko, 1999), and, in the 1920s, plant 
and animal cells and tissues (Czech, 1927; Prat, 1927; Gautheret, 1932; White, 1932). An 
important step in plant tissue cultivation was the discovery of phytohormones and 
development of specialized cultivating media that allowed inducing, on the one hand, 
dedifferentiation and callus formation, or, on the other hand, cell differentiation. These 
achievements helped to solve a number of problems, both theoretical and applied 
(Street, 1977; Butenko, 1999). With time, the spectrum of organisms introduced in cultures 
was widening, the principal methods of growing plant cells in vitro  were developed, and 
the foundations were laid for microclonal propagation. 
The said period was also marked by the formation and development of the notion of 
symbiosis. The revolutionary works of A.S. Famintsyn (1865) and S. Schwendener (1867)  (as 
cited in Famintsyn, 1907) discovered the dual nature of lichens. The notion of symbiosis was 
formulated in 1879 by A. de Bary. In the early 20th century, K.S. Mereschkowski established 
the theory of symbiogenetic origin for the eukaryotic cell and formulated the notion of two 
"plasms" (Mereschkowski, 1907, 1909). 
Symbiosis is currently studied by a special scientific discipline, symbiology, and regarded as 
a stable super-organism system undergoing balanced growth and characterized by specific 
interrelations of components, and by unique biochemistry and physiology (Ahmadjian & 
Paracer, 1986; Paracer & Ahmadjian, 2000). 
It is noteworthy that the development of each of the above-mentioned fields of study has 
not been independent. Constantly intervening with each other, works in all these fields were 
conductive to the formation of a new branch, already within the new science of symbiology. 
In the 1990s, this new branch was termed experimental symbiology. 
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2. Specifics of lichens as experimental systems. Peculiarities of the 
terminology 
Lichens are a classic example of symbiotic associations with multicomponent composition as 
their principal feature. According to the number of partners forming the thallus, two- and 
three-component lichens are recognized. The former consist of a fungal component (the 
mycobiont) and a photosynthetic component (the photobiont). In two-component lichens, the 
photobiont is represented either with a green alga or a cyanobacterium; in three-component 
lichens, with both: a green alga in the basal part of the thallus and a cyanobacterium in 
specialized formations, cephalodia (Rai, 1990, Paracer & Ahmadjian, 2000). 
According to the type of localization in the lichen, internal (intra-thallus) and external 
(surface) cephalodia are recognized. In nature, lichens with internal cephalodia are probably 
prevalent. Some investigators, e.g., P.A. Genkel and L.A. Yuzhakova (1936) (the history of 
the question is described in: A.N. Oksner, 1974) suggested that nitrogen-fixing bacteria 
(such as Azotobacter spp.) also constitute an obligatory symbiotic component of lichens. 
Experimental evidence did not support this view (Krasilnikov, 1949). On the other hand, it is 
currently believed that bacteria are associated, minor symbionts in the lichen system, 
participating in the morphogenesis of the thallus (Ahmadjian, 1989). 
In addition to morphology, lichens as symbiotic systems demonstrate a number of peculiar 
biochemical and ecological features. Only occasional findings of the so-called lichen 
compounds in monocultures of lichen symbionts (in most cases, mycobionts) have been 
reported (Ahmadjian, 1961, 1967). At the same time, large amounts of phenolic compounds 
(mainly depsides and depsidones), found almost nowhere else, are present in lichens 
(Culberson, 1969; Vainshtein, 1982a, 1982b, 1982c). The functions of these compounds are 
not yet fully known. Various compounds probably play different roles in the vital functions 
of lichens: some participate in the initiation of symbiotic interactions (Ahmadjian, 1989), 
some provide for the exchange of nutrients between the symbionts (Vainshtein, 1988), and 
some are used for adaptation to environmental conditions (e.g., in substrate destruction or 
in competition: Tolpysheva, 1984a, 1984b, 1985; Vainshtein & Tolpysheva 1992; Manojlovic 
et. al., 2002). Symbiosis helped lichens to become extremely widespread, but they are 
prevalent in extreme or simply oligotrophic habitats. This probably reflects the fact that 
lichens are capable of surviving considerable changes of temperature, drying, poor 
substrates, but at the same time, due to slow growth, it is hard for them to survive 
competition with higher plants (Paracer & Ahmadjian, 2000). 
The multicomponent composition of lichens makes it difficult to use them in biotechnology. 
Lichens are super-organism multicomponent systems, and we believe that it is necessary to 
discuss here the terminology used for growing lichens in culture. In English-language 
literature, the word "culture" is used for laboratory manipulations with lichen thalli and 
their fragments, but different authors understand this term differently. Taking into account 
the fact that experimental lichenology developed largely on the basis of approaches 
borrowed from plant physiology, we believe that it is advisable to define the notion of 
"culture" more accurately, in the light of the sense this term has in plant physiology, where it 
means the growing of dedifferentiated parts of an organism on growth media under 
controlled laboratory conditions (Street, 1977; Butenko, 1999). Lichens have no true tissues, 
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only plectenchymas, and thus the term "tissues" can be used only in quotation marks. We 
believe that it is possible, by analogy, to use also a number of other terms, such as explants, 
"callus cultures", etc. 
3. History and classification of the experimental approaches in lichenology 
Two principal groups of experimental approaches can be recognized in lichenology 
(Fig. 1, 2): first, resynthesis of lichens and producing of model systems (developed by V. 
Ahmadjian, M. Galun), and second, obtaining lichen "tissue cultures" (developed by Y. 
Yamamoto). The former groups of approaches is based on the dissociation of the initial 
thallus into components (Fig. 1) and subsequent attempt to resynthesize the initial sample or 
model it based on similar systems (Ahmadjian, 1973a, 1973b). In the latter case, 
dedifferentiated biomasses of the lichen are obtained (Fig. 2), using thallus fragments, 
soredia, or isidia (Yoshimura & Yamamoto, 1991; Yoshimura et al., 1993; Yamamoto et 
al., 1993). 
 
Fig. 1. Main stages of the method of lichen resynthesis. 
The former group of approaches reconstructs the general situation emerging in lichens in 
the course of sexual reproduction, and the latter resembles rather the processes that take 
place in nature in the course of their vegetative reproduction. For instance, soredia are 
dedifferentiated parts of the thallus consisting of cells of both symbionts, which makes 
them very convenient sources for obtaining "tissue cultures". Isidia, morphologically 
structured thallus fragments, are natural explants of microclonal propagation (Fig. 2). But 
soredia and isidia are found only in some lichens, which makes obtaining "lichen tissue 
cultures" from thallus fragments an important approach (Yamamoto et al., 1993; 
Yoshimura et al., 1993). Interestingly, lichen thalli develop similarly in all cases, 
independently of the approach used (Ahmadjian, 1973a, 1973b; Yoshimura et al., 1993; 
Stocker-Worgotter & Turk, 1989). 
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Attempts to synthesize lichens from separate components (fungi and green algae or 
cyanobacteria) were made simultaneously with the discovery of the dual nature of lichens 
by S. Schwendener in 1867. In the same year, A.S. Faminsyn and O.V. Baranetsky, 
cultivating fragments of lichen thalli, succeeded in describing for the first time the growth of 
the photobiont outside the thallus. However, almost all attempts to resynthesize a lichen 
from separate components in the late 19th century were unsuccessful (Bornet, 1873; Bonnier, 
1889; critique of these works: Ahmadjian & Jacobs, 1983). The cause of these failures was the 
lack of both theoretical and experimental foundations laid for such experiments. Successful 
experiments on lichen construction were performed only three decades later, due to the 
development of theoretical data on the biology of lichens and laying of methodological 
foundations for cultivating lichen component monocultures on artificial media. 
 
Fig. 2. Main stages of the method of "lichen tissue cultures". 
In 1939, E. Thomas was the first to successfully resynthesize the lichen Cladonia pyxidata 
(Paracer, Ahmadjian V., 2000).  However, he was unable to reproduce his experiment: none of 
the 800 subsequent attempts to resynthesize the lichen was successful. The 1950s mark the start 
of the epoch of experimental lichenology. In different countries, several scientific schools 
emerged, each of them developing approaches of its own and following its own general 
direction of studies: in the United States, V. Ahmadjian (resynthesis and construction of 
artificial associations); in Israel, M. Galun (sensory signal interactions); in Germany, S. Ott and 
his colleagues (lichen morphogenesis); in Japan, Y. Yamamoto (obtaining and biotechnological 
application of lichen "tissue cultures"). In the former Soviet Union, methods for isolating 
photobionts from  thalli were developed by E.A. Vainshtein and I.A. Shapiro. During this 
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period, methods for extracting mycobionts and photobionts from thalli were perfected, 
appropriate media for cultivating symbiont monocultures were developed, and new 
substrates for reconstructing lichen thalli were proposed (Ahmadjian, 1973a). 
Lichenologists became considerably more interested in resynthesizing the thalli of two-
component lichens thanks to the classic studies of Ahmadjian (1961, 1967, 1973a, 1973b, 
1990). His contribution to this area is hard to overestimate: over 40% of publications on 
lichen thalli resynthesis were produced by him alone or in collaboration with others. He 
developed the method for extracting and cultivating the mycobiont from apothecia. Thanks 
to Ahmadjian's work, thallus resynthesis of some lichen species became common practice. 
The principal advantages and disadvantages of the methods he proposed are now clear, but 
while the advantages are currently widely used in experimental studies, the disadvantages 
have not yet been overcome, restricting the area where this approach is applied (Ahmadjian, 
1973b, 1990). 
Integrating the first group of approaches and methods used for obtaining plant tissue 
cultures, Y. Yamamoto (1985) founded another branch of experimental lichenology: 
cultivation of ground lichen thallus fragments on artificial growth media (Fig. 2). One of the 
most important advantages of this approach was using vegetative parts of the thallus, which 
made the approach equally applicable to lichens with different modes of reproduction. In 
addition, Yamamoto's method allowed obtaining, under controlled conditions and on a tight 
timetable, a biological system consisting of both components and displaying a number of 
properties typical of intact lichens (Yoshimura et al., 1993; Yamamoto et al., 1993). Taking 
into account the fact that under particular conditions for cultivating such systems, thalli 
morphologically and anatomically similar to the natural ones are formed (Yoshimura & 
Yamamoto, 1991; Yoshimura et al., 1993), this approach can be used for reproducing lichens 
in vitro. 
The interest towards these studies can be illustrated by the fact that the number of lichen 
species cultivated in vitro increased from two in 1985 to 193 in 1993, and the collection of 
mycobiont and photobiont cultures and "tissue cultures" by that time comprised over 400 
lines (Yamamoto et al., 1993) and 400 species (Yamamoto et al., 1995). These included 
lichens from different climatic and geographical zones, growing in Canada, England, 
Finland, Israel, Japan, Antarctica, and Malaysia. 
4. Lichen resynthesis and producing artificial (model) associations 
The method of lichen resynthesis includes the following stages: (1) dissociation of the 
natural lichen into components; (2) obtaining monocultures of the mycobiont and 
photobiont; (3) mixed cultivation of the mycobiont and photobiont; and (4) producing a 
stable morphogenetic association (Fig. 1). 
4.1 Lichens used in attempts of resynthesis 
Although works on the experimental resynthesis of lichens are in progress since over 70 
years ago, the number of species of lichens resynthesized to date remains not too high 
(Table 1). Experiments were successful with far from all systems, and those lichen species 
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that produced more or less developed thalli in resynthesis experiments, such as Cladonia 
cristatella (Ahmadjian & Jacobs, 1983) and Xanthoria parietina (Bubrick et al., 1985; 
Galun, 1989), were repeatedly used subsequently for solving particular lichenological 
problems (Fig. 3). Most resynthesized species are crustose two-component forms, and only 
one, Stereocaulon vulcani, is three-component, which probably reflects the complexity of such 
systems (Table 1).  
 
Fig. 3. Lichen species used in attempts of resynthesis 
Most attempts to reconstruct thalli were made on lichens with green algal photobiont (Fig. 
4). Among lichens with cyanobacterial photobiont, successful resynthesis was achieved only 
in members of the genus Peltigera; attempts to resynthesize Leptogium issatschenkovi were 
unsuccessful (Ahmadjian, 1989). Among the almost 30 genera of green algae occurring as 
photobionts in lichens (Oksner, 1974; Ahmadjian & Paracer, 1986), members of only 10 were 
used in resynthesis experiments; in 60% of the studies, species of the genera Trebouxia, 














Fig. 4. Proportion of resynthesized lichens with different photobionts: A, proportion of 




2– algal photobiont 
3 – Trebouxia spp. 
4 – Desmococcus spp. 
5 – Chlorella spp. 
6 – all other species  
 
1 – Cladonia spp. 
2 – Endocarpon pusillum 
3 – Xanthoria parietina 
4 – Usnea strigosa 
5 – Rhizoplaca chrysoleuca 
6 – other species 
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Lichen name Photobiont genera Source 
Acarospora fuscata Trebouxia Cited by: Оksner, 1974 
Buelia spp. Trebouxia Cited by: Оksner, 1974 
Bacidia bagliettoana Chlorella Bornet, 1873 
Caloplaca decipiens Chlorella Cited by: Оksner, 1974 
Cladonia cristatella Trebouxia or Chlorella 
Remmer, Ahmadjian, Livdahl, 1986 — 
cited by: Ahmadjian & Paracer, 1986 ; 
Ahmadjian, 1967 
C. furcata Trebouxia or Chlorella Jahns, 1978  — cited by: Ahmadjian & Paracer, 1986 
C. pyxidata Trebouxia or Chlorella Thomas, 1939 — cited by: Оksner, 1974 
Collema limosum Nostoc Rees, 1871 — cited by: Оksner, 1974 
Dermatocarpon 
miniatum Hyalococcus or Protococcus Stocker-Worgotter & Turk, 1989 
Endocarpon pusillum Myrmecia Bertsch, Butin, 1967; Stahl, 1877 — цит по Stocker-Worgotter & Turk, 1988 
Graphidaceae g. sp. Trentepohlia Hеrriset, 1946 — cited by: Оksner, 1974 
Heppia echinulata Scytonema, cyanobacterium 
Marton, Galun, 1976  — cited by: 
Ahmadjian & Paracer, 1986 
Huilia albocaerolescens green alga Cited by: Ahmadjian & Paracer, 1986 
Lecanora spp. Protococcus 
Ahmadjian, Russell, Hildreth, 1980; 
Culberson, Ahmadjian, 1980 — cited 





Cited by: Ahmadjian & Paracer, 1986 
Lepraria spp. Stichococcus or Chlorella Cited by: Ahmadjian & Paracer, 1986 
Leptogium 
issatschenkovi Nostoc Danilov, 1929 — cited by: Оksner, 1974 
Peltigeria canina Nostoc Ahmadjian, 1989 
Physia stellaris Trebouxia Bonnier, 1888 
Rhizoplaca chrysoleuca Protococcus Cited by: Ahmadjian & Paracer, 1986 
Rinodina sophodes green alga Bonnier, 1888 
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that produced more or less developed thalli in resynthesis experiments, such as Cladonia 
cristatella (Ahmadjian & Jacobs, 1983) and Xanthoria parietina (Bubrick et al., 1985; 
Galun, 1989), were repeatedly used subsequently for solving particular lichenological 
problems (Fig. 3). Most resynthesized species are crustose two-component forms, and only 
one, Stereocaulon vulcani, is three-component, which probably reflects the complexity of such 
systems (Table 1).  
 
Fig. 3. Lichen species used in attempts of resynthesis 
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4). Among lichens with cyanobacterial photobiont, successful resynthesis was achieved only 
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unsuccessful (Ahmadjian, 1989). Among the almost 30 genera of green algae occurring as 
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Lichen name Photobiont genera Source 
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Remmer, Ahmadjian, Livdahl, 1986 — 
cited by: Ahmadjian & Paracer, 1986 ; 
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Culberson, Ahmadjian, 1980 — cited 
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The proportion of such studies performed on photobionts from the genus Trebouxia is 
especially high. This is explained by the fact that 90% of lichen species have photobionts 
belonging to this genus (Oksner, 1974). However, using photobionts of the genus Tribouxia 
in experiments on lichen thallus resynthesis (Ahmadjian, 1973a) did not guarantee success; 
this is why in 75% of experiments photobionts of other genera were used. In their natural 
environment, all resynthesized lichen species form sexual reproductive organs (apothecia or 
perithecia), and most form asexual reproductive organs as well: conidia, pycnoconidia, etc. 
(Fig. 5A). 
 
A: 1, sexual reproduction with apothecia; 2, asexual reproduction (with conidia etc.); 3, vegetative 
reproduction with soredia; 4, vegetative reproduction with isidia; 5, sexual reproduction with 
perithecia. 
B: 1, sexual reproduction with apothecia; 2, vegetative reproduction with soredia; 3, asexual 
reproduction (with conidia etc.); 4, vegetative reproduction with isidia; 5, sterile species (reproduction 
lacking or not observed). 
Fig. 5. Proportion of different modes of reproduction in resynthesized (A) and cultivated (B) 
lichens. 
Vegetative reproduction structures, soredia and isidia, are found only in three of the 
reconstructed lichen species. Experimental resynthesis requires a culture of the mycobiont, 
and Ahmajian (1973a) proposed using spores for extracting it from the naturally growing 
lichen. This is probably why lichens with mainly vegetative mode of reproduction were 
seldom used in such in vitro experiments. 
It has been found that successful resynthesis of a lichen thallus from mycobiont and 
photobiont monocultures requires experimental conditions imitating the natural 
environment: the substrate and medium should be poor, so that the lichen does not 
dissociate into components, and neither the mycobiont or photobiont get any advantages for 
growth at any stage of development. To induce thallus differentiation in a mixed culture, 
alternating drying and moistening periods should be imposed, and the drying of biomass 
should be gradual (Ahmadjian, 1973b). 
4.2 Producing artificial (model) associations 
Work on the resynthesis of lichens and producing model association has laid the foundation 
for solving a number of basic problems of the current lichenology. One of these problems is 
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the study of selectivity and specificity of symbiont interaction in lichens. For solving this 
problem in the course of lichen thallus resynthesis, it is possible to cultivate the mycobiont 
in pairs with free-living algae or photobionts in combinations not found in nature. In 50% of 
such experiments, the model systems revealed the lichenization of photobiont cells: the 
initial contact between the partners of the association took place, and pre-thalli were formed 
(Tables 2, 3). The same mycobiont showed both positive and negative results with algae of 
different species of the same genus or with photobionts extracted from the same lichen. The 
cause of this selective interaction of partners in pairs has not yet been revealed; however, 
several factors affecting the success of this process were determined, the most important of 












Cladonia cristatella Trebouxia ereci Friedmannia 
israeliensis 
free-living + 
Myrmecia sp. not specified - 
Nostoc sp. cycads - 
Pleurastrum terrestre free-living - 
Pseudochlorella sp. not specified - 
Pseudotrebouxia sp. Xanthoria parietina - 
Trebouxia sp. Pilophoron sp. + 
Trebouxia sp. Stereocaulon sp. + 
Trebouxia sp. Gymnoderma sp. + 
Trebouxia sp. Lecidia sp. + 
Trebouxia sp. Lepraria sp. + 
Trebouxia sp. Parmelia sp. - 
Trebouxia sp. Xanthoria aureola - 







Staurothele regulosa - 
Glyphis lepida Trentepohlia Trentepohlia sp. Pyrenula nitidula + 
Phaeographina 
fulganata 





Myrmecia biatorellae Endocarpon pusillum - 
Table 2. Model associations based on the mycobiont. Note: +, synthesis continued to 
prethallus; -, attempts of synthesis were unsuccessful 
For instance, species of the genus Trebouxia competent for the mycobiont C. cristatella were, 
with one exception, derived from lichens taxonomically close to the family Cladoniaceae, 
while attempts to synthesize thalli with photobionts of the same genus extracted from 
lichens of distantly related families were unsuccessful. Interestingly, the mycobiont 
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C. cristatella formed prethallus also with the free-living alga Friedmannia israeliensis 
(Ahmadjian & Jacobs, 1983). The synthesis, however, did not go any further, and, as in all 
the other cases with constructing lichen-based model systems, the mycobiont killed the algal 
cells. Unfortunately, these experiments were not continued. It is very likely that some 
changes in media and/or cultivating conditions would produce a new lichen species: after 
all, in experiments with compatible cultures of natural symbionts parasitism of the 
mycobiont on photobiont is also observed under certain conditions. 
 
Potential photobiont Source of photobiont Potential mycobiont Result 
Friedmannia israeliensis free-living Cladonia cristatella + 
Myrmecia sp. not specified Cladonia cristatella - 
Myrmecia biatorellae Endocarpon pusillum Staurothele regulosa - 
Nostoc sp. cycads Cladonia cristatella - 
Pleurastrum terrestre free-living Cladonia cristatella - 
Protococcus staurothelis Staurothele regulosa Endocarpon pusillum - 
Pseudochlorella sp. not specified Cladonia cristatella - 
Pseudotrebouxia sp. Xanthoria parietina Cladonia cristatella - 
Trebouxia sp. Pilophoron sp. Cladonia cristatella + 
Stereocaulon sp. Cladonia cristatella + 
Gymnoderma sp. Cladonia cristatella + 
Lecidia sp. Cladonia cristatella + 
Lepraria sp. Cladonia cristatella + 
Parmelia sp. Cladonia cristatella - 
Xanthoria aureola Cladonia cristatella - 
Trebouxia italiana Xanthoria parietina Cladonia cristatella + 
Trentepohlia sp. Pyrenula nitidula Glyphis lepida + 
Trentepohlia sp. Pyrenula nitidula Phaeographina 
fulganata 
+ 
Table 3. Model associations based on the photobiont. Note: +, synthesis continued to 
prethallus; -, attempts of synthesis were unsuccessful 
On the other hand, photobionts isolated from lichen X. parietina — Pseudotrebouxia sp. and 
Trebouxia sp. — interacted differently with the mycobiont C. cristatella: the mycobiont 
quickly Pseudotrebouxia sp., but formed  prethallus with Trebouxia sp. (Table 2). It has been 
found that some photobionts (Trebouxia spp., Trentepohlia spp.) and mycobionts 
(Graphidaceae g. spp.) are better than others (e.g., Myrmecia spp.) at forming artificial 
associations. All the attempts to synthesize model associations using the photobiont 
Trentepohlia sp. and mycobionts extracted from lichens of the family Graphidaceae were 
successful. This was probably determined, on the one hand, by the greater or smaller 
resistance of the alga to parasitism and by the degree of mycobiont aggression, and, on the 
other hand, by the proximity of the potential photobiont in a number of characters (type of 
vegetative reproduction, etc.) to the natural photobiont. In addition, there are more and less 
specialized and symbiotrophic genera or species of photobionts and mycobionts. 
Unfortunately, there are no data in the literature on model associations based on lichen 
photobionts and free-living fungi (Table 3). Meanwhile, we believe that this problem is 
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very interesting, since the photobiont, intensely influenced by the mycobiont in the lichen, 
has developed a number of protective adaptations. These adaptations may be conductive 
to success in producing model associations of the photobiont and free-living symbiotic 
fungi. 
Another problem is the construction of artificial three-component associations. For solving 
this problem, a third component, a cyanobiont, can be added to the resynthesized lichen to 
study the process of cephalodia formation (Ahmadjian, 1989; Ahmadjian & Jacobs, 1983; 
Ahmadjian & Paracer, 1986). Attempts to model three-component lichens have been made 
by adding strains of the symbiotrophic and free-living Nostoc sp. to two-component lichens 
with a green alga (e.g., to C. cristatella). In all such experiments, the mycobiont parasitized 
the cyanobiont, and the formation of cephalodia was not observed. 
A large field for work in experimental lichenology is opened by the opportunity to obtain 
protoplasts of the symbionts. The methodology of this procedure for a lichen mycobiont 
grown from a spore was developed by V. Ahmadjian (1991). Kinoshito (Yamamoto et al., 
1993; Kinoshito et al., 2001) modified this procedure to develop a method independent of 
the way of mycobiont extraction, making it possible to obtain mycobiont protoplasts from 
vegetative parts of the thallus (experiments on obtaining mycobiont protoplasts were 
performed only with members of the genus Cladonia). Using isolated protoplasts makes it 
possible to model intracellular interactions of the symbionts. Interestingly, a similar 
enigmatic organism is known in nature, the fungus Geosiphon pyriforme, which hosts inside 
the cell the cyanobacterium Nostoc punctatum (Wolf, Schüßler, 2005). 
5. "Tissue cultures" of lichen 
The field of experimental lichenology has been developed especially to obtain "callus tissue 
cultures" of lichens. Currently, lichens cultivated on solid growth media include 52 genera 
from 22 families, represented mainly by fruticose forms (52%), somewhat fewer foliose 
forms (36%), and only 12% crustose forms. The vast majority of the species maintained in 
"callus cultures" are two-component lichens with green algal photobionts. Attempts to 
introduce three-component lichens to a "callus culture" result in their dissociation into 
components and formation of "chimeric" forms (see below). 
The ratio of different modes of reproduction among cultivated lichens differs from that 
among reconstructed ones, and there is no pronounced prevalence of forms with sexual or 
asexual reproduction (necessary for extracting the mycobiont according to the first group of 
experimental approaches). On the contrary, there is quite a high proportion of lichens with 
vegetative reproductive structures, soredia and isidia: 36% together, the same as the 
proportion of lichens with apothecia (37%). Furthermore, the universality of the approach 
allows cultivating fragments of lichens that form apothecia extremely rarely (Fig. 5B). 
5.1 Problems emerging in the course of lichen cultivation 
Among difficulties of this experimental approach, the high proportion of explants infected 
with accompanying microorganisms and the low proportion of thallus fragment 
germination can be named. In the case of Usnea rubescens, growth was observed only in 27% 
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C. cristatella formed prethallus also with the free-living alga Friedmannia israeliensis 
(Ahmadjian & Jacobs, 1983). The synthesis, however, did not go any further, and, as in all 
the other cases with constructing lichen-based model systems, the mycobiont killed the algal 
cells. Unfortunately, these experiments were not continued. It is very likely that some 
changes in media and/or cultivating conditions would produce a new lichen species: after 
all, in experiments with compatible cultures of natural symbionts parasitism of the 
mycobiont on photobiont is also observed under certain conditions. 
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of the inoculated thallus fragments; in Peltigera praetextata, it was observed in 0.4–1.2% cases 
(maximum and minimum values are given). These parameters are influenced by a number 
of factors, such as species, habitat, area of the lichen's thallus, number of symbionts 
(Yoshimura et al., 1993; Yoshimura & Yamamoto, 1991; Smirnov & Lobakova, 2007). The 
best results are obtained by using soredia of two-component epiphytic fruticose lichens. One 
possible explanation of this is the fact that 1 g of wet lichen weight contains up to 1010 
microorganism cells, while in soredia their number is considerably lower (Krasilnikov, 
1949); thus, using specialized vegetative reproduction structures (both isidia and soredia) is 
probably quite promising. 
Yoshimura et al. (1993) note that attempts to cultivate fragments of the cyanolichen 
P. praetextata on growth media result in higher levels of infection by contaminant bacteria 
and myxomycetes, compared to attempts to cultivate explants of lichens with green algal 
symbionts. This is usually explained in the literature by the fact that symbiotic 
cyanobacteria have strong, complexly organized surface structures (polysaccharide 
sheaths), serving as habitats for associated bacteria, complicating the process of obtaining 
sterile cyanolichen explants (Yoshimura & Yamamoto, 1991; Gusev & Mineeva, 1992). 
However, in our experiments, in spite of the higher affection level actually observed in 
fragments of cyanolichens cultivated on growth media, compared to other kinds of 
lichens, cyanobiont isolates extracted from cyanolichen thallus fragments contained fewer 
accompanying bacteria than green algal isolates from the same lichens (Smirnov & 
Lobakova, 2007). 
One drawback of the method for obtaining lichen "tissue cultures" described in the literature 
is the total lack of any primary sterilization of explants. Although some studies refer to 
unsuccessful attempts to sterilize thallus fragments with mercuric chloride (Ahmadjian, 
1989), our data (Smirnov & Lobakova, 2007) demonstrate the efficiency of consistent 
complex usage of "mild" sterilizing agents (such as hydrogen peroxide, alcohol, 
chlorhexidine). 
In our opinion, works aimed by obtaining "suspension cell cultures" of lichens are 
especially promising. Experiments in this branch of lichenology are rare and fragmentary, 
while maintaining symbiont monocultures in liquid media are currently a common 
practice (Ahmadjian & Jacobs, 1983). In "suspension cultures" of lichens, thalli are not 
formed; this is why in most studies aimed at obtaining structured lichen thalli, even if 
thallus fragments were inoculated into liquid growth media, the experiments were never 
completed, because provisional results did not comply with the initial aims. On the other 
hand, obtaining "suspension cultures" of lichens is of considerable interest for 
biotechnology, since methods based on "suspension cultures" are easier to introduce into 
the industry. Thus, this mode of growth will probably allow obtaining large amounts of 
dedifferentiated cell biomass and using it in biotechnology as sources of lichen 
compounds. 
A promising approach for obtaining both "suspension cultures" and "callus cultures" of 
lichens involves using "nurse cultures" (Smirnov & Lobakova, 2008) and conditioning 
(processing) the cultivating media with metabolites of associated organisms. Data available 
in the literature give evidence that the initiation of symbiont growth (especially of the 
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mycobiont) requires compounds secreted by the photobiont or associated bacteria. It has 
been found that the development of the mycobiont was quicker and more intense if (1) non-
sterile tree bark was used as the substrate; (2) the cultivating medium was conditioned by 
metabolites of the photobiont or bacteria; (3) the spores were infected by bacteria 
(Ahmadjian, 1989; Yolando et al., 2002; Smirnov, 2006). Our results show that conditioning 
the media with simple metabolites (after sterilization) is inefficient, compared to using 
native metabolites (dialysis cultivation). 
5.2 Study of lichen morphogenesis 
A special place among experimental works in lichenology is occupied by the branch 
involving the study of lichen thallus morphogenesis and revealing the factors influencing 
this process. A number of studies have addressed the problem of inducing morphogenesis 
in "callus cultures" of soredia, both in the laboratory, and in the natural environment 
(Stocker-Worgotter & Turk, 1988; Stocker-Worgotter & Turk, 1989; Yoshimura & Yamamoto, 
1991; Armaleo, 1991; Yoshimura et al., 1993). Comparison of natural lichen thalli with those 
obtained by inducing morphogenesis in in vitro systems demonstrates their anatomical and 
morphological similarity; the same layers are formed: upper cortex (in some species, lower 
cortex), photobiont layer, medulla. One drawback of this approach is the fact that non-
homogeneous material, e.g. in the shape and size of scales, is often formed in the laboratory, 
probably because of the heterogeneity of various thallus parts caused by the parasexual 
process (Stocker-Worgotter & Turk, 1988) or by somatic variation (Street, 1977; Butenko, 
1999). 
Lichens with different modes of reproduction (sexual, asexual and vegetative) under 
laboratory conditions with morphogenesis induction undergo the same stages of 
development (lag phase, arachnoid phase, prethallus and thallus: Ahmadjian, 1973а, 1973b; 
Ahmadjian & Jacobs, 1983; Stocker-Worgotter & Turk, 1989; Yoshimura et al., 1993) as in 
nature (Ott, 1988). The only difference is the duration of particular stages, depending on the 
type of the explant and conditions of its cultivation. In P. didactyla, thallus develops quicker 
than in other species (especially at the final stages). It has been found (Stocker-Worgotter & 
Turk, 1988), that using soredia as explants is conductive to the quick (2–4 times quicker) 
formation of thallus in vitro; however, rates of morphogenesis as high as in nature have not 
yet been achieved under laboratory conditions. 
The experimental approaches in lichenology described here are currently used for solving a 
number of basic problems like those persistent in biotechnology. The former approaches 
include studying the ecological and morphological plasticity of lichens and revealing 
differentiation factors of thalli and the share of each partner in the formation of the unique 
super-organism system. 
In this respect it is especially interesting to study the development of the "tissue cultures" of 
three-component lichens, such as Peltigera aphthosa, with a green alga as the photobiont and 
a cyanobiont in cephalodia. In "tissue cultures" of P. aphthosa, explants often formed a 
homoiomerous cyanolichen, and the green alga was expelled from the association and 
remained in the culture as free-living colonies. The drying of the system increased the 
number of green algal colonies, and they were included into the composition of non-
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differentiated mixed aggregates. The slightly raised and drying areas of the homoiomerous 
cyanothallus became colourless (the cyanobiont disappeared) and were gradually colonized 
by the green alga, while in other areas, which preserved contact with the substrate, 
cyanobacteria were preserved. These areas resembled primordia of new green lobes; 
however, no further development was observed. Due to the difficulties of moisture control, 
normal thalli did not form in the experiments; the formation of cephalodial primordia was, 
nevertheless, observed. 
The phenomenon described provides an experimental confirmation of the idea that 
mycobionts can include several morphotypes (as analysis of their DNA has also shown), 
and/or the formation of chimeric lichens is possible. While the existence of such chimeras 
was earlier considered unproven, now the reality of this phenomenon has been confirmed 
both by some field studies (for review, see: Plyusnin, 2002) and by laboratory 
experiments. 
Morphogenetic "tissue cultures" of lichens are convenient experimental models for the 
study of this phenomenon. The results of using them allow us to state that the formation 
of a particular morphotype or chimeric lichen depends on moisture. For instance, these 
results allow suggesting that the cyanobacterial morphotype is more widespread than has 
been believed earlier and unidentified species of the genus Peltigera with cyanobacteria 
often represent one of the morphotypes of three-component lichens (Yoshimura et al., 
1993). 
It can be assumed that experimental approaches will also play an important role in the 
molecular biology of cyanolichens: they will allow studying the exchange of genes, inferred 
by some authors, between the symbionts by means of plasmids in the course of 
morphogenesis (Ahmadjian, 1991). Reviewing the data available in the literature has shown 
that for studying the early stages of lichen thallus morphogenesis, it is better to use methods 
of resynthesis, while for the study of specificity and selectivity of interactions between 
components of this symbiosis, as well as of different stages of thallus differentiation, the 
"tissue culture" and morphogenesis induction methods are more suitable. 
Dedifferentiated mixed cellular aggregates of a "callus culture" of lichens can be used in the 
study of the genetic control over symbionts in the course of the formation of a balanced 
super-organism system (Yamamoto et al., 1993; Yoshimura et al., 1993). 
5.3 The biotechnological potential of lichen "tissue cultures" 
Using experimental approaches is promising also for producing from lichens their unique 
secondary metabolites, the lichen compounds. The biosynthesis of lichen compounds in 
"tissue cultures" is usually no different from that in the natural thallus in the composition of 
depsides, tridepsides, and depsidones; triterpenoid compounds are, however, a more labile 
class of substances, and in "callus cultures" of lichens they often disappear (Table 4). 
In most cases, the concentration of lichen compounds in a "culture" is considerably lower 
than in a natural thallus: the content of the usnic acid in Usnea rubescens is 0.9% in the 
natural state and 0.162% in a "callus culture", i.e., five times higher; in Ramalina yasudae, it is 
even 100 times higher (Yamamoto et al., 1985). But since "tissue cultures" of some lichen 
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species grow considerably quicker (their biomass increases at least by a factor of 5 over 14 
weeks), using the Yamamoto method for industrial production of lichen compounds 
(Yamamoto et al., 1985; Yamamoto et al., 1993) is very promising. Importantly, using "tissue 
cultures" of lichens, we can decrease the number of lichens that are removed from their 




















globin acid + -         
connorsticic 
acid - +         
cryptostictic 
acid - +         
methyl 
lecanorate   - - - - - - + + 
norstictic acid + +         
protocetraric 
acid   + + + + - - - - 
salazanic acid   + - + - - - - - 
usnic acid + + + + + + - - - - 
fumaroprotocetr
aric acid + -         
evernic acid   + - + - - - - - 
tridepsides 
methyl 
gyrophorate   - - - - + + + + 
tenuiorin   - - - - + + + + 
triterpenoids 
dolichorrhizin   - - - - + - - - 
zeorin   - - - - + - - - 
phlebeic acid   - - - - - - + - 
Table 4. Comparison of lichen compound production by "tissue cultures", resynthesized 
thalli, and natural thalli, from: Ahmadjian & Jacobs, 1983; Yamamoto et al., 1985; Yoshimura 
& Yamamoto, 1991. Note: +, compound present; -, compound not found; t, compound 
extract from natural thallus; c, from resynthesized thallus; c, from "tissue culture". 
The expediency of using lichen "tissue cultures" for obtaining biologically active compounds 
is also supported by the fact that their methanol and acetone extracts demonstrate a levels of 
superoxide dismutase activity, and have antibacterial (against Gram-positive bacteria:  
Fig. 6) and antiviral (when EBV test system is used: Fig. 7) effects (Yamamoto et al., 1993; 
Yamamoto et al., 1995). 
The degrees of antibacterial and antiviral activities strongly vary between different lichens, 
even among species of the same genus (Fig. 7). In most cases, the inhibitory action of 
extracts of natural thalli is higher than that of "tissue culture" extracts; there are, however, 
some exceptions: laboratory extracts of Cladia aggregata and Evernia prunastri displayed 
higher levels of activity than extracts of their natural thalli. Interestingly, "tissue cultures" of 
lichens of the genera Cetraria, Evernia and Cladonia, the extracts of which demonstrated 
considerable levels of antiviral activity, had no antibacterial effect. 
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Fig. 6. Antiviral activity of extracts from thalli and "tissue cultures" of lichens (on the base: 
Yamamoto et al., 1993, 1995). ЕВV test system was used. RI, ratio of CV in experiments with 
particular lichen extract and CV in control samples; СV(сеll viabilility), percentage of 
surviving cells 48 hours after the start of the experiment. 
On the other hand, "tissue cultures" of lichens of the genera Usnea, Umbilicaria and Ramalina, 
which strongly inhibited the growth of Gram-positive bacteria, poorly inhibited viral 
growth in a EBV test system (Fig. 7). One exception was the "tissue culture" of Cladia 
aggregata, which demonstrated considerable activity in both cases. 
 
Fig. 7. Antibacterial effect of extracts from thalli and "tissue cultures" of lichens (on the base: 
Yamamoto et al., 1993). Antibacterial activity (АА) is given in relative units. Tests were 
performed on the species Propionibacterium acnes, Staphylococcus aureus, Bacillus subtilis.  
Interestingly, the concentration of lichen compounds in reconstructed lichen thalli is often 
higher than in nature; Ahmadjian and Jacobs (1985) explain this by the more favourable 
conditions for lichen development formed in the course of resynthesis. It is noteworthy that 
producing artificial associations, with symbiont combinations not found in nature, can be used 
as a promising source of new antibiotic compounds. The possibility of this application is 
demonstrated by the two novel compounds, not typical of this species in nature, found in the 
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of this approach for producing lichen compounds is currently restricted by the low rate of the 
system's growth, surmountable in the future by optimizing cultivation methods. 
A special place among the problems of current lichenology is occupied by the conservation 
of rare lichen species and their re-introduction into the natural environment. The above-
described experimental approaches can be used, among other purposes, for solving these 
problems. Methods of rare species gene pool conservation in collections and cryobanks are 
well-developed for higher plants (Street, 1977; Butenko, 1999). Some authors (Tolpysheva, 
1998) believe that it would be useful to apply this experience to lichens as well. 
6. Conclusion 
Among experimental approaches in lichenology, two groups of methods can be recognized: 
lichen resynthesis and cultivation. The former approach helped to find the answers to many 
questions of lichen biology, but currently it faces a number of insoluble problems (e.g., the 
failure of attempts to produce mature spores in sporocarps), due to which the number of 
studies on lichen reconstruction has considerably decreased (Ahmadjian, 1990). The latter 
approach is promising for introducing lichens into the field of biotechnological developments. 
However, this is largely hindered by the low yield of lichen biomass in the course of 
cultivation. Two principal causes of this can be named: the considerable level of infection with 
fungi and bacteria (Yamamoto et. al, 2004) and the insufficiently quick growth of the culture of 
the lichen itself. The solution to the problem of "explant" infection with contaminant species 
may be found in surface sterilization of lichens, similar to that used in plant physiology 
(Smirnov & Lobakova, 2007). The solution to the problem of culture growth acceleration may 
be found in conditioning the media with secondary metabolites of various origins. The 
analysed literature contained no mentions of using "nurse cultures", a method widely used in 
plant physiology, considerably increasing the rate of growth in cultures (Street, 1977; Butenko, 
1999; Butenko et al., 1987). At the same time, a number of authors have shown that secondary 
metabolites, both of associated fungi and algae, extracted from lichens (Vainshtein, 1988), and 
of accompanying fungi and algae (Ahmadjian, 1989), can accelerate growth in cultures of 
isolated symbionts, both mycobionts and phycobionts. Another way of accelerating the 
growth of cultures, both of the symbionts and of the lichen as a whole, may be found in using 
suspension cultures. Conditioning of media and suspension cultures can also be useful in the 
first group of experimental approaches, especially in producing model associations based on 
lichen photobionts (according to the literature, in most cases it was the mycobiont that served 
as the basis for novel associations). 
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(Smirnov & Lobakova, 2007). The solution to the problem of culture growth acceleration may 
be found in conditioning the media with secondary metabolites of various origins. The 
analysed literature contained no mentions of using "nurse cultures", a method widely used in 
plant physiology, considerably increasing the rate of growth in cultures (Street, 1977; Butenko, 
1999; Butenko et al., 1987). At the same time, a number of authors have shown that secondary 
metabolites, both of associated fungi and algae, extracted from lichens (Vainshtein, 1988), and 
of accompanying fungi and algae (Ahmadjian, 1989), can accelerate growth in cultures of 
isolated symbionts, both mycobionts and phycobionts. Another way of accelerating the 
growth of cultures, both of the symbionts and of the lichen as a whole, may be found in using 
suspension cultures. Conditioning of media and suspension cultures can also be useful in the 
first group of experimental approaches, especially in producing model associations based on 
lichen photobionts (according to the literature, in most cases it was the mycobiont that served 
as the basis for novel associations). 
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